ss_tp,ss_tx_d,ss_sbclllr_frctn,chmbl_d,ss_rgnsm,dscrptn,vrnt_d,dc_d,rltnshp_tp,cll_d,crtd_b,ss_ctgr,ss_strn,ss_tss,tss_d,ss_cll_tp,src_d,cnfdnc_scr,src_ss_d,b_frmt,ss_d,ss_tst_tp,td
A,10116.0,,CHEMBL618647,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7524,In vivo,50597
A,10116.0,,CHEMBL618648,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7525,In vivo,50597
A,10116.0,,CHEMBL618649,Rattus norvegicus,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7526,In vivo,50597
A,10116.0,,CHEMBL618650,Rattus norvegicus,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7527,In vivo,50597
A,10116.0,,CHEMBL618651,Rattus norvegicus,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7528,In vivo,50597
A,10116.0,,CHEMBL876497,Rattus norvegicus,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7529,In vivo,50597
A,10116.0,,CHEMBL618652,Rattus norvegicus,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7530,In vivo,50597
A,10116.0,,CHEMBL618653,Rattus norvegicus,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,,9866,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7531,In vivo,50597
A,10116.0,,CHEMBL618654,Rattus norvegicus,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7532,In vivo,50597
A,10116.0,,CHEMBL618655,Rattus norvegicus,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,,6351,N,,Intermediate,,,,,,1,1,,BAO_0000218,7533,,50597
A,10116.0,,CHEMBL618656,Rattus norvegicus,Compound was tested for solubility in water,,1465,N,,Intermediate,,,,,,1,1,,BAO_0000218,7534,,50597
P,,,CHEMBL618657,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,5182,U,,Intermediate,,,,,,1,0,,BAO_0000100,7535,,22229
A,10116.0,,CHEMBL618658,Rattus norvegicus,Solubility was determined,,17847,N,,Intermediate,,,,,,1,1,,BAO_0000218,7536,,50597
A,10116.0,,CHEMBL618659,Rattus norvegicus,solubility in water (ug/mL) at 37 degree C.,,15339,N,,Intermediate,,,,,,1,1,,BAO_0000218,7537,,50597
A,10116.0,,CHEMBL618660,Rattus norvegicus,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,,5202,N,,Intermediate,,,,,,1,1,,BAO_0000218,7538,,50597
A,10116.0,,CHEMBL618661,Rattus norvegicus,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,,1088,N,,Intermediate,,,,,,1,1,,BAO_0000218,7539,,50597
A,10116.0,,CHEMBL873807,Rattus norvegicus,Half life in rats,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7540,,50597
A,10116.0,,CHEMBL618662,Rattus norvegicus,Half life in Dawley rat,,5353,N,,Intermediate,,,,,,1,1,,BAO_0000218,7541,,50597
A,10116.0,,CHEMBL618663,Rattus norvegicus,Half life period after 3 mg/kg iv administration,,2864,N,,Intermediate,,,,,,1,1,,BAO_0000218,7542,In vivo,50597
A,10116.0,,CHEMBL618664,Rattus norvegicus,Half life period after 3 mg/kg iv administration in rat,,2864,N,,Intermediate,,,,,,1,1,,BAO_0000218,7543,In vivo,50597
A,10116.0,,CHEMBL618665,Rattus norvegicus,Half life period after 3 mg/kg iv administration in the rat,,2864,N,,Intermediate,,,,,,1,1,,BAO_0000218,7544,In vivo,50597
A,10116.0,,CHEMBL876498,Rattus norvegicus,Half life period in female Sprague-Dawley rats,,6362,N,,Intermediate,,,,,,1,1,,BAO_0000218,7545,,50597
A,10116.0,,CHEMBL618666,Rattus norvegicus,Half life period in rat,,6249,N,,Intermediate,,,,,,1,1,,BAO_0000218,7546,,50597
A,10116.0,,CHEMBL620440,Rattus norvegicus,Half-life in rats was determined,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7547,,50597
A,10116.0,,CHEMBL620441,Rattus norvegicus,Half-life in rats with metabolic oxidation,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7548,,50597
A,10116.0,,CHEMBL620442,Rattus norvegicus,Half-life in rats,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7549,,50597
A,10116.0,,CHEMBL620443,Rattus norvegicus,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7550,In vivo,50597
A,10116.0,,CHEMBL620444,Rattus norvegicus,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7551,In vivo,50597
A,10116.0,,CHEMBL620445,Rattus norvegicus,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7552,In vivo,50597
A,10116.0,,CHEMBL620446,Rattus norvegicus,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7553,In vivo,50597
A,10116.0,,CHEMBL620447,Rattus norvegicus,Biological half-life measured in plasma of rat,,2879,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7554,,50597
A,10116.0,,CHEMBL621129,Rattus norvegicus,Biological half-life measured in plasma of rat; 22-25,,2879,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7555,,50597
A,10116.0,,CHEMBL621130,Rattus norvegicus,Biological half-life measured in plasma of rat; 9-16,,2879,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7556,,50597
A,10116.0,,CHEMBL873808,Rattus norvegicus,Compound was evaluated for its half life when administered intravenously in rat,,3184,N,,Intermediate,,,,,,1,1,,BAO_0000218,7557,In vivo,50597
A,10116.0,,CHEMBL876598,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,,4891,N,,Intermediate,,,,,,1,1,,BAO_0000218,7558,In vivo,50597
A,10116.0,,CHEMBL621131,Rattus norvegicus,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,7559,In vivo,50597
A,10116.0,,CHEMBL621132,Rattus norvegicus,Half life (T1/2) after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,7560,In vivo,50597
A,10116.0,,CHEMBL621133,Rattus norvegicus,Half life of compound after iv administration of 20 mg/kg dose in rat,,4413,N,,Intermediate,,,,,,1,1,,BAO_0000218,7561,In vivo,50597
A,10116.0,,CHEMBL621312,Rattus norvegicus,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,7562,In vivo,50597
A,10116.0,,CHEMBL621313,Rattus norvegicus,Half life of compound was determined in rat,,17267,N,,Intermediate,,,,,,1,1,,BAO_0000218,7563,,50597
A,10116.0,,CHEMBL621314,Rattus norvegicus,Half life of compound was determined in rat blood,,4727,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7564,,50597
A,10116.0,,CHEMBL621315,Rattus norvegicus,Half life at 1 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,7565,In vivo,50597
A,10116.0,,CHEMBL621316,Rattus norvegicus,Half life at 10 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,7566,In vivo,50597
A,10116.0,,CHEMBL621317,Rattus norvegicus,Half life in rats,,401,N,,Intermediate,,,,,,1,1,,BAO_0000218,7567,,50597
A,10116.0,,CHEMBL621318,Rattus norvegicus,Half life in rats in hours,,4942,N,,Intermediate,,,,,,1,1,,BAO_0000218,7568,,50597
A,10116.0,,CHEMBL621319,Rattus norvegicus,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,17735,N,,Intermediate,,,,,,1,1,,BAO_0000218,7569,In vivo,50597
A,10116.0,,CHEMBL621377,Rattus norvegicus,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,,6056,N,,Intermediate,,,,,,1,1,,BAO_0000218,7570,In vivo,50597
A,10116.0,,CHEMBL621378,Rattus norvegicus,Half life was determined,,5213,N,,Intermediate,,,,,,1,1,,BAO_0000218,7571,,50597
A,10116.0,,CHEMBL876599,Rattus norvegicus,Half life after i.v. administration,,6616,N,,Intermediate,,,,,,1,1,,BAO_0000218,7572,In vivo,50597
A,10116.0,,CHEMBL621379,Rattus norvegicus,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,,5937,N,,Intermediate,,,,,,1,1,,BAO_0000218,7573,In vivo,50597
A,10116.0,,CHEMBL621380,Rattus norvegicus,Half life in rat plasma,,5819,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7574,,50597
A,10116.0,,CHEMBL621381,Rattus norvegicus,Half life in rat plasma; Not detected,,5819,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7575,,50597
A,10116.0,,CHEMBL618515,Rattus norvegicus,Half life in rats,,6803,N,,Intermediate,,,,,,1,1,,BAO_0000218,7576,,50597
A,10116.0,,CHEMBL618516,Rattus norvegicus,Half life period of compound was determined after peroral administration,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,7577,In vivo,50597
A,10116.0,,CHEMBL618517,Rattus norvegicus,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,7578,In vivo,50597
A,10116.0,,CHEMBL618518,Rattus norvegicus,Half life period in rat,,5948,N,,Intermediate,,,,,,1,1,,BAO_0000218,7579,,50597
A,10116.0,,CHEMBL618519,Rattus norvegicus,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,7580,In vivo,50597
A,10116.0,,CHEMBL618698,Rattus norvegicus,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,7581,In vivo,50597
A,10116.0,,CHEMBL618862,Rattus norvegicus,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,7582,In vivo,50597
A,10116.0,,CHEMBL618863,Rattus norvegicus,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,7583,In vivo,50597
A,10116.0,,CHEMBL618864,Rattus norvegicus,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,7584,In vivo,50597
A,10116.0,,CHEMBL618865,Rattus norvegicus,Half life time in rat the dose of 2 mg/kg,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,7585,In vivo,50597
A,10116.0,,CHEMBL618866,Rattus norvegicus,Half-life 24 hr after 10 mg/kg iv administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,7586,In vivo,50597
A,10116.0,,CHEMBL618867,Rattus norvegicus,Half-life 24 hr after 2 mg/kg iv administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,7587,In vivo,50597
A,10116.0,,CHEMBL875828,Rattus norvegicus,Half-life consistent with the observed metabolic steady state in rats,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,7588,,50597
A,10116.0,,CHEMBL618868,Rattus norvegicus,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,17735,N,,Intermediate,,,,,,1,1,,BAO_0000218,7589,In vivo,50597
A,10116.0,,CHEMBL618869,Rattus norvegicus,Half-life for oxidative metabolic stability was determined using male human,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,7590,,50597
A,10116.0,,CHEMBL618870,Rattus norvegicus,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",,17670,N,,Intermediate,,,,,,1,1,,BAO_0000218,7591,In vivo,50597
A,10116.0,,CHEMBL618871,Rattus norvegicus,Half-life in rat plasma,,1696,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7592,,50597
A,10116.0,,CHEMBL618872,Rattus norvegicus,Half-life in rat plasma was determined,,1742,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7593,,50597
A,10116.0,,CHEMBL873816,Rattus norvegicus,Half-life in rats was determined,,17800,N,,Intermediate,,,,,,1,1,,BAO_0000218,7594,,50597
A,,,CHEMBL618873,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,12923,U,,Autocuration,,,,,,1,0,,BAO_0000218,7595,,22224
A,,,CHEMBL621602,,Area under curve after oral dose of 0.1 mg//kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000019,7596,,22224
A,,,CHEMBL621603,,Area under curve after oral dose of 0.3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7597,,22224
A,,,CHEMBL621604,,Area under curve after oral dose of 1 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7598,,22224
A,,,CHEMBL621605,,Area under curve after oral dose of 10 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7599,,22224
A,,,CHEMBL621606,,Area under curve after oral dose of 23.4 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7600,,22224
A,,,CHEMBL621607,,Area under curve after oral dose of 3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7601,,22224
A,,,CHEMBL621608,,Area under curve after oral dose of 3.87 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,7602,,22224
A,,,CHEMBL621609,,Area under curve was determined,,5237,U,,Autocuration,,,,,,1,0,,BAO_0000019,7603,,22224
A,,,CHEMBL621610,,Area under curve at a dose of 10 mg/kg,,4026,U,,Autocuration,,,,,,1,0,,BAO_0000218,7604,,22224
A,10116.0,,CHEMBL621611,Rattus norvegicus,Area under curve was determined; ND=No data,,5237,N,,Intermediate,,,,,,1,1,,BAO_0000218,7605,,50597
A,10116.0,,CHEMBL621612,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7606,,50597
A,10116.0,,CHEMBL622308,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7607,,50597
A,10116.0,,CHEMBL622309,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7608,,50597
A,10116.0,,CHEMBL622310,Rattus norvegicus,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7609,,50597
A,10116.0,,CHEMBL622311,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7610,,50597
A,10116.0,,CHEMBL622312,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7611,,50597
A,10116.0,,CHEMBL622931,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7612,,50597
A,10116.0,,CHEMBL622932,Rattus norvegicus,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,7613,,50597
A,10116.0,,CHEMBL622736,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7614,,50597
A,10116.0,,CHEMBL622737,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7615,,50597
A,10116.0,,CHEMBL622738,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7616,,50597
A,10116.0,,CHEMBL622739,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7617,,50597
A,10116.0,,CHEMBL622740,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7618,,50597
A,10116.0,,CHEMBL622741,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7619,,50597
A,10116.0,,CHEMBL622742,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7620,,50597
A,10116.0,,CHEMBL622743,Rattus norvegicus,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7621,,50597
A,10090.0,,CHEMBL622744,Mus musculus,AUC in mice,,11637,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7622,,50594
A,,,CHEMBL624134,,Area under curve was measured from the graph obtained from concentration Vs time,,11149,U,,Autocuration,,,,,,1,0,,BAO_0000019,7623,,22224
A,,,CHEMBL624135,,Area under curve value of compound per hour after oral administration,,10016,U,,Autocuration,,,,,,1,0,,BAO_0000019,7624,,22224
A,10116.0,,CHEMBL624136,Rattus norvegicus,Area under curve was determined after oral administration in rats,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,7625,,50597
A,10116.0,,CHEMBL624137,Rattus norvegicus,Area under curve was determined after oral administration in rats; No data,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,7626,,50597
A,10116.0,,CHEMBL624320,Rattus norvegicus,Area under curve was determined after oral administration in rats;No data,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,7627,,50597
A,9615.0,,CHEMBL624321,Canis lupus familiaris,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,12923,N,,Intermediate,,,,,,1,1,,BAO_0000218,7628,,50588
A,10116.0,,CHEMBL624322,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7629,,50597
A,10116.0,,CHEMBL624323,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 5.06 in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7630,,50597
A,10116.0,,CHEMBL624324,Rattus norvegicus,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7631,,50597
A,10116.0,,CHEMBL624325,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7632,,50597
A,10116.0,,CHEMBL624326,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7633,,50597
A,10116.0,,CHEMBL624327,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7634,,50597
A,10116.0,,CHEMBL624328,Rattus norvegicus,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,7635,,50597
A,9615.0,,CHEMBL627848,Canis lupus familiaris,Area under curve was determined in Dogs after peroral administration,,14169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7636,,50588
A,10116.0,,CHEMBL627849,Rattus norvegicus,Area under curve was determined in Rats after peroral administration,,14169,N,,Intermediate,,,,,,1,1,,BAO_0000218,7637,,50597
A,10116.0,,CHEMBL627850,Rattus norvegicus,Area under curve was determined in carotid blood of rat when administered intradermally,,14258,N,,Intermediate,,,,,,1,1,,BAO_0000218,7638,,50597
A,10116.0,,CHEMBL627851,Rattus norvegicus,Area under curve was determined in portal blood of rat when administered intradermally,,14258,N,,Intermediate,,,,,,1,1,,BAO_0000218,7639,,50597
A,10090.0,,CHEMBL627852,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7640,,50594
A,10090.0,,CHEMBL627853,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7641,,50594
A,10090.0,,CHEMBL627854,Mus musculus,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7642,,50594
A,10090.0,,CHEMBL627855,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7643,,50594
A,10090.0,,CHEMBL627856,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7644,,50594
A,10090.0,,CHEMBL875339,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7645,,50594
A,10090.0,,CHEMBL627857,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7646,,50594
A,10116.0,,CHEMBL627858,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,,11195,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7647,In vivo,50597
A,10116.0,,CHEMBL627859,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7648,,50597
A,10116.0,,CHEMBL627860,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,7649,,50597
A,10116.0,,CHEMBL627019,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7650,,50597
A,10116.0,,CHEMBL627020,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7651,,50597
A,10116.0,,CHEMBL627021,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7652,,50597
A,10116.0,,CHEMBL627022,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7653,,50597
A,10116.0,,CHEMBL627023,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,7654,,50597
A,10116.0,,CHEMBL627024,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7655,,50597
A,10116.0,,CHEMBL627025,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,7656,,50597
A,10116.0,,CHEMBL627026,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7657,,50597
A,10116.0,,CHEMBL627027,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7658,,50597
A,10116.0,,CHEMBL627028,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,7659,,50597
A,10116.0,,CHEMBL627029,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7660,,50597
A,10116.0,,CHEMBL627030,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7661,,50597
A,10116.0,,CHEMBL627031,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7662,,50597
A,10116.0,,CHEMBL627032,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7663,,50597
A,10116.0,,CHEMBL627033,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7664,,50597
A,10116.0,,CHEMBL627034,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,7665,,50597
A,10116.0,,CHEMBL627035,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7666,,50597
A,10116.0,,CHEMBL627036,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,7667,,50597
A,10116.0,,CHEMBL875340,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7668,,50597
A,10116.0,,CHEMBL627037,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7669,,50597
A,10116.0,,CHEMBL627038,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7670,,50597
A,10116.0,,CHEMBL627039,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7671,,50597
A,10116.0,,CHEMBL627040,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7672,,50597
A,10116.0,,CHEMBL624663,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7673,,50597
A,10116.0,,CHEMBL625963,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,7674,,50597
A,10116.0,,CHEMBL876799,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,7675,,50597
A,10116.0,,CHEMBL626133,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,,10130,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,7676,,50597
A,10116.0,,CHEMBL626134,Rattus norvegicus,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,7677,,50597
A,10116.0,,CHEMBL626135,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,6295,N,,Intermediate,,,,,,1,1,,BAO_0000218,7678,,50597
A,10116.0,,CHEMBL626136,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,,6296,N,,Intermediate,,,,,,1,1,,BAO_0000218,7679,,50597
A,10116.0,,CHEMBL626137,Rattus norvegicus,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,,6296,N,,Intermediate,,,,,,1,1,,BAO_0000218,7680,,50597
A,10116.0,,CHEMBL626138,Rattus norvegicus,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,6295,N,,Intermediate,,,,,,1,1,,BAO_0000218,7681,,50597
A,10116.0,,CHEMBL626139,Rattus norvegicus,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,,6296,N,,Intermediate,,,,,,1,1,,BAO_0000218,7682,,50597
A,10116.0,,CHEMBL626140,Rattus norvegicus,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7683,In vivo,50597
A,10116.0,,CHEMBL626141,Rattus norvegicus,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7684,In vivo,50597
A,10116.0,,CHEMBL626142,Rattus norvegicus,C24h in rat p.o. at 20 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,7685,,50597
A,10116.0,,CHEMBL627930,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7686,In vivo,50597
A,10116.0,,CHEMBL627931,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7687,In vivo,50597
A,10116.0,,CHEMBL627932,Rattus norvegicus,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,7688,In vivo,50597
A,10116.0,,CHEMBL627933,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7689,In vivo,50597
A,10116.0,,CHEMBL627934,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7690,In vivo,50597
A,10116.0,,CHEMBL627935,Rattus norvegicus,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,7691,In vivo,50597
A,10116.0,,CHEMBL627936,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7692,In vivo,50597
A,10116.0,,CHEMBL627937,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7693,In vivo,50597
A,10116.0,,CHEMBL627938,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7694,In vivo,50597
A,10116.0,,CHEMBL627939,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7695,In vivo,50597
A,10116.0,,CHEMBL627940,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7696,In vivo,50597
A,10116.0,,CHEMBL627941,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7697,In vivo,50597
A,10116.0,,CHEMBL876800,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7698,In vivo,50597
A,10116.0,,CHEMBL627942,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7699,In vivo,50597
A,10116.0,,CHEMBL627943,Rattus norvegicus,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7700,In vivo,50597
A,10116.0,,CHEMBL627944,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7701,In vivo,50597
A,10116.0,,CHEMBL627945,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7702,In vivo,50597
A,10116.0,,CHEMBL628584,Rattus norvegicus,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7703,In vivo,50597
A,10116.0,,CHEMBL628585,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 15 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7704,In vivo,50597
A,10116.0,,CHEMBL628586,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7705,In vivo,50597
A,10116.0,,CHEMBL628587,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 30 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7706,In vivo,50597
A,10116.0,,CHEMBL628588,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7707,In vivo,50597
A,10116.0,,CHEMBL628589,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7708,In vivo,50597
A,10116.0,,CHEMBL625304,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7709,In vivo,50597
A,10116.0,,CHEMBL625305,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7710,In vivo,50597
A,10116.0,,CHEMBL625306,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7711,In vivo,50597
A,10116.0,,CHEMBL625307,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7712,In vivo,50597
A,10116.0,,CHEMBL625308,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7713,In vivo,50597
A,10116.0,,CHEMBL627740,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7714,In vivo,50597
A,10116.0,,CHEMBL627741,Rattus norvegicus,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7715,In vivo,50597
A,10116.0,,CHEMBL627742,Rattus norvegicus,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7716,In vivo,50597
A,10116.0,,CHEMBL627743,Rattus norvegicus,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7717,In vivo,50597
A,10116.0,,CHEMBL627744,Rattus norvegicus,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,7718,In vivo,50597
A,10116.0,,CHEMBL627745,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7719,In vivo,50597
A,10116.0,,CHEMBL627746,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7720,In vivo,50597
A,10116.0,,CHEMBL627747,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7721,In vivo,50597
A,10116.0,,CHEMBL876810,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7722,In vivo,50597
A,10116.0,,CHEMBL627748,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7723,In vivo,50597
A,10116.0,,CHEMBL627749,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7724,In vivo,50597
A,10116.0,,CHEMBL627750,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7725,In vivo,50597
A,10116.0,,CHEMBL618728,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7726,In vivo,50597
A,10116.0,,CHEMBL618729,Rattus norvegicus,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7727,In vivo,50597
A,10116.0,,CHEMBL618730,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 15 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7728,In vivo,50597
A,10116.0,,CHEMBL618731,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7729,In vivo,50597
A,10116.0,,CHEMBL618732,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 30 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7730,In vivo,50597
A,10116.0,,CHEMBL618733,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7731,In vivo,50597
A,10116.0,,CHEMBL618734,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7732,In vivo,50597
A,10116.0,,CHEMBL618735,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7733,In vivo,50597
A,10116.0,,CHEMBL876602,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7734,In vivo,50597
A,10116.0,,CHEMBL618736,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7735,In vivo,50597
A,10116.0,,CHEMBL618737,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7736,In vivo,50597
A,10116.0,,CHEMBL618738,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7737,In vivo,50597
A,10116.0,,CHEMBL618739,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7738,In vivo,50597
A,10116.0,,CHEMBL618740,Rattus norvegicus,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7739,In vivo,50597
A,10116.0,,CHEMBL618741,Rattus norvegicus,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7740,In vivo,50597
A,10116.0,,CHEMBL618742,Rattus norvegicus,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7741,In vivo,50597
A,10116.0,,CHEMBL618743,Rattus norvegicus,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,7742,In vivo,50597
A,10116.0,,CHEMBL618744,Rattus norvegicus,Half-life from rat plasma at a single oral dose of 25 mg/kg,,17752,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7743,In vivo,50597
A,10116.0,,CHEMBL618745,Rattus norvegicus,Half-life in male rat,,5610,N,,Intermediate,,,,,,1,1,,BAO_0000218,7744,,50597
A,10116.0,,CHEMBL620479,Rattus norvegicus,Half-life in rat after peroral administration at 10 mg/kg concentration,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,7745,In vivo,50597
A,10116.0,,CHEMBL620480,Rattus norvegicus,Half-life in rat after peroral administration at 5 mg/kg concentration,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,7746,In vivo,50597
A,10116.0,,CHEMBL620481,Rattus norvegicus,Half-life in rat at a dose of 3 mg/kg,,17771,N,,Intermediate,,,,,,1,1,,BAO_0000218,7747,In vivo,50597
A,10116.0,,CHEMBL620482,Rattus norvegicus,Half-life was evaluated in rats,,1974,N,,Intermediate,,,,,,1,1,,BAO_0000218,7748,,50597
A,10116.0,,CHEMBL876603,Rattus norvegicus,Half-life was measured in rat,,4239,N,,Intermediate,,,,,,1,1,,BAO_0000218,7749,,50597
A,10116.0,,CHEMBL620483,Rattus norvegicus,Half-life period for the compound was determined in rats at 50 mg/kg dose,,6681,N,,Intermediate,,,,,,1,1,,BAO_0000218,7750,In vivo,50597
A,10116.0,,CHEMBL620484,Rattus norvegicus,Half-life period in rats after intravenous administration at 5 mg/kg,,17752,N,,Intermediate,,,,,,1,1,,BAO_0000218,7751,In vivo,50597
A,10116.0,,CHEMBL620485,Rattus norvegicus,Half-life period in rat at 10 mg/kg,,6046,N,,Intermediate,,,,,,1,1,,BAO_0000218,7752,In vivo,50597
A,10116.0,,CHEMBL620486,Rattus norvegicus,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,7753,In vivo,50597
A,10116.0,,CHEMBL620487,Rattus norvegicus,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,7754,In vivo,50597
A,10116.0,,CHEMBL620488,Rattus norvegicus,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,7755,In vivo,50597
A,10116.0,,CHEMBL620489,Rattus norvegicus,Half-life time in rat the dose of 2 mg/kg,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,7756,In vivo,50597
A,10116.0,,CHEMBL620490,Rattus norvegicus,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,,1088,N,,Intermediate,,,,,,1,1,,BAO_0000218,7757,In vivo,50597
A,10116.0,,CHEMBL620491,Rattus norvegicus,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,,5610,N,,Intermediate,,,,,,1,1,,BAO_0000218,7758,In vivo,50597
A,10116.0,,CHEMBL876604,Rattus norvegicus,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,3032,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7759,In vivo,50597
A,10116.0,,CHEMBL620492,Rattus norvegicus,Oral half life was determined,,5199,N,,Intermediate,,,,,,1,1,,BAO_0000218,7760,In vivo,50597
A,10116.0,,CHEMBL620493,Rattus norvegicus,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,7761,In vivo,50597
A,10116.0,,CHEMBL620494,Rattus norvegicus,Pharmacokinetic property (t1/2) in rat,,4408,N,,Intermediate,,,,,,1,1,,BAO_0000218,7762,In vivo,50597
A,10116.0,,CHEMBL620495,Rattus norvegicus,Plasma elimination half-life was determined,,2552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7763,,50597
A,10116.0,,CHEMBL620496,Rattus norvegicus,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,5199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7764,In vivo,50597
A,10116.0,,CHEMBL620497,Rattus norvegicus,Plasma half life was observed after intravenous administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7765,In vivo,50597
A,10116.0,,CHEMBL620498,Rattus norvegicus,Plasma half-life was determined,,1465,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7766,,50597
A,10116.0,,CHEMBL620499,Rattus norvegicus,Plasma half-life following oral administration in Fisher rats,,1446,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7767,In vivo,50597
A,10116.0,,CHEMBL620500,Rattus norvegicus,Plasma half-life in rat,,6824,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7768,,50597
A,10116.0,,CHEMBL873809,Rattus norvegicus,Plasmatic Half-life after intravenous administration to rat,,17533,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7769,In vivo,50597
A,10116.0,,CHEMBL620501,Rattus norvegicus,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,5979,N,,Intermediate,,,,,,1,1,,BAO_0000218,7770,In vivo,50597
A,10116.0,,CHEMBL620502,Rattus norvegicus,Terminal half life after intravenous administration (1 mg/kg) in rat,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,7771,In vivo,50597
A,10116.0,,CHEMBL620503,Rattus norvegicus,Terminal half life in Rat at a oral dose of 5 mg/kg,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,7772,In vivo,50597
A,10116.0,,CHEMBL620504,Rattus norvegicus,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,2463,N,,Intermediate,,,,,,1,1,,BAO_0000218,7773,In vivo,50597
A,10116.0,,CHEMBL876605,Rattus norvegicus,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,7774,In vivo,50597
A,10116.0,,CHEMBL620505,Rattus norvegicus,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,7775,In vivo,50597
A,10116.0,,CHEMBL873811,Rattus norvegicus,plasma half life was observed after intravenous administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7776,In vivo,50597
A,10116.0,,CHEMBL624016,Rattus norvegicus,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,7777,In vivo,50597
A,10116.0,,CHEMBL624017,Rattus norvegicus,Half life of compound determined in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,7778,,50597
A,10116.0,,CHEMBL624018,Rattus norvegicus,Mean residence time determined in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,7779,,50597
A,10116.0,,CHEMBL624019,Rattus norvegicus,Plasma half life determined in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,7780,,50597
A,10116.0,,CHEMBL624020,Rattus norvegicus,Compound was evaluated for Tmax in brain after intravenous administration in male rats,,4910,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,7781,In vivo,50597
A,10116.0,,CHEMBL624201,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter maximum time period,,4891,N,,Intermediate,,,,,,1,1,,BAO_0000218,7782,In vivo,50597
A,10116.0,,CHEMBL872528,Rattus norvegicus,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,7783,In vivo,50597
A,10116.0,,CHEMBL624202,Rattus norvegicus,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,7784,In vivo,50597
A,10116.0,,CHEMBL624203,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,7785,In vivo,50597
A,10116.0,,CHEMBL624350,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,7786,In vivo,50597
A,10116.0,,CHEMBL621320,Rattus norvegicus,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,7787,In vivo,50597
A,10116.0,,CHEMBL621321,Rattus norvegicus,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,7788,In vivo,50597
A,10116.0,,CHEMBL621322,Rattus norvegicus,Maximum time (Tmax) required to reach Cmax in rats,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,7789,,50597
A,10116.0,,CHEMBL621323,Rattus norvegicus,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,7790,In vivo,50597
A,10116.0,,CHEMBL621324,Rattus norvegicus,Maximum time of clearance of compound in rats after peroral administration,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,7791,In vivo,50597
A,10116.0,,CHEMBL621325,Rattus norvegicus,Maximum time at the dose of 2 mg/kg in rat,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,7792,,50597
A,10116.0,,CHEMBL875837,Rattus norvegicus,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,,17651,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7793,In vivo,50597
A,10116.0,,CHEMBL621326,Rattus norvegicus,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,,17651,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7794,In vivo,50597
A,10116.0,,CHEMBL621327,Rattus norvegicus,Tmax in Guinea pig (PO dose),,14465,N,,Intermediate,,,,,,1,1,,BAO_0000218,7795,In vivo,50597
A,10116.0,,CHEMBL621328,Rattus norvegicus,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,7796,In vivo,50597
A,10116.0,,CHEMBL621329,Rattus norvegicus,Pharmacokinetic parameter (Tmax) in rat,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,7797,In vivo,50597
A,10116.0,,CHEMBL621330,Rattus norvegicus,Pharmacokinetic parameter (Tmax) was estimated,,5022,N,,Intermediate,,,,,,1,1,,BAO_0000218,7798,In vivo,50597
A,10116.0,,CHEMBL621331,Rattus norvegicus,Pharmacokinetic property (Tmax) in rat,,4408,N,,Intermediate,,,,,,1,1,,BAO_0000218,7799,In vivo,50597
A,10116.0,,CHEMBL621332,Rattus norvegicus,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,7800,In vivo,50597
A,10116.0,,CHEMBL621333,Rattus norvegicus,T max in Rat at a oral dose of 5 mg/kg,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,7801,In vivo,50597
A,10116.0,,CHEMBL621334,Rattus norvegicus,T max was determined at 10 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,7802,In vivo,50597
A,10090.0,,CHEMBL621335,Mus musculus,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,7803,,50594
A,9615.0,,CHEMBL621336,Canis lupus familiaris,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,,14180,N,,Intermediate,,,,,,1,1,,BAO_0000218,7804,,50588
A,10116.0,,CHEMBL621337,Rattus norvegicus,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,,14180,N,,Intermediate,,,,,,1,1,,BAO_0000218,7805,,50597
A,9615.0,,CHEMBL621338,Canis lupus familiaris,Area under curve was measured after i.v. administration into Beagle dog.,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,7806,,50588
A,9615.0,,CHEMBL875838,Canis lupus familiaris,Area under curve was measured after iv administration into Beagle dog,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,7807,,50588
A,9615.0,,CHEMBL621339,Canis lupus familiaris,Area under curve was measured after po administration into Beagle dog,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,7808,,50588
A,9615.0,,CHEMBL621340,Canis lupus familiaris,Area under curve was measured after po administration into Beagle dog.,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,7809,,50588
A,,,CHEMBL621341,,Area under curve was measured at peroral dose of 3 mg/kg,,15675,U,,Autocuration,,,,,,1,0,,BAO_0000218,7810,,22224
A,,,CHEMBL621342,,Area under curve was measured by using concentration Vs time,,12706,U,,Autocuration,,,,,,1,0,,BAO_0000019,7811,,22224
A,,,CHEMBL621343,,Area under curve was measured by using concentration Vs time; not tested,,12706,U,,Autocuration,,,,,,1,0,,BAO_0000019,7812,,22224
A,10090.0,,CHEMBL621344,Mus musculus,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),,9750,N,,Intermediate,,,,,,1,1,,BAO_0000218,7813,,50594
A,10090.0,,CHEMBL621345,Mus musculus,Area under curve(AUC) was measured in mice after oral administration.,,9750,N,,Intermediate,,,,,,1,1,,BAO_0000218,7814,,50594
A,,,CHEMBL621346,,Area under curve(AUC) value of the compound,,14691,U,,Autocuration,,,,,,1,0,,BAO_0000019,7815,,22224
A,,,CHEMBL621347,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,14691,U,,Autocuration,,,,,,1,0,,BAO_0000218,7816,,22224
A,9615.0,,CHEMBL621348,Canis lupus familiaris,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,,14691,N,,Intermediate,,,,,,1,1,,BAO_0000218,7817,,50588
A,,,CHEMBL621349,,Area under curve(carotid artery) was determined by the availability in blood,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7818,,22224
A,,,CHEMBL621350,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7819,,22224
A,,,CHEMBL875839,,Area under curve(carotid artery) was determined by the availability in blood; No data,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7820,,22224
A,,,CHEMBL620211,,Area under curve(portal vein) was determined by the availability in blood,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7821,,22224
A,,,CHEMBL620212,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7822,,22224
A,,,CHEMBL620213,,Area under curve(portal vein) was determined by the availability in blood; No data,,2939,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,7823,,22224
A,9544.0,,CHEMBL620214,Macaca mulatta,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,9552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7824,,50797
A,9544.0,,CHEMBL620215,Macaca mulatta,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",,9552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7825,,50797
A,9544.0,,CHEMBL620216,Macaca mulatta,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,,9552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7826,,50797
A,9615.0,,CHEMBL620888,Canis lupus familiaris,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",,9552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7827,,50588
A,9615.0,,CHEMBL620889,Canis lupus familiaris,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",,9552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7828,,50588
A,,,CHEMBL620890,,Area under plasma concentration vs time curve observed in rats for 0-3 h,,9552,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,7829,,22224
A,10116.0,,CHEMBL620891,Rattus norvegicus,Area under plasma time curve determined in male rat,,11911,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7830,,50597
A,,,CHEMBL620892,,Area under the MAP curve measured over 5 min.,,16618,U,,Autocuration,,,,,,1,0,,BAO_0000019,7831,,22224
A,10090.0,,CHEMBL621079,Mus musculus,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,,14387,N,,Intermediate,,,,,,1,1,,BAO_0000218,7832,,50594
A,10090.0,,CHEMBL621080,Mus musculus,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,,14387,N,,Intermediate,,,,,,1,1,,BAO_0000218,7833,,50594
A,9615.0,,CHEMBL621081,Canis lupus familiaris,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,7834,,50588
A,10026.0,,CHEMBL621082,Cricetinae,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,7835,,100712
A,10116.0,,CHEMBL621083,Rattus norvegicus,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,7836,,50597
A,9615.0,,CHEMBL621084,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,,14339,N,,Intermediate,,,,,,1,1,,BAO_0000218,7837,,50588
A,9615.0,,CHEMBL621085,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,,14339,N,,Intermediate,,,,,,1,1,,BAO_0000218,7838,,50588
A,9615.0,,CHEMBL621086,Canis lupus familiaris,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,,14339,N,,Intermediate,,,,,,1,1,,BAO_0000218,7839,,50588
A,9615.0,,CHEMBL621087,Canis lupus familiaris,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,10524,N,,Intermediate,,,,,,1,1,,BAO_0000218,7840,,50588
A,9615.0,,CHEMBL622607,Canis lupus familiaris,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),,9994,N,,Intermediate,,,,,,1,1,,BAO_0000218,7841,,50588
A,9615.0,,CHEMBL622608,Canis lupus familiaris,Serum AUC in marmosets (IV dose),,11325,N,,Intermediate,,,,,,1,1,,BAO_0000218,7842,,50588
A,,,CHEMBL624481,,Area under the curve after intravenous administration at a dose of 10 umol/kg,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000019,7843,,22224
A,,,CHEMBL624482,,Area under the curve after intravenous administration at a dose of 2 umol/kg,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000019,7844,,22224
A,,,CHEMBL624483,,Area under the curve after intravenous administration at a dose of 4 umol/kg,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000019,7845,,22224
A,,,CHEMBL624484,,Area under the curve after intravenous administration at a dose of 40 umol/kg,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000019,7846,,22224
A,,,CHEMBL624485,,Area under the curve after intravenous administration at a dose of 5 umol/kg,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000019,7847,,22224
A,10116.0,,CHEMBL624486,Rattus norvegicus,Area under the curve for fumarate salt was evaluated in F344 Rats.,,15556,N,,Intermediate,,,,,,1,1,,BAO_0000218,7848,,50597
A,,,CHEMBL624487,,Area under the curve for the compound was calculated.,,2809,U,,Autocuration,,,,,,1,0,,BAO_0000019,7849,,22224
A,,,CHEMBL624488,,Area under the curve in concentration/ time,,9511,U,,Autocuration,,,,,,1,0,,BAO_0000019,7850,,22224
A,10116.0,,CHEMBL624489,Rattus norvegicus,Area under the curve administered intraintestinal in rats.,,12818,N,,Intermediate,,,,,,1,1,,BAO_0000218,7851,,50597
A,10116.0,,CHEMBL625184,Rattus norvegicus,Area under the curve administered intravenously in rats.,,12818,N,,Intermediate,,,,,,1,1,,BAO_0000218,7852,,50597
A,,,CHEMBL625185,,Area under the curve during intravenous administration,,15118,U,,Autocuration,,,,,,1,0,,BAO_0000019,7853,,22224
A,,,CHEMBL875954,,Area under the curve during intravenous administration; Not determined,,15118,U,,Autocuration,,,,,,1,0,,BAO_0000019,7854,,22224
A,,,CHEMBL625186,,Area under the curve during systemic administration,,15118,U,,Autocuration,,,,,,1,0,,BAO_0000019,7855,,22224
A,,,CHEMBL625187,,Area under the curve during systemic administration; Not determined,,15118,U,,Autocuration,,,,,,1,0,,BAO_0000019,7856,,22224
A,,,CHEMBL625188,,Area under the curve was calculated for the compound.,,2632,U,,Autocuration,,,,,,1,0,,BAO_0000019,7857,,22224
A,9615.0,,CHEMBL625189,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,7858,,50588
A,9615.0,,CHEMBL625190,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,7859,,50588
A,10116.0,,CHEMBL621733,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,7860,,50597
A,10116.0,,CHEMBL621734,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,7861,,50597
A,10116.0,,CHEMBL621735,Rattus norvegicus,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,,11149,N,,Intermediate,,,,,,1,1,,BAO_0000218,7862,,50597
A,10116.0,,CHEMBL621736,Rattus norvegicus,Clearance of the drug was measured in the plasma of rat; No data,,17796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7863,,50597
A,10116.0,,CHEMBL621737,Rattus norvegicus,The pharmacokinetic parameter plasma clearance in vivo in rats,,5247,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7864,,50597
A,10116.0,,CHEMBL621738,Rattus norvegicus,Plasma clearance at the dose of 2 mg/kg in rat,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,7865,,50597
A,10116.0,,CHEMBL622806,Rattus norvegicus,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,7866,In vivo,50597
A,10116.0,,CHEMBL623519,Rattus norvegicus,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,7867,In vivo,50597
A,10116.0,,CHEMBL623520,Rattus norvegicus,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,7868,In vivo,50597
A,10116.0,,CHEMBL623521,Rattus norvegicus,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,N,,Intermediate,,,,,,1,1,,BAO_0000218,7869,In vivo,50597
A,10116.0,,CHEMBL623522,Rattus norvegicus,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,7870,In vivo,50597
A,10116.0,,CHEMBL623523,Rattus norvegicus,Clearance rate in rat,,6672,N,,Intermediate,,,,,,1,1,,BAO_0000218,7871,In vivo,50597
A,10116.0,,CHEMBL623690,Rattus norvegicus,Clearance rate in rat,,6673,N,,Intermediate,,,,,,1,1,,BAO_0000218,7872,In vivo,50597
A,10116.0,,CHEMBL623691,Rattus norvegicus,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,7873,In vivo,50597
A,10116.0,,CHEMBL623692,Rattus norvegicus,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,7874,In vivo,50597
A,10116.0,,CHEMBL623693,Rattus norvegicus,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,7875,In vivo,50597
A,10116.0,,CHEMBL623694,Rattus norvegicus,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,7876,In vivo,50597
A,10116.0,,CHEMBL623695,Rattus norvegicus,Clearance of compound after iv administration of 20 mg/kg dose in rat,,4413,N,,Intermediate,,,,,,1,1,,BAO_0000218,7877,In vivo,50597
A,10116.0,,CHEMBL623696,Rattus norvegicus,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,7878,In vivo,50597
A,10116.0,,CHEMBL623697,Rattus norvegicus,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,7879,In vivo,50597
A,9544.0,,CHEMBL623698,Macaca mulatta,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000218,7880,In vivo,22224
A,10116.0,,CHEMBL623699,Rattus norvegicus,Compound was tested for its plasma clearance rate in Sprague Dawley rats,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000218,7881,In vivo,22224
A,10116.0,,CHEMBL623700,Rattus norvegicus,Mean (%CV) PK parameters for CL(mL/min/kg).,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,7882,In vivo,50597
A,10116.0,,CHEMBL623701,Rattus norvegicus,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,,3747,N,,Intermediate,,,,,,1,1,,BAO_0000218,7883,In vivo,50597
A,10116.0,,CHEMBL623702,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,,16366,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7884,In vivo,50597
A,10116.0,,CHEMBL623703,Rattus norvegicus,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,7885,In vivo,50597
A,10116.0,,CHEMBL623704,Rattus norvegicus,Plasma clearance in rat was determined,,17267,N,,Intermediate,,,,,,1,1,,BAO_0000218,7886,In vivo,50597
A,10116.0,,CHEMBL623705,Rattus norvegicus,Plasma clearance in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,7887,In vivo,50597
A,10116.0,,CHEMBL623706,Rattus norvegicus,Plasma clearance in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,7888,In vivo,50597
A,10116.0,,CHEMBL623707,Rattus norvegicus,Plasma clearance was determined,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,7889,In vivo,50597
A,10116.0,,CHEMBL623708,Rattus norvegicus,Plasma clearance in rat,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,7890,In vivo,50597
A,10116.0,,CHEMBL623709,Rattus norvegicus,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,,5937,N,,Intermediate,,,,,,1,1,,BAO_0000218,7891,In vivo,50597
A,10116.0,,CHEMBL623710,Rattus norvegicus,Plasma clearance in rat by iv administration,,5871,N,,Intermediate,,,,,,1,1,,BAO_0000218,7892,In vivo,50597
A,10116.0,,CHEMBL623711,Rattus norvegicus,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,7893,In vivo,50597
A,10116.0,,CHEMBL623712,Rattus norvegicus,Plasma clearance in rat p.o.,,6504,N,,Intermediate,,,,,,1,1,,BAO_0000218,7894,In vivo,50597
A,10116.0,,CHEMBL623713,Rattus norvegicus,Plasma clearance in rats,,6803,N,,Intermediate,,,,,,1,1,,BAO_0000218,7895,In vivo,50597
A,10116.0,,CHEMBL623714,Rattus norvegicus,Plasma clearance was determined; ND denotes no data,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,7896,In vivo,50597
A,10116.0,,CHEMBL623715,Rattus norvegicus,Plasma clearance was determined; ND denotes not determined,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,7897,In vivo,50597
A,10116.0,,CHEMBL623716,Rattus norvegicus,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,7898,In vivo,50597
A,10116.0,,CHEMBL622980,Rattus norvegicus,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,5199,N,,Intermediate,,,,,,1,1,,BAO_0000218,7899,In vivo,50597
A,10116.0,,CHEMBL622981,Rattus norvegicus,Plasma administration to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,7900,In vivo,50597
A,10116.0,,CHEMBL622982,Rattus norvegicus,Plasma clearance of the compound in female Sprague-Dawley rats,,6362,N,,Intermediate,,,,,,1,1,,BAO_0000218,7901,In vivo,50597
A,10116.0,,CHEMBL622983,Rattus norvegicus,Plasma clearance was observed after intravenous administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,7902,In vivo,50597
A,10116.0,,CHEMBL622984,Rattus norvegicus,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,,6215,N,,Intermediate,,,,,,1,1,,BAO_0000218,7903,In vivo,50597
A,10116.0,,CHEMBL622985,Rattus norvegicus,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,7904,In vivo,50597
A,10116.0,,CHEMBL623631,Rattus norvegicus,plasma clearance was observed after intravenous administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7905,In vivo,50597
A,10116.0,,CHEMBL623632,Rattus norvegicus,In vivo CL/F determined,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,7906,In vivo,50597
A,10116.0,,CHEMBL623633,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7907,In vivo,50597
A,10116.0,,CHEMBL623634,Rattus norvegicus,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7908,In vivo,50597
A,10116.0,,CHEMBL623635,Rattus norvegicus,Compound was tested for the lower blood clearance in rat,,5213,N,,Intermediate,,,,,,1,1,,BAO_0000218,7909,In vivo,50597
A,10116.0,,CHEMBL621195,Rattus norvegicus,Evaluated for the low clearance in rat (in vivo),,4687,N,,Intermediate,,,,,,1,1,,BAO_0000218,7910,In vivo,50597
A,10116.0,,CHEMBL621196,Rattus norvegicus,Pharmacokinetic property (CLb)of the compound was determined in rat,,3371,N,,Intermediate,,,,,,1,1,,BAO_0000218,7911,In vivo,50597
A,10116.0,,CHEMBL875287,Rattus norvegicus,Rapid clearance after intravenous administration in rat was determined,,4690,N,,Intermediate,,,,,,1,1,,BAO_0000218,7912,In vivo,50597
A,10116.0,,CHEMBL621197,Rattus norvegicus,Clearance measured in rat,,5702,N,,Intermediate,,,,,,1,1,,BAO_0000218,7913,In vivo,50597
A,10116.0,,CHEMBL621198,Rattus norvegicus,Compound was evaluated for plasma clearance in rat,,740,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7914,In vivo,50597
A,10116.0,,CHEMBL621199,Rattus norvegicus,Low plasma clearance was calculated in rat,,4853,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7915,In vivo,50597
A,10116.0,,CHEMBL621200,Rattus norvegicus,Pharmacokinetic property (Clp) in rat,,5789,N,,Intermediate,,,,,,1,1,,BAO_0000218,7916,In vivo,50597
A,10116.0,,CHEMBL621201,Rattus norvegicus,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,7917,In vivo,50597
A,10116.0,,CHEMBL621202,Rattus norvegicus,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,7918,In vivo,50597
A,10116.0,,CHEMBL621203,Rattus norvegicus,Plasma clearance after IV dosing at 0.5 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,7919,In vivo,50597
A,10116.0,,CHEMBL621204,Rattus norvegicus,Plasma clearance after IV dosing at 1 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,7920,In vivo,50597
A,10116.0,,CHEMBL621205,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7921,In vivo,50597
A,10116.0,,CHEMBL621206,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7922,In vivo,50597
A,10116.0,,CHEMBL621207,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7923,In vivo,50597
A,10116.0,,CHEMBL621208,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7924,In vivo,50597
A,10116.0,,CHEMBL621209,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7925,In vivo,50597
A,10116.0,,CHEMBL876484,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7926,In vivo,50597
A,10116.0,,CHEMBL621210,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7927,In vivo,50597
A,10116.0,,CHEMBL621211,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7928,In vivo,50597
A,10116.0,,CHEMBL621212,Rattus norvegicus,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7929,In vivo,50597
A,10116.0,,CHEMBL621213,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 15 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7930,In vivo,50597
A,10116.0,,CHEMBL621214,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7931,In vivo,50597
A,10116.0,,CHEMBL621215,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 30 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7932,In vivo,50597
A,10116.0,,CHEMBL621216,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7933,In vivo,50597
A,10116.0,,CHEMBL621217,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7934,In vivo,50597
A,10116.0,,CHEMBL621218,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7935,In vivo,50597
A,10116.0,,CHEMBL621219,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7936,In vivo,50597
A,10116.0,,CHEMBL621220,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7937,In vivo,50597
A,10116.0,,CHEMBL621221,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7938,In vivo,50597
A,10116.0,,CHEMBL621222,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7939,In vivo,50597
A,10116.0,,CHEMBL621223,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7940,In vivo,50597
A,10116.0,,CHEMBL876485,Rattus norvegicus,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7941,In vivo,50597
A,10116.0,,CHEMBL621224,Rattus norvegicus,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7942,In vivo,50597
A,10116.0,,CHEMBL621225,Rattus norvegicus,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7943,In vivo,50597
A,10116.0,,CHEMBL621226,Rattus norvegicus,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,7944,In vivo,50597
A,10116.0,,CHEMBL621227,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7945,In vivo,50597
A,10116.0,,CHEMBL621228,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7946,In vivo,50597
A,10116.0,,CHEMBL621229,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7947,In vivo,50597
A,10116.0,,CHEMBL621230,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7948,In vivo,50597
A,10116.0,,CHEMBL621231,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7949,In vivo,50597
A,10116.0,,CHEMBL621232,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7950,In vivo,50597
A,10116.0,,CHEMBL621233,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7951,In vivo,50597
A,10116.0,,CHEMBL621234,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7952,In vivo,50597
A,10116.0,,CHEMBL621235,Rattus norvegicus,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7953,In vivo,50597
A,10116.0,,CHEMBL621236,Rattus norvegicus,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7954,In vivo,50597
A,10116.0,,CHEMBL621237,Rattus norvegicus,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7955,In vivo,50597
A,10116.0,,CHEMBL876486,Rattus norvegicus,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,7956,In vivo,50597
A,10116.0,,CHEMBL622436,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,7957,In vivo,50597
A,10116.0,,CHEMBL622437,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,7958,In vivo,50597
A,10116.0,,CHEMBL622438,Rattus norvegicus,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,7959,In vivo,50597
A,10116.0,,CHEMBL622439,Rattus norvegicus,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7960,In vivo,50597
A,10116.0,,CHEMBL622440,Rattus norvegicus,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7961,In vivo,50597
A,10116.0,,CHEMBL622441,Rattus norvegicus,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7962,In vivo,50597
A,10116.0,,CHEMBL622442,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7963,In vivo,50597
A,10116.0,,CHEMBL622443,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7964,In vivo,50597
A,10116.0,,CHEMBL622444,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7965,In vivo,50597
A,10116.0,,CHEMBL622445,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7966,In vivo,50597
A,10116.0,,CHEMBL622446,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7967,In vivo,50597
A,10116.0,,CHEMBL622447,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7968,In vivo,50597
A,10116.0,,CHEMBL622448,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7969,In vivo,50597
A,10116.0,,CHEMBL622449,Rattus norvegicus,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7970,In vivo,50597
A,10116.0,,CHEMBL622450,Rattus norvegicus,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7971,In vivo,50597
A,10116.0,,CHEMBL622451,Rattus norvegicus,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7972,In vivo,50597
A,10116.0,,CHEMBL622452,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 15 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7973,In vivo,50597
A,10116.0,,CHEMBL622453,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7974,In vivo,50597
A,10116.0,,CHEMBL622454,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 30 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7975,In vivo,50597
A,10116.0,,CHEMBL622455,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7976,In vivo,50597
A,10116.0,,CHEMBL876024,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,7977,In vivo,50597
A,10116.0,,CHEMBL622456,Rattus norvegicus,T max was determined at 3 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,7978,In vivo,50597
A,10116.0,,CHEMBL622457,Rattus norvegicus,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,7979,In vivo,50597
A,10116.0,,CHEMBL622458,Rattus norvegicus,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,7980,In vivo,50597
A,10116.0,,CHEMBL622459,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,7981,,50597
A,10116.0,,CHEMBL873343,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,7982,,50597
A,10116.0,,CHEMBL622460,Rattus norvegicus,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,7983,,50597
A,10116.0,,CHEMBL622461,Rattus norvegicus,Time for maximum plasma concentration determined in rat,,4576,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7984,,50597
A,10116.0,,CHEMBL622462,Rattus norvegicus,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,6681,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7985,In vivo,50597
A,10116.0,,CHEMBL622463,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,7986,In vivo,50597
A,10116.0,,CHEMBL622464,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,7987,In vivo,50597
A,10116.0,,CHEMBL622465,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,7988,In vivo,50597
A,10116.0,,CHEMBL622466,Rattus norvegicus,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,7989,In vivo,50597
A,10116.0,,CHEMBL622467,Rattus norvegicus,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,7990,In vivo,50597
A,10116.0,,CHEMBL622468,Rattus norvegicus,Time of maximum plasma concentration in rat,,6824,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7991,,50597
A,10116.0,,CHEMBL876025,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7992,,50597
A,10116.0,,CHEMBL622469,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7993,,50597
A,10116.0,,CHEMBL622470,Rattus norvegicus,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7994,,50597
A,10116.0,,CHEMBL622471,Rattus norvegicus,Time required to reach maximum concentration (Cmax) after oral administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,7995,In vivo,50597
A,10116.0,,CHEMBL622472,Rattus norvegicus,Time required to reach maximum concentration in rat plasma,,1742,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7996,,50597
A,10116.0,,CHEMBL622473,Rattus norvegicus,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,2774,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7997,In vivo,50597
A,10116.0,,CHEMBL624282,Rattus norvegicus,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,5199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7998,In vivo,50597
A,10116.0,,CHEMBL624283,Rattus norvegicus,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,7999,In vivo,50597
A,10116.0,,CHEMBL624284,Rattus norvegicus,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8000,In vivo,50597
A,10116.0,,CHEMBL624285,Rattus norvegicus,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1916,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8001,In vivo,50597
A,10116.0,,CHEMBL624286,Rattus norvegicus,Time to reach Cmax after oral administration to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,8002,In vivo,50597
A,10116.0,,CHEMBL624287,Rattus norvegicus,Time to reach Cmax when a dose of 1 mg/kg is administered orally,,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,8003,In vivo,50597
A,10116.0,,CHEMBL624288,Rattus norvegicus,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,,216,N,,Intermediate,,,,,,1,1,,BAO_0000218,8004,,50597
A,10116.0,,CHEMBL624289,Rattus norvegicus,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,,6410,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8005,In vivo,50597
A,10116.0,,CHEMBL873344,Rattus norvegicus,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8006,In vivo,50597
A,10116.0,,CHEMBL619623,Rattus norvegicus,Tmax after peroral administration (10 mg/kg) was determined in rat,,6215,N,,Intermediate,,,,,,1,1,,BAO_0000218,8007,In vivo,50597
A,10116.0,,CHEMBL621399,Rattus norvegicus,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,8008,In vivo,50597
A,10116.0,,CHEMBL621400,Rattus norvegicus,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,8009,In vivo,50597
A,10116.0,,CHEMBL621401,Rattus norvegicus,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",,17670,N,,Intermediate,,,,,,1,1,,BAO_0000218,8010,In vivo,50597
A,10116.0,,CHEMBL621402,Rattus norvegicus,Tmax was determined,,1465,N,,Intermediate,,,,,,1,1,,BAO_0000218,8011,,50597
A,10116.0,,CHEMBL621403,Rattus norvegicus,Tmax was determined,,2552,N,,Intermediate,,,,,,1,1,,BAO_0000218,8012,,50597
A,10116.0,,CHEMBL621121,Rattus norvegicus,Tmax after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,8013,In vivo,50597
A,10116.0,,CHEMBL872525,Rattus norvegicus,Tmax after peroral administration in rats at 2.4 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,8014,In vivo,50597
A,10116.0,,CHEMBL621122,Rattus norvegicus,Tmax in male rat,,5610,N,,Intermediate,,,,,,1,1,,BAO_0000218,8015,,50597
A,10116.0,,CHEMBL621123,Rattus norvegicus,Tmax in rat at 10 mg/kg,,6046,N,,Intermediate,,,,,,1,1,,BAO_0000218,8016,In vivo,50597
A,10116.0,,CHEMBL621124,Rattus norvegicus,Tmax in rat by po administration at a dose of 40 mg/kg,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,8017,In vivo,50597
A,10116.0,,CHEMBL621125,Rattus norvegicus,Tmax in rats,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,8018,,50597
A,10116.0,,CHEMBL621126,Rattus norvegicus,Tmax was measured in rats after peroral administration at 5 mg/kg,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,8019,In vivo,50597
A,10116.0,,CHEMBL621127,Rattus norvegicus,Tmax value after oral dose at a dose of 10 mg/kg in rats.,,1908,N,,Intermediate,,,,,,1,1,,BAO_0000218,8020,In vivo,50597
A,10116.0,,CHEMBL621128,Rattus norvegicus,Tmax value after administration of 20 mg/Kg oral dose in rat,,2959,N,,Intermediate,,,,,,1,1,,BAO_0000218,8021,In vivo,50597
A,10116.0,,CHEMBL618263,Rattus norvegicus,Tmax value at a dose of 10 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8022,In vivo,50597
A,10116.0,,CHEMBL618264,Rattus norvegicus,Tmax value at a dose of 100 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8023,In vivo,50597
A,10116.0,,CHEMBL618265,Rattus norvegicus,Tmax value at a dose of 50 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8024,In vivo,50597
A,10116.0,,CHEMBL618266,Rattus norvegicus,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,4186,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8025,In vivo,50597
A,10116.0,,CHEMBL618267,Rattus norvegicus,time required to reach maximum concentration (Cmax) after oral administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,8026,In vivo,50597
A,10116.0,,CHEMBL618450,Rattus norvegicus,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),,429,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,8027,,50597
A,10116.0,,CHEMBL618451,Rattus norvegicus,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),,429,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,8028,,50597
A,10116.0,,CHEMBL618452,Rattus norvegicus,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,5546,N,,Intermediate,,,,,,1,1,,BAO_0000218,8029,,50597
A,10116.0,,CHEMBL618453,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,,3173,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,8030,,50597
A,10116.0,,CHEMBL618454,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,,3173,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,8031,,50597
A,10116.0,,CHEMBL618455,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,,3173,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,8032,,50597
A,10116.0,,CHEMBL618456,Rattus norvegicus,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,,4257,N,,Intermediate,,,,,,1,1,,BAO_0000218,8033,In vivo,50597
A,10116.0,,CHEMBL618457,Rattus norvegicus,Compound distribution in rat tissues was determined,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,8034,In vivo,50597
A,10116.0,,CHEMBL618458,Rattus norvegicus,Volume of distribution was evaluated in rat,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,8035,In vivo,50597
A,10116.0,,CHEMBL618459,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8036,,50597
A,10116.0,,CHEMBL876733,Rattus norvegicus,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8037,,50597
A,9615.0,,CHEMBL618460,Canis lupus familiaris,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8038,,50588
A,10116.0,,CHEMBL618461,Rattus norvegicus,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8039,,50597
A,,,CHEMBL618462,,Area under the curve was determined after oral administration (300 uM/Kg),,15469,U,,Autocuration,,,,,,1,0,,BAO_0000019,8040,,22224
A,10116.0,,CHEMBL618463,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8041,,50597
A,10116.0,,CHEMBL618464,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8042,,50597
A,10116.0,,CHEMBL618465,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8043,,50597
A,10116.0,,CHEMBL618466,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8044,,50597
A,10116.0,,CHEMBL618467,Rattus norvegicus,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,8045,,50597
A,10116.0,,CHEMBL618468,Rattus norvegicus,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,8046,,50597
A,9615.0,,CHEMBL618469,Canis lupus familiaris,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,,12935,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8047,,50588
A,9615.0,,CHEMBL618470,Canis lupus familiaris,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,,12935,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8048,,50588
A,,,CHEMBL618471,,Plasma drug AUC in rat (PO dose),,14813,U,,Autocuration,,,,,,1,0,,BAO_0000218,8049,,22224
A,10090.0,,CHEMBL618472,Mus musculus,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,,15792,N,,Intermediate,,,,,,1,1,,BAO_0000218,8050,,50594
A,,,CHEMBL618473,,Area under was determined at a dose of 30 mg/kg,,3579,U,,Autocuration,,,,,,1,0,,BAO_0000218,8051,,22224
A,9669.0,,CHEMBL621699,Mustela putorius furo,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8052,,50506
A,10116.0,,CHEMBL621700,Rattus norvegicus,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8053,,50597
A,10116.0,,CHEMBL621701,Rattus norvegicus,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8054,,50597
A,9669.0,,CHEMBL621702,Mustela putorius furo,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8055,,50506
A,9615.0,,CHEMBL621703,Canis lupus familiaris,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8056,,50588
A,9615.0,,CHEMBL621704,Canis lupus familiaris,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,8057,,50588
A,10116.0,,CHEMBL624259,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8058,,50597
A,10116.0,,CHEMBL624260,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8059,,50597
A,10116.0,,CHEMBL624430,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8060,,50597
A,10116.0,,CHEMBL624431,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8061,,50597
A,10116.0,,CHEMBL624432,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8062,,50597
A,10116.0,,CHEMBL624433,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8063,,50597
A,10116.0,,CHEMBL624434,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8064,,50597
A,10116.0,,CHEMBL624435,Rattus norvegicus,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,8065,,50597
A,10090.0,,CHEMBL618570,Mus musculus,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8066,,50594
A,10090.0,,CHEMBL618571,Mus musculus,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8067,,50594
A,10090.0,,CHEMBL618572,Mus musculus,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8068,,50594
A,10090.0,,CHEMBL618573,Mus musculus,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8069,,50594
A,10090.0,,CHEMBL619267,Mus musculus,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8070,,50594
A,10090.0,,CHEMBL619431,Mus musculus,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8071,,50594
A,10090.0,,CHEMBL619432,Mus musculus,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8072,,50594
A,10090.0,,CHEMBL619433,Mus musculus,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,8073,,50594
A,,,CHEMBL619434,,AUC in mice after oral dose (50 mg/kg),,13298,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,8074,,22224
A,10090.0,,CHEMBL619435,Mus musculus,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,,12226,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,8075,,50594
A,,,CHEMBL619436,,AUC (0-4 hr) ug/ml/h,,12634,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,8076,,22224
A,10116.0,,CHEMBL619437,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,,14810,N,,Intermediate,,,,,,1,1,,BAO_0000218,8077,,50597
A,,,CHEMBL619438,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,13889,U,,Autocuration,,,,,,1,0,,BAO_0000218,8078,,22224
A,10090.0,,CHEMBL619439,Mus musculus,Compound was evaluated for Area under curve in mice,,10018,N,,Intermediate,,,,,,1,1,,BAO_0000218,8079,,50594
A,10116.0,,CHEMBL619440,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,N,,Intermediate,,,,,,1,1,,BAO_0000218,8080,,50597
F,,,CHEMBL619441,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,U,,Autocuration,,,,,,1,0,,BAO_0000218,8081,,22224
A,10116.0,,CHEMBL619442,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8758,N,,Intermediate,,,,,,1,1,,BAO_0000218,8082,,50597
A,,,CHEMBL875156,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,2249,U,,Autocuration,,,,,,1,0,,BAO_0000019,8083,,22224
A,,,CHEMBL619443,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,2249,U,,Autocuration,,,,,,1,0,,BAO_0000019,8084,,22224
A,,,CHEMBL619444,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,2249,U,,Autocuration,,,,,,1,0,,BAO_0000019,8085,,22224
A,,,CHEMBL623464,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,2249,U,,Autocuration,,,,,,1,0,,BAO_0000019,8086,,22224
A,10090.0,,CHEMBL623465,Mus musculus,Compound was evaluated for area under curve when administered through oral route in mouse,,15115,N,,Intermediate,,,,,,1,1,,BAO_0000218,8087,,50594
A,10116.0,,CHEMBL623466,Rattus norvegicus,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8088,In vivo,50597
A,10116.0,,CHEMBL623467,Rattus norvegicus,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8089,In vivo,50597
A,10116.0,,CHEMBL623468,Rattus norvegicus,Plasma clearance in rat,,6249,N,,Intermediate,,,,,,1,1,,BAO_0000218,8090,In vivo,50597
A,10116.0,,CHEMBL622660,Rattus norvegicus,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,,2463,N,,Intermediate,,,,,,1,1,,BAO_0000218,8091,In vivo,50597
A,10116.0,,CHEMBL622661,Rattus norvegicus,Plasma clearance rate in Sprague-Dawley rats,,4969,N,,Intermediate,,,,,,1,1,,BAO_0000218,8092,In vivo,50597
F,10116.0,,CHEMBL622662,Rattus norvegicus,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,,,,1,1,,BAO_0000218,8093,In vivo,50597
A,10116.0,,CHEMBL622663,Rattus norvegicus,Pharmacokinetic property (total body clearance) in rat,,3457,N,,Intermediate,,,,,,1,1,,BAO_0000218,8094,In vivo,50597
A,10116.0,,CHEMBL622664,Rattus norvegicus,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,8095,In vivo,50597
A,10116.0,,CHEMBL622665,Rattus norvegicus,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,6295,N,,Intermediate,,,,,,1,1,,BAO_0000218,8096,,50597
A,10116.0,,CHEMBL622666,Rattus norvegicus,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,,6296,N,,Intermediate,,,,,,1,1,,BAO_0000218,8097,,50597
A,10116.0,,CHEMBL621615,Rattus norvegicus,Cl in rat i.v. at 2 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,8098,In vivo,50597
A,10116.0,,CHEMBL621616,Rattus norvegicus,Clearance of compound after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,8099,In vivo,50597
A,10116.0,,CHEMBL621617,Rattus norvegicus,Clearance was determined,,5503,N,,Intermediate,,,,,,1,1,,BAO_0000218,8100,In vivo,50597
A,10116.0,,CHEMBL621618,Rattus norvegicus,Clearance by intravenous administration of 3.4 mg/kg in rat,,4368,N,,Intermediate,,,,,,1,1,,BAO_0000218,8101,In vivo,50597
A,10116.0,,CHEMBL621619,Rattus norvegicus,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,6005,N,,Intermediate,,,,,,1,1,,BAO_0000218,8102,In vivo,50597
A,10116.0,,CHEMBL621620,Rattus norvegicus,Clearance rate after i.v. administration in rats,,5031,N,,Intermediate,,,,,,1,1,,BAO_0000218,8103,In vivo,50597
A,10116.0,,CHEMBL621786,Rattus norvegicus,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,8104,In vivo,50597
A,10116.0,,CHEMBL621787,Rattus norvegicus,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,8105,In vivo,50597
A,10116.0,,CHEMBL621788,Rattus norvegicus,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,,5979,N,,Intermediate,,,,,,1,1,,BAO_0000218,8106,In vivo,50597
A,10116.0,,CHEMBL621789,Rattus norvegicus,Clearance (Cl) after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,8107,In vivo,50597
A,10116.0,,CHEMBL621790,Rattus norvegicus,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,8108,In vivo,50597
A,10116.0,,CHEMBL621791,Rattus norvegicus,Compound was tested for plasma clearance in rat,,4839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8109,In vivo,50597
A,10116.0,Microsomes,CHEMBL621792,Rattus norvegicus,In vitro microsome metabolism clearance in rat was determined,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,8110,In vitro,50597
A,10116.0,Microsomes,CHEMBL621793,Rattus norvegicus,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,8111,In vitro,50597
A,10116.0,,CHEMBL621794,Rattus norvegicus,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8112,In vivo,50597
A,10116.0,,CHEMBL621795,Rattus norvegicus,In vivo plasma clearance was determined,,5496,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8113,In vivo,50597
A,10116.0,,CHEMBL621796,Rattus norvegicus,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,,5739,N,,Intermediate,,,,,,1,1,,BAO_0000218,8114,In vivo,50597
A,10116.0,,CHEMBL621797,Rattus norvegicus,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,,5676,N,401.0,Intermediate,,,Liver,2107.0,Hepatocyte,1,1,,BAO_0000218,8115,In vivo,50597
A,10116.0,,CHEMBL621798,Rattus norvegicus,Pharmacokinetic property (Plasma clearance) was measured in rat,,4239,N,,Intermediate,,,,,,1,1,,BAO_0000218,8116,In vivo,50597
A,10116.0,,CHEMBL621799,Rattus norvegicus,Pharmacokinetic property (clearance) in rat i.v.,,5676,N,,Intermediate,,,,,,1,1,,BAO_0000218,8117,In vivo,50597
A,10116.0,,CHEMBL621800,Rattus norvegicus,"Plasma Clearance was evaluated in rats, iv",,1918,N,,Intermediate,,,,,,1,1,,BAO_0000218,8118,In vivo,50597
A,10116.0,,CHEMBL621801,Rattus norvegicus,Plasma clearance (in vivo) in rats was determined,,17800,N,,Intermediate,,,,,,1,1,,BAO_0000218,8119,In vivo,50597
A,10116.0,,CHEMBL621802,Rattus norvegicus,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,,6056,N,,Intermediate,,,,,,1,1,,BAO_0000218,8120,In vivo,50597
A,10116.0,,CHEMBL618596,Rattus norvegicus,Plasma clearance was determined,,5496,N,,Intermediate,,,,,,1,1,,BAO_0000218,8121,In vivo,50597
A,10116.0,,CHEMBL618597,Rattus norvegicus,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,8122,In vivo,50597
A,10116.0,,CHEMBL618598,Rattus norvegicus,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,8123,In vivo,50597
A,10116.0,,CHEMBL618599,Rattus norvegicus,Plasma clearance in rats,,17752,N,,Intermediate,,,,,,1,1,,BAO_0000218,8124,In vivo,50597
A,10116.0,,CHEMBL618600,Rattus norvegicus,Plasma clearance rate determined in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,8125,In vivo,50597
A,10116.0,,CHEMBL618601,Rattus norvegicus,Plasma clearance was determined in rat,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,8126,In vivo,50597
A,10116.0,,CHEMBL618602,Rattus norvegicus,Plasma clearance was determined,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,8127,In vivo,50597
A,10116.0,,CHEMBL618603,Rattus norvegicus,Plasma clearance value in rat,,5948,N,,Intermediate,,,,,,1,1,,BAO_0000218,8128,In vivo,50597
A,10116.0,,CHEMBL618604,Rattus norvegicus,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,6125,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8129,Ex vivo,50597
A,10116.0,,CHEMBL618605,Rattus norvegicus,Clearance in rat,,4839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8130,In vivo,50597
A,10116.0,,CHEMBL618606,Rattus norvegicus,Total body clearance in rat i.v. at 2 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,8131,In vivo,50597
A,10116.0,,CHEMBL618607,Rattus norvegicus,Clearance of compound in rats after intravenous administration,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,8132,In vivo,50597
A,10116.0,,CHEMBL618608,Rattus norvegicus,Clearance after iv administration to rats,,3364,N,,Intermediate,,,,,,1,1,,BAO_0000218,8133,In vivo,50597
A,10116.0,,CHEMBL618609,Rattus norvegicus,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8134,In vivo,50597
A,10116.0,,CHEMBL618610,Rattus norvegicus,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8135,In vivo,50597
A,10116.0,,CHEMBL618611,Rattus norvegicus,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8136,In vivo,50597
A,10116.0,,CHEMBL618612,Rattus norvegicus,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8137,In vivo,50597
A,10116.0,,CHEMBL618613,Rattus norvegicus,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8138,In vivo,50597
A,10116.0,,CHEMBL621076,Rattus norvegicus,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8139,In vivo,50597
A,10116.0,,CHEMBL621077,Rattus norvegicus,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8140,In vivo,50597
A,10116.0,,CHEMBL621078,Rattus norvegicus,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",,17670,N,,Intermediate,,,,,,1,1,,BAO_0000218,8141,In vivo,50597
A,10116.0,,CHEMBL621251,Rattus norvegicus,Clearance in rat,,5970,N,,Intermediate,,,,,,1,1,,BAO_0000218,8142,In vivo,50597
A,10116.0,,CHEMBL621252,Rattus norvegicus,Clearance in rat after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,8143,In vivo,50597
A,10116.0,,CHEMBL621253,Rattus norvegicus,Clearance in rat.,,4590,N,,Intermediate,,,,,,1,1,,BAO_0000218,8144,In vivo,50597
A,10116.0,,CHEMBL621254,Rattus norvegicus,Clearance rate following an oral dose of 20 mg/kg in rats,,6193,N,,Intermediate,,,,,,1,1,,BAO_0000218,8145,In vivo,50597
A,10116.0,,CHEMBL621255,Rattus norvegicus,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,,2832,N,,Intermediate,,,,,,1,1,,BAO_0000218,8146,In vivo,50597
A,10116.0,,CHEMBL621256,Rattus norvegicus,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,,1052,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8147,In vivo,50597
A,10116.0,,CHEMBL621257,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8148,In vivo,50597
A,10116.0,,CHEMBL621258,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8149,In vivo,50597
A,10116.0,,CHEMBL621259,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8150,In vivo,50597
A,10116.0,,CHEMBL621260,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8151,In vivo,50597
A,10116.0,,CHEMBL876494,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8152,In vivo,50597
A,10116.0,,CHEMBL621261,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8153,In vivo,50597
A,10116.0,,CHEMBL621262,Rattus norvegicus,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8154,In vivo,50597
A,10116.0,,CHEMBL621263,Rattus norvegicus,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8155,In vivo,50597
A,10116.0,,CHEMBL621264,Rattus norvegicus,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8156,In vivo,50597
A,10116.0,,CHEMBL621265,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8157,In vivo,50597
A,10116.0,,CHEMBL621266,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8158,In vivo,50597
A,10116.0,,CHEMBL621267,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8159,In vivo,50597
A,10116.0,,CHEMBL621268,Rattus norvegicus,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8160,In vivo,50597
A,10116.0,,CHEMBL621269,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8161,In vivo,50597
A,10116.0,,CHEMBL621270,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8162,In vivo,50597
A,10116.0,,CHEMBL621271,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8163,In vivo,50597
A,10116.0,,CHEMBL621272,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8164,In vivo,50597
A,10116.0,,CHEMBL621273,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8165,In vivo,50597
A,10116.0,,CHEMBL621274,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8166,In vivo,50597
A,10116.0,,CHEMBL876495,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8167,In vivo,50597
A,10116.0,,CHEMBL621275,Rattus norvegicus,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8168,In vivo,50597
A,10116.0,,CHEMBL621276,Rattus norvegicus,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8169,In vivo,50597
A,10116.0,,CHEMBL621277,Rattus norvegicus,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8170,In vivo,50597
A,10116.0,,CHEMBL621278,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8171,In vivo,50597
A,10116.0,,CHEMBL621279,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8172,In vivo,50597
A,10116.0,,CHEMBL621280,Rattus norvegicus,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),,9866,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8173,In vivo,50597
A,10116.0,,CHEMBL621281,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8174,In vivo,50597
A,10116.0,,CHEMBL621282,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8175,In vivo,50597
A,10116.0,,CHEMBL621283,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8176,In vivo,50597
A,10116.0,,CHEMBL621284,Rattus norvegicus,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8177,In vivo,50597
A,10116.0,,CHEMBL621285,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8178,In vivo,50597
A,10116.0,,CHEMBL621286,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8179,In vivo,50597
A,10116.0,,CHEMBL623220,Rattus norvegicus,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8180,In vivo,50597
A,10116.0,,CHEMBL623221,Rattus norvegicus,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8181,In vivo,50597
A,10116.0,,CHEMBL876029,Rattus norvegicus,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,,9866,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8182,In vivo,50597
A,10116.0,,CHEMBL623222,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,,9866,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8183,In vivo,50597
A,10116.0,,CHEMBL623223,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,,9866,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8184,In vivo,50597
A,10116.0,,CHEMBL621445,Rattus norvegicus,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,,9866,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8185,In vivo,50597
A,10116.0,,CHEMBL621446,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8186,In vivo,50597
A,10116.0,,CHEMBL621447,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8187,In vivo,50597
A,10116.0,,CHEMBL619681,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8188,In vivo,50597
A,10116.0,,CHEMBL619682,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8189,In vivo,50597
A,10116.0,,CHEMBL619683,Rattus norvegicus,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8190,In vivo,50597
A,10116.0,,CHEMBL619684,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8191,In vivo,50597
A,10116.0,,CHEMBL619685,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8192,In vivo,50597
A,10116.0,,CHEMBL619686,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8193,In vivo,50597
A,10116.0,,CHEMBL619687,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8194,In vivo,50597
A,10116.0,,CHEMBL619688,Rattus norvegicus,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8195,In vivo,50597
A,10116.0,,CHEMBL619689,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8196,In vivo,50597
A,10116.0,,CHEMBL619690,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8197,In vivo,50597
A,10116.0,,CHEMBL619691,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8198,In vivo,50597
A,10116.0,,CHEMBL619692,Rattus norvegicus,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,8199,In vivo,50597
A,10116.0,,CHEMBL619693,Rattus norvegicus,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,8200,,50597
A,10116.0,,CHEMBL619694,Rattus norvegicus,Vc value after IV dose at a dose of 5 mg/kg in rats.,,1908,N,,Intermediate,,,,,,1,1,,BAO_0000218,8201,In vivo,50597
A,10116.0,,CHEMBL619695,Rattus norvegicus,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,8202,In vivo,50597
A,10116.0,,CHEMBL619696,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter volume of distribution,,4891,N,,Intermediate,,,,,,1,1,,BAO_0000218,8203,In vivo,50597
A,10116.0,,CHEMBL619697,Rattus norvegicus,Compound was evaluated for volume of distribution in rat,,740,N,,Intermediate,,,,,,1,1,,BAO_0000218,8204,In vivo,50597
A,10116.0,,CHEMBL619698,Rattus norvegicus,Steady state volume distribution was determined; steady state(ss),,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,8205,In vivo,50597
A,10116.0,,CHEMBL619699,Rattus norvegicus,Steady state volume of distribution after iv administration to rats,,3364,N,,Intermediate,,,,,,1,1,,BAO_0000218,8206,In vivo,50597
A,10116.0,,CHEMBL619700,Rattus norvegicus,Steady state volume of distribution dosing at 3 mg/kg iv,,2552,N,,Intermediate,,,,,,1,1,,BAO_0000218,8207,In vivo,50597
A,10116.0,,CHEMBL619701,Rattus norvegicus,The compound was evaluated for volume of distribution in rat,,406,N,,Intermediate,,,,,,1,1,,BAO_0000218,8208,In vivo,50597
A,10116.0,,CHEMBL619702,Rattus norvegicus,The compound was tested for volume of distribution in rat,,12500,N,,Intermediate,,,,,,1,1,,BAO_0000218,8209,In vivo,50597
A,10116.0,,CHEMBL620335,Rattus norvegicus,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,,12500,N,,Intermediate,,,,,,1,1,,BAO_0000218,8210,In vivo,50597
A,10116.0,,CHEMBL620336,Rattus norvegicus,Volume distribution (VD) after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,8211,In vivo,50597
A,10116.0,,CHEMBL620337,Rattus norvegicus,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,8212,In vivo,50597
A,10116.0,,CHEMBL620520,Rattus norvegicus,Volume distribution in rat,,1094,N,,Intermediate,,,,,,1,1,,BAO_0000218,8213,In vivo,50597
A,10116.0,,CHEMBL620521,Rattus norvegicus,Volume distribution in rat,,5833,N,,Intermediate,,,,,,1,1,,BAO_0000218,8214,In vivo,50597
A,10116.0,,CHEMBL875825,Rattus norvegicus,Volume distribution in rat after peroral administration at 10 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,8215,In vivo,50597
A,10116.0,,CHEMBL620522,Rattus norvegicus,Volume distribution in rat after peroral administration at 5 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,8216,In vivo,50597
A,10116.0,,CHEMBL620523,Rattus norvegicus,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,6005,N,,Intermediate,,,,,,1,1,,BAO_0000218,8217,In vivo,50597
A,10116.0,,CHEMBL620524,Rattus norvegicus,Volume of distribution in rat.,,1696,N,,Intermediate,,,,,,1,1,,BAO_0000218,8218,In vivo,50597
A,10116.0,,CHEMBL620525,Rattus norvegicus,Volume of distribution in rat,,6672,N,,Intermediate,,,,,,1,1,,BAO_0000218,8219,In vivo,50597
A,10116.0,,CHEMBL620526,Rattus norvegicus,Volume of distribution in rat,,6673,N,,Intermediate,,,,,,1,1,,BAO_0000218,8220,In vivo,50597
A,10116.0,,CHEMBL620527,Rattus norvegicus,Volume of distribution in rat by iv administration,,5871,N,,Intermediate,,,,,,1,1,,BAO_0000218,8221,In vivo,50597
A,10116.0,,CHEMBL620528,Rattus norvegicus,Volume of distribution in rats,,6803,N,,Intermediate,,,,,,1,1,,BAO_0000218,8222,In vivo,50597
A,10116.0,,CHEMBL620529,Rattus norvegicus,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,,5199,N,,Intermediate,,,,,,1,1,,BAO_0000218,8223,In vivo,50597
A,10116.0,,CHEMBL620530,Rattus norvegicus,Volume distribution at the dose of 2 mg/kg in rat,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,8224,,50597
A,10116.0,,CHEMBL620531,Rattus norvegicus,Steady state volume of distribution was determined,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,8225,In vivo,50597
A,9544.0,,CHEMBL620532,Macaca mulatta,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,,5005,U,,Intermediate,,,,,,1,0,,BAO_0000218,8226,In vivo,22224
A,10116.0,,CHEMBL620533,Rattus norvegicus,Compound was tested for its plasma volume distribution in Sprague Dawley rats,,5005,U,,Intermediate,,,,,,1,0,,BAO_0000218,8227,In vivo,22224
A,10116.0,,CHEMBL620534,Rattus norvegicus,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,,5005,U,,Intermediate,,,,,,1,0,,BAO_0000218,8228,In vivo,22224
A,10116.0,,CHEMBL620535,Rattus norvegicus,Mean (%CV) PK parameters for Vdss(mL/kg).,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,8229,In vivo,50597
A,10116.0,,CHEMBL875826,Rattus norvegicus,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,8230,In vivo,50597
A,10116.0,,CHEMBL620536,Rattus norvegicus,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,8231,In vivo,50597
A,10116.0,,CHEMBL620537,Rattus norvegicus,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8232,In vivo,50597
A,10116.0,,CHEMBL618526,Rattus norvegicus,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8233,In vivo,50597
A,10116.0,,CHEMBL618527,Rattus norvegicus,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,,5739,N,,Intermediate,,,,,,1,1,,BAO_0000218,8234,In vivo,50597
A,10116.0,,CHEMBL618528,Rattus norvegicus,Pharmacokinetic property (Vdss) in rat,,5789,N,,Intermediate,,,,,,1,1,,BAO_0000218,8235,In vivo,50597
A,10116.0,,CHEMBL618529,Rattus norvegicus,Pharmacokinetic property (vdss) was measured in rat,,4239,N,,Intermediate,,,,,,1,1,,BAO_0000218,8236,In vivo,50597
A,10116.0,,CHEMBL618530,Rattus norvegicus,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,8237,In vivo,50597
A,10116.0,,CHEMBL618531,Rattus norvegicus,Volume of distribution in rat,,6642,N,,Intermediate,,,,,,1,1,,BAO_0000218,8238,In vivo,50597
A,10116.0,,CHEMBL618532,Rattus norvegicus,The pharmacokinetic parameter volume of distribution in vivo in rats,,5247,N,,Intermediate,,,,,,1,1,,BAO_0000218,8239,In vivo,50597
F,10116.0,,CHEMBL618533,Rattus norvegicus,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,,,,1,1,,BAO_0000218,8240,In vivo,50597
A,10116.0,,CHEMBL618534,Rattus norvegicus,Vdss in rat i.v. at 2 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,8241,In vivo,50597
A,10116.0,,CHEMBL618535,Rattus norvegicus,Volume distribution after intravenous administration (1 mg/kg) in rat,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,8242,In vivo,50597
A,10116.0,,CHEMBL618536,Rattus norvegicus,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,8243,In vivo,50597
A,10116.0,,CHEMBL618537,Rattus norvegicus,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,8244,In vivo,50597
A,10116.0,,CHEMBL618538,Rattus norvegicus,Volume distribution at a dose of 10 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,8245,In vivo,50597
A,10116.0,,CHEMBL618539,Rattus norvegicus,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,4521,N,,Intermediate,,,,,,1,1,,BAO_0000218,8246,In vivo,50597
A,10116.0,,CHEMBL618540,Rattus norvegicus,Volume distribution was calculated in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,8247,In vivo,50597
A,10116.0,,CHEMBL618541,Rattus norvegicus,Volume distribution was determined,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,8248,In vivo,50597
A,10116.0,,CHEMBL618542,Rattus norvegicus,Volume of distribution after intravenous administration was evaluated in rat,,2938,N,,Intermediate,,,,,,1,1,,BAO_0000218,8249,In vivo,50597
A,10116.0,,CHEMBL622544,Rattus norvegicus,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,6679,N,,Intermediate,,,,,,1,1,,BAO_0000218,8250,In vivo,50597
A,10116.0,,CHEMBL622545,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8251,In vivo,50597
A,10116.0,,CHEMBL622546,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8252,In vivo,50597
A,10116.0,,CHEMBL622547,Rattus norvegicus,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8253,In vivo,50597
A,10116.0,,CHEMBL622548,Rattus norvegicus,Volume of distribution in steady state was determined in rat,,5145,N,,Intermediate,,,,,,1,1,,BAO_0000218,8254,In vivo,50597
A,10116.0,,CHEMBL622549,Rattus norvegicus,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,8255,In vivo,50597
A,10116.0,,CHEMBL622550,Rattus norvegicus,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,8256,In vivo,50597
A,10090.0,,CHEMBL622551,Mus musculus,Compound was evaluated for area under curve when administered through oral route to mouse,,15115,N,,Intermediate,,,,,,1,1,,BAO_0000218,8257,,50594
A,10116.0,,CHEMBL622552,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,8758,N,,Intermediate,,,,,,1,1,,BAO_0000218,8258,,50597
A,10116.0,,CHEMBL622553,Rattus norvegicus,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,,8758,N,,Intermediate,,,,,,1,1,,BAO_0000218,8259,,50597
F,,,CHEMBL622554,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,8267,U,,Autocuration,,,,,,1,0,,BAO_0000218,8260,In vivo,22224
A,9615.0,,CHEMBL622555,Canis lupus familiaris,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,,8267,N,,Intermediate,,,,,,1,1,,BAO_0000218,8261,,50588
A,10090.0,,CHEMBL622556,Mus musculus,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,,14239,N,,Intermediate,,,,,,1,1,,BAO_0000218,8262,,50594
A,10090.0,,CHEMBL622557,Mus musculus,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,,14239,N,,Intermediate,,,,,,1,1,,BAO_0000218,8263,,50594
A,10090.0,,CHEMBL622558,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8264,,50594
A,10090.0,,CHEMBL622559,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8265,,50594
A,9615.0,,CHEMBL622560,Canis lupus familiaris,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,,10754,N,,Intermediate,,,,,,1,1,,BAO_0000218,8266,,50588
A,10116.0,,CHEMBL622561,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,,14681,N,,Intermediate,,,,,,1,1,,BAO_0000218,8267,,50597
A,10116.0,,CHEMBL622562,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,,14681,N,,Intermediate,,,,,,1,1,,BAO_0000218,8268,,50597
A,10116.0,,CHEMBL622563,Rattus norvegicus,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,14681,N,,Intermediate,,,,,,1,1,,BAO_0000218,8269,,50597
A,,,CHEMBL622564,,Concentration of compound in Central nervous system,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,8270,,22224
A,,,CHEMBL622565,,Concentration of compound in Central nervous system; Not detectable,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,8271,,22224
A,10090.0,,CHEMBL622566,Mus musculus,"Concentration of diester in the blood, following oral administration in mice",,13318,N,,Intermediate,,,,,,1,1,,BAO_0000218,8272,,50594
A,10090.0,,CHEMBL624515,Mus musculus,"Concentration of monoester in the blood, following oral administration in mice",,13318,N,,Intermediate,,,,,,1,1,,BAO_0000218,8273,,50594
A,10090.0,,CHEMBL624516,Mus musculus,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,,13318,N,,Intermediate,,,,,,1,1,,BAO_0000218,8274,,50594
A,,,CHEMBL624517,,Evaluated for Pharmacokinetic property: Area under the curve,,15692,U,,Autocuration,,,,,,1,0,,BAO_0000019,8275,,22224
A,10090.0,,CHEMBL624518,Mus musculus,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8276,,50594
A,9541.0,,CHEMBL624519,Macaca fascicularis,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8277,,100710
A,9541.0,,CHEMBL624520,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8278,,100710
A,9541.0,,CHEMBL624521,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8279,,100710
A,9541.0,,CHEMBL624522,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8280,,100710
A,9541.0,,CHEMBL624523,Macaca fascicularis,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8281,,100710
A,9541.0,,CHEMBL624409,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8282,,100710
A,9541.0,,CHEMBL624410,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8283,,100710
A,9541.0,,CHEMBL624411,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8284,,100710
A,9541.0,,CHEMBL623531,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8285,,100710
A,9541.0,,CHEMBL623532,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8286,,100710
A,9541.0,,CHEMBL623533,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8287,,100710
A,9541.0,,CHEMBL623534,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8288,,100710
A,10090.0,,CHEMBL623535,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8289,,50594
A,10090.0,,CHEMBL623536,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8290,,50594
A,10090.0,,CHEMBL623537,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8291,,50594
A,10090.0,,CHEMBL623538,Mus musculus,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8292,,50594
A,10090.0,,CHEMBL623539,Mus musculus,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8293,,50594
A,10090.0,,CHEMBL623540,Mus musculus,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8294,,50594
A,10090.0,,CHEMBL623541,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8295,,50594
A,10090.0,,CHEMBL623542,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8296,,50594
A,10090.0,,CHEMBL623543,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8297,,50594
A,10090.0,,CHEMBL623544,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8298,,50594
A,10090.0,,CHEMBL623545,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8299,,50594
A,10090.0,,CHEMBL623546,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,8300,,50594
A,10116.0,,CHEMBL623547,Rattus norvegicus,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,,5408,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8301,In vivo,50597
A,10116.0,,CHEMBL623548,Rattus norvegicus,High i.v. clearance in Dawley rats,,6827,N,,Intermediate,,,,,,1,1,,BAO_0000218,8302,In vivo,50597
A,10116.0,Microsomes,CHEMBL623549,Rattus norvegicus,In vitro clearance in rat liver microsomes,,17538,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8303,In vitro,50597
A,10116.0,Microsomes,CHEMBL623550,Rattus norvegicus,Intrinsic clearance in rat liver microsomes was determined,,6331,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8304,In vitro,50597
A,10116.0,,CHEMBL875276,Rattus norvegicus,Intrinsic clearance in rat hepatocytes was determined,,5948,N,401.0,Intermediate,,,Liver,2107.0,Hepatocyte,1,1,,BAO_0000218,8305,In vitro,50597
A,10116.0,,CHEMBL621872,Rattus norvegicus,Plasma Clearance was determined,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,8306,In vivo,50597
A,10116.0,,CHEMBL621873,Rattus norvegicus,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,,6647,N,,Intermediate,,,,,,1,1,,BAO_0000218,8307,In vivo,50597
A,10116.0,,CHEMBL621874,Rattus norvegicus,Plasma clearance in rat.,,1696,N,,Intermediate,,,,,,1,1,,BAO_0000218,8308,In vivo,50597
A,10116.0,,CHEMBL621875,Rattus norvegicus,Plasma clearance in rats,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,8309,In vivo,50597
A,10116.0,,CHEMBL621876,Rattus norvegicus,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,,347,N,,Intermediate,,,,,,1,1,,BAO_0000218,8310,In vivo,50597
A,10116.0,,CHEMBL621877,Rattus norvegicus,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,8311,In vivo,50597
A,10116.0,,CHEMBL621878,Rattus norvegicus,Plasma clearance was measured in rat,,2879,N,,Intermediate,,,,,,1,1,,BAO_0000218,8312,In vivo,50597
A,10116.0,,CHEMBL621879,Rattus norvegicus,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,8313,In vivo,50597
A,10116.0,,CHEMBL621880,Rattus norvegicus,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",,5328,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8314,In vivo,50597
A,10116.0,,CHEMBL621881,Rattus norvegicus,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,,5160,N,,Intermediate,,,,,,1,1,,BAO_0000218,8315,In vivo,50597
A,10116.0,,CHEMBL621882,Rattus norvegicus,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,8316,In vivo,50597
A,10116.0,,CHEMBL875283,Rattus norvegicus,Total clearance at 1 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,8317,In vivo,50597
A,10116.0,,CHEMBL621883,Rattus norvegicus,Total clearance at 10 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,8318,In vivo,50597
A,10116.0,,CHEMBL621884,Rattus norvegicus,Clearance in rat,,6596,N,,Intermediate,,,,,,1,1,,BAO_0000218,8319,In vivo,50597
A,10116.0,,CHEMBL621885,Rattus norvegicus,Plasma clearance rate determined in rats,,4796,N,,Intermediate,,,,,,1,1,,BAO_0000218,8320,In vivo,50597
A,10116.0,,CHEMBL621886,Rattus norvegicus,Clearance of compound in rat was evaluated,,6850,N,,Intermediate,,,,,,1,1,,BAO_0000218,8321,In vivo,50597
A,10116.0,,CHEMBL621887,Rattus norvegicus,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8322,In vivo,50597
A,10116.0,,CHEMBL621888,Rattus norvegicus,Pharmacokinetic property (blood clearance) in rat,,3371,N,,Intermediate,,,,,,1,1,,BAO_0000218,8323,In vivo,50597
A,10116.0,,CHEMBL621889,Rattus norvegicus,Plasma clearance in rat,,2083,N,,Intermediate,,,,,,1,1,,BAO_0000218,8324,In vivo,50597
A,10116.0,,CHEMBL621890,Rattus norvegicus,Plasma clearance in rats,,4942,N,,Intermediate,,,,,,1,1,,BAO_0000218,8325,In vivo,50597
A,10116.0,Microsomes,CHEMBL621891,Rattus norvegicus,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,,6838,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8326,In vitro,50597
A,10116.0,,CHEMBL621892,Rattus norvegicus,Clearance in Dawley rat,,5353,N,,Intermediate,,,,,,1,1,,BAO_0000218,8327,In vivo,50597
A,10116.0,,CHEMBL621893,Rattus norvegicus,Clearance rat,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8328,In vivo,50597
A,10116.0,,CHEMBL621894,Rattus norvegicus,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8329,In vivo,50597
A,10116.0,,CHEMBL621895,Rattus norvegicus,Clearance rat; Not determined,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8330,In vivo,50597
A,10116.0,,CHEMBL875284,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8331,In vivo,50597
A,10116.0,,CHEMBL618699,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8332,In vivo,50597
A,10116.0,,CHEMBL618700,Rattus norvegicus,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8333,In vivo,50597
A,10116.0,,CHEMBL618701,Rattus norvegicus,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,6211,N,,Intermediate,,,,,,1,1,,BAO_0000218,8334,In vivo,50597
A,10116.0,,CHEMBL876600,Rattus norvegicus,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8335,In vivo,50597
A,10116.0,,CHEMBL618702,Rattus norvegicus,Clearance of compound in rat after 1 mg/kg i.v. administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,8336,In vivo,50597
A,10116.0,,CHEMBL618703,Rattus norvegicus,Compound was evaluated for Hepatic clearance in rat,,3341,N,,Intermediate,,,,,,1,1,,BAO_0000218,8337,In vivo,50597
A,10116.0,,CHEMBL618704,Rattus norvegicus,In vivo clearance after 5 mg/kg dose,,4891,N,,Intermediate,,,,,,1,1,,BAO_0000218,8338,In vivo,50597
A,10116.0,,CHEMBL618705,Rattus norvegicus,Compound was tested for plasma clearance in rats,,1094,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8339,In vivo,50597
A,10116.0,,CHEMBL618706,Rattus norvegicus,Hepatic clearance after intravenous administration was evaluated in rat,,2938,N,,Intermediate,,,,,,1,1,,BAO_0000218,8340,In vivo,50597
A,10116.0,,CHEMBL618707,Rattus norvegicus,Lower clearance in rat (i.v.) at 0.5 mpk,,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,8341,In vivo,50597
A,10116.0,,CHEMBL618708,Rattus norvegicus,Pharmacokinetic parameter expressed as plasma clearance in rat,,6049,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8342,In vivo,50597
A,10116.0,,CHEMBL618709,Rattus norvegicus,Pharmacokinetic property (Clp) in rat,,5789,N,,Intermediate,,,,,,1,1,,BAO_0000218,8343,In vivo,50597
A,10116.0,,CHEMBL618710,Rattus norvegicus,Plasma clearance in Sprague-Dawley rats,,4514,N,,Intermediate,,,,,,1,1,,BAO_0000218,8344,In vivo,50597
A,10116.0,,CHEMBL618711,Rattus norvegicus,Plasma clearance (Clp) in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,8345,In vivo,50597
A,10116.0,,CHEMBL618712,Rattus norvegicus,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,8346,In vivo,50597
A,10116.0,,CHEMBL618713,Rattus norvegicus,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,8347,In vivo,50597
A,10116.0,,CHEMBL618714,Rattus norvegicus,Plasma clearance after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,8348,In vivo,50597
A,10116.0,,CHEMBL618715,Rattus norvegicus,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,4521,N,,Intermediate,,,,,,1,1,,BAO_0000218,8349,In vivo,50597
A,10116.0,,CHEMBL618716,Rattus norvegicus,Plasma clearance in rat was determined,,1742,N,,Intermediate,,,,,,1,1,,BAO_0000218,8350,In vivo,50597
A,10116.0,,CHEMBL876601,Rattus norvegicus,Plasma clearance measured in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,8351,In vivo,50597
A,10116.0,,CHEMBL618717,Rattus norvegicus,Plasma clearance was calculated in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,8352,In vivo,50597
A,10116.0,,CHEMBL618718,Rattus norvegicus,Plasma clearance in rat,,5145,N,,Intermediate,,,,,,1,1,,BAO_0000218,8353,In vivo,50597
A,10116.0,,CHEMBL618719,Rattus norvegicus,Plasma clearance in rat,,5833,N,,Intermediate,,,,,,1,1,,BAO_0000218,8354,In vivo,50597
A,10116.0,,CHEMBL618720,Rattus norvegicus,Plasma clearance in rat,,6453,N,,Intermediate,,,,,,1,1,,BAO_0000218,8355,In vivo,50597
A,10116.0,,CHEMBL618721,Rattus norvegicus,Plasma clearance in rat,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,8356,In vivo,50597
A,10116.0,,CHEMBL621477,Rattus norvegicus,Plasma clearance in rats,,6305,N,,Intermediate,,,,,,1,1,,BAO_0000218,8357,In vivo,50597
A,10116.0,,CHEMBL621478,Rattus norvegicus,Plasma clearance in rat,,6642,N,,Intermediate,,,,,,1,1,,BAO_0000218,8358,In vivo,50597
A,10116.0,,CHEMBL621479,Rattus norvegicus,Plasma clearance was evaluated in rat,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,8359,In vivo,50597
A,10116.0,,CHEMBL621480,Rattus norvegicus,Plasma clearance was evaluated in rat; Not tested,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,8360,In vivo,50597
A,10116.0,,CHEMBL621481,Rattus norvegicus,Plasma clearance rate was determined for the compound in rat,,5144,N,,Intermediate,,,,,,1,1,,BAO_0000218,8361,In vivo,50597
A,10116.0,,CHEMBL621482,Rattus norvegicus,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8362,In vivo,50597
A,10116.0,,CHEMBL621483,Rattus norvegicus,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8363,In vivo,50597
A,10116.0,,CHEMBL621484,Rattus norvegicus,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,8364,In vivo,50597
A,10116.0,,CHEMBL621485,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8365,In vivo,50597
A,10116.0,,CHEMBL621486,Rattus norvegicus,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8366,In vivo,50597
A,10116.0,,CHEMBL621487,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8367,In vivo,50597
A,10116.0,,CHEMBL621488,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8368,In vivo,50597
A,10116.0,,CHEMBL621489,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8369,In vivo,50597
A,10116.0,,CHEMBL621490,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8370,In vivo,50597
A,10116.0,,CHEMBL621491,Rattus norvegicus,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,8371,In vivo,50597
A,10116.0,,CHEMBL621492,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8372,In vivo,50597
A,10116.0,,CHEMBL621493,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8373,In vivo,50597
A,10116.0,,CHEMBL621494,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8374,In vivo,50597
A,10116.0,,CHEMBL621495,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8375,In vivo,50597
A,10116.0,,CHEMBL621496,Rattus norvegicus,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8376,In vivo,50597
A,10116.0,,CHEMBL621497,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8377,In vivo,50597
A,10116.0,,CHEMBL621498,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8378,In vivo,50597
A,10116.0,,CHEMBL621499,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8379,In vivo,50597
A,10116.0,,CHEMBL618634,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8380,In vivo,50597
A,10116.0,,CHEMBL618635,Rattus norvegicus,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8381,In vivo,50597
A,10116.0,,CHEMBL618636,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8382,In vivo,50597
A,10116.0,,CHEMBL619737,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8383,In vivo,50597
A,10116.0,,CHEMBL619738,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8384,In vivo,50597
A,10116.0,,CHEMBL624329,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8385,In vivo,50597
A,10116.0,,CHEMBL624330,Rattus norvegicus,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8386,In vivo,50597
A,10116.0,,CHEMBL624331,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8387,In vivo,50597
A,10116.0,,CHEMBL624332,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8388,In vivo,50597
A,10116.0,,CHEMBL624333,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8389,In vivo,50597
A,10116.0,,CHEMBL624334,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8390,In vivo,50597
A,10116.0,,CHEMBL624335,Rattus norvegicus,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8391,In vivo,50597
A,10116.0,,CHEMBL620016,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8392,In vivo,50597
A,10116.0,,CHEMBL620169,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8393,In vivo,50597
A,10116.0,,CHEMBL620170,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8394,In vivo,50597
A,10116.0,,CHEMBL620171,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8395,In vivo,50597
A,10116.0,,CHEMBL620172,Rattus norvegicus,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8396,In vivo,50597
A,10116.0,,CHEMBL620173,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8397,In vivo,50597
A,10116.0,,CHEMBL620174,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8398,In vivo,50597
A,10116.0,,CHEMBL620175,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8399,In vivo,50597
A,10116.0,,CHEMBL620176,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8400,In vivo,50597
A,10116.0,,CHEMBL620177,Rattus norvegicus,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,8401,In vivo,50597
A,10116.0,,CHEMBL620178,Rattus norvegicus,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8402,,50597
A,10116.0,,CHEMBL620179,Rattus norvegicus,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8403,,50597
A,10116.0,,CHEMBL620180,Rattus norvegicus,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8404,,50597
A,10116.0,,CHEMBL620181,Rattus norvegicus,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,8405,In vivo,50597
A,10116.0,,CHEMBL620182,Rattus norvegicus,Volume of distribution of compound in rats after intravenous administration,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,8406,In vivo,50597
A,10116.0,,CHEMBL620183,Rattus norvegicus,Volume of distribution in rat,,6453,N,,Intermediate,,,,,,1,1,,BAO_0000218,8407,In vivo,50597
A,10116.0,,CHEMBL620184,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8408,In vivo,50597
A,10116.0,,CHEMBL620185,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8409,In vivo,50597
A,10116.0,,CHEMBL620186,Rattus norvegicus,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,8410,In vivo,50597
A,10116.0,,CHEMBL620187,Rattus norvegicus,Volume of distribution was determined in Dawley rat,,5353,N,,Intermediate,,,,,,1,1,,BAO_0000218,8411,In vivo,50597
A,10116.0,,CHEMBL620188,Rattus norvegicus,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8412,In vivo,50597
A,10116.0,,CHEMBL620189,Rattus norvegicus,Volume of distribution was reported in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8413,In vivo,50597
A,10116.0,,CHEMBL620190,Rattus norvegicus,Volumes of distribution in rat after peroral administration,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8414,In vivo,50597
A,10116.0,,CHEMBL620191,Rattus norvegicus,Volumes of distribution in rat after po administration,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8415,In vivo,50597
A,10116.0,,CHEMBL620192,Rattus norvegicus,Volumes of distribution in rat after po administration; Not determined,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,8416,In vivo,50597
A,10116.0,,CHEMBL620193,Rattus norvegicus,Pharmacokinetic property (Volume) in rat i.v.,,5676,N,,Intermediate,,,,,,1,1,,BAO_0000218,8417,In vivo,50597
A,10116.0,,CHEMBL620194,Rattus norvegicus,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,8418,In vivo,50597
A,10116.0,,CHEMBL876730,Rattus norvegicus,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",,17670,N,,Intermediate,,,,,,1,1,,BAO_0000218,8419,In vivo,50597
A,10116.0,,CHEMBL620195,Rattus norvegicus,Volume distribution in rat after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,8420,In vivo,50597
A,10116.0,,CHEMBL620196,Rattus norvegicus,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,,5408,N,,Intermediate,,,,,,1,1,,BAO_0000218,8421,In vivo,50597
A,10116.0,,CHEMBL620197,Rattus norvegicus,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,8422,In vivo,50597
A,10116.0,,CHEMBL620198,Rattus norvegicus,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,,6647,N,,Intermediate,,,,,,1,1,,BAO_0000218,8423,In vivo,50597
A,10116.0,,CHEMBL620199,Rattus norvegicus,Volume of distribution in rats,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,8424,In vivo,50597
A,10116.0,,CHEMBL620200,Rattus norvegicus,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,8425,In vivo,50597
A,10116.0,,CHEMBL620201,Rattus norvegicus,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,8426,In vivo,50597
A,10116.0,,CHEMBL620202,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8427,In vivo,50597
A,10116.0,,CHEMBL620203,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8428,In vivo,50597
A,10116.0,,CHEMBL620204,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8429,In vivo,50597
A,10116.0,,CHEMBL620205,Rattus norvegicus,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8430,In vivo,50597
A,10116.0,,CHEMBL624664,Rattus norvegicus,Pharmacokinetic parameter (Vss) in rat,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,8431,In vivo,50597
A,10116.0,,CHEMBL624665,Rattus norvegicus,Pharmacokinetic property (Volume) in rat i.v.,,5676,N,,Intermediate,,,,,,1,1,,BAO_0000218,8432,In vivo,50597
A,10116.0,,CHEMBL624666,Rattus norvegicus,Pharmacokinetic property (Vss) in rat,,5948,N,,Intermediate,,,,,,1,1,,BAO_0000218,8433,,50597
A,10116.0,,CHEMBL624667,Rattus norvegicus,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,,5979,N,,Intermediate,,,,,,1,1,,BAO_0000218,8434,In vivo,50597
A,10116.0,,CHEMBL624668,Rattus norvegicus,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,8435,In vivo,50597
A,10116.0,,CHEMBL624669,Rattus norvegicus,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,8436,In vivo,50597
A,10116.0,,CHEMBL624670,Rattus norvegicus,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,8437,In vivo,50597
A,10116.0,,CHEMBL624671,Rattus norvegicus,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,8438,In vivo,50597
A,10116.0,,CHEMBL624672,Rattus norvegicus,Steady state volume distribution in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,8439,In vivo,50597
A,10116.0,,CHEMBL624673,Rattus norvegicus,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8440,In vivo,50597
A,10116.0,,CHEMBL624674,Rattus norvegicus,Steady state volume of distribution determined in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,8441,In vivo,50597
A,10116.0,,CHEMBL624675,Rattus norvegicus,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,8442,In vivo,50597
A,10116.0,,CHEMBL621728,Rattus norvegicus,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,8443,In vivo,50597
A,10116.0,,CHEMBL621729,Rattus norvegicus,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,8444,,50597
A,10116.0,,CHEMBL621730,Rattus norvegicus,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,8445,,50597
A,10116.0,,CHEMBL621731,Rattus norvegicus,Volume distribution in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,8446,In vivo,50597
A,10116.0,,CHEMBL621732,Rattus norvegicus,Volume distribution in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,8447,In vivo,50597
A,10116.0,,CHEMBL621908,Rattus norvegicus,Volume in steady state distribution value was determined,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,8448,In vivo,50597
A,10116.0,,CHEMBL875347,Rattus norvegicus,Volume in steady state distribution value was determined; ND denotes no data,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,8449,In vivo,50597
A,10116.0,,CHEMBL621909,Rattus norvegicus,Volume in steady state distribution value was determined; ND denotes not determined,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,8450,In vivo,50597
A,10116.0,,CHEMBL621910,Rattus norvegicus,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,N,,Intermediate,,,,,,1,1,,BAO_0000218,8451,In vivo,50597
A,10116.0,,CHEMBL621911,Rattus norvegicus,Volume of distribution at steady state was evaluated in rats,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,8452,In vivo,50597
A,10116.0,,CHEMBL621912,Rattus norvegicus,Volume of distribution at steady state was observed after intravenous administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,8453,In vivo,50597
A,10116.0,,CHEMBL621913,Rattus norvegicus,Volume of distribution in steady state was determined in rat,,6485,N,,Intermediate,,,,,,1,1,,BAO_0000218,8454,In vivo,50597
A,10116.0,,CHEMBL621914,Rattus norvegicus,Volume of distribution in steady state was determined in rat,,17655,N,,Intermediate,,,,,,1,1,,BAO_0000218,8455,In vivo,50597
A,10116.0,,CHEMBL621915,Rattus norvegicus,Volume of distribution after i.v. administration,,6616,N,,Intermediate,,,,,,1,1,,BAO_0000218,8456,In vivo,50597
A,10116.0,,CHEMBL621916,Rattus norvegicus,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,8457,In vivo,50597
A,10090.0,,CHEMBL621917,Mus musculus,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,16438,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8458,In vivo,50594
A,10090.0,,CHEMBL621918,Mus musculus,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,16438,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8459,In vivo,50594
A,10090.0,,CHEMBL621919,Mus musculus,Biodistribution of compound (oxidized form) in spleen tissue,,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8460,In vivo,50594
A,10090.0,,CHEMBL621920,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8461,In vivo,50594
A,10090.0,,CHEMBL621921,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8462,In vivo,50594
A,10090.0,,CHEMBL622401,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8463,In vivo,50594
A,10090.0,,CHEMBL875348,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8464,In vivo,50594
A,10090.0,,CHEMBL622402,Mus musculus,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8465,In vivo,50594
A,10090.0,,CHEMBL622403,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,,16438,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8466,In vivo,50594
A,10090.0,,CHEMBL622404,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8467,In vivo,50594
A,10090.0,,CHEMBL622405,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,,16438,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8468,In vivo,50594
A,10090.0,,CHEMBL622406,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8469,In vivo,50594
A,10090.0,,CHEMBL622407,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8470,In vivo,50594
A,10090.0,,CHEMBL622408,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,,16438,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8471,In vivo,50594
A,10090.0,,CHEMBL622409,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8472,In vivo,50594
A,10090.0,,CHEMBL622410,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8473,In vivo,50594
A,10090.0,,CHEMBL622411,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,,16438,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8474,In vivo,50594
A,10090.0,,CHEMBL627864,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",,16438,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8475,In vivo,50594
A,10090.0,,CHEMBL627865,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8476,In vivo,50594
A,10090.0,,CHEMBL627866,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,,16438,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8477,In vivo,50594
A,10090.0,,CHEMBL627751,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8478,In vivo,50594
A,10090.0,,CHEMBL627752,Mus musculus,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8479,In vivo,50594
A,10090.0,,CHEMBL627753,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8480,In vivo,50594
A,10090.0,,CHEMBL627754,Mus musculus,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",,16438,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8481,In vivo,50594
A,10090.0,,CHEMBL627755,Mus musculus,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,,12467,N,,Intermediate,,,,,,1,1,,BAO_0000218,8482,,50594
A,10090.0,,CHEMBL627756,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8483,In vivo,50594
A,10090.0,,CHEMBL627757,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8484,In vivo,50594
A,10090.0,,CHEMBL627758,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8485,In vivo,50594
A,10090.0,,CHEMBL627759,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8486,In vivo,50594
A,10090.0,,CHEMBL627760,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8487,In vivo,50594
A,10090.0,,CHEMBL627761,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8488,In vivo,50594
A,10090.0,,CHEMBL876811,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8489,In vivo,50594
A,10090.0,,CHEMBL627762,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8490,In vivo,50594
A,10090.0,,CHEMBL627763,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8491,In vivo,50594
A,10090.0,,CHEMBL627764,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8492,In vivo,50594
A,10090.0,,CHEMBL627765,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8493,In vivo,50594
A,10090.0,,CHEMBL627766,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8494,In vivo,50594
A,10090.0,,CHEMBL627767,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8495,In vivo,50594
A,10090.0,,CHEMBL627768,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8496,In vivo,50594
A,10090.0,,CHEMBL628422,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8497,In vivo,50594
A,10090.0,,CHEMBL628423,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8498,In vivo,50594
A,10116.0,,CHEMBL628424,Rattus norvegicus,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,,5089,N,,Intermediate,,,,,,1,1,,BAO_0000218,8499,In vivo,50597
A,10116.0,,CHEMBL628425,Rattus norvegicus,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,,5089,N,,Intermediate,,,,,,1,1,,BAO_0000218,8500,In vivo,50597
A,10116.0,,CHEMBL628426,Rattus norvegicus,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,,4257,N,,Intermediate,,,,,,1,1,,BAO_0000218,8501,In vivo,50597
A,10116.0,,CHEMBL628427,Rattus norvegicus,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,6679,N,,Intermediate,,,,,,1,1,,BAO_0000218,8502,In vivo,50597
A,10116.0,,CHEMBL626938,Rattus norvegicus,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,5546,N,,Intermediate,,,,,,1,1,,BAO_0000218,8503,In vivo,50597
A,10116.0,,CHEMBL626939,Rattus norvegicus,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,6141,N,,Intermediate,,,,,,1,1,,BAO_0000218,8504,In vivo,50597
A,10116.0,,CHEMBL626940,Rattus norvegicus,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8505,In vivo,50597
A,10116.0,,CHEMBL626941,Rattus norvegicus,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8506,In vivo,50597
A,10116.0,,CHEMBL626942,Rattus norvegicus,Plasma clearance was reported in Sprague-Dawley rat,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,8507,In vivo,50597
A,10116.0,,CHEMBL876812,Rattus norvegicus,Plasma clearance after intravenous administration (1 mg/kg) in rat,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,8508,In vivo,50597
A,10116.0,,CHEMBL626943,Rattus norvegicus,Plasma clearance of compound in rats was evaluated,,6848,N,,Intermediate,,,,,,1,1,,BAO_0000218,8509,In vivo,50597
A,10116.0,,CHEMBL626944,Rattus norvegicus,Plasma clearance of compound in rats was evaluated; ND indicates not determined,,6848,N,,Intermediate,,,,,,1,1,,BAO_0000218,8510,In vivo,50597
A,10116.0,,CHEMBL626945,Rattus norvegicus,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,8511,In vivo,50597
A,10116.0,,CHEMBL626946,Rattus norvegicus,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,8512,In vivo,50597
A,10116.0,,CHEMBL626856,Rattus norvegicus,Plasma clearance rate in Sprague-Dawley rats,,4956,N,,Intermediate,,,,,,1,1,,BAO_0000218,8513,In vivo,50597
A,10116.0,,CHEMBL626857,Rattus norvegicus,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),,5529,N,,Intermediate,,,,,,1,1,,BAO_0000218,8514,In vivo,50597
A,10116.0,,CHEMBL626858,Rattus norvegicus,The compound was evaluated for plasma clearance in rat,,406,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8515,In vivo,50597
A,10116.0,,CHEMBL627018,Rattus norvegicus,Total plasma clearance in rat,,17655,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8516,In vivo,50597
A,10116.0,,CHEMBL625331,Rattus norvegicus,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,,3293,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8517,In vivo,50597
A,10116.0,,CHEMBL625332,Rattus norvegicus,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,,4075,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8518,In vivo,50597
A,10116.0,,CHEMBL877590,Rattus norvegicus,C max was determined at 10 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,8519,In vivo,50597
A,10116.0,,CHEMBL625333,Rattus norvegicus,C max was determined at 3 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,8520,In vivo,50597
A,10116.0,,CHEMBL625334,Rattus norvegicus,Cmax after repeated oral dose of compound at 1 mg/kg in rats,,17594,N,,Intermediate,,,,,,1,1,,BAO_0000218,8521,In vivo,50597
A,10116.0,,CHEMBL625335,Rattus norvegicus,Cmax after single intravenous bolus of 1 mg/kg in rats,,17594,N,,Intermediate,,,,,,1,1,,BAO_0000218,8522,In vivo,50597
A,10116.0,,CHEMBL625336,Rattus norvegicus,Cmax of compound at 5 mg/kg after po administration was determined in rat,,4762,N,,Intermediate,,,,,,1,1,,BAO_0000218,8523,In vivo,50597
A,10116.0,,CHEMBL625337,Rattus norvegicus,Cmax 24 hr after 10 mg/kg oral administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,8524,In vivo,50597
A,10116.0,,CHEMBL625338,Rattus norvegicus,Cmax 24 hr after 2 mg/kg oral administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,8525,In vivo,50597
A,10116.0,,CHEMBL625339,Rattus norvegicus,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8526,In vivo,50597
A,10116.0,,CHEMBL625340,Rattus norvegicus,Cmax in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,8527,In vivo,50597
A,10116.0,,CHEMBL625341,Rattus norvegicus,Cmax in rat after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,8528,In vivo,50597
A,10116.0,,CHEMBL622687,Rattus norvegicus,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,8529,In vivo,50597
A,10116.0,,CHEMBL622688,Rattus norvegicus,Cmax wa determined in rat plasma at 30 mg/kg after po administration,,6515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8530,In vivo,50597
A,10116.0,,CHEMBL622689,Rattus norvegicus,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,,11149,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8531,In vivo,50597
A,10116.0,,CHEMBL620295,Rattus norvegicus,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,,11149,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8532,In vivo,50597
A,10116.0,,CHEMBL620296,Rattus norvegicus,Cmax after 10 mg/kg oral administration in rat,,17858,N,,Intermediate,,,,,,1,1,,BAO_0000218,8533,In vivo,50597
A,10116.0,,CHEMBL620297,Rattus norvegicus,Cmax after IV dosing at 0.5 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8534,In vivo,50597
A,10116.0,,CHEMBL620298,Rattus norvegicus,Cmax after IV dosing at 1 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8535,In vivo,50597
A,10116.0,,CHEMBL620299,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,8536,In vivo,50597
A,10116.0,,CHEMBL620300,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats; Not performed.,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,8537,In vivo,50597
A,10116.0,,CHEMBL620301,Rattus norvegicus,Cmax after oral administration at 20 mpk in rats d; Not performed.,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,8538,In vivo,50597
A,10116.0,,CHEMBL620302,Rattus norvegicus,Cmax after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,8539,In vivo,50597
A,10116.0,,CHEMBL620303,Rattus norvegicus,Cmax after oral administration at a dose of 2 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8540,In vivo,50597
A,10116.0,,CHEMBL620304,Rattus norvegicus,Cmax after oral administration at a dose of 4 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,8541,In vivo,50597
A,10116.0,,CHEMBL620305,Rattus norvegicus,Cmax in rats after 20 mg/kg oral dose,,6113,N,,Intermediate,,,,,,1,1,,BAO_0000218,8542,In vivo,50597
A,10116.0,,CHEMBL620306,Rattus norvegicus,Cmax after peroral administration in rats at 2.4 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,8543,In vivo,50597
A,10116.0,,CHEMBL620307,Rattus norvegicus,Cmax at the dose of 2 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,8544,In vivo,50597
A,10116.0,,CHEMBL620308,Rattus norvegicus,Cmax at the dose of 5 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,8545,In vivo,50597
A,10116.0,,CHEMBL620309,Rattus norvegicus,Cmax by administering at 20 mg/kg p.o. in rats,,6402,N,,Intermediate,,,,,,1,1,,BAO_0000218,8546,In vivo,50597
A,10116.0,,CHEMBL620310,Rattus norvegicus,Cmax in male rat,,5610,N,,Intermediate,,,,,,1,1,,BAO_0000218,8547,In vivo,50597
A,10116.0,,CHEMBL620311,Rattus norvegicus,Cmax in rat,,5207,N,,Intermediate,,,,,,1,1,,BAO_0000218,8548,In vivo,50597
A,10116.0,,CHEMBL620312,Rattus norvegicus,Cmax in rat,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,8549,In vivo,50597
A,10116.0,,CHEMBL620313,Rattus norvegicus,Cmax in rat,,6504,N,,Intermediate,,,,,,1,1,,BAO_0000218,8550,In vivo,50597
A,10116.0,,CHEMBL620314,Rattus norvegicus,Cmax in rat at 10 mg/kg,,6046,N,,Intermediate,,,,,,1,1,,BAO_0000218,8551,In vivo,50597
A,10116.0,,CHEMBL620315,Rattus norvegicus,Cmax in rat at the dose of 1 mg/kg i.v.,,6504,N,,Intermediate,,,,,,1,1,,BAO_0000218,8552,In vivo,50597
A,10116.0,,CHEMBL620316,Rattus norvegicus,Cmax in rat by po administration at a dose of 40 mg/kg,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,8553,In vivo,50597
A,10116.0,,CHEMBL620317,Rattus norvegicus,Cmax in rat p.o. at 20 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,8554,In vivo,50597
A,10116.0,,CHEMBL620318,Rattus norvegicus,Cmax in rats,,5836,N,,Intermediate,,,,,,1,1,,BAO_0000218,8555,In vivo,50597
A,10116.0,,CHEMBL620319,Rattus norvegicus,Cmax in rats,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,8556,In vivo,50597
A,10116.0,,CHEMBL620320,Rattus norvegicus,Cmax was evaluated after 20 uM/kg of peroral administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,8557,In vivo,50597
A,10116.0,,CHEMBL620321,Rattus norvegicus,Cmax was measured in rats after peroral administration at 3 mg/kg,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,8558,In vivo,50597
A,10116.0,,CHEMBL620322,Rattus norvegicus,Cmax value after oral dose at a dose of 10 mg/kg in rats.,,1908,N,,Intermediate,,,,,,1,1,,BAO_0000218,8559,In vivo,50597
A,10116.0,,CHEMBL620323,Rattus norvegicus,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8560,,50597
A,10116.0,,CHEMBL620324,Rattus norvegicus,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Frontal cortex,1870.0,,1,1,,BAO_0000218,8561,,50597
A,10116.0,,CHEMBL620325,Rattus norvegicus,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Frontal cortex,1870.0,,1,1,,BAO_0000218,8562,,50597
A,10116.0,,CHEMBL620326,Rattus norvegicus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8563,,50597
A,10116.0,,CHEMBL620327,Rattus norvegicus,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8564,,50597
A,10116.0,,CHEMBL620328,Rattus norvegicus,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8565,,50597
A,10116.0,,CHEMBL620329,Rattus norvegicus,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8566,,50597
A,10116.0,,CHEMBL620330,Rattus norvegicus,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Midbrain,1891.0,,1,1,,BAO_0000218,8567,,50597
A,10116.0,,CHEMBL875286,Rattus norvegicus,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Midbrain,1891.0,,1,1,,BAO_0000218,8568,,50597
A,10116.0,,CHEMBL620331,Rattus norvegicus,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8569,,50597
A,10116.0,,CHEMBL620332,Rattus norvegicus,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,,,,1,1,,BAO_0000218,8570,,50597
A,10116.0,,CHEMBL620333,Rattus norvegicus,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8571,,50597
A,10116.0,,CHEMBL620334,Rattus norvegicus,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,,13950,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8572,,50597
A,10116.0,,CHEMBL621015,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8573,,50597
A,10116.0,,CHEMBL621016,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8574,,50597
A,10116.0,,CHEMBL621191,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8575,,50597
A,10116.0,,CHEMBL621192,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8576,,50597
A,10116.0,,CHEMBL621193,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8577,,50597
A,10116.0,,CHEMBL621194,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8578,,50597
A,10116.0,,CHEMBL624204,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8579,,50597
A,10116.0,,CHEMBL624205,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8580,,50597
A,10116.0,,CHEMBL624206,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8581,,50597
A,10116.0,,CHEMBL624207,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8582,,50597
A,10116.0,,CHEMBL624208,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8583,,50597
A,10116.0,,CHEMBL624209,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8584,,50597
A,10116.0,,CHEMBL624210,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8585,,50597
A,10116.0,,CHEMBL624211,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8586,,50597
A,10116.0,,CHEMBL624212,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8587,,50597
A,10116.0,,CHEMBL624213,Rattus norvegicus,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8588,,50597
A,10116.0,,CHEMBL876611,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8589,,50597
A,10116.0,,CHEMBL624214,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8590,,50597
A,10116.0,,CHEMBL624215,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8591,,50597
A,10116.0,,CHEMBL624216,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8592,,50597
A,10116.0,,CHEMBL624217,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8593,,50597
A,10116.0,,CHEMBL624218,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8594,,50597
A,10116.0,,CHEMBL624219,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8595,,50597
A,10116.0,,CHEMBL624220,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8596,,50597
A,10116.0,,CHEMBL624221,Rattus norvegicus,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8597,,50597
A,10116.0,,CHEMBL624222,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8598,,50597
A,10116.0,,CHEMBL624223,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8599,,50597
A,10116.0,,CHEMBL624224,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8600,,50597
A,10116.0,,CHEMBL624225,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8601,,50597
A,10116.0,,CHEMBL622420,Rattus norvegicus,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,8602,In vivo,50597
A,10116.0,,CHEMBL622421,Rattus norvegicus,Volume of steady state distribution after i.v. administration in rats,,5031,N,,Intermediate,,,,,,1,1,,BAO_0000218,8603,In vivo,50597
A,10116.0,,CHEMBL622422,Rattus norvegicus,Vss after intravenous administration (5.0 mg/kg) was determined in rat,,6215,N,,Intermediate,,,,,,1,1,,BAO_0000218,8604,In vivo,50597
A,10116.0,,CHEMBL622423,Rattus norvegicus,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,8605,In vivo,50597
A,10116.0,,CHEMBL622424,Rattus norvegicus,Vss was determined,,17752,N,,Intermediate,,,,,,1,1,,BAO_0000218,8606,In vivo,50597
A,10116.0,,CHEMBL622425,Rattus norvegicus,Vss in rat,,6596,N,,Intermediate,,,,,,1,1,,BAO_0000218,8607,In vivo,50597
A,10116.0,,CHEMBL876612,Rattus norvegicus,Vss was evaluated after 10 uM/kg of intra arterial administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,8608,In vivo,50597
A,10116.0,,CHEMBL622426,Rattus norvegicus,volume of distribution at steady state was observed after intravenous administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,8609,In vivo,50597
A,10116.0,,CHEMBL622427,Rattus norvegicus,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,8610,In vivo,50597
A,10116.0,,CHEMBL622428,Rattus norvegicus,Pharmacokinetic (PK) parameter Vz in rat,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,8611,In vivo,50597
A,10116.0,,CHEMBL622429,Rattus norvegicus,Volume distribution in rats,,4942,N,,Intermediate,,,,,,1,1,,BAO_0000218,8612,In vivo,50597
A,10116.0,,CHEMBL622430,Rattus norvegicus,Volume of distribution in rat; No data,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,8613,In vivo,50597
A,10116.0,,CHEMBL622431,Rattus norvegicus,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,8614,In vivo,50597
A,10116.0,,CHEMBL622432,Rattus norvegicus,% absorption predicted from in vitro rat ileum transport studies,,15765,N,,Intermediate,,,Ileum,2116.0,,1,1,,BAO_0000218,8615,,50597
A,10116.0,,CHEMBL622433,Rattus norvegicus,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8616,In vivo,50597
A,10116.0,,CHEMBL622434,Rattus norvegicus,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8617,In vivo,50597
A,10116.0,,CHEMBL622435,Rattus norvegicus,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8618,In vivo,50597
A,10116.0,,CHEMBL618748,Rattus norvegicus,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8619,In vivo,50597
A,10116.0,,CHEMBL618749,Rattus norvegicus,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8620,In vivo,50597
A,10116.0,,CHEMBL618750,Rattus norvegicus,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8621,In vivo,50597
A,10116.0,,CHEMBL618751,Rattus norvegicus,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8622,In vivo,50597
A,10116.0,,CHEMBL618752,Rattus norvegicus,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,,13569,N,,Intermediate,,,,,,1,1,,BAO_0000218,8623,In vivo,50597
A,10116.0,,CHEMBL618753,Rattus norvegicus,Oral bioavailability in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,8624,In vivo,50597
A,10116.0,,CHEMBL618754,Rattus norvegicus,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,,750,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8625,In vivo,50597
A,10116.0,,CHEMBL618755,Rattus norvegicus,Oral bioavailability in rat,,750,N,,Intermediate,,,,,,1,1,,BAO_0000218,8626,In vivo,50597
A,10116.0,,CHEMBL618756,Rattus norvegicus,Oral bioavailability in rat,,4590,N,,Intermediate,,,,,,1,1,,BAO_0000218,8627,In vivo,50597
A,10116.0,,CHEMBL618757,Rattus norvegicus,Oral bioavailability in rat,,1716,N,,Intermediate,,,,,,1,1,,BAO_0000218,8628,In vivo,50597
A,10116.0,,CHEMBL618758,Rattus norvegicus,Bioavailability in rat,,1974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8629,In vivo,50597
A,10116.0,,CHEMBL621088,Rattus norvegicus,Oral bioavailability in rat (dose 30 mg/kg),,4502,N,,Intermediate,,,,,,1,1,,BAO_0000218,8630,In vivo,50597
A,10116.0,,CHEMBL621089,Rattus norvegicus,Pharmacokinetic property (cLogP) in rat,,3371,N,,Intermediate,,,,,,1,1,,BAO_0000218,8631,,50597
F,10116.0,,CHEMBL621090,Rattus norvegicus,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,,9099,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8632,,50597
F,10116.0,,CHEMBL621091,Rattus norvegicus,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,,9099,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8633,,50597
A,10116.0,,CHEMBL876731,Rattus norvegicus,Clearance in rat.,,4590,N,,Intermediate,,,,,,1,1,,BAO_0000218,8634,In vivo,50597
A,10116.0,,CHEMBL621092,Rattus norvegicus,Compound was evaluated for its clearance when administered intravenously in rat,,3184,N,,Intermediate,,,,,,1,1,,BAO_0000218,8635,In vivo,50597
A,10116.0,,CHEMBL621093,Rattus norvegicus,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,16456,N,,Intermediate,,,,,,1,1,,BAO_0000218,8636,In vivo,50597
A,10116.0,,CHEMBL621094,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat,,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,8637,,50597
A,10116.0,,CHEMBL621095,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,8638,,50597
A,10116.0,,CHEMBL621096,Rattus norvegicus,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,8639,,50597
A,10116.0,,CHEMBL621097,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8640,In vivo,50597
F,10116.0,,CHEMBL621098,Rattus norvegicus,Percent dose excreted in 0-48 hours administered ip to male rat,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,8641,,50597
A,10116.0,,CHEMBL621099,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8642,,50597
A,10116.0,,CHEMBL621100,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8643,,50597
A,10116.0,,CHEMBL621101,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8644,,50597
A,10116.0,,CHEMBL621102,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8645,,50597
A,10116.0,,CHEMBL876732,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,8646,,50597
A,10116.0,,CHEMBL621103,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8647,,50597
A,10116.0,,CHEMBL621104,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8648,,50597
A,10116.0,,CHEMBL621105,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8649,,50597
A,10116.0,,CHEMBL621106,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8650,,50597
A,10116.0,,CHEMBL621107,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8651,,50597
A,10116.0,,CHEMBL621108,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8652,,50597
A,10116.0,,CHEMBL621109,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8653,,50597
A,10090.0,,CHEMBL621110,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8654,In vivo,50594
A,10090.0,,CHEMBL621111,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8655,In vivo,50594
A,10090.0,,CHEMBL622541,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8656,In vivo,50594
A,10090.0,,CHEMBL622542,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8657,In vivo,50594
A,10090.0,,CHEMBL622543,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8658,In vivo,50594
A,10090.0,,CHEMBL624412,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8659,In vivo,50594
A,10090.0,,CHEMBL624413,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8660,In vivo,50594
A,10090.0,,CHEMBL624414,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8661,In vivo,50594
A,10090.0,,CHEMBL624415,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8662,In vivo,50594
A,10090.0,,CHEMBL624416,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8663,In vivo,50594
A,10090.0,,CHEMBL624417,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8664,In vivo,50594
A,10090.0,,CHEMBL624418,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8665,In vivo,50594
A,10090.0,,CHEMBL624419,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8666,In vivo,50594
A,10090.0,,CHEMBL624420,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8667,In vivo,50594
A,10090.0,,CHEMBL624421,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8668,In vivo,50594
A,10090.0,,CHEMBL624422,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8669,In vivo,50594
A,10090.0,,CHEMBL624423,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8670,In vivo,50594
A,10090.0,,CHEMBL625123,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8671,In vivo,50594
A,10090.0,,CHEMBL625124,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8672,In vivo,50594
A,10090.0,,CHEMBL625125,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8673,In vivo,50594
A,10090.0,,CHEMBL625126,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8674,In vivo,50594
A,10090.0,,CHEMBL626947,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8675,In vivo,50594
A,10090.0,,CHEMBL626948,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8676,In vivo,50594
A,10090.0,,CHEMBL626949,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8677,In vivo,50594
A,10090.0,,CHEMBL626950,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8678,In vivo,50594
A,10090.0,,CHEMBL626951,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8679,In vivo,50594
A,10090.0,,CHEMBL626952,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8680,In vivo,50594
A,10090.0,,CHEMBL626953,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8681,In vivo,50594
A,10090.0,,CHEMBL626954,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8682,In vivo,50594
A,10090.0,,CHEMBL626955,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8683,In vivo,50594
A,10090.0,,CHEMBL626956,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8684,In vivo,50594
A,10090.0,,CHEMBL626957,Mus musculus,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,8685,In vivo,50594
A,10090.0,,CHEMBL626958,Mus musculus,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8686,In vivo,50594
A,10090.0,,CHEMBL626959,Mus musculus,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8687,In vivo,50594
A,10090.0,,CHEMBL626960,Mus musculus,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8688,In vivo,50594
A,10090.0,,CHEMBL626961,Mus musculus,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8689,In vivo,50594
A,10090.0,,CHEMBL627589,Mus musculus,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8690,In vivo,50594
A,10090.0,,CHEMBL627590,Mus musculus,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),,17208,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8691,In vivo,50594
A,10090.0,,CHEMBL627591,Mus musculus,Time taken for EC90 was determined when tested in mouse,,3132,N,,Intermediate,,,,,,1,1,,BAO_0000218,8692,,50594
A,10090.0,,CHEMBL627592,Mus musculus,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,,3132,N,,Intermediate,,,,,,1,1,,BAO_0000218,8693,,50594
A,10090.0,,CHEMBL627593,Mus musculus,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),,16597,N,,Intermediate,,,,,,1,1,,BAO_0000218,8694,In vivo,50594
A,10090.0,,CHEMBL627594,Mus musculus,Half life in mice,,5727,N,,Intermediate,,,,,,1,1,,BAO_0000218,8695,,50594
A,10090.0,,CHEMBL876813,Mus musculus,Half life period in mouse after 10 mg/Kg dose,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,8696,In vivo,50594
A,10090.0,,CHEMBL627595,Mus musculus,Half life period in mouse after 10 mg/kg dose,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,8697,In vivo,50594
A,10090.0,,CHEMBL627596,Mus musculus,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,,6348,N,,Intermediate,,,,,,1,1,,BAO_0000218,8698,In vivo,50594
A,10116.0,,CHEMBL627597,Rattus norvegicus,Cmax value at 5 mg/kg po was determined in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,8699,In vivo,50597
A,10116.0,,CHEMBL627598,Rattus norvegicus,Cmax value evaluated in rat,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,8700,In vivo,50597
A,10116.0,,CHEMBL627599,Rattus norvegicus,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,,5206,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8701,In vivo,50597
A,10116.0,,CHEMBL627600,Rattus norvegicus,Cmax value after administration of 20 mg/Kg oral dose in rat,,2959,N,,Intermediate,,,,,,1,1,,BAO_0000218,8702,In vivo,50597
A,10116.0,,CHEMBL627601,Rattus norvegicus,Cmax value at 1 mg/kg po in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,8703,In vivo,50597
A,10116.0,,CHEMBL627776,Rattus norvegicus,Cmax value at 5 mg/kg po in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,8704,In vivo,50597
A,10116.0,,CHEMBL627777,Rattus norvegicus,Cmax value at a dose of 10 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8705,In vivo,50597
A,10116.0,,CHEMBL627778,Rattus norvegicus,Cmax value at a dose of 100 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8706,In vivo,50597
A,10116.0,,CHEMBL627779,Rattus norvegicus,Cmax value at a dose of 50 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,8707,In vivo,50597
A,10116.0,,CHEMBL876814,Rattus norvegicus,Cmax value in rats at 10 mg/kg,,17617,N,,Intermediate,,,,,,1,1,,BAO_0000218,8708,In vivo,50597
A,10116.0,,CHEMBL627780,Rattus norvegicus,Cmax value was evaluated in rats at a dose of 20 mg/kg,,1445,N,,Intermediate,,,,,,1,1,,BAO_0000218,8709,In vivo,50597
A,10116.0,,CHEMBL627781,Rattus norvegicus,Cmax value was determined after peroral administration of 20 mg/kg in rat,,6082,N,,Intermediate,,,,,,1,1,,BAO_0000218,8710,In vivo,50597
A,10116.0,,CHEMBL627782,Rattus norvegicus,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,1446,N,,Intermediate,,,,,,1,1,,BAO_0000218,8711,In vivo,50597
A,10116.0,,CHEMBL627783,Rattus norvegicus,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,,5407,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8712,In vivo,50597
A,10116.0,,CHEMBL627784,Rattus norvegicus,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,,2690,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8713,In vivo,50597
A,10116.0,,CHEMBL627785,Rattus norvegicus,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,8714,In vivo,50597
A,10116.0,,CHEMBL627786,Rattus norvegicus,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,8715,In vivo,50597
A,10116.0,,CHEMBL627787,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,,4891,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8716,In vivo,50597
A,10116.0,,CHEMBL627788,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,,2807,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8717,In vivo,50597
A,10116.0,,CHEMBL626579,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,,2807,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8718,In vivo,50597
A,10116.0,,CHEMBL626580,Rattus norvegicus,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,,2807,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8719,In vivo,50597
A,10116.0,,CHEMBL876815,Rattus norvegicus,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,,3634,N,,Intermediate,,,,,,1,1,,BAO_0000218,8720,In vivo,50597
A,10116.0,,CHEMBL626581,Rattus norvegicus,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,,1881,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8721,In vivo,50597
A,10116.0,,CHEMBL626582,Rattus norvegicus,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,,1881,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8722,In vivo,50597
A,10116.0,,CHEMBL626583,Rattus norvegicus,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,8723,In vivo,50597
A,10116.0,,CHEMBL626205,Rattus norvegicus,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8724,In vivo,50597
A,10116.0,,CHEMBL626206,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8725,In vivo,50597
A,10116.0,,CHEMBL626207,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8726,In vivo,50597
A,10116.0,,CHEMBL623882,Rattus norvegicus,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8727,In vivo,50597
A,10116.0,,CHEMBL623883,Rattus norvegicus,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,8728,In vivo,50597
A,10116.0,,CHEMBL623884,Rattus norvegicus,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,8729,In vivo,50597
A,10116.0,,CHEMBL623885,Rattus norvegicus,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",,3032,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8730,In vivo,50597
A,10116.0,,CHEMBL623886,Rattus norvegicus,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,,6295,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8731,In vivo,50597
A,10116.0,,CHEMBL623887,Rattus norvegicus,Maximal concentration in rat was determined,,6619,N,,Intermediate,,,,,,1,1,,BAO_0000218,8732,In vivo,50597
A,10116.0,,CHEMBL623888,Rattus norvegicus,Maximal concentration after i.v. administration,,6616,N,,Intermediate,,,,,,1,1,,BAO_0000218,8733,In vivo,50597
A,10116.0,,CHEMBL623889,Rattus norvegicus,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,,3249,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8734,In vivo,50597
A,10116.0,,CHEMBL623890,Rattus norvegicus,Maximal plasma concentration in rat after oral administration at 50 mg/kg,,17791,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8735,In vivo,50597
A,10116.0,,CHEMBL623891,Rattus norvegicus,Cmax in rat plasma after oral dose (50 mg/Kg),,17791,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8736,In vivo,50597
A,10116.0,,CHEMBL623892,Rattus norvegicus,Maximal plasma concentration was determined.,,1360,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8737,In vivo,50597
A,10116.0,,CHEMBL623893,Rattus norvegicus,Maximal plasma drug concentration was determined,,2552,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8738,In vivo,50597
A,10116.0,,CHEMBL877616,Rattus norvegicus,Maximal concentration in rats after peroral administration,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,8739,In vivo,50597
A,10116.0,,CHEMBL623894,Rattus norvegicus,Maximum concentration in rat after 2 mg/kg peroral administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,8740,In vivo,50597
A,10116.0,,CHEMBL623895,Rattus norvegicus,Maximum concentration in rat plasma after 5 mg/kg oral gavage,,6567,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8741,In vivo,50597
A,10116.0,,CHEMBL623896,Rattus norvegicus,Maximum concentration of compound in rat was evaluated.,,3031,N,,Intermediate,,,,,,1,1,,BAO_0000218,8742,In vivo,50597
A,10116.0,,CHEMBL623897,Rattus norvegicus,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,,3436,N,,Intermediate,,,,,,1,1,,BAO_0000218,8743,In vivo,50597
A,10116.0,,CHEMBL623898,Rattus norvegicus,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,,3436,N,,Intermediate,,,,,,1,1,,BAO_0000218,8744,In vivo,50597
A,10116.0,,CHEMBL623899,Rattus norvegicus,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,,2083,N,,Intermediate,,,,,,1,1,,BAO_0000218,8745,In vivo,50597
A,10116.0,,CHEMBL623900,Rattus norvegicus,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,,3436,N,,Intermediate,,,,,,1,1,,BAO_0000218,8746,In vivo,50597
A,10116.0,,CHEMBL623901,Rattus norvegicus,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,8747,In vivo,50597
A,10116.0,,CHEMBL623902,Rattus norvegicus,Maximum concentration was evaluated in rats,,1974,N,,Intermediate,,,,,,1,1,,BAO_0000218,8748,In vivo,50597
A,10116.0,,CHEMBL623903,Rattus norvegicus,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,,3307,N,,Intermediate,,,Cerebrospinal fluid,1359.0,,1,1,,BAO_0000218,8749,In vivo,50597
A,10116.0,,CHEMBL623904,Rattus norvegicus,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,,3307,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8750,In vivo,50597
A,10116.0,,CHEMBL877617,Rattus norvegicus,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,,1916,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8751,In vivo,50597
A,10116.0,,CHEMBL623905,Rattus norvegicus,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,,1500,N,,Intermediate,,,,,,1,1,,BAO_0000218,8752,In vivo,50597
A,10116.0,,CHEMBL623906,Rattus norvegicus,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,,1500,N,,Intermediate,,,,,,1,1,,BAO_0000218,8753,In vivo,50597
A,10116.0,,CHEMBL623907,Rattus norvegicus,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,4186,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8754,In vivo,50597
A,10116.0,,CHEMBL623908,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8755,,50597
A,10116.0,,CHEMBL623909,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8756,,50597
A,10116.0,,CHEMBL623910,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8757,,50597
A,10116.0,,CHEMBL623911,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8758,,50597
A,10116.0,,CHEMBL623912,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8759,,50597
A,10116.0,,CHEMBL624616,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8760,,50597
A,10116.0,,CHEMBL624617,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8761,,50597
A,10116.0,,CHEMBL624618,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8762,,50597
A,10116.0,,CHEMBL624619,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8763,,50597
A,10116.0,,CHEMBL624794,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8764,,50597
A,10116.0,,CHEMBL624795,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8765,,50597
A,10116.0,,CHEMBL623921,Rattus norvegicus,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8766,,50597
A,10116.0,,CHEMBL623922,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8767,,50597
A,10116.0,,CHEMBL623923,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8768,,50597
A,10116.0,,CHEMBL623924,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,8769,,50597
A,10116.0,,CHEMBL623925,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8770,,50597
A,10116.0,,CHEMBL623926,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8771,,50597
A,10116.0,,CHEMBL623927,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8772,,50597
A,10116.0,,CHEMBL623928,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8773,,50597
A,10116.0,,CHEMBL623929,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8774,,50597
A,10116.0,,CHEMBL623930,Rattus norvegicus,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,8775,,50597
A,10116.0,,CHEMBL623931,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8776,,50597
A,10116.0,,CHEMBL622165,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8777,,50597
A,10116.0,,CHEMBL621249,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8778,,50597
A,10116.0,,CHEMBL621250,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8779,,50597
A,10116.0,,CHEMBL621448,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8780,,50597
A,10116.0,,CHEMBL621449,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8781,,50597
A,10116.0,,CHEMBL621450,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8782,,50597
A,10116.0,,CHEMBL621451,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8783,,50597
A,10116.0,,CHEMBL621452,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8784,,50597
A,10116.0,,CHEMBL621453,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8785,,50597
A,10116.0,,CHEMBL621454,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8786,,50597
A,10116.0,,CHEMBL621455,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8787,,50597
A,10116.0,,CHEMBL621456,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8788,,50597
A,10116.0,,CHEMBL625145,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8789,,50597
A,10116.0,,CHEMBL875847,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8790,,50597
A,10116.0,,CHEMBL625146,Rattus norvegicus,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8791,,50597
A,10116.0,,CHEMBL625147,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8792,,50597
A,10116.0,,CHEMBL625148,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8793,,50597
A,10116.0,,CHEMBL625149,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8794,,50597
A,10116.0,,CHEMBL625150,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8795,,50597
A,10116.0,,CHEMBL625151,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8796,,50597
A,10116.0,,CHEMBL625152,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8797,,50597
A,10116.0,,CHEMBL625153,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8798,,50597
A,10116.0,,CHEMBL625154,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8799,,50597
A,10116.0,,CHEMBL625155,Rattus norvegicus,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8800,,50597
A,10116.0,,CHEMBL625156,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8801,,50597
A,10116.0,,CHEMBL624354,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,8802,,50597
A,10116.0,,CHEMBL624355,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8803,,50597
A,10116.0,,CHEMBL624356,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8804,,50597
A,10116.0,,CHEMBL624357,Rattus norvegicus,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8805,,50597
A,10116.0,,CHEMBL624358,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,8806,,50597
A,10116.0,,CHEMBL624359,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8807,,50597
A,10116.0,,CHEMBL624360,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8808,,50597
A,10116.0,,CHEMBL624361,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8809,,50597
A,10116.0,,CHEMBL624362,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8810,,50597
A,10116.0,,CHEMBL624363,Rattus norvegicus,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,8811,,50597
A,10116.0,,CHEMBL624364,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8812,In vivo,50597
A,10116.0,,CHEMBL624365,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8813,In vivo,50597
A,10116.0,,CHEMBL624366,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8814,In vivo,50597
A,10116.0,,CHEMBL624367,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8815,In vivo,50597
A,10116.0,,CHEMBL624368,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8816,In vivo,50597
A,10116.0,,CHEMBL624369,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8817,In vivo,50597
A,10116.0,,CHEMBL624370,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8818,In vivo,50597
A,10116.0,,CHEMBL625069,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8819,In vivo,50597
A,10116.0,,CHEMBL625070,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8820,In vivo,50597
A,10116.0,,CHEMBL626051,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8821,In vivo,50597
A,10116.0,,CHEMBL626052,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8822,In vivo,50597
A,10116.0,,CHEMBL626053,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8823,In vivo,50597
A,10116.0,,CHEMBL626054,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8824,In vivo,50597
A,10116.0,,CHEMBL626055,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8825,In vivo,50597
A,10116.0,,CHEMBL626056,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8826,In vivo,50597
A,10116.0,,CHEMBL626057,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8827,In vivo,50597
A,10116.0,,CHEMBL625193,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8828,In vivo,50597
A,10116.0,,CHEMBL625194,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8829,In vivo,50597
A,10116.0,,CHEMBL625195,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8830,In vivo,50597
A,10116.0,,CHEMBL625196,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8831,In vivo,50597
A,10116.0,,CHEMBL625197,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8832,In vivo,50597
A,10116.0,,CHEMBL625198,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8833,In vivo,50597
A,10116.0,,CHEMBL627929,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,8834,In vivo,50597
A,10116.0,,CHEMBL627074,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8835,In vivo,50597
A,10116.0,,CHEMBL627075,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8836,In vivo,50597
A,10116.0,,CHEMBL627076,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8837,In vivo,50597
A,10116.0,,CHEMBL627077,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8838,In vivo,50597
A,10116.0,,CHEMBL627078,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,8839,In vivo,50597
A,10116.0,,CHEMBL627079,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8840,In vivo,50597
A,10090.0,,CHEMBL873824,Mus musculus,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,,4573,N,,Intermediate,,,,,,1,1,,BAO_0000218,8841,In vivo,50594
A,10090.0,,CHEMBL627080,Mus musculus,Half life in mouse plasma was determined at dose 25 mg/kg,,3132,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8842,In vivo,50594
A,10090.0,,CHEMBL627081,Mus musculus,Half life was determined,,17718,N,,Intermediate,,,,,,1,1,,BAO_0000218,8843,,50594
A,10090.0,,CHEMBL627082,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8844,In vivo,50594
A,10090.0,,CHEMBL627083,Mus musculus,Half-life in male mice after 1 mg/kg intravenous dose,,5961,N,,Intermediate,,,,,,1,1,,BAO_0000218,8845,In vivo,50594
A,10090.0,,CHEMBL627085,Mus musculus,Half life in mice plasma,,17731,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8847,,50594
A,10090.0,,CHEMBL627086,Mus musculus,Half life in mouse,,17592,N,,Intermediate,,,,,,1,1,,BAO_0000218,8848,,50594
A,10090.0,,CHEMBL627087,Mus musculus,Half life in mouse plasma at dose 25 mg/kg,,3132,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8849,In vivo,50594
A,10090.0,,CHEMBL627088,Mus musculus,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,,17729,N,,Intermediate,,,,,,1,1,,BAO_0000218,8850,In vivo,50594
A,10090.0,,CHEMBL627089,Mus musculus,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,,17729,N,,Intermediate,,,,,,1,1,,BAO_0000218,8851,In vivo,50594
A,10090.0,,CHEMBL627090,Mus musculus,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,,17729,N,,Intermediate,,,,,,1,1,,BAO_0000218,8852,In vivo,50594
A,10090.0,,CHEMBL627091,Mus musculus,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),,3277,N,,Intermediate,,,,,,1,1,,BAO_0000218,8853,In vivo,50594
A,10090.0,,CHEMBL627092,Mus musculus,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",,3760,N,,Intermediate,,,,,,1,1,,BAO_0000218,8854,In vivo,50594
A,10090.0,,CHEMBL876785,Mus musculus,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",,3760,N,,Intermediate,,,,,,1,1,,BAO_0000218,8855,In vivo,50594
A,10090.0,,CHEMBL627093,Mus musculus,Half-life by iv administration in mouse,,2862,N,,Intermediate,,,,,,1,1,,BAO_0000218,8856,In vivo,50594
A,10090.0,,CHEMBL627094,Mus musculus,Half-life by oral administration in mouse,,2862,N,,Intermediate,,,,,,1,1,,BAO_0000218,8857,In vivo,50594
A,10090.0,,CHEMBL627095,Mus musculus,Half-life in mice,,5980,N,,Intermediate,,,,,,1,1,,BAO_0000218,8858,,50594
A,10090.0,,CHEMBL627096,Mus musculus,Half-life using mouse brain homogenate,,6159,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8859,,50594
A,10090.0,,CHEMBL627097,Mus musculus,Half-life was measured in mice,,6254,N,,Intermediate,,,,,,1,1,,BAO_0000218,8860,,50594
A,10090.0,,CHEMBL627098,Mus musculus,Half-life was measured in mouse after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,8861,In vivo,50594
A,10090.0,,CHEMBL627099,Mus musculus,Half-life period was determined in mouse blood,,1574,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8862,,50594
A,10090.0,,CHEMBL627100,Mus musculus,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",,56,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8863,,50594
A,10090.0,,CHEMBL627101,Mus musculus,Plasma half life in mouse,,993,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8864,,50594
A,10090.0,,CHEMBL627102,Mus musculus,Stability of the peptide in the presence of mouse serum,,6652,N,,Intermediate,,,,,,1,1,,BAO_0000218,8865,,50594
A,10090.0,,CHEMBL627103,Mus musculus,Terminal half life of compound was determined in mouse,,17852,N,,Intermediate,,,,,,1,1,,BAO_0000218,8866,,50594
A,10090.0,,CHEMBL627104,Mus musculus,Terminal half life was evaluated in mice after intravenous administration,,2675,N,,Intermediate,,,,,,1,1,,BAO_0000218,8867,In vivo,50594
A,10090.0,,CHEMBL627105,Mus musculus,Terminal half life was evaluated in mice after oral administration,,2675,N,,Intermediate,,,,,,1,1,,BAO_0000218,8868,In vivo,50594
A,10090.0,,CHEMBL876786,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,,499,N,,Intermediate,,,,,,1,1,,BAO_0000218,8869,,50594
A,10090.0,,CHEMBL873825,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,,499,N,,Intermediate,,,,,,1,1,,BAO_0000218,8870,,50594
A,10090.0,,CHEMBL627106,Mus musculus,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,,499,N,,Intermediate,,,,,,1,1,,BAO_0000218,8871,,50594
A,10090.0,,CHEMBL626336,Mus musculus,half life period is evaluated by administering intravenously at 25 mg/kg in mice,,14239,N,,Intermediate,,,,,,1,1,,BAO_0000218,8872,In vivo,50594
A,10090.0,,CHEMBL877462,Mus musculus,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",,5506,N,,Intermediate,,,,,,1,1,,BAO_0000218,8873,In vivo,50594
A,10090.0,,CHEMBL626337,Mus musculus,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",,5506,N,,Intermediate,,,,,,1,1,,BAO_0000218,8874,In vivo,50594
A,10090.0,,CHEMBL626338,Mus musculus,Half life after intraperitoneal administration of 100 mg/kg in mice,,17734,N,,Intermediate,,,,,,1,1,,BAO_0000218,8875,,50594
A,10090.0,,CHEMBL626339,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8876,In vivo,50594
A,10090.0,,CHEMBL626340,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8877,In vivo,50594
A,10090.0,,CHEMBL625377,Mus musculus,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8878,In vivo,50594
A,10090.0,,CHEMBL625378,Mus musculus,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8879,In vivo,50594
A,10090.0,,CHEMBL625379,Mus musculus,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,,17728,N,,Intermediate,,,,,,1,1,,BAO_0000218,8880,In vivo,50594
A,9823.0,Microsomes,CHEMBL625380,Sus scrofa,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),,14294,U,,Autocuration,,,,,,1,0,,BAO_0000251,8881,,22224
A,9823.0,Microsomes,CHEMBL625381,Sus scrofa,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),,14294,U,,Autocuration,,,,,,1,0,,BAO_0000251,8882,,22224
A,9823.0,,CHEMBL625382,Sus scrofa,Stability to porcine renal DHP-I,,6056,U,,Autocuration,,,,,,1,0,,BAO_0000019,8883,,22224
A,9823.0,,CHEMBL873828,Sus scrofa,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,,1317,U,,Autocuration,,,,,,1,0,,BAO_0000218,8884,In vivo,22224
A,9823.0,,CHEMBL625383,Sus scrofa,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,,1317,U,,Autocuration,,,,,,1,0,,BAO_0000218,8885,In vivo,22224
A,9823.0,,CHEMBL625384,Sus scrofa,Half-life of the parent prodrug in porcine esterase solution,,5229,U,,Autocuration,,,,,,1,0,,BAO_0000019,8886,,22224
A,9823.0,,CHEMBL625385,Sus scrofa,"First order rate constant, k was determined in in pig liver Esterase",,4231,U,,Autocuration,,,,,,1,0,,BAO_0000019,8887,,22224
A,9823.0,,CHEMBL625386,Sus scrofa,Half life of the in pig liver Esterase,,4231,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8888,,22224
A,9823.0,,CHEMBL623571,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,,5318,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8889,,22224
A,9823.0,,CHEMBL623572,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,,5318,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8890,,22224
A,9823.0,,CHEMBL623573,Sus scrofa,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,,5318,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8891,,22224
A,9823.0,,CHEMBL623574,Sus scrofa,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,,3305,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8892,,22224
A,9823.0,,CHEMBL623575,Sus scrofa,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,,3305,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8893,,22224
A,9823.0,,CHEMBL623749,Sus scrofa,Half-life in the presence of pig liver esterase(PLE) was evaluated.,,2842,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8894,,22224
A,9823.0,,CHEMBL623750,Sus scrofa,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,,2842,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8895,,22224
A,9823.0,,CHEMBL623751,Sus scrofa,Half-life in vitro in pig liver,,889,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8896,In vitro,22224
A,9823.0,,CHEMBL623752,Sus scrofa,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,,1904,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,8897,,22224
A,10116.0,,CHEMBL623753,Rattus norvegicus,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,,4186,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8898,In vivo,50597
A,10116.0,,CHEMBL623754,Rattus norvegicus,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,,2774,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8899,In vivo,50597
A,10116.0,,CHEMBL623755,Rattus norvegicus,Maximum concentration in rat plasma was determined,,1742,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8900,In vivo,50597
A,10116.0,,CHEMBL623756,Rattus norvegicus,Maximum concentration in rats,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,8901,In vivo,50597
A,10116.0,,CHEMBL623757,Rattus norvegicus,Maximum concentration in rats at 1-2 hours,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,8902,In vivo,50597
A,10116.0,,CHEMBL623758,Rattus norvegicus,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,,2081,N,,Intermediate,,,,,,1,1,,BAO_0000218,8903,In vivo,50597
A,10116.0,,CHEMBL623759,Rattus norvegicus,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,,3307,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,8904,In vivo,50597
A,10116.0,,CHEMBL623760,Rattus norvegicus,Maximum concentration at the dose of 2 mg/kg in rat,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,8905,In vivo,50597
A,10116.0,,CHEMBL623761,Rattus norvegicus,Maximum concentration was evaluated in rats,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,8906,In vivo,50597
A,10116.0,,CHEMBL623762,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,,16365,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8907,In vivo,50597
A,10116.0,,CHEMBL877594,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,,16365,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8908,In vivo,50597
A,10116.0,,CHEMBL623763,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,,16365,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8909,In vivo,50597
A,10116.0,,CHEMBL623764,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,,16365,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8910,In vivo,50597
A,10116.0,,CHEMBL623765,Rattus norvegicus,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,,16365,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8911,In vivo,50597
A,10116.0,,CHEMBL623766,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,,2591,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8912,In vivo,50597
A,10116.0,,CHEMBL623767,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,,2591,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8913,In vivo,50597
A,10116.0,,CHEMBL623768,Rattus norvegicus,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,,2591,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,8914,In vivo,50597
A,10116.0,,CHEMBL623769,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8915,In vivo,50597
A,10116.0,,CHEMBL623770,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8916,In vivo,50597
A,10116.0,,CHEMBL623771,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8917,In vivo,50597
A,10116.0,,CHEMBL623772,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8918,In vivo,50597
A,10116.0,,CHEMBL623773,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8919,In vivo,50597
A,10116.0,,CHEMBL623774,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8920,In vivo,50597
A,10116.0,,CHEMBL623775,Rattus norvegicus,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,,5978,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8921,In vivo,50597
A,10116.0,,CHEMBL623776,Rattus norvegicus,Cmax in rat (PO dose),,14465,N,,Intermediate,,,,,,1,1,,BAO_0000218,8922,In vivo,50597
A,10116.0,,CHEMBL622191,Rattus norvegicus,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8923,In vivo,50597
A,10116.0,,CHEMBL622192,Rattus norvegicus,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8924,In vivo,50597
A,10116.0,,CHEMBL622193,Rattus norvegicus,Maximum plasma concentration determined in rat,,4576,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8925,In vivo,50597
A,10116.0,,CHEMBL622194,Rattus norvegicus,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8926,In vivo,50597
A,10116.0,,CHEMBL622195,Rattus norvegicus,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8927,In vivo,50597
A,10116.0,,CHEMBL622196,Rattus norvegicus,Maximum plasma concentration in rat,,6824,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8928,In vivo,50597
A,10116.0,,CHEMBL622197,Rattus norvegicus,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8929,In vivo,50597
A,10116.0,,CHEMBL622198,Rattus norvegicus,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,,2932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8930,In vivo,50597
A,10116.0,,CHEMBL622199,Rattus norvegicus,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,,2932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8931,In vivo,50597
A,10116.0,,CHEMBL622200,Rattus norvegicus,Maximum plasma concentration of compound was measured in rat,,2879,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8932,In vivo,50597
A,10116.0,,CHEMBL622201,Rattus norvegicus,Maximum plasma concentration after 20 mg/kg oral administration in rat,,2864,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8933,In vivo,50597
A,10116.0,,CHEMBL623990,Rattus norvegicus,Maximum plasma concentration after oral administration to rats,,16367,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8934,In vivo,50597
A,10116.0,,CHEMBL623991,Rattus norvegicus,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8935,In vivo,50597
A,10116.0,,CHEMBL623992,Rattus norvegicus,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",,17717,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8936,In vivo,50597
A,10116.0,,CHEMBL623993,Rattus norvegicus,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8937,In vivo,50597
A,10116.0,,CHEMBL623994,Rattus norvegicus,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,,17717,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8938,In vivo,50597
F,10116.0,,CHEMBL623995,Rattus norvegicus,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8939,In vivo,50597
F,10116.0,,CHEMBL623996,Rattus norvegicus,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8940,In vivo,50597
F,10116.0,,CHEMBL623997,Rattus norvegicus,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8941,In vivo,50597
A,10116.0,,CHEMBL623998,Rattus norvegicus,Maximum plasma concentration dosed orally in rats,,4516,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8942,In vivo,50597
A,10116.0,,CHEMBL623999,Rattus norvegicus,Maximum plasma concentration dosed orally in rats after 6 hours,,4516,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8943,In vivo,50597
A,10116.0,,CHEMBL624000,Rattus norvegicus,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,,4516,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8944,In vivo,50597
A,10116.0,,CHEMBL624001,Rattus norvegicus,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,,5199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8945,In vivo,50597
A,10116.0,,CHEMBL624002,Rattus norvegicus,Maximum plasma concentration in rat after po administration,,17538,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8946,In vivo,50597
A,10116.0,,CHEMBL624003,Rattus norvegicus,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8947,In vivo,50597
A,10116.0,,CHEMBL624004,Rattus norvegicus,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,8948,In vivo,50597
A,10116.0,,CHEMBL624005,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8949,,50597
A,10116.0,,CHEMBL624006,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8950,,50597
A,10116.0,,CHEMBL624007,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8951,,50597
A,10116.0,,CHEMBL624008,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8952,,50597
A,10116.0,,CHEMBL624009,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8953,,50597
A,10116.0,,CHEMBL874387,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8954,,50597
A,10116.0,,CHEMBL624010,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8955,,50597
A,10116.0,,CHEMBL624011,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8956,,50597
A,10116.0,,CHEMBL624012,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8957,,50597
A,10116.0,,CHEMBL624013,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8958,,50597
A,10116.0,,CHEMBL624736,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8959,,50597
A,10116.0,,CHEMBL624737,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8960,,50597
A,10116.0,,CHEMBL624738,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8961,,50597
A,10116.0,,CHEMBL624739,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8962,,50597
A,10116.0,,CHEMBL624740,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8963,,50597
A,10116.0,,CHEMBL624896,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8964,,50597
A,10116.0,,CHEMBL624897,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8965,,50597
A,10116.0,,CHEMBL624108,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8966,,50597
A,10116.0,,CHEMBL624109,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8967,,50597
A,10116.0,,CHEMBL624110,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8968,,50597
A,10116.0,,CHEMBL624111,Rattus norvegicus,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8969,,50597
A,10116.0,,CHEMBL624112,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8970,,50597
A,10116.0,,CHEMBL624113,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8971,,50597
A,10116.0,,CHEMBL619709,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8972,,50597
A,10116.0,,CHEMBL619710,Rattus norvegicus,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,8973,,50597
A,10116.0,,CHEMBL619711,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8974,,50597
A,10116.0,,CHEMBL619712,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8975,,50597
A,10116.0,,CHEMBL619713,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8976,,50597
A,10116.0,,CHEMBL619714,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8977,,50597
A,10116.0,,CHEMBL619715,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8978,,50597
A,10116.0,,CHEMBL619716,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8979,,50597
A,10116.0,,CHEMBL619717,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8980,,50597
A,10116.0,,CHEMBL619718,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8981,,50597
A,10116.0,,CHEMBL619719,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8982,,50597
A,10116.0,,CHEMBL875329,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8983,,50597
A,10116.0,,CHEMBL619720,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8984,,50597
A,10116.0,,CHEMBL619721,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8985,,50597
A,10116.0,,CHEMBL619722,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8986,,50597
A,10116.0,,CHEMBL619723,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8987,,50597
A,10116.0,,CHEMBL619724,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8988,,50597
A,10116.0,,CHEMBL619725,Rattus norvegicus,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8989,,50597
A,10116.0,,CHEMBL619726,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8990,,50597
A,10116.0,,CHEMBL619727,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8991,,50597
A,10116.0,,CHEMBL619728,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8992,,50597
A,10116.0,,CHEMBL619729,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,8993,,50597
A,10116.0,,CHEMBL619730,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8994,In vivo,50597
A,10116.0,,CHEMBL619731,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8995,In vivo,50597
A,10116.0,,CHEMBL619732,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8996,In vivo,50597
A,10116.0,,CHEMBL619733,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8997,In vivo,50597
A,10116.0,,CHEMBL619734,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,8998,In vivo,50597
A,10116.0,,CHEMBL619735,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,8999,In vivo,50597
A,10116.0,,CHEMBL875330,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9000,In vivo,50597
A,10116.0,,CHEMBL628465,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9001,In vivo,50597
A,10116.0,,CHEMBL628466,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9002,In vivo,50597
A,10116.0,,CHEMBL628467,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9003,In vivo,50597
A,10116.0,,CHEMBL628468,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9004,In vivo,50597
A,10116.0,,CHEMBL628469,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9005,In vivo,50597
A,10116.0,,CHEMBL628470,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9006,In vivo,50597
A,10116.0,,CHEMBL628471,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9007,In vivo,50597
A,10116.0,,CHEMBL628472,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9008,In vivo,50597
A,10116.0,,CHEMBL625191,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9009,In vivo,50597
A,10116.0,,CHEMBL625192,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9010,In vivo,50597
A,10116.0,,CHEMBL875337,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),,11977,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9011,In vivo,50597
A,10116.0,,CHEMBL626341,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9012,In vivo,50597
A,10116.0,,CHEMBL626342,Rattus norvegicus,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9013,In vivo,50597
A,10116.0,,CHEMBL621943,Rattus norvegicus,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),,11977,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9014,In vivo,50597
A,10116.0,,CHEMBL621944,Rattus norvegicus,Half life in rats,,3748,N,,Intermediate,,,,,,1,1,,BAO_0000218,9015,,50597
A,10116.0,,CHEMBL621945,Rattus norvegicus,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9016,,50597
A,10116.0,,CHEMBL621946,Rattus norvegicus,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),,4871,N,,Intermediate,,,,,,1,1,,BAO_0000218,9017,,50597
A,10116.0,,CHEMBL621947,Rattus norvegicus,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,,4871,N,,Intermediate,,,,,,1,1,,BAO_0000218,9018,,50597
A,10116.0,,CHEMBL621948,Rattus norvegicus,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),,4872,N,,Intermediate,,,,,,1,1,,BAO_0000218,9019,,50597
A,10116.0,,CHEMBL621949,Rattus norvegicus,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,,4872,N,,Intermediate,,,,,,1,1,,BAO_0000218,9020,,50597
A,10116.0,,CHEMBL621950,Rattus norvegicus,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),,5413,N,,Intermediate,,,,,,1,1,,BAO_0000218,9021,,50597
A,10116.0,,CHEMBL621951,Rattus norvegicus,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,,5413,N,,Intermediate,,,,,,1,1,,BAO_0000218,9022,,50597
A,10116.0,,CHEMBL621952,Rattus norvegicus,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,,15272,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9023,In vivo,50597
A,10116.0,,CHEMBL621953,Rattus norvegicus,Stability (%) in rat liver microsomes,,4689,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9024,,50597
A,10116.0,,CHEMBL621954,Rattus norvegicus,Area under curve was calculated after intravenous administration,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,9025,,50597
A,10116.0,,CHEMBL621955,Rattus norvegicus,Area under the curve was calculated after iv administration in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,9026,,50597
A,10116.0,,CHEMBL621956,Rattus norvegicus,Area under the curve was calculated in rat after peroral administration,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,9027,,50597
A,10116.0,,CHEMBL621957,Rattus norvegicus,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,6211,N,,Intermediate,,,,,,1,1,,BAO_0000218,9028,,50597
A,10116.0,,CHEMBL621958,Rattus norvegicus,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,9029,,50597
A,10116.0,,CHEMBL621959,Rattus norvegicus,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,9030,,50597
A,10116.0,,CHEMBL621960,Rattus norvegicus,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,9031,,50597
A,10116.0,,CHEMBL621961,Rattus norvegicus,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,9032,,50597
A,10116.0,,CHEMBL621962,Rattus norvegicus,p value of the compound,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9033,,50597
F,10116.0,,CHEMBL876787,Rattus norvegicus,p value of the compound,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9034,,50597
A,10116.0,,CHEMBL621963,Rattus norvegicus,p value of the compound,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9035,,50597
A,10116.0,,CHEMBL622637,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9036,,50597
A,10116.0,,CHEMBL622638,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9037,,50597
A,10116.0,,CHEMBL626561,Rattus norvegicus,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9038,,50597
F,9986.0,,CHEMBL626562,Oryctolagus cuniculus,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),,7991,U,,Autocuration,,,,,,1,0,,BAO_0000019,9039,,22224
A,9986.0,,CHEMBL626563,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),,429,U,,Autocuration,,,,,,1,0,,BAO_0000218,9040,,22224
A,9986.0,,CHEMBL626564,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),,429,U,,Autocuration,,,,,,1,0,,BAO_0000218,9041,,22224
A,9986.0,,CHEMBL626565,Oryctolagus cuniculus,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,6253,U,,Autocuration,,,,,,1,0,,BAO_0000218,9042,In vivo,22224
A,9986.0,,CHEMBL626566,Oryctolagus cuniculus,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,6253,U,,Autocuration,,,,,,1,0,,BAO_0000218,9043,In vivo,22224
A,9986.0,,CHEMBL626567,Oryctolagus cuniculus,Clearance rate in rabbits,,3615,U,,Autocuration,,,,,,1,0,,BAO_0000218,9044,In vivo,22224
A,9986.0,,CHEMBL626568,Oryctolagus cuniculus,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,4059,U,,Autocuration,,,,,,1,0,,BAO_0000218,9045,In vivo,22224
A,9986.0,,CHEMBL626569,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9046,In vivo,22224
A,9986.0,,CHEMBL626570,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9047,In vivo,22224
A,9986.0,,CHEMBL626571,Oryctolagus cuniculus,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9048,In vivo,22224
A,9986.0,,CHEMBL626572,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,,429,U,,Autocuration,,,,,,1,0,,BAO_0000218,9049,In vivo,22224
A,9986.0,,CHEMBL626573,Oryctolagus cuniculus,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,,4059,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,9050,In vivo,22224
A,9986.0,Microsomes,CHEMBL626574,Oryctolagus cuniculus,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,,9659,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000251,9051,,22224
A,9986.0,Microsomes,CHEMBL626575,Oryctolagus cuniculus,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,,9659,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000251,9052,,22224
A,9986.0,,CHEMBL626576,Oryctolagus cuniculus,Dose at which bioavailability of intravenously administered compound was tested in rabbit,,3639,U,,Autocuration,,,,,,1,0,,BAO_0000218,9053,,22224
A,9986.0,,CHEMBL626577,Oryctolagus cuniculus,Dose at which bioavailability of perorally administered compound was tested in rabbit,,3639,U,,Autocuration,,,,,,1,0,,BAO_0000218,9054,,22224
A,9986.0,,CHEMBL626578,Oryctolagus cuniculus,The compound was tested for its bioavailability in rabbit (by oral dosage).,,3639,U,,Autocuration,,,,,,1,0,,BAO_0000218,9055,In vivo,22224
A,9986.0,,CHEMBL625263,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9056,In vivo,22224
A,9986.0,,CHEMBL625264,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9057,In vivo,22224
A,9986.0,,CHEMBL625265,Oryctolagus cuniculus,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,5124,U,,Autocuration,,,,,,1,0,,BAO_0000218,9058,In vivo,22224
A,9986.0,Microsomes,CHEMBL625266,Oryctolagus cuniculus,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),,14294,U,,Autocuration,,,,,,1,0,,BAO_0000251,9059,,22224
A,9986.0,Microsomes,CHEMBL876796,Oryctolagus cuniculus,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),,14294,U,,Autocuration,,,,,,1,0,,BAO_0000251,9060,,22224
A,9986.0,,CHEMBL625267,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,,429,U,,Autocuration,,,,,,1,0,,BAO_0000218,9061,In vivo,22224
A,9986.0,,CHEMBL625268,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,,5124,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,9062,In vivo,22224
A,9986.0,,CHEMBL625269,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,,5124,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,9063,In vivo,22224
A,9986.0,,CHEMBL624689,Oryctolagus cuniculus,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,,5124,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,9064,In vivo,22224
A,9986.0,,CHEMBL624690,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,,429,U,,Autocuration,,,,,,1,0,,BAO_0000218,9065,In vivo,22224
A,9986.0,,CHEMBL624691,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),,429,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,9066,,22224
A,9986.0,,CHEMBL624692,Oryctolagus cuniculus,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),,429,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,9067,,22224
A,9986.0,,CHEMBL624693,Oryctolagus cuniculus,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,,4059,U,,Autocuration,,,,,,1,0,,BAO_0000218,9068,In vivo,22224
A,9986.0,,CHEMBL624694,Oryctolagus cuniculus,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,,4137,U,,Autocuration,,,,,,1,0,,BAO_0000218,9069,In vivo,22224
A,9986.0,,CHEMBL877596,Oryctolagus cuniculus,In vitro Biological half-life in crude homogenate of rabbit renal cortex,,11672,U,,Autocuration,,,,,,1,0,,BAO_0000221,9070,In vitro,22224
A,9986.0,,CHEMBL624695,Oryctolagus cuniculus,Time within which only 10% of the drug was degraded,,12886,U,,Autocuration,,,,,,1,0,,BAO_0000019,9071,,22224
A,9986.0,,CHEMBL624696,Oryctolagus cuniculus,Half life period in rabbit liver homogenate,,3853,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000221,9072,,22224
A,9986.0,,CHEMBL624697,Oryctolagus cuniculus,Half life value in rabbits,,3615,U,,Autocuration,,,,,,1,0,,BAO_0000019,9073,,22224
A,9986.0,,CHEMBL624698,Oryctolagus cuniculus,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,,6253,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,9074,In vivo,22224
A,9986.0,,CHEMBL624699,Oryctolagus cuniculus,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,,6253,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,9075,In vivo,22224
A,9986.0,,CHEMBL624700,Oryctolagus cuniculus,Half-life period in rabbits following intravenous administration at 2 mg/kg,,6077,U,,Autocuration,,,,,,1,0,,BAO_0000218,9076,In vivo,22224
A,10116.0,,CHEMBL622903,Rattus norvegicus,AUC 0-8 hr value in rats at 10 mg/kg,,17617,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9077,,50597
A,10116.0,,CHEMBL622904,Rattus norvegicus,AUC after administration at 2000 mg/kg/day in rats,,17594,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9078,,50597
A,10116.0,,CHEMBL622905,Rattus norvegicus,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,,6149,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9079,,50597
A,10116.0,,CHEMBL622906,Rattus norvegicus,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,,17260,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9080,,50597
A,10116.0,,CHEMBL622907,Rattus norvegicus,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9081,,50597
A,10116.0,,CHEMBL622908,Rattus norvegicus,AUC in rat after oral administration at 10.5 mg/kg dose,,6644,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9082,,50597
A,10116.0,,CHEMBL622909,Rattus norvegicus,AUC in rat after oral administration at 11.2 mg/kg dose,,6644,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9083,,50597
A,10116.0,,CHEMBL622910,Rattus norvegicus,AUC in rat after oral administration at 9.7 mg/kg dose,,6644,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9084,,50597
A,10116.0,,CHEMBL622911,Rattus norvegicus,AUC in rat brain after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9085,,50597
A,10116.0,,CHEMBL622912,Rattus norvegicus,AUC in rat p.o.,,6504,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9086,,50597
A,10116.0,,CHEMBL622913,Rattus norvegicus,AUC in rat p.o. at 20 mg/kg concentration,,17686,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9087,,50597
A,10116.0,,CHEMBL622914,Rattus norvegicus,AUC in rat plasma after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9088,,50597
A,10116.0,,CHEMBL622915,Rattus norvegicus,AUC in rats,,216,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9089,,50597
A,10116.0,,CHEMBL622916,Rattus norvegicus,AUC value after IV dose at a dose of 5 mg/kg in rats.,,1908,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9090,,50597
A,10116.0,,CHEMBL622917,Rattus norvegicus,AUC value after oral dose at a dose of 10 mg/kg in rats.,,1908,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9091,,50597
A,10116.0,,CHEMBL622918,Rattus norvegicus,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,6685,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9092,In vivo,50597
A,10116.0,,CHEMBL622919,Rattus norvegicus,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,,216,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9093,In vivo,50597
A,10116.0,,CHEMBL622920,Rattus norvegicus,Maximum plasma concentration was evaluated in rat,,6049,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9094,In vivo,50597
A,10116.0,,CHEMBL622921,Rattus norvegicus,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,2463,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9095,In vivo,50597
A,10116.0,,CHEMBL622922,Rattus norvegicus,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,,6679,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9096,In vivo,50597
A,10116.0,,CHEMBL622923,Rattus norvegicus,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,,6681,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9097,In vivo,50597
A,10116.0,,CHEMBL877604,Rattus norvegicus,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9098,In vivo,50597
A,10116.0,,CHEMBL622924,Rattus norvegicus,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,,6410,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9099,In vivo,50597
A,10116.0,,CHEMBL622925,Rattus norvegicus,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9100,In vivo,50597
A,10116.0,,CHEMBL622926,Rattus norvegicus,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,,16366,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9101,In vivo,50597
A,10116.0,,CHEMBL623625,Rattus norvegicus,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,,6227,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9102,In vivo,50597
A,10116.0,,CHEMBL623626,Rattus norvegicus,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,Plasma,1969.0,,1,1,,BAO_0000218,9103,In vivo,50597
A,10116.0,,CHEMBL623627,Rattus norvegicus,Maximum plasma drug concentration was determined,,1465,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9104,In vivo,50597
A,10116.0,,CHEMBL623628,Rattus norvegicus,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,,4368,N,,Intermediate,,,,,,1,1,,BAO_0000218,9105,In vivo,50597
A,10116.0,,CHEMBL623629,Rattus norvegicus,Mean peak plasma concentration was observed after intravenous administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9106,In vivo,50597
A,10116.0,,CHEMBL623630,Rattus norvegicus,Mean peak plasma concentration was observed after oral administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9107,In vivo,50597
A,10116.0,,CHEMBL623804,Rattus norvegicus,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9108,In vivo,50597
A,10116.0,,CHEMBL623805,Rattus norvegicus,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9109,In vivo,50597
A,10116.0,,CHEMBL623806,Rattus norvegicus,Peak oral plasma concentration was determined in rats by oral administration,,1567,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9110,In vivo,50597
A,10116.0,,CHEMBL623807,Rattus norvegicus,Peak plasma concentration (Cmax) was determined,,4026,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9111,In vivo,50597
A,10116.0,,CHEMBL623808,Rattus norvegicus,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,,6193,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9112,In vivo,50597
A,10116.0,,CHEMBL623809,Rattus norvegicus,Peak plasma concentration (Cmax) in rats,,4026,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9113,In vivo,50597
A,10116.0,,CHEMBL623810,Rattus norvegicus,Peak plasma concentration at 1 mg/kg peroral administration,,6485,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9114,In vivo,50597
A,10116.0,,CHEMBL623811,Rattus norvegicus,Peak plasma concentration in rat,,17655,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9115,In vivo,50597
A,10116.0,,CHEMBL623812,Rattus norvegicus,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9116,In vivo,50597
A,10116.0,,CHEMBL877605,Rattus norvegicus,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,,5394,N,,Intermediate,,,,,,1,1,,BAO_0000218,9117,In vivo,50597
A,10116.0,,CHEMBL623813,Rattus norvegicus,Pharmacokinetic property (Cmax) in rat,,4408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9118,In vivo,50597
A,10116.0,,CHEMBL623814,Rattus norvegicus,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,9119,In vivo,50597
A,10116.0,,CHEMBL623815,Rattus norvegicus,Cmax in rat after 3mg/kg oral dose,,4878,N,,Intermediate,,,,,,1,1,,BAO_0000218,9120,In vivo,50597
A,10116.0,,CHEMBL623816,Rattus norvegicus,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,,5862,N,,Intermediate,,Sprague-Dawley,,,,1,1,,BAO_0000218,9121,In vivo,50597
A,10116.0,,CHEMBL623145,Rattus norvegicus,Cmax in rats after 20 mg/kg oral dose,,4517,N,,Intermediate,,,,,,1,1,,BAO_0000218,9122,In vivo,50597
A,10116.0,,CHEMBL623146,Rattus norvegicus,Cmax in rat plasma after 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9123,In vivo,50597
A,10116.0,,CHEMBL623147,Rattus norvegicus,Plasma concentration after oral administration of 100 mg/kg to rats,,5436,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9124,In vivo,50597
A,10116.0,,CHEMBL623042,Rattus norvegicus,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,4910,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9125,In vivo,50597
A,10116.0,,CHEMBL623043,Rattus norvegicus,Tested for the Cmax in rat at 10 mg/kg per orally,,4950,N,,Intermediate,,,,,,1,1,,BAO_0000218,9126,In vivo,50597
A,10116.0,,CHEMBL623044,Rattus norvegicus,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9127,In vivo,50597
A,10116.0,,CHEMBL623045,Rattus norvegicus,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9128,In vivo,50597
A,10116.0,,CHEMBL623046,Rattus norvegicus,Bioavailability as oral Cmax in rats at 30 mins,,3360,N,,Intermediate,,,,,,1,1,,BAO_0000218,9129,In vivo,50597
A,10116.0,,CHEMBL623226,Rattus norvegicus,Bioavailability as oral Cmax in rats at 6hr,,3360,N,,Intermediate,,,,,,1,1,,BAO_0000218,9130,In vivo,50597
A,10116.0,,CHEMBL623227,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 100 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9131,In vivo,50597
A,10116.0,,CHEMBL623228,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 300 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9132,In vivo,50597
A,10116.0,,CHEMBL623229,Rattus norvegicus,The maximum concentration of compound was measured at the dose of 30 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9133,In vivo,50597
A,10116.0,,CHEMBL623230,Rattus norvegicus,The maximum plasma levels for the compounds were determined by LC-MS.,,5160,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9134,In vivo,50597
A,10116.0,,CHEMBL623231,Rattus norvegicus,mean peak plasma concentration was observed after intravenous administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9135,In vivo,50597
A,10116.0,,CHEMBL623232,Rattus norvegicus,mean peak plasma concentration was observed after oral administration in rat,,15662,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9136,In vivo,50597
A,10116.0,,CHEMBL623233,Rattus norvegicus,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,9137,,50597
A,10116.0,,CHEMBL623234,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9138,,50597
A,10116.0,,CHEMBL623235,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 1 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9139,,50597
A,10116.0,,CHEMBL623236,Rattus norvegicus,Concentration in plasma (portal) following oral dose in rats at 2 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9140,,50597
A,10116.0,,CHEMBL623237,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9141,,50597
A,10116.0,,CHEMBL623238,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 1 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9142,,50597
A,10116.0,,CHEMBL623239,Rattus norvegicus,Concentration in plasma (systemic) following oral dose in rats at 2 hr,,3535,N,,Intermediate,,,,,,1,1,,BAO_0000218,9143,,50597
A,10116.0,,CHEMBL623240,Rattus norvegicus,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000218,9144,In vivo,22224
A,10116.0,,CHEMBL623241,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",,6326,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,9145,,50597
A,10116.0,,CHEMBL623242,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",,6326,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,9146,,50597
A,10116.0,,CHEMBL874394,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",,6326,N,,Intermediate,,,,,,1,1,,BAO_0000218,9147,,50597
A,10116.0,,CHEMBL623243,Rattus norvegicus,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",,6326,N,,Intermediate,,,,,,1,1,,BAO_0000218,9148,,50597
A,10116.0,,CHEMBL623244,Rattus norvegicus,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9149,,50597
A,10116.0,,CHEMBL623245,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9150,,50597
A,10116.0,,CHEMBL623246,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9151,,50597
A,10116.0,,CHEMBL623247,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9152,,50597
A,10116.0,,CHEMBL623248,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9153,,50597
A,10116.0,,CHEMBL623249,Rattus norvegicus,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9154,,50597
A,10116.0,,CHEMBL625072,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9155,,50597
A,10116.0,,CHEMBL625073,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9156,,50597
A,10116.0,,CHEMBL625074,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9157,,50597
A,10116.0,,CHEMBL625075,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9158,,50597
A,10116.0,,CHEMBL625076,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9159,,50597
A,10116.0,,CHEMBL625077,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9160,,50597
A,10116.0,,CHEMBL625078,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9161,,50597
A,10116.0,,CHEMBL874395,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9162,,50597
A,10116.0,,CHEMBL625079,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9163,,50597
A,10116.0,,CHEMBL625080,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9164,,50597
A,10116.0,,CHEMBL625081,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9165,,50597
A,10116.0,,CHEMBL625082,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9166,,50597
A,10116.0,,CHEMBL625083,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9167,,50597
A,10116.0,,CHEMBL625084,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9168,,50597
A,10116.0,,CHEMBL625085,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9169,,50597
A,10116.0,,CHEMBL625086,Rattus norvegicus,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9170,,50597
A,10116.0,,CHEMBL625087,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9171,,50597
A,10116.0,,CHEMBL625088,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9172,,50597
A,10116.0,,CHEMBL622205,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9173,,50597
A,10116.0,,CHEMBL622206,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9174,,50597
A,10116.0,,CHEMBL622207,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9175,,50597
A,10116.0,,CHEMBL622366,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9176,,50597
A,10116.0,,CHEMBL622367,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9177,,50597
A,10116.0,,CHEMBL875331,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9178,,50597
A,10116.0,,CHEMBL622368,Rattus norvegicus,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9179,,50597
A,10116.0,,CHEMBL622369,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9180,,50597
A,10116.0,,CHEMBL622370,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9181,,50597
A,10116.0,,CHEMBL622371,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9182,,50597
A,10116.0,,CHEMBL622372,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9183,,50597
A,10116.0,,CHEMBL622373,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9184,,50597
A,10116.0,,CHEMBL622374,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9185,,50597
A,10116.0,,CHEMBL622375,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9186,,50597
A,10116.0,,CHEMBL622376,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9187,,50597
A,10116.0,,CHEMBL622377,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9188,,50597
A,10116.0,,CHEMBL622378,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9189,,50597
A,10116.0,,CHEMBL622379,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9190,,50597
A,10116.0,,CHEMBL622380,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9191,,50597
A,10116.0,,CHEMBL622381,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9192,,50597
A,10116.0,,CHEMBL622382,Rattus norvegicus,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9193,,50597
A,10116.0,,CHEMBL622383,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9194,,50597
A,10116.0,,CHEMBL875332,Rattus norvegicus,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9195,,50597
A,10116.0,,CHEMBL622384,Rattus norvegicus,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9196,,50597
A,10116.0,,CHEMBL622385,Rattus norvegicus,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9197,,50597
A,10116.0,,CHEMBL622386,Rattus norvegicus,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),,6175,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9198,,50597
A,10116.0,,CHEMBL622387,Rattus norvegicus,The compound was tested for the plasma binding in rat,,10839,N,,Intermediate,,,,,,1,1,,BAO_0000218,9199,,50597
A,10116.0,,CHEMBL622388,Rattus norvegicus,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9200,,50597
A,10116.0,,CHEMBL622389,Rattus norvegicus,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9201,,50597
A,10116.0,,CHEMBL622390,Rattus norvegicus,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9202,,50597
A,10116.0,,CHEMBL622391,Rattus norvegicus,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9203,,50597
A,10116.0,,CHEMBL622392,Rattus norvegicus,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9204,,50597
A,10116.0,,CHEMBL622393,Rattus norvegicus,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),,16459,N,,Intermediate,,,,,,1,1,,BAO_0000218,9205,,50597
A,10116.0,,CHEMBL622394,Rattus norvegicus,Plasma level at 2 hr after administration of the compound,,3278,N,,Intermediate,,,,,,1,1,,BAO_0000218,9206,,50597
A,10116.0,,CHEMBL622395,Rattus norvegicus,plasma level at 2 hr after administration of the compound,,3278,N,,Intermediate,,,,,,1,1,,BAO_0000218,9207,,50597
A,10116.0,,CHEMBL622396,Rattus norvegicus,Stability in rat serum measured as % recovery at 1 min,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9208,,50597
A,10116.0,,CHEMBL624894,Rattus norvegicus,Stability in rat serum measured as % recovery at 10 min,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9209,,50597
A,10116.0,,CHEMBL624895,Rattus norvegicus,Stability in rat serum measured as % recovery at 10 mins,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9210,,50597
A,10116.0,,CHEMBL624058,Rattus norvegicus,Stability in rat serum measured as % recovery at 2 hr,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9211,,50597
A,10116.0,,CHEMBL624059,Rattus norvegicus,Stability in rat serum measured as % recovery at 3 min,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9212,,50597
A,10116.0,,CHEMBL624060,Rattus norvegicus,Stability in rat serum measured as % recovery at 3 mins,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9213,,50597
A,10116.0,,CHEMBL624061,Rattus norvegicus,Stability in rat serum measured as % recovery at 5 min,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9214,,50597
A,10116.0,,CHEMBL624062,Rattus norvegicus,Stability in rat serum measured as % recovery at 5 mins,,4684,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9215,,50597
A,10116.0,,CHEMBL624063,Rattus norvegicus,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,16456,N,,Intermediate,,,,,,1,1,,BAO_0000218,9216,In vivo,50597
A,10116.0,,CHEMBL624064,Rattus norvegicus,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,16456,N,,Intermediate,,,,,,1,1,,BAO_0000218,9217,In vivo,50597
A,10116.0,,CHEMBL624065,Rattus norvegicus,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,,723,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9218,,50597
A,10116.0,,CHEMBL624066,Rattus norvegicus,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,,723,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9219,,50597
A,10116.0,,CHEMBL877490,Rattus norvegicus,Half life tested in mature male rat at a dose of 30 mg/kg,,5160,N,,Intermediate,,,,,,1,1,,BAO_0000218,9220,In vivo,50597
A,10116.0,,CHEMBL874442,Rattus norvegicus,Half life after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,9221,In vivo,50597
A,10116.0,,CHEMBL626890,Rattus norvegicus,Half life period after administration (30 mg/kg) in rat,,5633,N,,Intermediate,,,,,,1,1,,BAO_0000218,9222,In vivo,50597
A,10116.0,,CHEMBL626891,Rattus norvegicus,Half life period in rat after 5 mg/Kg dose,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,9223,In vivo,50597
A,10116.0,,CHEMBL626892,Rattus norvegicus,Half life period in rat after 5 mg/kg dose,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,9224,In vivo,50597
A,10116.0,,CHEMBL626893,Rattus norvegicus,Half life period was determined,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9225,,50597
A,10116.0,,CHEMBL626894,Rattus norvegicus,Half life period was evaluated in rat,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9226,,50597
A,10116.0,,CHEMBL626895,Rattus norvegicus,Half life period was evaluated in rat; 0.5-1.0,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9227,,50597
A,10116.0,,CHEMBL626896,Rattus norvegicus,Half life period was evaluated in rat; 5.9-7.5,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9228,,50597
A,10116.0,,CHEMBL626897,Rattus norvegicus,Half-life in rat plasma,,14512,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9229,,50597
A,10116.0,,CHEMBL626898,Rattus norvegicus,Half-life time in rat was determined,,6230,N,,Intermediate,,,,,,1,1,,BAO_0000218,9230,,50597
A,10116.0,,CHEMBL626899,Rattus norvegicus,Terminal half-life after iv administration to rats,,3364,N,,Intermediate,,,,,,1,1,,BAO_0000218,9231,In vivo,50597
A,10116.0,,CHEMBL626900,Rattus norvegicus,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,,6874,N,,Intermediate,,,,,,1,1,,BAO_0000218,9232,In vivo,50597
A,10116.0,,CHEMBL626901,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,,857,N,,Intermediate,,,,,,1,1,,BAO_0000218,9233,,50597
A,10116.0,,CHEMBL626902,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),,858,N,,Intermediate,,,,,,1,1,,BAO_0000218,9234,In vivo,50597
A,10116.0,,CHEMBL626903,Rattus norvegicus,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),,858,N,,Intermediate,,,,,,1,1,,BAO_0000218,9235,In vivo,50597
A,10116.0,,CHEMBL874443,Rattus norvegicus,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9236,In vivo,50597
A,10116.0,,CHEMBL626904,Rattus norvegicus,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9237,In vivo,50597
A,10116.0,,CHEMBL626905,Rattus norvegicus,Half life in rats,,6305,N,,Intermediate,,,,,,1,1,,BAO_0000218,9238,,50597
A,10116.0,,CHEMBL873830,Rattus norvegicus,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,,13501,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9239,In vivo,50597
A,10116.0,,CHEMBL626906,Rattus norvegicus,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,,17594,N,,Intermediate,,,,,,1,1,,BAO_0000218,9240,In vivo,50597
A,10116.0,,CHEMBL631076,Rattus norvegicus,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,4186,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9241,In vivo,50597
A,10116.0,,CHEMBL631077,Rattus norvegicus,Biological half-life was measured in plasma of rats,,2932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9242,,50597
A,10116.0,,CHEMBL631078,Rattus norvegicus,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,N,,Intermediate,,,,,,1,1,,BAO_0000218,9243,In vivo,50597
A,10116.0,,CHEMBL631079,Rattus norvegicus,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9244,In vivo,50597
A,10116.0,,CHEMBL631080,Rattus norvegicus,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,,2713,N,,Intermediate,,,,,,1,1,,BAO_0000218,9245,In vivo,50597
A,10116.0,,CHEMBL631081,Rattus norvegicus,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9246,In vivo,50597
A,10116.0,,CHEMBL631239,Rattus norvegicus,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9247,In vivo,50597
A,10116.0,,CHEMBL631240,Rattus norvegicus,Compound was evaluated for plasma half life in rat,,740,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9248,,50597
A,10116.0,,CHEMBL631241,Rattus norvegicus,AUC value at a dose of 5 mg/kg (p.o.) in rats,,6597,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9249,,50597
A,10116.0,,CHEMBL631242,Rattus norvegicus,AUC value after administration of 20 mg/Kg oral dose in rat,,2959,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9250,,50597
A,10116.0,,CHEMBL631243,Rattus norvegicus,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,,17594,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9251,,50597
A,10116.0,,CHEMBL874444,Rattus norvegicus,AUC0-96 after administration at 50 mg/kg,,17596,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9252,,50597
A,10116.0,,CHEMBL631244,Rattus norvegicus,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,,17594,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9253,,50597
A,10116.0,,CHEMBL631245,Rattus norvegicus,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",,3293,N,,Intermediate,,,,,,1,1,,BAO_0000218,9254,,50597
A,10116.0,,CHEMBL627162,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,9255,,50597
A,10116.0,,CHEMBL627163,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,9256,,50597
A,10116.0,,CHEMBL627164,Rattus norvegicus,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,,6757,N,,Intermediate,,,,,,1,1,,BAO_0000218,9257,,50597
A,10116.0,,CHEMBL627165,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,,5979,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9258,,50597
A,10116.0,,CHEMBL627166,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,,5979,N,,Intermediate,,,,,,1,1,,BAO_0000218,9259,,50597
A,10116.0,,CHEMBL627167,Rattus norvegicus,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,,5979,N,,Intermediate,,,,,,1,1,,BAO_0000218,9260,,50597
A,10116.0,,CHEMBL627822,Rattus norvegicus,Area under curve (AUC) at a dose of 30 mg/kg in rats,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,9261,,50597
A,10116.0,,CHEMBL627823,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9262,,50597
A,10116.0,,CHEMBL627824,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9263,,50597
A,10116.0,,CHEMBL627825,Rattus norvegicus,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,,5355,N,,Intermediate,,,,,,1,1,,BAO_0000218,9264,,50597
A,10116.0,,CHEMBL627826,Rattus norvegicus,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,,5633,N,,Intermediate,,,,,,1,1,,BAO_0000218,9265,,50597
A,10116.0,,CHEMBL627827,Rattus norvegicus,Area under curve (Pharmacokinetic property) was determined,,1716,N,,Intermediate,,,,,,1,1,,BAO_0000218,9266,,50597
A,10116.0,,CHEMBL627828,Rattus norvegicus,Area under curve (Pharmacokinetic property) of the compound; Not determined,,1716,N,,Intermediate,,,,,,1,1,,BAO_0000218,9267,,50597
A,10116.0,,CHEMBL627829,Rattus norvegicus,Area under curve after intravenous administration (1 mg/kg) in rat,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,9268,,50597
A,10116.0,,CHEMBL627830,Rattus norvegicus,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,9269,,50597
A,10116.0,,CHEMBL627831,Rattus norvegicus,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,9270,,50597
A,10116.0,,CHEMBL627832,Rattus norvegicus,Area under curve in male SD rats was observed after oral administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,9271,,50597
A,10116.0,,CHEMBL627833,Rattus norvegicus,Area under curve of compound after iv administration of 20 mg/kg dose in rat,,4413,N,,Intermediate,,,,,,1,1,,BAO_0000218,9272,,50597
A,10116.0,,CHEMBL627834,Rattus norvegicus,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,9273,,50597
A,10116.0,,CHEMBL628004,Rattus norvegicus,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,9274,,50597
A,10116.0,,CHEMBL628005,Rattus norvegicus,Area under curve at 5 mg/kg po was determined in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,9275,,50597
A,10116.0,,CHEMBL628006,Rattus norvegicus,Area under curve in Rat at a oral dose of 5 mg/kg,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,9276,,50597
A,10116.0,,CHEMBL628007,Rattus norvegicus,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,,4186,N,,Intermediate,,,,,,1,1,,BAO_0000218,9277,,50597
A,10116.0,,CHEMBL625676,Rattus norvegicus,Area under curve was determined,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,9278,,50597
A,10116.0,,CHEMBL631309,Rattus norvegicus,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,,17858,N,,Intermediate,,,,,,1,1,,BAO_0000218,9279,,50597
A,10116.0,,CHEMBL631310,Rattus norvegicus,Area under curve after intravenous administration at 3 mg/kg,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,9280,,50597
A,10116.0,,CHEMBL631311,Rattus norvegicus,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,,6106,N,,Intermediate,,,,,,1,1,,BAO_0000218,9281,,50597
A,10116.0,,CHEMBL631312,Rattus norvegicus,Area under curve at 4 hr in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,9282,,50597
A,10116.0,,CHEMBL631313,Rattus norvegicus,Area under curve at a dose of 30 mg/kg,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,9283,,50597
A,10116.0,,CHEMBL631314,Rattus norvegicus,Area under curve at the dose of 2 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,9284,,50597
A,10116.0,,CHEMBL631315,Rattus norvegicus,Area under curve at the dose of 5 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,9285,,50597
A,10116.0,,CHEMBL631316,Rattus norvegicus,Area under curve for a 2-mpk po dose in SD rats,,5862,N,,Intermediate,,,,,,1,1,,BAO_0000218,9286,,50597
A,10116.0,,CHEMBL631317,Rattus norvegicus,Area under curve in SD rats,,5862,N,,Intermediate,,,,,,1,1,,BAO_0000218,9287,,50597
A,10116.0,,CHEMBL874471,Rattus norvegicus,Area under curve in rat after oral administration at 13 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,9288,,50597
A,10116.0,,CHEMBL631318,Rattus norvegicus,Area under curve in rat by po administration at 0-24 hr,,5871,N,,Intermediate,,,,,,1,1,,BAO_0000218,9289,,50597
A,10116.0,,CHEMBL631319,Rattus norvegicus,Area under curve in rat plasma,,5919,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9290,,50597
A,10116.0,,CHEMBL631320,Rattus norvegicus,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,9291,,50597
A,10116.0,,CHEMBL631321,Rattus norvegicus,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,9292,,50597
A,10116.0,,CHEMBL631322,Rattus norvegicus,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,,10,N,,Intermediate,,,,,,1,1,,BAO_0000218,9293,,50597
A,10116.0,,CHEMBL631323,Rattus norvegicus,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,,11149,N,,Intermediate,,,,,,1,1,,BAO_0000218,9294,,50597
A,10116.0,,CHEMBL631324,Rattus norvegicus,Area under curve value in rat at a dose of 5 mg/kg,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,9295,,50597
A,10116.0,,CHEMBL631325,Rattus norvegicus,Area under curve was determined after oral administration in rats,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,9296,,50597
A,10116.0,,CHEMBL631326,Rattus norvegicus,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,9297,,50597
A,10116.0,,CHEMBL631327,Rattus norvegicus,Area under curve was determined after peroral administration in rat,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,9298,,50597
A,10116.0,,CHEMBL631328,Rattus norvegicus,Area under curve was determined at a dose 30 mpk administered orally.,,5375,N,,Intermediate,,,,,,1,1,,BAO_0000218,9299,,50597
A,10116.0,,CHEMBL631329,Rattus norvegicus,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,9300,,50597
A,10116.0,,CHEMBL627217,Rattus norvegicus,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,,4368,N,,Intermediate,,,,,,1,1,,BAO_0000218,9301,,50597
A,10116.0,,CHEMBL626352,Rattus norvegicus,Area under curve was determined in male rat,,5610,N,,Intermediate,,,,,,1,1,,BAO_0000218,9302,,50597
A,10116.0,,CHEMBL626353,Rattus norvegicus,Area under curve was determined in rat after PO administration,,5833,N,,Intermediate,,,,,,1,1,,BAO_0000218,9303,,50597
A,10116.0,,CHEMBL626354,Rattus norvegicus,Area under curve was determined in rat after a 3 mg/kg of oral dose,,4257,N,,Intermediate,,,,,,1,1,,BAO_0000218,9304,,50597
A,10116.0,,CHEMBL626355,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,,5937,N,,Intermediate,,,,,,1,1,,BAO_0000218,9305,,50597
A,10116.0,,CHEMBL626356,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,,5932,N,,Intermediate,,,,,,1,1,,BAO_0000218,9306,,50597
A,10116.0,,CHEMBL626357,Rattus norvegicus,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,,5932,N,,Intermediate,,,,,,1,1,,BAO_0000218,9307,,50597
A,10116.0,,CHEMBL626358,Rattus norvegicus,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9308,,50597
A,10116.0,,CHEMBL626359,Rattus norvegicus,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9309,,50597
A,10116.0,,CHEMBL626360,Rattus norvegicus,Peak plasma concentration in rat at a dose of 3 mg/kg,,17771,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9310,,50597
A,10116.0,,CHEMBL626361,Rattus norvegicus,Plasma concentration at 2 hr in rats was evaluated.,,1628,N,,Intermediate,,,,,,1,1,,BAO_0000218,9311,,50597
A,10116.0,,CHEMBL626362,Rattus norvegicus,Plasma concentration at 2 hr in rats was evaluated; Not available,,1628,N,,Intermediate,,,,,,1,1,,BAO_0000218,9312,,50597
A,10116.0,,CHEMBL626363,Rattus norvegicus,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9313,,50597
A,10116.0,,CHEMBL626970,Rattus norvegicus,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,9314,,50597
A,10116.0,,CHEMBL626971,Rattus norvegicus,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,9315,,50597
A,10116.0,,CHEMBL626972,Rattus norvegicus,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9316,,50597
A,10116.0,,CHEMBL626973,Rattus norvegicus,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9317,,50597
A,10116.0,,CHEMBL626974,Rattus norvegicus,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9318,,50597
A,10116.0,,CHEMBL874592,Rattus norvegicus,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9319,,50597
A,10116.0,,CHEMBL626975,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,9320,,50597
A,10116.0,,CHEMBL626976,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,9321,,50597
A,10116.0,,CHEMBL626977,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,9322,,50597
A,10116.0,,CHEMBL626978,Rattus norvegicus,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,9323,,50597
A,10116.0,,CHEMBL626979,Rattus norvegicus,PK study was carried to determine the relative absorption ranking in rat.,,16427,N,,Intermediate,,,,,,1,1,,BAO_0000218,9324,,50597
A,10116.0,,CHEMBL626980,Rattus norvegicus,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,,4689,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9325,In vivo,50597
A,10116.0,,CHEMBL626981,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9326,,50597
A,10116.0,,CHEMBL626982,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9327,,50597
A,10116.0,,CHEMBL626983,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9328,,50597
A,10116.0,,CHEMBL622522,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9329,,50597
A,10116.0,,CHEMBL622523,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9330,,50597
A,10116.0,,CHEMBL622524,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",,11450,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9331,,50597
A,10116.0,,CHEMBL622525,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9332,,50597
A,10116.0,,CHEMBL622526,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9333,,50597
A,10116.0,,CHEMBL619849,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9334,,50597
A,10116.0,,CHEMBL619850,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9335,,50597
A,10116.0,,CHEMBL623864,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9336,,50597
A,10116.0,,CHEMBL623865,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",,11450,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9337,,50597
A,10116.0,,CHEMBL623866,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9338,,50597
A,10116.0,,CHEMBL623867,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9339,,50597
A,10116.0,,CHEMBL877615,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9340,,50597
A,10116.0,,CHEMBL623868,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9341,,50597
A,10116.0,,CHEMBL623869,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9342,,50597
A,10116.0,,CHEMBL623870,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",,11450,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9343,,50597
A,10116.0,,CHEMBL623871,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9344,,50597
A,10116.0,,CHEMBL623872,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9345,,50597
A,10116.0,,CHEMBL622129,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9346,,50597
A,10116.0,,CHEMBL622130,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9347,,50597
A,10116.0,,CHEMBL622131,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9348,,50597
A,10116.0,,CHEMBL622132,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9349,,50597
A,10116.0,,CHEMBL622133,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9350,,50597
A,10116.0,,CHEMBL622134,Rattus norvegicus,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9351,,50597
A,10116.0,,CHEMBL622135,Rattus norvegicus,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9352,,50597
A,10116.0,,CHEMBL622136,Rattus norvegicus,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9353,,50597
A,10116.0,,CHEMBL622137,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9354,,50597
A,10116.0,,CHEMBL622138,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9355,,50597
A,10116.0,,CHEMBL623017,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9356,,50597
A,10116.0,,CHEMBL623018,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9357,,50597
A,10116.0,,CHEMBL623019,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9358,,50597
A,10116.0,,CHEMBL623020,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9359,,50597
A,10116.0,,CHEMBL623021,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9360,,50597
A,10116.0,,CHEMBL623022,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9361,,50597
A,10116.0,,CHEMBL623023,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9362,,50597
A,10116.0,,CHEMBL623024,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9363,,50597
A,10116.0,,CHEMBL623025,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9364,,50597
A,10116.0,,CHEMBL620545,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9365,,50597
A,10116.0,,CHEMBL620546,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9366,,50597
A,10116.0,,CHEMBL620547,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9367,,50597
A,10116.0,,CHEMBL620548,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9368,,50597
A,10116.0,,CHEMBL620549,Rattus norvegicus,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9369,,50597
A,10116.0,,CHEMBL620550,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9370,,50597
A,10116.0,,CHEMBL620551,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9371,,50597
A,10116.0,,CHEMBL620552,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9372,,50597
A,10116.0,,CHEMBL620553,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9373,,50597
A,10116.0,,CHEMBL620554,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9374,,50597
A,10116.0,,CHEMBL875845,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9375,,50597
A,10116.0,,CHEMBL620555,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9376,,50597
A,10116.0,,CHEMBL620556,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9377,,50597
A,10116.0,,CHEMBL620557,Rattus norvegicus,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9378,,50597
A,10116.0,,CHEMBL620558,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9379,,50597
A,10116.0,,CHEMBL620559,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9380,,50597
A,10116.0,,CHEMBL622939,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9381,,50597
A,10116.0,,CHEMBL622940,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9382,,50597
A,10116.0,,CHEMBL622941,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9383,,50597
A,10116.0,,CHEMBL622942,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9384,,50597
A,10116.0,,CHEMBL622943,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9385,,50597
A,10116.0,,CHEMBL622944,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9386,,50597
A,10116.0,,CHEMBL622945,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9387,,50597
A,10116.0,,CHEMBL622946,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9388,,50597
A,10116.0,,CHEMBL622947,Rattus norvegicus,Compound was evaluated for terminal half life in rat,,3341,N,,Intermediate,,,,,,1,1,,BAO_0000218,9389,,50597
A,10116.0,,CHEMBL622948,Rattus norvegicus,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,,3634,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9390,In vivo,50597
A,10116.0,,CHEMBL622949,Rattus norvegicus,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,,3634,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9391,In vivo,50597
A,10116.0,,CHEMBL622950,Rattus norvegicus,Compound was tested for its half life in rat,,4839,N,,Intermediate,,,,,,1,1,,BAO_0000218,9392,,50597
A,9544.0,,CHEMBL622951,Macaca mulatta,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000218,9393,In vivo,22224
A,10116.0,,CHEMBL622952,Rattus norvegicus,Compound was tested for its plasma half life in Sprague Dawley rats,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000366,9394,,22224
A,10116.0,,CHEMBL622953,Rattus norvegicus,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,,5005,U,,Intermediate,,,Plasma,1969.0,,1,0,,BAO_0000366,9395,,22224
A,10116.0,,CHEMBL873818,Rattus norvegicus,Compound was tested for plasma half-life period in rat,,1094,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9396,,50597
A,10116.0,,CHEMBL622954,Rattus norvegicus,Elimination half life after i.v. administration of compound in rats,,5031,N,,Intermediate,,,,,,1,1,,BAO_0000218,9397,In vivo,50597
A,10116.0,,CHEMBL622955,Rattus norvegicus,Elimination half-life after IV dosing at 0.5 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,9398,In vivo,50597
A,10116.0,,CHEMBL875229,Rattus norvegicus,Elimination half-life after IV dosing at 1 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,9399,In vivo,50597
A,10116.0,,CHEMBL622956,Rattus norvegicus,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,9400,In vivo,50597
A,10116.0,,CHEMBL622957,Rattus norvegicus,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,9401,In vivo,50597
A,10116.0,,CHEMBL622958,Rattus norvegicus,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,5408,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9402,In vivo,50597
A,10116.0,,CHEMBL622959,Rattus norvegicus,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,5408,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9403,In vivo,50597
A,10116.0,,CHEMBL622960,Rattus norvegicus,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,5408,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9404,In vivo,50597
A,10116.0,,CHEMBL622961,Rattus norvegicus,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,5408,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9405,In vivo,50597
A,10116.0,,CHEMBL622962,Rattus norvegicus,Evaluated for the half life in rat (in vivo),,4687,N,,Intermediate,,,,,,1,1,,BAO_0000218,9406,In vivo,50597
A,10116.0,,CHEMBL622963,Rattus norvegicus,Hafl life in rat,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,9407,,50597
A,10116.0,,CHEMBL622964,Rattus norvegicus,Hafl life rat,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,9408,,50597
A,10116.0,,CHEMBL622965,Rattus norvegicus,Hafl life rat,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,9409,,50597
A,10116.0,,CHEMBL622966,Rattus norvegicus,Hafl life rat; Not determined,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,9410,,50597
A,10116.0,,CHEMBL622967,Rattus norvegicus,Hafl life rat; Not determined,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,9411,,50597
A,10116.0,,CHEMBL622968,Rattus norvegicus,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9412,In vivo,50597
A,10116.0,,CHEMBL622969,Rattus norvegicus,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9413,In vivo,50597
A,10116.0,,CHEMBL875327,Rattus norvegicus,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9414,In vivo,50597
A,10116.0,,CHEMBL628638,Rattus norvegicus,Half life in rat after 1 mg/kg i.v. administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,9415,In vivo,50597
A,10116.0,,CHEMBL628639,Rattus norvegicus,Half life in rat after 2 mg/kg peroral administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,9416,In vivo,50597
A,10116.0,,CHEMBL625840,Rattus norvegicus,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9417,In vivo,50597
A,10116.0,,CHEMBL625841,Rattus norvegicus,Half life of 10 mg/kg oral dose determined in rats,,4722,N,,Intermediate,,,,,,1,1,,BAO_0000218,9418,In vivo,50597
A,10116.0,,CHEMBL625842,Rattus norvegicus,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9419,In vivo,50597
A,10116.0,,CHEMBL625843,Rattus norvegicus,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9420,In vivo,50597
A,10116.0,,CHEMBL625844,Rattus norvegicus,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9421,In vivo,50597
A,10116.0,,CHEMBL873822,Rattus norvegicus,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9422,In vivo,50597
A,10116.0,,CHEMBL625845,Rattus norvegicus,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9423,In vivo,50597
A,10116.0,,CHEMBL627059,Rattus norvegicus,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9424,In vivo,50597
A,10116.0,,CHEMBL627060,Rattus norvegicus,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9425,In vivo,50597
A,10116.0,,CHEMBL627061,Rattus norvegicus,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,9426,In vivo,50597
A,10116.0,,CHEMBL627709,Rattus norvegicus,Half life of compound at 5 mg/kg after po administration was determined in rat,,4762,N,,Intermediate,,,,,,1,1,,BAO_0000218,9427,In vivo,50597
A,10116.0,,CHEMBL627710,Rattus norvegicus,Half life of compound determined after intravenous administration to rat,,5327,N,,Intermediate,,,,,,1,1,,BAO_0000218,9428,In vivo,50597
A,10116.0,,CHEMBL627711,Rattus norvegicus,Half life of compound was determined in rat,,4847,N,,Intermediate,,,,,,1,1,,BAO_0000218,9429,,50597
A,10116.0,,CHEMBL627712,Rattus norvegicus,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9430,In vivo,50597
A,10116.0,,CHEMBL627713,Rattus norvegicus,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9431,In vivo,50597
A,10116.0,,CHEMBL627714,Rattus norvegicus,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9432,In vivo,50597
A,9541.0,,CHEMBL627889,Macaca fascicularis,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,,4256,U,,Intermediate,,,,,,1,0,,BAO_0000218,9433,In vivo,22224
A,10116.0,,CHEMBL627890,Rattus norvegicus,Half life determined in rat by intravenous administration,,4256,U,,Intermediate,,,,,,1,0,,BAO_0000218,9434,In vivo,22224
A,10116.0,,CHEMBL627891,Rattus norvegicus,Half life determined in rats after iv administration,,4722,N,,Intermediate,,,,,,1,1,,BAO_0000218,9435,In vivo,50597
A,10116.0,,CHEMBL627892,Rattus norvegicus,Half life in rat plasma after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9436,In vivo,50597
A,10116.0,,CHEMBL627893,Rattus norvegicus,Half life in rat plasma after administration of 2 mg/kg iv,,6535,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9437,In vivo,50597
A,10116.0,,CHEMBL627894,Rattus norvegicus,Half life in rat plasma was determined,,1435,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9438,,50597
A,10116.0,,CHEMBL627895,Rattus norvegicus,Half life in rat plasma was determined; NA means not applicable,,1435,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9439,,50597
A,10116.0,,CHEMBL627896,Rattus norvegicus,Half life in rat was tested,,5206,N,,Intermediate,,,,,,1,1,,BAO_0000218,9440,,50597
A,10116.0,,CHEMBL627897,Rattus norvegicus,Half life measured in rat plasma,,6080,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9441,,50597
A,10116.0,,CHEMBL627898,Rattus norvegicus,Half life recorded in rats,,4449,N,,Intermediate,,,,,,1,1,,BAO_0000218,9442,,50597
A,10116.0,,CHEMBL627899,Rattus norvegicus,Half life was calculated,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,9443,,50597
A,10116.0,,CHEMBL873823,Rattus norvegicus,Half life was calculated in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,9444,,50597
A,10116.0,,CHEMBL627900,Rattus norvegicus,Half life was determined,,3747,N,,Intermediate,,,,,,1,1,,BAO_0000218,9445,,50597
A,10116.0,,CHEMBL627901,Rattus norvegicus,Half life after 10 mg/kg oral administration in rat,,17858,N,,Intermediate,,,,,,1,1,,BAO_0000218,9446,In vivo,50597
A,10116.0,,CHEMBL627902,Rattus norvegicus,Half life after administering orally a dose of 10 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9447,In vivo,50597
A,10116.0,,CHEMBL627903,Rattus norvegicus,Half life after administering orally a dose of 30 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9448,In vivo,50597
A,10116.0,,CHEMBL627904,Rattus norvegicus,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,,5031,N,,Intermediate,,,,,,1,1,,BAO_0000218,9449,,50597
A,10116.0,,CHEMBL627905,Rattus norvegicus,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,,4722,N,,Intermediate,,,,,,1,1,,BAO_0000218,9450,,50597
A,10116.0,,CHEMBL627906,Rattus norvegicus,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9451,,50597
A,10116.0,,CHEMBL627907,Rattus norvegicus,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9452,,50597
A,10116.0,,CHEMBL876783,Rattus norvegicus,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9453,,50597
A,10116.0,,CHEMBL627908,Rattus norvegicus,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9454,,50597
A,10116.0,,CHEMBL627909,Rattus norvegicus,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,,17065,N,,Intermediate,,,,,,1,1,,BAO_0000218,9455,,50597
A,10116.0,,CHEMBL627910,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,,1353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9456,,50597
A,10116.0,,CHEMBL627911,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),,1353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9457,,50597
A,10116.0,,CHEMBL627912,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),,1353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9458,,50597
A,10116.0,,CHEMBL627913,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),,1353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9459,,50597
A,10116.0,,CHEMBL627914,Rattus norvegicus,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),,1353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9460,,50597
A,10116.0,,CHEMBL627915,Rattus norvegicus,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,9461,,50597
A,10116.0,,CHEMBL627916,Rattus norvegicus,Area under the curve was evaluated after 20 uM/kg of peroral administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,9462,,50597
A,10116.0,,CHEMBL627917,Rattus norvegicus,Area under the curve was measured in rat after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,9463,,50597
A,10116.0,,CHEMBL627918,Rattus norvegicus,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,,6056,N,,Intermediate,,,,,,1,1,,BAO_0000218,9464,,50597
A,10116.0,,CHEMBL627919,Rattus norvegicus,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,9465,,50597
A,10116.0,,CHEMBL627920,Rattus norvegicus,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,9466,,50597
A,10116.0,,CHEMBL627921,Rattus norvegicus,Area under the curve was evaluated at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,9467,,50597
A,10116.0,,CHEMBL627922,Rattus norvegicus,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9468,,50597
A,10116.0,,CHEMBL876784,Rattus norvegicus,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9469,,50597
A,10116.0,,CHEMBL627923,Rattus norvegicus,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9470,,50597
A,10116.0,,CHEMBL626208,Rattus norvegicus,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9471,,50597
A,10116.0,,CHEMBL626209,Rattus norvegicus,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9472,,50597
A,10116.0,,CHEMBL626210,Rattus norvegicus,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,9473,,50597
A,10116.0,,CHEMBL627994,Rattus norvegicus,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,,2463,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9474,,50597
A,10116.0,,CHEMBL627995,Rattus norvegicus,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,9475,,50597
A,10116.0,,CHEMBL627996,Rattus norvegicus,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,,4075,N,,Intermediate,,,,,,1,1,,BAO_0000218,9476,,50597
A,10116.0,,CHEMBL627997,Rattus norvegicus,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,,5394,N,,Intermediate,,,,,,1,1,,BAO_0000218,9477,,50597
A,10116.0,,CHEMBL627998,Rattus norvegicus,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9478,,50597
A,10116.0,,CHEMBL628640,Rattus norvegicus,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9479,,50597
A,10116.0,,CHEMBL628641,Rattus norvegicus,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9480,,50597
A,10116.0,,CHEMBL628642,Rattus norvegicus,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,9481,,50597
A,10116.0,,CHEMBL628643,Rattus norvegicus,Compound was evaluated for area under the curve expressed as (h*ug/ml),,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9482,,50597
A,10116.0,,CHEMBL628644,Rattus norvegicus,Compound was tested for area under curve in rat,,2591,N,,Intermediate,,,,,,1,1,,BAO_0000218,9483,,50597
A,10116.0,,CHEMBL628645,Rattus norvegicus,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,,6567,N,,Intermediate,,,,,,1,1,,BAO_0000218,9484,,50597
A,10116.0,,CHEMBL628646,Rattus norvegicus,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,,6211,N,,Intermediate,,,,,,1,1,,BAO_0000218,9485,,50597
A,10116.0,,CHEMBL628647,Rattus norvegicus,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),,5529,N,,Intermediate,,,,,,1,1,,BAO_0000218,9486,,50597
A,10116.0,,CHEMBL628648,Rattus norvegicus,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,,5408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9487,,50597
A,10116.0,,CHEMBL625358,Rattus norvegicus,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,,5408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9488,,50597
A,10116.0,,CHEMBL625359,Rattus norvegicus,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,,5408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9489,,50597
A,10116.0,,CHEMBL625360,Rattus norvegicus,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,,5408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9490,,50597
A,10116.0,,CHEMBL625361,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,9491,,50597
A,10116.0,,CHEMBL625362,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,9492,,50597
A,10116.0,,CHEMBL625363,Rattus norvegicus,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,9493,,50597
A,10116.0,,CHEMBL625364,Rattus norvegicus,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,4796,N,,Intermediate,,,,,,1,1,,BAO_0000218,9494,,50597
A,10116.0,,CHEMBL625365,Rattus norvegicus,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,9495,,50597
A,10116.0,,CHEMBL625366,Rattus norvegicus,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,9496,,50597
A,10116.0,,CHEMBL625367,Rattus norvegicus,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,9497,,50597
A,10116.0,,CHEMBL625368,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9498,,50597
A,10116.0,,CHEMBL625369,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9499,,50597
A,10116.0,,CHEMBL625370,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9500,,50597
A,10116.0,,CHEMBL625371,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9501,,50597
A,10116.0,,CHEMBL625372,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9502,,50597
A,10116.0,,CHEMBL625373,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",,11450,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9503,,50597
A,10116.0,,CHEMBL625374,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9504,,50597
A,10116.0,,CHEMBL877593,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9505,,50597
A,10116.0,,CHEMBL625375,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9506,,50597
A,10116.0,,CHEMBL625376,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9507,,50597
A,10116.0,,CHEMBL621973,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9508,,50597
A,10116.0,,CHEMBL621974,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",,11450,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9509,,50597
A,10116.0,,CHEMBL621975,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9510,,50597
A,10116.0,,CHEMBL622166,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9511,,50597
A,10116.0,,CHEMBL622167,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9512,,50597
A,10116.0,,CHEMBL622168,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9513,,50597
A,10116.0,,CHEMBL622169,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9514,,50597
A,10116.0,,CHEMBL622170,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",,11450,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9515,,50597
A,10116.0,,CHEMBL622171,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9516,,50597
A,10116.0,,CHEMBL622172,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9517,,50597
A,10116.0,,CHEMBL622173,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9518,,50597
A,10116.0,,CHEMBL622174,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9519,,50597
A,10116.0,,CHEMBL622175,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9520,,50597
A,10116.0,,CHEMBL622176,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9521,,50597
A,10116.0,,CHEMBL622177,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9522,,50597
A,10116.0,,CHEMBL622178,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9523,,50597
A,10116.0,,CHEMBL622179,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9524,,50597
A,10116.0,,CHEMBL622180,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9525,,50597
A,10116.0,,CHEMBL622181,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9526,,50597
A,10116.0,,CHEMBL622182,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9527,,50597
A,10116.0,,CHEMBL622183,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9528,,50597
A,10116.0,,CHEMBL622184,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9529,,50597
A,10116.0,,CHEMBL622185,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9530,,50597
A,10116.0,,CHEMBL622186,Rattus norvegicus,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9531,,50597
A,10116.0,,CHEMBL622187,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9532,,50597
A,10116.0,,CHEMBL625002,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9533,,50597
A,10116.0,,CHEMBL622090,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9534,,50597
A,10116.0,,CHEMBL622091,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9535,,50597
A,10116.0,,CHEMBL622092,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9536,,50597
A,10116.0,,CHEMBL622093,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9537,,50597
A,10116.0,,CHEMBL622094,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9538,,50597
A,10116.0,,CHEMBL622095,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9539,,50597
A,10116.0,,CHEMBL622264,Rattus norvegicus,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9540,,50597
A,10116.0,,CHEMBL622265,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9541,,50597
A,10116.0,,CHEMBL622266,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9542,,50597
A,10116.0,,CHEMBL622267,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9543,,50597
A,10116.0,,CHEMBL622268,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9544,,50597
A,10116.0,,CHEMBL622269,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9545,,50597
A,10116.0,,CHEMBL625071,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9546,,50597
A,10116.0,,CHEMBL621621,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9547,,50597
A,10116.0,,CHEMBL621622,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9548,,50597
A,10116.0,,CHEMBL621623,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9549,,50597
A,10116.0,,CHEMBL621624,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9550,,50597
A,10116.0,,CHEMBL621625,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9551,,50597
A,10116.0,,CHEMBL621626,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9552,,50597
A,10116.0,,CHEMBL621627,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9553,,50597
A,10116.0,,CHEMBL621628,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9554,,50597
A,10116.0,,CHEMBL875328,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9555,,50597
A,10116.0,,CHEMBL621629,Rattus norvegicus,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9556,,50597
A,10116.0,,CHEMBL621630,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9557,,50597
A,10116.0,,CHEMBL621631,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9558,,50597
A,10116.0,,CHEMBL621632,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9559,,50597
A,10116.0,,CHEMBL621633,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9560,,50597
A,10116.0,,CHEMBL621634,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9561,,50597
A,10116.0,,CHEMBL621635,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9562,,50597
A,10116.0,,CHEMBL621636,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9563,,50597
A,10116.0,,CHEMBL621637,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9564,,50597
A,10116.0,,CHEMBL621638,Rattus norvegicus,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9565,,50597
A,10116.0,,CHEMBL618883,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9566,,50597
A,10116.0,,CHEMBL618884,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9567,,50597
A,10116.0,,CHEMBL628627,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9568,,50597
A,10116.0,,CHEMBL628628,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9569,,50597
A,10116.0,,CHEMBL628629,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9570,,50597
A,10116.0,,CHEMBL628630,Rattus norvegicus,Half life after administering orally a dose of 3 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9571,In vivo,50597
A,10116.0,,CHEMBL628631,Rattus norvegicus,Half life after administering orally a dose of 3 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9572,In vivo,50597
A,10116.0,,CHEMBL628632,Rattus norvegicus,Half life after administering intravenously a dose of 1 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9573,In vivo,50597
A,10116.0,,CHEMBL628633,Rattus norvegicus,Half life after oral dosing in rats,,526,N,,Intermediate,,,,,,1,1,,BAO_0000218,9574,In vivo,50597
A,10116.0,,CHEMBL628634,Rattus norvegicus,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9575,In vivo,50597
A,10116.0,,CHEMBL627789,Rattus norvegicus,Half life by intravenous administration of 3.4 mg/kg in rat,,4368,N,,Intermediate,,,,,,1,1,,BAO_0000218,9576,In vivo,50597
A,10116.0,,CHEMBL627790,Rattus norvegicus,Half life in rat,,3371,N,,Intermediate,,,,,,1,1,,BAO_0000218,9577,,50597
A,10116.0,,CHEMBL627791,Rattus norvegicus,Half life in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,9578,,50597
A,10116.0,,CHEMBL627792,Rattus norvegicus,Half life in rat,,6453,N,,Intermediate,,,,,,1,1,,BAO_0000218,9579,,50597
A,10116.0,,CHEMBL627793,Rattus norvegicus,Half life in rat after intravenous administration of the compound,,4353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9580,In vivo,50597
A,10116.0,,CHEMBL627794,Rattus norvegicus,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,,4353,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9581,In vivo,50597
A,10116.0,,CHEMBL627795,Rattus norvegicus,Half life in rat after po administration of the compound,,4353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9582,In vivo,50597
A,10116.0,,CHEMBL627796,Rattus norvegicus,Half life in rat after po administration of the compound; ND means Not determined,,4353,N,,Intermediate,,,,,,1,1,,BAO_0000218,9583,In vivo,50597
A,10116.0,,CHEMBL875335,Rattus norvegicus,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,,4353,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9584,In vivo,50597
A,10116.0,,CHEMBL627797,Rattus norvegicus,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,,4353,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9585,In vivo,50597
A,10116.0,,CHEMBL627798,Rattus norvegicus,Half life in rat i.v.,,5789,N,,Intermediate,,,,,,1,1,,BAO_0000218,9586,In vivo,50597
A,10116.0,,CHEMBL627799,Rattus norvegicus,Half life in rat i.v. at 2 mg/kg concentration,,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,9587,In vivo,50597
A,10116.0,,CHEMBL627800,Rattus norvegicus,Half life in rats,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,9588,,50597
A,10116.0,,CHEMBL627801,Rattus norvegicus,Half life in rats after intravenous administration,,484,N,,Intermediate,,,,,,1,1,,BAO_0000218,9589,In vivo,50597
A,10116.0,,CHEMBL627802,Rattus norvegicus,Half life in rats at the dose of 1.0 mpk by i.v. administration,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,9590,In vivo,50597
A,10116.0,,CHEMBL627803,Rattus norvegicus,Half life in rat,,6642,N,,Expert,,,,,,1,1,,BAO_0000218,9591,,50597
A,10116.0,,CHEMBL873820,Rattus norvegicus,Half life was evaluated after intravenous administration to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,9592,In vivo,50597
A,10116.0,,CHEMBL627804,Rattus norvegicus,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),,1369,N,,Intermediate,,,,,,1,1,,BAO_0000218,9593,,50597
A,10116.0,,CHEMBL627805,Rattus norvegicus,Half life was evaluated in rat,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,9594,,50597
A,10116.0,,CHEMBL627806,Rattus norvegicus,Half life was evaluated in rat,,6049,N,,Intermediate,,,,,,1,1,,BAO_0000218,9595,,50597
A,10116.0,,CHEMBL627107,Rattus norvegicus,Half life was evaluated in rat; Not tested,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,9596,,50597
A,10116.0,,CHEMBL627108,Rattus norvegicus,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,9597,In vivo,50597
A,10116.0,,CHEMBL627109,Rattus norvegicus,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,,11149,N,,Intermediate,,,,,,1,1,,BAO_0000218,9598,In vivo,50597
A,10116.0,,CHEMBL627110,Rattus norvegicus,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,,11149,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9599,In vivo,50597
A,9443.0,,CHEMBL627111,Primates,Half life was measured in monkey at dose of 10 mg/kg by po administration,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,9600,In vivo,22224
A,9443.0,,CHEMBL627112,Primates,Half life was measured in monkey at dose of 10 mg/kg by po administration,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,9601,In vivo,22224
A,10116.0,,CHEMBL627113,Rattus norvegicus,Half life was measured in rat at dose of 30 mg/kg by iv administration,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,9602,In vivo,22224
A,10116.0,,CHEMBL627114,Rattus norvegicus,Half life was measured in rat at dose of 30 mg/kg by po administration,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,9603,In vivo,22224
A,10116.0,,CHEMBL627115,Rattus norvegicus,Half life (t1/2) was determined,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,9604,,50597
A,10116.0,,CHEMBL627116,Rattus norvegicus,Half life period at a dose of 10 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,9605,,50597
A,10116.0,,CHEMBL627117,Rattus norvegicus,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,9606,In vivo,50597
A,10116.0,,CHEMBL627118,Rattus norvegicus,Half life period was determined,,5503,N,,Intermediate,,,,,,1,1,,BAO_0000218,9607,,50597
A,10116.0,,CHEMBL627119,Rattus norvegicus,Half life period after intravenous administration at 20 mpk in rats,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,9608,In vivo,50597
A,10116.0,,CHEMBL627120,Rattus norvegicus,Half life period after intravenous administration at 20 mpk in rats; Not performed.,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,9609,In vivo,50597
A,10116.0,,CHEMBL626922,Rattus norvegicus,Half life period after intravenous administration in rat,,6109,N,,Intermediate,,,,,,1,1,,BAO_0000218,9610,In vivo,50597
A,10116.0,,CHEMBL626923,Rattus norvegicus,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,9611,In vivo,50597
A,10116.0,,CHEMBL626924,Rattus norvegicus,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,9612,In vivo,50597
A,10116.0,,CHEMBL626925,Rattus norvegicus,Half life period in 80% rat plasma at 37 degree Centigrade,,4755,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9613,,50597
A,10116.0,,CHEMBL626926,Rattus norvegicus,Half life period in SD rats,,5862,N,,Intermediate,,,,,,1,1,,BAO_0000218,9614,,50597
A,10116.0,,CHEMBL626927,Rattus norvegicus,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9615,,50597
A,10116.0,,CHEMBL626928,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9616,,50597
A,10116.0,,CHEMBL626929,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9617,,50597
A,10116.0,,CHEMBL626930,Rattus norvegicus,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9618,,50597
A,10116.0,,CHEMBL626931,Rattus norvegicus,Half life period in rat,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,9619,,50597
A,10116.0,,CHEMBL626932,Rattus norvegicus,Half life period in rat,,6103,N,,Intermediate,,,,,,1,1,,BAO_0000218,9620,,50597
A,10116.0,,CHEMBL626933,Rattus norvegicus,Half life period in rat,,6317,N,,Intermediate,,,,,,1,1,,BAO_0000218,9621,,50597
A,10116.0,,CHEMBL873826,Rattus norvegicus,Half life period in rat after oral administration at 10.5 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,9622,In vivo,50597
A,10116.0,,CHEMBL626934,Rattus norvegicus,Half life period in rat after oral administration at 11.2 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,9623,In vivo,50597
A,10116.0,,CHEMBL626935,Rattus norvegicus,Half life period in rat after oral administration at 13 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,9624,In vivo,50597
A,10116.0,,CHEMBL626936,Rattus norvegicus,Half life period in rat after oral administration at 9.7 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,9625,In vivo,50597
A,10116.0,,CHEMBL626937,Rattus norvegicus,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,9626,,50597
A,10116.0,,CHEMBL625906,Rattus norvegicus,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,6295,N,,Intermediate,,,,,,1,1,,BAO_0000218,9627,,50597
A,10116.0,,CHEMBL625907,Rattus norvegicus,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,,6296,N,,Intermediate,,,,,,1,1,,BAO_0000218,9628,,50597
A,10116.0,,CHEMBL625908,Rattus norvegicus,PK study was carried to determine AUC (area under curve) value in rat,,16427,N,,Intermediate,,,,,,1,1,,BAO_0000218,9629,,50597
A,10116.0,,CHEMBL625909,Rattus norvegicus,Pharmacokinetic parameter AUC after intravenous administration to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,9630,,50597
A,10116.0,,CHEMBL625910,Rattus norvegicus,Pharmacokinetic parameter AUC after oral administration to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,9631,,50597
A,10116.0,,CHEMBL625911,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9632,,50597
A,10116.0,,CHEMBL625912,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9633,,50597
A,10116.0,,CHEMBL626538,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9634,,50597
A,10116.0,,CHEMBL876794,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9635,,50597
A,10116.0,,CHEMBL626539,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9636,,50597
A,10116.0,,CHEMBL626540,Rattus norvegicus,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,9637,,50597
A,10116.0,,CHEMBL626541,Rattus norvegicus,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,,5394,N,,Intermediate,,,,,,1,1,,BAO_0000218,9638,,50597
A,10116.0,,CHEMBL626542,Rattus norvegicus,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,,5394,N,,Intermediate,,,,,,1,1,,BAO_0000218,9639,,50597
A,10116.0,,CHEMBL626543,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,9640,,50597
A,10116.0,,CHEMBL626544,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,9641,,50597
A,10116.0,,CHEMBL626545,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,9642,,50597
A,10116.0,,CHEMBL626546,Rattus norvegicus,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,9643,,50597
A,10116.0,,CHEMBL626547,Rattus norvegicus,Pharmacokinetic parameter area under curve was reported,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,9644,,50597
A,10116.0,,CHEMBL626548,Rattus norvegicus,Pharmacokinetic property (AUC) in rat,,4408,N,,Intermediate,,,,,,1,1,,BAO_0000218,9645,,50597
A,10116.0,,CHEMBL626549,Rattus norvegicus,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,9646,,50597
A,10116.0,,CHEMBL626550,Rattus norvegicus,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,,4397,N,,Intermediate,,,,,,1,1,,BAO_0000218,9647,,50597
A,10116.0,,CHEMBL626551,Rattus norvegicus,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,,4397,N,,Intermediate,,,,,,1,1,,BAO_0000218,9648,,50597
A,10116.0,,CHEMBL623777,Rattus norvegicus,Pharmacokinetic property was determined,,5491,N,,Intermediate,,,,,,1,1,,BAO_0000218,9649,,50597
A,10116.0,,CHEMBL623778,Rattus norvegicus,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,,5491,N,,Intermediate,,,,,,1,1,,BAO_0000218,9650,,50597
A,10116.0,,CHEMBL623779,Rattus norvegicus,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,,5491,N,,Intermediate,,,,,,1,1,,BAO_0000218,9651,,50597
A,10116.0,,CHEMBL623780,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,4199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9652,,50597
A,10116.0,,CHEMBL622015,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,,4199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9653,,50597
A,10116.0,,CHEMBL622016,Rattus norvegicus,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,,4199,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9654,,50597
A,10116.0,,CHEMBL622017,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",,5173,N,,Intermediate,,,,,,1,1,,BAO_0000218,9655,,50597
A,10116.0,,CHEMBL622018,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",,5173,N,,Intermediate,,,,,,1,1,,BAO_0000218,9656,,50597
A,10116.0,,CHEMBL622019,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",,5173,N,,Intermediate,,,,,,1,1,,BAO_0000218,9657,,50597
A,10116.0,,CHEMBL622020,Rattus norvegicus,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",,5173,N,,Intermediate,,,,,,1,1,,BAO_0000218,9658,,50597
A,10116.0,,CHEMBL622021,Rattus norvegicus,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,9659,,50597
A,10116.0,,CHEMBL622022,Rattus norvegicus,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,9660,,50597
A,10116.0,,CHEMBL622023,Rattus norvegicus,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,,5327,N,,Intermediate,,,,,,1,1,,BAO_0000218,9661,,50597
A,10116.0,,CHEMBL622024,Rattus norvegicus,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,,6681,N,,Intermediate,,,,,,1,1,,BAO_0000218,9662,,50597
A,10116.0,,CHEMBL622693,Rattus norvegicus,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),,12873,N,,Intermediate,,,,,,1,1,,BAO_0000218,9663,,50597
A,10116.0,,CHEMBL622694,Rattus norvegicus,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),,12873,N,,Intermediate,,,,,,1,1,,BAO_0000218,9664,,50597
A,10116.0,,CHEMBL622695,Rattus norvegicus,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,9665,,50597
A,10116.0,,CHEMBL622696,Rattus norvegicus,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,9666,,50597
A,10116.0,,CHEMBL622697,Rattus norvegicus,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,9667,,50597
A,10116.0,,CHEMBL622874,Rattus norvegicus,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",,6619,N,,Intermediate,,,,,,1,1,,BAO_0000218,9668,,50597
A,10116.0,,CHEMBL622875,Rattus norvegicus,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",,6619,N,,Intermediate,,,,,,1,1,,BAO_0000218,9669,,50597
A,10116.0,,CHEMBL622876,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,10363,N,,Intermediate,,,,,,1,1,,BAO_0000218,9670,,50597
A,10116.0,,CHEMBL622877,Rattus norvegicus,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,,4796,N,,Intermediate,,,,,,1,1,,BAO_0000218,9671,,50597
A,10116.0,,CHEMBL622878,Rattus norvegicus,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,9672,,50597
A,10116.0,,CHEMBL622879,Rattus norvegicus,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9673,,50597
A,10116.0,,CHEMBL877602,Rattus norvegicus,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,,4839,N,,Intermediate,,,,,,1,1,,BAO_0000218,9674,,50597
A,10116.0,,CHEMBL622880,Rattus norvegicus,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9675,,50597
A,10116.0,,CHEMBL622881,Rattus norvegicus,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9676,,50597
A,10116.0,,CHEMBL622882,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9677,,50597
A,10116.0,,CHEMBL622883,Rattus norvegicus,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9678,,50597
A,10116.0,,CHEMBL622884,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9679,,50597
A,10116.0,,CHEMBL622885,Rattus norvegicus,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",,11450,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9680,,50597
A,10116.0,,CHEMBL622886,Rattus norvegicus,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,9681,,50597
A,10116.0,,CHEMBL622887,Rattus norvegicus,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,9682,,50597
A,10116.0,,CHEMBL622888,Rattus norvegicus,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9683,,50597
A,10116.0,,CHEMBL622889,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9684,In vivo,50597
A,10116.0,,CHEMBL622890,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9685,In vivo,50597
A,10116.0,,CHEMBL622891,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9686,In vivo,50597
A,10116.0,,CHEMBL877603,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9687,In vivo,50597
A,10116.0,,CHEMBL622892,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9688,In vivo,50597
A,10116.0,,CHEMBL622893,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9689,In vivo,50597
A,10116.0,,CHEMBL622894,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9690,In vivo,50597
A,10116.0,,CHEMBL622895,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9691,In vivo,50597
A,10116.0,,CHEMBL622896,Rattus norvegicus,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,,8677,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9692,In vivo,50597
A,10116.0,,CHEMBL622897,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9693,In vivo,50597
A,10116.0,,CHEMBL622898,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9694,In vivo,50597
A,10116.0,,CHEMBL622899,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9695,In vivo,50597
A,10116.0,,CHEMBL622900,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9696,In vivo,50597
A,10116.0,,CHEMBL624114,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9697,In vivo,50597
A,10116.0,,CHEMBL624115,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9698,In vivo,50597
A,10116.0,,CHEMBL624116,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9699,In vivo,50597
A,10116.0,,CHEMBL624117,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9700,In vivo,50597
A,10116.0,,CHEMBL624118,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9701,In vivo,50597
A,10116.0,,CHEMBL624119,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9702,In vivo,50597
A,10116.0,,CHEMBL624120,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9703,In vivo,50597
A,10116.0,,CHEMBL624121,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9704,In vivo,50597
A,10116.0,,CHEMBL624122,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9705,In vivo,50597
A,10116.0,,CHEMBL624123,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9706,In vivo,50597
A,10116.0,,CHEMBL624124,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9707,In vivo,50597
A,10116.0,,CHEMBL624125,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9708,In vivo,50597
A,10116.0,,CHEMBL624126,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9709,In vivo,50597
A,10116.0,,CHEMBL624127,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9710,In vivo,50597
A,10116.0,,CHEMBL624128,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9711,In vivo,50597
A,10116.0,,CHEMBL624129,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9712,In vivo,50597
A,10116.0,,CHEMBL624130,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9713,In vivo,50597
A,10116.0,,CHEMBL622340,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9714,In vivo,50597
A,10116.0,,CHEMBL622341,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,9715,In vivo,50597
A,10116.0,,CHEMBL622342,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,9716,In vivo,50597
A,10116.0,,CHEMBL622343,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,9717,In vivo,50597
A,10116.0,,CHEMBL622344,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,9718,In vivo,50597
A,10116.0,,CHEMBL622345,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,9719,In vivo,50597
A,10116.0,,CHEMBL622346,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9720,In vivo,50597
A,10116.0,,CHEMBL622347,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9721,In vivo,50597
A,10116.0,,CHEMBL622348,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9722,In vivo,50597
A,10116.0,,CHEMBL622349,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9723,In vivo,50597
A,10116.0,,CHEMBL622350,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9724,,50597
A,10116.0,,CHEMBL622351,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9725,,50597
A,10116.0,,CHEMBL622352,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9726,,50597
A,10116.0,,CHEMBL622353,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9727,,50597
A,10116.0,,CHEMBL622354,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9728,,50597
A,10116.0,,CHEMBL622355,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9729,,50597
A,10116.0,,CHEMBL622356,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9730,,50597
A,10116.0,,CHEMBL622357,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9731,,50597
A,10116.0,,CHEMBL622358,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9732,,50597
A,10116.0,,CHEMBL622359,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9733,,50597
A,10116.0,,CHEMBL874393,Rattus norvegicus,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9734,,50597
A,10116.0,,CHEMBL622872,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9735,,50597
A,10116.0,,CHEMBL622873,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9736,,50597
A,10116.0,,CHEMBL623047,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9737,,50597
A,10116.0,,CHEMBL623048,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9738,,50597
A,10116.0,,CHEMBL623049,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9739,,50597
A,10116.0,,CHEMBL623050,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9740,,50597
A,10116.0,,CHEMBL623051,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9741,,50597
A,10116.0,,CHEMBL623052,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9742,,50597
A,10116.0,,CHEMBL626343,Rattus norvegicus,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9743,,50597
A,10116.0,,CHEMBL626344,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9744,,50597
A,10116.0,,CHEMBL626345,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9745,,50597
A,10116.0,,CHEMBL626346,Rattus norvegicus,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9746,,50597
A,10116.0,,CHEMBL626347,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9747,,50597
A,10116.0,,CHEMBL626348,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9748,,50597
A,10116.0,,CHEMBL626349,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,,16434,N,,Intermediate,,,,,,1,1,,BAO_0000218,9749,,50597
F,10116.0,,CHEMBL626350,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9750,,50597
A,10116.0,,CHEMBL626351,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9751,,50597
A,10116.0,,CHEMBL627650,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9752,,50597
F,10116.0,,CHEMBL627651,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9753,,50597
A,10116.0,,CHEMBL627652,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9754,,50597
A,10116.0,,CHEMBL627653,Rattus norvegicus,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,,16435,N,,Intermediate,,,,,,1,1,,BAO_0000218,9755,,50597
A,10116.0,,CHEMBL627654,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9756,,50597
A,10116.0,,CHEMBL627835,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9757,,50597
A,10116.0,,CHEMBL627836,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9758,,50597
A,10116.0,,CHEMBL627837,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9759,,50597
A,10116.0,,CHEMBL627838,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9760,,50597
A,10116.0,,CHEMBL875338,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9761,,50597
A,10116.0,,CHEMBL627839,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9762,,50597
A,10116.0,,CHEMBL627840,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9763,,50597
A,10116.0,,CHEMBL627841,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9764,,50597
A,10116.0,,CHEMBL627842,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9765,,50597
A,10116.0,,CHEMBL627843,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9766,,50597
A,10116.0,,CHEMBL627844,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9767,,50597
A,10116.0,,CHEMBL627845,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9768,,50597
A,10116.0,,CHEMBL627846,Rattus norvegicus,Half life period in rat by iv administration at a dose of 3 mg/kg,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,9769,In vivo,50597
A,10116.0,,CHEMBL627847,Rattus norvegicus,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9770,,50597
A,10116.0,,CHEMBL873821,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9771,,50597
A,10116.0,,CHEMBL626079,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9772,,50597
A,10116.0,,CHEMBL626080,Rattus norvegicus,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,,1515,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9773,,50597
A,10116.0,,CHEMBL626081,Rattus norvegicus,Half life period was evaluated in rat plasma,,5491,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9774,,50597
A,10116.0,,CHEMBL875344,Rattus norvegicus,Half life period was evaluated in rat plasma; Not tested,,5491,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9775,,50597
A,10116.0,,CHEMBL626082,Rattus norvegicus,Half life period was evaluated in rats,,1918,N,,Intermediate,,,,,,1,1,,BAO_0000218,9776,,50597
A,10116.0,,CHEMBL626250,Rattus norvegicus,"Half life period was evaluated in rats, iv",,1918,N,,Intermediate,,,,,,1,1,,BAO_0000218,9777,In vivo,50597
A,10116.0,,CHEMBL626251,Rattus norvegicus,Half life period after intravenous administration at 5 mg/kg in rat,,6113,N,,Intermediate,,,,,,1,1,,BAO_0000218,9778,In vivo,50597
A,10116.0,,CHEMBL626252,Rattus norvegicus,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,,5546,N,,Intermediate,,,,,,1,1,,BAO_0000218,9779,In vivo,50597
A,10116.0,,CHEMBL626253,Rattus norvegicus,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,,5553,N,,Intermediate,,,,,,1,1,,BAO_0000218,9780,In vivo,50597
A,10116.0,,CHEMBL626254,Rattus norvegicus,Half life stability of compound was evaluated in rat plasma,,4188,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9781,,50597
A,10116.0,,CHEMBL626255,Rattus norvegicus,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,,6215,N,,Intermediate,,,,,,1,1,,BAO_0000218,9782,In vivo,50597
A,10116.0,,CHEMBL626256,Rattus norvegicus,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,,6141,N,,Intermediate,,,,,,1,1,,BAO_0000218,9783,In vivo,50597
A,10116.0,,CHEMBL626257,Rattus norvegicus,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,9784,In vivo,50597
A,10116.0,,CHEMBL626258,Rattus norvegicus,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,9785,In vivo,50597
A,10116.0,,CHEMBL626259,Rattus norvegicus,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,9786,In vivo,50597
A,10116.0,,CHEMBL626260,Rattus norvegicus,Half in rat i.v.,,5789,N,,Intermediate,,,,,,1,1,,BAO_0000218,9787,In vivo,50597
A,10116.0,,CHEMBL875345,Rattus norvegicus,Half period in rat after intravenous administration,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,9788,In vivo,50597
A,10116.0,,CHEMBL626261,Rattus norvegicus,Half-life after repeated oral dose of compound at 1 mg/kg in rats,,17594,N,,Intermediate,,,,,,1,1,,BAO_0000218,9789,In vivo,50597
A,10116.0,,CHEMBL626262,Rattus norvegicus,Half-life measured in in vitro Cathepsin B assay in rat liver,,12357,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9790,In vitro,50597
A,10116.0,,CHEMBL626263,Rattus norvegicus,Half-life of compound was determined in rats,,5210,N,,Intermediate,,,,,,1,1,,BAO_0000218,9791,,50597
A,10116.0,,CHEMBL625270,Rattus norvegicus,Half-life at 10 mg/kg in rat upon intravenous administration,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,9792,In vivo,50597
A,10116.0,,CHEMBL625271,Rattus norvegicus,Half-life determined in rat,,6672,N,,Intermediate,,,,,,1,1,,BAO_0000218,9793,,50597
A,10116.0,,CHEMBL625272,Rattus norvegicus,Half-life determined in rat,,6673,N,,Intermediate,,,,,,1,1,,BAO_0000218,9794,,50597
A,10116.0,,CHEMBL625273,Rattus norvegicus,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,,4910,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9795,In vivo,50597
A,10116.0,,CHEMBL625274,Rattus norvegicus,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",,3741,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9796,,50597
A,10116.0,,CHEMBL625275,Rattus norvegicus,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,9797,In vivo,50597
A,10116.0,,CHEMBL625276,Rattus norvegicus,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,,4910,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9798,In vivo,50597
A,10116.0,,CHEMBL625277,Rattus norvegicus,Half-life in rat plasma,,17537,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9799,,50597
A,10116.0,,CHEMBL625278,Rattus norvegicus,Half-life in rat plasma was determined,,4965,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9800,,50597
A,10116.0,,CHEMBL625279,Rattus norvegicus,Half-life in rat plasma; Not tested,,17537,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9801,,50597
A,10116.0,,CHEMBL625280,Rattus norvegicus,Half-life in rat serum,,6124,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9802,,50597
A,10116.0,,CHEMBL876797,Rattus norvegicus,Half-life in rat serum; na is not available,,6124,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,9803,,50597
A,10116.0,,CHEMBL625281,Rattus norvegicus,Half-life was calculated in rat,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9804,,50597
A,10116.0,,CHEMBL873827,Rattus norvegicus,Half-life was calculated in rat plasma,,17668,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9805,,50597
A,10116.0,,CHEMBL625282,Rattus norvegicus,Half-life was determined,,3185,N,,Intermediate,,,,,,1,1,,BAO_0000218,9806,,50597
A,10116.0,,CHEMBL625283,Rattus norvegicus,Half-life was determined,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,9807,,50597
A,10116.0,,CHEMBL625284,Rattus norvegicus,Half-life after administration of 20 mg/Kg oral dose in rat,,2959,N,,Intermediate,,,,,,1,1,,BAO_0000218,9808,In vivo,50597
A,10116.0,,CHEMBL625285,Rattus norvegicus,Half-life after administration of 3.2 mg/kg intravenously in male rat,,4029,N,,Intermediate,,,,,,1,1,,BAO_0000218,9809,In vivo,50597
A,10116.0,,CHEMBL625286,Rattus norvegicus,Half-life after intravenous administration in female rat,,4029,N,,Intermediate,,,,,,1,1,,BAO_0000218,9810,In vivo,50597
A,10116.0,,CHEMBL625287,Rattus norvegicus,Half-life after intravenous administration in male rat,,4029,N,,Intermediate,,,,,,1,1,,BAO_0000218,9811,In vivo,50597
A,10116.0,,CHEMBL625288,Rattus norvegicus,Half-life after intravenous dose in rat,,6180,N,,Intermediate,,,,,,1,1,,BAO_0000218,9812,In vivo,50597
A,10116.0,,CHEMBL625289,Rattus norvegicus,Half-life in a rat liver homogenate preparation,,1557,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9813,,50597
A,10116.0,,CHEMBL625290,Rattus norvegicus,Half-life in plasma of rat,,12500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9814,,50597
A,10116.0,,CHEMBL876798,Rattus norvegicus,Half-life in plasma of rat at dose of 3-10 mgkg,,12500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9815,,50597
A,10116.0,,CHEMBL625291,Rattus norvegicus,Half-life in rat,,5064,N,,Intermediate,,,,,,1,1,,BAO_0000218,9816,,50597
A,10116.0,,CHEMBL625292,Rattus norvegicus,Half-life in rat,,5145,N,,Intermediate,,,,,,1,1,,BAO_0000218,9817,,50597
A,10116.0,,CHEMBL625293,Rattus norvegicus,Half-life in rat,,5147,N,,Intermediate,,,,,,1,1,,BAO_0000218,9818,,50597
A,10116.0,,CHEMBL622832,Rattus norvegicus,Half-life in rat,,5833,N,,Intermediate,,,,,,1,1,,BAO_0000218,9819,,50597
A,10116.0,,CHEMBL622833,Rattus norvegicus,Half-life in rat,,6596,N,,Intermediate,,,,,,1,1,,BAO_0000218,9820,,50597
A,10116.0,,CHEMBL622834,Rattus norvegicus,Half-life in rat,,17655,N,,Intermediate,,,,,,1,1,,BAO_0000218,9821,,50597
A,10116.0,,CHEMBL622835,Rattus norvegicus,Half-life in rat after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,9822,In vivo,50597
A,10116.0,,CHEMBL622836,Rattus norvegicus,Half-life in rat after po administration at a dose of 10 mg/kg,,17538,N,,Intermediate,,,,,,1,1,,BAO_0000218,9823,In vivo,50597
A,10116.0,,CHEMBL622837,Rattus norvegicus,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,,17538,N,,Intermediate,,,,,,1,1,,BAO_0000218,9824,In vivo,50597
A,10116.0,,CHEMBL622838,Rattus norvegicus,Half-life in rat at 3 mg/kg dose administered intravenously,,10,N,,Intermediate,,,,,,1,1,,BAO_0000218,9825,In vivo,50597
A,10116.0,,CHEMBL622839,Rattus norvegicus,Half-life in rat brain homogenate,,17669,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9826,,50597
A,10116.0,,CHEMBL622840,Rattus norvegicus,Half-life in rat plasma,,17065,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9827,,50597
A,10116.0,,CHEMBL622841,Rattus norvegicus,Half-life in rats,,4333,N,,Intermediate,,,,,,1,1,,BAO_0000218,9828,,50597
A,10116.0,,CHEMBL622842,Rattus norvegicus,Half-life in Dawley rats,,6827,N,,Intermediate,,,,,,1,1,,BAO_0000218,9829,,50597
A,10116.0,,CHEMBL622843,Rattus norvegicus,Half-life in vitro in rat plasma,,889,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9830,In vitro,50597
A,10116.0,,CHEMBL622844,Rattus norvegicus,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,,889,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9831,In vitro,50597
A,10116.0,,CHEMBL622845,Rattus norvegicus,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",,3747,N,,Intermediate,,,,,,1,1,,BAO_0000218,9832,,50597
A,10116.0,,CHEMBL622846,Rattus norvegicus,The area under the curve of compound was measured at the dose of 100 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9833,,50597
A,10116.0,,CHEMBL622847,Rattus norvegicus,The area under the curve of compound was measured at the dose of 300 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9834,,50597
A,10116.0,,CHEMBL622848,Rattus norvegicus,The area under the curve of compound was measured at the dose of 30 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,9835,,50597
A,10116.0,,CHEMBL622849,Rattus norvegicus,Bioavailability as oral AUC in rats,,3360,N,,Intermediate,,,,,,1,1,,BAO_0000218,9836,In vivo,50597
A,10116.0,,CHEMBL622850,Rattus norvegicus,The plasma concentration versus time curve (AUC) was determined,,5334,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9837,,50597
A,10116.0,,CHEMBL876807,Rattus norvegicus,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9838,,50597
A,10116.0,,CHEMBL622851,Rattus norvegicus,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9839,,50597
A,10116.0,,CHEMBL622852,Rattus norvegicus,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9840,,50597
A,10116.0,,CHEMBL622853,Rattus norvegicus,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,9841,,50597
A,10116.0,,CHEMBL622854,Rattus norvegicus,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,9842,,50597
A,10116.0,,CHEMBL622855,Rattus norvegicus,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,,17411,N,,Intermediate,,,,,,1,1,,BAO_0000218,9843,,50597
A,10116.0,,CHEMBL622856,Rattus norvegicus,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9844,,50597
A,10116.0,,CHEMBL622857,Rattus norvegicus,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9845,,50597
A,10116.0,,CHEMBL622858,Rattus norvegicus,AUC in rat after po administration at a dose of 10 mg/kg,,17538,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9846,,50597
A,10116.0,,CHEMBL622859,Rattus norvegicus,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,,17752,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9847,,50597
A,10116.0,,CHEMBL622860,Rattus norvegicus,Area under curve value 24 hr after 10 mg/kg iv administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,9848,,50597
A,10116.0,,CHEMBL622861,Rattus norvegicus,Area under curve value 24 hr after 10 mg/kg oral administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,9849,,50597
A,10116.0,,CHEMBL622862,Rattus norvegicus,Area under curve value 24 hr after 2 mg/kg iv administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,9850,,50597
A,10116.0,,CHEMBL622863,Rattus norvegicus,Area under curve value 24 hr after 2 mg/kg oral administration in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,9851,,50597
A,10116.0,,CHEMBL623817,Rattus norvegicus,Area under curve value 6 hr after po administration in rat,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,9852,,50597
A,10116.0,,CHEMBL623818,Rattus norvegicus,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,9853,,50597
A,10116.0,,CHEMBL623819,Rattus norvegicus,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,9854,,50597
A,10116.0,,CHEMBL623820,Rattus norvegicus,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,9855,,50597
A,10116.0,,CHEMBL623821,Rattus norvegicus,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,9856,,50597
A,10116.0,,CHEMBL623822,Rattus norvegicus,AUC normalized for dose (AUCN) in rat,,6642,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9857,,50597
A,10116.0,,CHEMBL623823,Rattus norvegicus,Area under curve in rat after p.o. administration,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,9858,,50597
A,10116.0,,CHEMBL623824,Rattus norvegicus,Area under curve in rat after p.o. administration,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,9859,,50597
A,10116.0,,CHEMBL623825,Rattus norvegicus,Area under curve in rat after p.o. administration; Not determined,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,9860,,50597
A,10116.0,,CHEMBL622070,Rattus norvegicus,Area under curve in rat after peroral administration,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,9861,,50597
A,10116.0,,CHEMBL622071,Rattus norvegicus,Area under curve (carotid artery) value of the compound,,3603,N,,Intermediate,,,,,,1,1,,BAO_0000218,9862,,50597
A,10116.0,,CHEMBL622072,Rattus norvegicus,Bioavailability expressed as the area under curve of rat carotid artery,,3550,N,,Intermediate,,,,,,1,1,,BAO_0000218,9863,,50597
A,10116.0,,CHEMBL622073,Rattus norvegicus,Area under curve in male SD rats was observed after intravenous administration in rat,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,9864,,50597
A,10116.0,,CHEMBL622074,Rattus norvegicus,Area under curve of the compound was determined,,17720,N,,Intermediate,,,,,,1,1,,BAO_0000218,9865,,50597
A,10116.0,,CHEMBL622075,Rattus norvegicus,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,,5407,N,,Intermediate,,,,,,1,1,,BAO_0000218,9866,,50597
A,10116.0,,CHEMBL622076,Rattus norvegicus,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,,17752,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9867,,50597
A,10116.0,,CHEMBL622077,Rattus norvegicus,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,,17752,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9868,,50597
A,10116.0,,CHEMBL622078,Rattus norvegicus,Area under curve (portal vein) value of the compound,,3603,N,,Intermediate,,,,,,1,1,,BAO_0000218,9869,,50597
A,10116.0,,CHEMBL622079,Rattus norvegicus,Bioavailability expressed as the area under curve of rat portal vein,,3550,N,,Intermediate,,,,,,1,1,,BAO_0000218,9870,,50597
A,10116.0,,CHEMBL622080,Rattus norvegicus,Area Under plasma concentration time curve in rat upon peroral administration,,17655,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9871,,50597
A,10116.0,,CHEMBL877612,Rattus norvegicus,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,9872,,50597
A,10116.0,,CHEMBL622081,Rattus norvegicus,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,9873,,50597
A,10116.0,,CHEMBL622082,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9874,,50597
A,10116.0,,CHEMBL622083,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats after iv administration,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9875,,50597
A,10116.0,,CHEMBL622084,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 30-80,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9876,,50597
A,10116.0,,CHEMBL622085,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 50-60,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9877,,50597
A,10116.0,,CHEMBL622086,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; no data,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9878,,50597
A,10116.0,,CHEMBL622087,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; peptide,,17791,N,,Intermediate,,,,,,1,1,,BAO_0000218,9879,,50597
A,10116.0,,CHEMBL622088,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9880,,50597
A,10116.0,,CHEMBL622089,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9881,,50597
A,10116.0,,CHEMBL623685,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9882,,50597
A,10116.0,,CHEMBL623686,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9883,,50597
A,10116.0,,CHEMBL623687,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9884,In vivo,50597
A,10116.0,,CHEMBL623688,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9885,In vivo,50597
A,10116.0,,CHEMBL623689,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9886,In vivo,50597
A,10116.0,,CHEMBL622485,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,9887,In vivo,50597
A,10116.0,,CHEMBL622486,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9888,In vivo,50597
A,10116.0,,CHEMBL877613,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9889,In vivo,50597
A,10116.0,,CHEMBL622487,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9890,In vivo,50597
A,10116.0,,CHEMBL622488,Rattus norvegicus,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,9891,In vivo,50597
A,10116.0,,CHEMBL622489,Rattus norvegicus,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",,8677,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9892,In vivo,50597
A,10116.0,,CHEMBL622490,Rattus norvegicus,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9893,,50597
A,10116.0,,CHEMBL622491,Rattus norvegicus,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,6899,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9894,,50597
A,10116.0,,CHEMBL622492,Rattus norvegicus,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,,6899,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9895,,50597
A,10116.0,,CHEMBL622493,Rattus norvegicus,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9896,,50597
A,10116.0,,CHEMBL622494,Rattus norvegicus,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,,6899,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9897,,50597
A,10116.0,,CHEMBL622495,Rattus norvegicus,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",,8677,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9898,,50597
A,10116.0,,CHEMBL622496,Rattus norvegicus,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,,6899,N,,Intermediate,,,,,,1,1,,BAO_0000218,9899,,50597
A,10116.0,,CHEMBL622497,Rattus norvegicus,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,,6899,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9900,,50597
A,10116.0,,CHEMBL622498,Rattus norvegicus,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,,2189,N,,Intermediate,,,,,,1,1,,BAO_0000218,9901,,50597
A,10116.0,,CHEMBL624918,Rattus norvegicus,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,,2189,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9902,,50597
A,10116.0,,CHEMBL624919,Rattus norvegicus,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,,2189,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9903,,50597
A,10116.0,,CHEMBL624920,Rattus norvegicus,Biodistribution of compound in rat blood after 5 min of administration,,10839,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9904,In vivo,50597
A,10116.0,,CHEMBL624921,Rattus norvegicus,Biodistribution of compound in rat blood after 5 min of administration.,,10839,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,9905,In vivo,50597
A,10116.0,,CHEMBL624922,Rattus norvegicus,Biodistribution of compound in rat brain after 5 min of administration,,10839,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,9906,In vivo,50597
A,10116.0,,CHEMBL624923,Rattus norvegicus,Biodistribution of compound in rat heart after 5 min of administration,,10839,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9907,In vivo,50597
A,10116.0,,CHEMBL624924,Rattus norvegicus,Biodistribution of compound in rat heart after 5 min of administration.,,10839,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9908,In vivo,50597
A,10116.0,,CHEMBL624925,Rattus norvegicus,Biodistribution of compound in rat kidney after 5 min of administration,,10839,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9909,In vivo,50597
A,10116.0,,CHEMBL624926,Rattus norvegicus,Biodistribution of compound in rat kidney after 5 min of administration.,,10839,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9910,In vivo,50597
A,10116.0,,CHEMBL624927,Rattus norvegicus,Biodistribution of compound in rat liver after 5 min of administration,,10839,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9911,In vivo,50597
A,10116.0,,CHEMBL874402,Rattus norvegicus,Biodistribution of compound in rat liver after 5 min of administration.,,10839,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9912,In vivo,50597
A,10116.0,,CHEMBL624928,Rattus norvegicus,Biodistribution of compound in rat lung after 5 min of administration,,10839,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9913,In vivo,50597
A,10116.0,,CHEMBL624929,Rattus norvegicus,Biodistribution of compound in rat lung after 5 min of administration.,,10839,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,9914,In vivo,50597
A,10116.0,,CHEMBL624930,Rattus norvegicus,Biodistribution of compound in rat muscle after 5 min of administration,,10839,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9915,In vivo,50597
A,10116.0,,CHEMBL624931,Rattus norvegicus,Biodistribution of compound in rat muscle after 5 min of administration.,,10839,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9916,In vivo,50597
A,10116.0,,CHEMBL624932,Rattus norvegicus,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9917,,50597
A,10116.0,,CHEMBL624933,Rattus norvegicus,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,9918,,50597
A,10116.0,,CHEMBL624934,Rattus norvegicus,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9919,,50597
A,10116.0,,CHEMBL624935,Rattus norvegicus,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9920,,50597
A,10116.0,,CHEMBL624936,Rattus norvegicus,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,,,,1,1,,BAO_0000218,9921,,50597
A,10116.0,,CHEMBL624937,Rattus norvegicus,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,,,,1,1,,BAO_0000218,9922,,50597
A,10116.0,,CHEMBL624938,Rattus norvegicus,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9923,,50597
A,10116.0,,CHEMBL624939,Rattus norvegicus,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,9924,,50597
A,10116.0,,CHEMBL624940,Rattus norvegicus,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,,,,1,1,,BAO_0000218,9925,,50597
A,10116.0,,CHEMBL874403,Rattus norvegicus,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,,4043,N,,Intermediate,,,,,,1,1,,BAO_0000218,9926,,50597
A,10116.0,,CHEMBL624941,Rattus norvegicus,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,,1446,N,,Intermediate,,,,,,1,1,,BAO_0000218,9927,,50597
A,10116.0,,CHEMBL624942,Rattus norvegicus,Dose required to lower urine osmolality to 300 mOsm/kg in rat,,9971,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9928,,50597
A,10116.0,,CHEMBL624943,Rattus norvegicus,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,,9971,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,9929,,50597
A,10116.0,,CHEMBL624944,Rattus norvegicus,% Bioavailability after 1 day of the drug administration in rats,,5765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9930,In vivo,50597
A,10116.0,,CHEMBL624945,Rattus norvegicus,% Bioavailability after 4 day of the drug administration in rats,,5765,N,,Intermediate,,,,,,1,1,,BAO_0000218,9931,In vivo,50597
A,10116.0,,CHEMBL624946,Rattus norvegicus,Absolute bioavailability was evaluated in rat,,4257,N,,Intermediate,,,,,,1,1,,BAO_0000218,9932,In vivo,50597
A,10116.0,,CHEMBL624947,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9933,,50597
A,10116.0,,CHEMBL624948,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9934,,50597
A,10116.0,,CHEMBL624949,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9935,,50597
A,10116.0,,CHEMBL622025,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,,13091,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9936,,50597
A,10116.0,,CHEMBL622026,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,,13091,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9937,,50597
A,10116.0,,CHEMBL622027,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,,13091,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9938,,50597
A,10116.0,,CHEMBL622028,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,,13091,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,9939,,50597
A,10116.0,,CHEMBL622029,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,,13091,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9940,,50597
A,10116.0,,CHEMBL622208,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,,13091,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9941,,50597
A,10116.0,,CHEMBL622209,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,,13091,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9942,,50597
A,10116.0,,CHEMBL622210,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,,13091,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,9943,,50597
A,10116.0,,CHEMBL622211,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9944,,50597
A,10116.0,,CHEMBL622212,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9945,,50597
A,10116.0,,CHEMBL622213,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9946,,50597
A,10116.0,,CHEMBL874404,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9947,,50597
A,10116.0,,CHEMBL620452,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9948,,50597
A,10116.0,,CHEMBL620453,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9949,,50597
A,10116.0,,CHEMBL620454,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9950,,50597
A,10116.0,,CHEMBL624067,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9951,,50597
A,10116.0,,CHEMBL624068,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9952,,50597
A,10116.0,,CHEMBL624069,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,,13091,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,9953,,50597
A,10116.0,,CHEMBL624070,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,,13091,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,9954,,50597
A,10116.0,,CHEMBL624071,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,,13091,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,9955,,50597
A,10116.0,,CHEMBL624072,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,,13091,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,9956,,50597
A,10116.0,,CHEMBL624073,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,,13091,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,9957,,50597
A,10116.0,,CHEMBL624788,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,,13091,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,9958,,50597
A,10116.0,,CHEMBL624789,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,,13091,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,9959,,50597
A,10116.0,,CHEMBL624790,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9960,,50597
A,10116.0,,CHEMBL624791,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9961,,50597
A,10116.0,,CHEMBL624792,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9962,,50597
A,10116.0,,CHEMBL624793,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,,13091,N,,Intermediate,,,,,,1,1,,BAO_0000218,9963,,50597
A,10116.0,,CHEMBL877491,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9964,,50597
A,10116.0,,CHEMBL624957,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9965,,50597
A,10116.0,,CHEMBL624958,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9966,,50597
A,10116.0,,CHEMBL624959,Rattus norvegicus,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,,13091,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,9967,,50597
A,10116.0,,CHEMBL624960,Rattus norvegicus,Dissociation constant was determined,,11977,N,,Intermediate,,,,,,1,1,,BAO_0000218,9968,,50597
A,10116.0,,CHEMBL624961,Rattus norvegicus,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,9969,,50597
A,10116.0,,CHEMBL624962,Rattus norvegicus,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9970,,50597
A,10116.0,,CHEMBL624963,Rattus norvegicus,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,9971,,50597
A,10116.0,,CHEMBL624964,Rattus norvegicus,Observed rate constant in 80% rat plasma at 37 degree Centigrade,,4755,N,,Intermediate,,,,,,1,1,,BAO_0000218,9972,,50597
A,10116.0,,CHEMBL624965,Rattus norvegicus,LogP value was evaluated in the in situ rat gut perfusion assay,,589,N,,Intermediate,,,,,,1,1,,BAO_0000218,9973,,50597
A,10116.0,,CHEMBL624966,Rattus norvegicus,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,9974,In vivo,50597
A,10116.0,,CHEMBL624967,Rattus norvegicus,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,,5031,N,,Intermediate,,,,,,1,1,,BAO_0000218,9975,In vivo,50597
A,10116.0,,CHEMBL624968,Rattus norvegicus,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,9976,In vivo,50597
A,10116.0,,CHEMBL624969,Rattus norvegicus,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,,,,1,1,,BAO_0000218,9977,,50597
F,10116.0,,CHEMBL624970,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,,2862,N,,Expert,,,,,,1,1,,BAO_0000218,9978,,50597
A,10116.0,,CHEMBL624971,Rattus norvegicus,Half-life was evaluated after 10 uM/kg of intra arterial administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,9979,,50597
A,10116.0,,CHEMBL624972,Rattus norvegicus,Half-life was evaluated after 20 uM/kg of peroral administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,9980,In vivo,50597
A,10116.0,,CHEMBL624973,Rattus norvegicus,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,,6005,N,,Intermediate,,,,,,1,1,,BAO_0000218,9981,In vivo,50597
A,10116.0,,CHEMBL624974,Rattus norvegicus,Half-life was evaluated in plasma of rat,,2938,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9982,,50597
A,10116.0,,CHEMBL624975,Rattus norvegicus,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,9983,In vivo,50597
A,10116.0,,CHEMBL877492,Rattus norvegicus,Half-life was evaluated in rats at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,9984,In vivo,50597
A,10116.0,,CHEMBL624976,Rattus norvegicus,Half-life was measured in rat after an iv dose of 1 mg/kg,,6062,N,,Intermediate,,,,,,1,1,,BAO_0000218,9985,In vivo,50597
A,10116.0,,CHEMBL624977,Rattus norvegicus,Half-life period of compound in rats after peroral administration,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,9986,In vivo,50597
A,10116.0,,CHEMBL626848,Rattus norvegicus,Half-life period of compound was measured in rat plasma.,,3136,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9987,,50597
A,10116.0,,CHEMBL626849,Rattus norvegicus,Half-life period of compound was measured in rat plasma; ND is not determined,,3136,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9988,,50597
A,10116.0,,CHEMBL626850,Rattus norvegicus,Half-life period of compound was measured in rat plasma; not determined,,3136,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,9989,,50597
A,10116.0,,CHEMBL626851,Rattus norvegicus,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,4521,N,,Intermediate,,,,,,1,1,,BAO_0000218,9990,In vivo,50597
A,10116.0,,CHEMBL626852,Rattus norvegicus,Half-life period in rat by iv administration,,5871,N,,Intermediate,,,,,,1,1,,BAO_0000218,9991,In vivo,50597
A,10116.0,,CHEMBL626853,Rattus norvegicus,Half-life period in rats following intravenous administration at 2 mg/kg,,6077,N,,Intermediate,,,,,,1,1,,BAO_0000218,9992,In vivo,50597
A,10116.0,,CHEMBL626854,Rattus norvegicus,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,6679,N,,Intermediate,,,,,,1,1,,BAO_0000218,9993,In vivo,50597
A,10116.0,,CHEMBL627486,Rattus norvegicus,Half-life period was determined for the compound in rat,,5144,N,,Intermediate,,,,,,1,1,,BAO_0000218,9994,,50597
A,10116.0,,CHEMBL627487,Rattus norvegicus,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",,4498,N,,Intermediate,,,,,,1,1,,BAO_0000218,9995,In vivo,50597
A,10116.0,,CHEMBL627488,Rattus norvegicus,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",,4498,N,,Intermediate,,,,,,1,1,,BAO_0000218,9996,In vivo,50597
A,10116.0,,CHEMBL627489,Rattus norvegicus,Half-life value after IV dose at a dose of 5 mg/kg in rats.,,1908,N,,Intermediate,,,,,,1,1,,BAO_0000218,9997,In vivo,50597
A,10116.0,,CHEMBL627490,Rattus norvegicus,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,,6211,N,,Intermediate,,,,,,1,1,,BAO_0000218,9998,In vivo,50597
A,10116.0,,CHEMBL873829,Rattus norvegicus,Half-life was determined in rat after intravenous administration (0.5 mg/kg),,5529,N,,Intermediate,,,,,,1,1,,BAO_0000218,9999,In vivo,50597
A,10116.0,,CHEMBL627655,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,10000,In vivo,50597
A,10116.0,,CHEMBL625994,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,10001,In vivo,50597
A,10116.0,,CHEMBL625995,Rattus norvegicus,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,,6444,N,,Intermediate,,,,,,1,1,,BAO_0000218,10002,In vivo,50597
A,10116.0,,CHEMBL625996,Rattus norvegicus,Half-life in rat,,5207,N,,Intermediate,,,,,,1,1,,BAO_0000218,10003,,50597
A,10116.0,,CHEMBL625850,Rattus norvegicus,In vitro half life in rat plasma,,530,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10004,In vitro,50597
A,10116.0,,CHEMBL625851,Rattus norvegicus,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",,1116,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10005,In vitro,50597
A,10116.0,,CHEMBL625852,Rattus norvegicus,In vitro half life in rat,,3219,N,,Intermediate,,,,,,1,1,,BAO_0000218,10006,In vitro,50597
A,10116.0,,CHEMBL625853,Rattus norvegicus,In vivo half life period after intravenous administration in rat,,6109,N,,Intermediate,,,,,,1,1,,BAO_0000218,10007,In vivo,50597
A,10116.0,,CHEMBL625854,Rattus norvegicus,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,10008,In vivo,50597
A,10116.0,,CHEMBL874450,Rattus norvegicus,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,10009,In vivo,50597
A,10116.0,,CHEMBL625855,Rattus norvegicus,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10010,In vivo,50597
A,10116.0,,CHEMBL625856,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10011,In vivo,50597
A,10116.0,,CHEMBL625857,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10012,In vivo,50597
A,10116.0,,CHEMBL873831,Rattus norvegicus,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10013,In vivo,50597
A,10116.0,,CHEMBL625858,Rattus norvegicus,Longer half-life in rat (i.v.) at 0.5 mpk,,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10014,In vivo,50597
A,10116.0,,CHEMBL625859,Rattus norvegicus,Longer half-life in rat (p.o.) at 2.0 mpk,,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10015,In vivo,50597
A,10116.0,,CHEMBL625860,Rattus norvegicus,Pharmacokinetic property (half life) in rat,,3457,N,,Intermediate,,,,,,1,1,,BAO_0000218,10016,,50597
A,10116.0,,CHEMBL625861,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,10017,In vivo,50597
A,10116.0,,CHEMBL625862,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,10018,In vivo,50597
A,10116.0,,CHEMBL625863,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,10019,In vivo,50597
A,10116.0,,CHEMBL625864,Rattus norvegicus,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,10020,In vivo,50597
A,10116.0,,CHEMBL625865,Rattus norvegicus,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,,5739,N,,Intermediate,,,,,,1,1,,BAO_0000218,10021,In vivo,50597
A,10116.0,,CHEMBL625866,Rattus norvegicus,Pharmacokinetic half time was determined intravenously in rats.,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,10022,In vivo,50597
A,10116.0,,CHEMBL625867,Rattus norvegicus,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,,6567,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10023,In vivo,50597
A,10116.0,,CHEMBL625868,Rattus norvegicus,Plasma half life of hydrolysis of the compound,,2448,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10024,,50597
A,10116.0,,CHEMBL625869,Rattus norvegicus,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,,5423,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10025,In vivo,50597
A,10116.0,,CHEMBL874451,Rattus norvegicus,Plasma half life period was calculated in rat,,4853,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10026,,50597
A,10116.0,,CHEMBL625870,Rattus norvegicus,Plasma half-life in Sprague-Dawley rats,,4514,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10027,,50597
A,10116.0,,CHEMBL625871,Rattus norvegicus,Plasma half-life in Sprague-Dawley rats; Not determined,,4514,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10028,,50597
A,10116.0,,CHEMBL625872,Rattus norvegicus,Plasma half-life in rats,,1500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10029,,50597
A,10116.0,,CHEMBL625873,Rattus norvegicus,Plasma half-life in rats; <MQL,,1500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10030,,50597
A,10116.0,,CHEMBL625874,Rattus norvegicus,Plasma half-life period (0-8 h) was determined,,5334,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10031,,50597
A,10116.0,,CHEMBL625875,Rattus norvegicus,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,,5334,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10032,,50597
A,10116.0,,CHEMBL625876,Rattus norvegicus,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10033,In vivo,50597
A,10116.0,,CHEMBL631258,Rattus norvegicus,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,,5334,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10034,In vivo,50597
A,10116.0,,CHEMBL631259,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,,4956,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10035,,50597
A,10116.0,,CHEMBL631260,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,,4956,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10036,,50597
A,10116.0,,CHEMBL631261,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10037,,50597
A,10116.0,,CHEMBL631262,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10038,,50597
A,10116.0,,CHEMBL631263,Rattus norvegicus,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",,7768,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10039,,50597
A,10116.0,,CHEMBL631264,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10040,,50597
A,10116.0,,CHEMBL631265,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10041,,50597
A,10116.0,,CHEMBL631266,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10042,,50597
A,10116.0,,CHEMBL631267,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10043,,50597
A,10116.0,,CHEMBL631268,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10044,,50597
A,10116.0,,CHEMBL631269,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10045,,50597
A,10116.0,,CHEMBL631270,Rattus norvegicus,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",,7768,N,,Intermediate,,,,,,1,1,,BAO_0000218,10046,,50597
A,10116.0,,CHEMBL631271,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10047,,50597
A,10116.0,,CHEMBL631272,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10048,,50597
A,10116.0,,CHEMBL631273,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10049,,50597
A,10116.0,,CHEMBL631274,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10050,,50597
A,10116.0,,CHEMBL631275,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10051,,50597
A,10116.0,,CHEMBL626984,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10052,,50597
A,10116.0,,CHEMBL626985,Rattus norvegicus,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",,7768,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10053,,50597
A,10116.0,,CHEMBL626986,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10054,,50597
A,10116.0,,CHEMBL626987,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10055,,50597
A,10116.0,,CHEMBL626988,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10056,,50597
A,10116.0,,CHEMBL626989,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10057,,50597
A,10116.0,,CHEMBL626990,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10058,,50597
A,10116.0,,CHEMBL626991,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10059,,50597
A,10116.0,,CHEMBL626992,Rattus norvegicus,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",,7768,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10060,,50597
A,10116.0,,CHEMBL626993,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10061,,50597
A,10116.0,,CHEMBL874593,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10062,,50597
A,10116.0,,CHEMBL626994,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10063,,50597
A,10116.0,,CHEMBL626995,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10064,,50597
A,10116.0,,CHEMBL626190,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10065,,50597
A,10116.0,,CHEMBL626191,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10066,,50597
A,10116.0,,CHEMBL626364,Rattus norvegicus,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",,7768,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10067,,50597
A,10116.0,,CHEMBL626365,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10068,,50597
A,10116.0,,CHEMBL626366,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10069,,50597
A,10116.0,,CHEMBL626367,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10070,,50597
A,10116.0,,CHEMBL626368,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10071,,50597
A,10116.0,,CHEMBL626369,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10072,,50597
A,10116.0,,CHEMBL626370,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10073,,50597
A,10116.0,,CHEMBL626371,Rattus norvegicus,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",,4498,N,,Intermediate,,,,,,1,1,,BAO_0000218,10074,In vivo,50597
A,10116.0,,CHEMBL626372,Rattus norvegicus,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",,4498,N,,Intermediate,,,,,,1,1,,BAO_0000218,10075,In vivo,50597
A,10116.0,,CHEMBL626373,Rattus norvegicus,Bioavailability after a dose of 10 mg/kg p.o.,,3603,N,,Intermediate,,,,,,1,1,,BAO_0000218,10076,In vivo,50597
A,10116.0,,CHEMBL626374,Rattus norvegicus,Bioavailability after peroral administration (10 mg/kg) was determined in rat,,6215,N,,Intermediate,,,,,,1,1,,BAO_0000218,10077,In vivo,50597
A,10116.0,,CHEMBL626375,Rattus norvegicus,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,10078,In vivo,50597
A,10116.0,,CHEMBL626376,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),,5710,N,,Intermediate,,,,,,1,1,,BAO_0000218,10079,In vivo,50597
A,10116.0,,CHEMBL626377,Rattus norvegicus,Bioavailability in rat po was determined,,5676,N,,Intermediate,,,,,,1,1,,BAO_0000218,10080,In vivo,50597
A,10116.0,,CHEMBL626378,Rattus norvegicus,Bioavailability of compound at 10 mg/kg in rat after oral administration,,17667,N,,Intermediate,,,,,,1,1,,BAO_0000218,10081,In vivo,50597
A,10116.0,,CHEMBL626379,Rattus norvegicus,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,,17667,N,,Intermediate,,,,,,1,1,,BAO_0000218,10082,In vivo,50597
A,10116.0,,CHEMBL626380,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,6848,N,,Intermediate,,,,,,1,1,,BAO_0000218,10083,In vivo,50597
A,10116.0,,CHEMBL626381,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,6848,N,,Intermediate,,,,,,1,1,,BAO_0000218,10084,In vivo,50597
A,10116.0,,CHEMBL626382,Rattus norvegicus,Bioavailability in rat,,17267,N,,Intermediate,,,,,,1,1,,BAO_0000218,10085,In vivo,50597
A,10116.0,,CHEMBL626383,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (female),,6362,N,,Intermediate,,,,,,1,1,,BAO_0000218,10086,In vivo,50597
A,10116.0,,CHEMBL874652,Rattus norvegicus,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,10087,In vivo,50597
A,10116.0,,CHEMBL626384,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),,17671,N,,Intermediate,,,,,,1,1,,BAO_0000218,10088,In vivo,50597
A,10116.0,,CHEMBL626385,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,,4333,N,,Intermediate,,,,,,1,1,,BAO_0000218,10089,In vivo,50597
A,10116.0,,CHEMBL626386,Rattus norvegicus,Bioavailability in rat at an oral dose of 2 mg/kg,,6077,N,,Intermediate,,,,,,1,1,,BAO_0000218,10090,In vivo,50597
A,10116.0,,CHEMBL626387,Rattus norvegicus,Bioavailability in rat,,3278,N,,Intermediate,,,,,,1,1,,BAO_0000218,10091,In vivo,50597
A,10116.0,,CHEMBL626388,Rattus norvegicus,Bioavailability in rat,,5964,N,,Intermediate,,,,,,1,1,,BAO_0000218,10092,In vivo,50597
A,10116.0,,CHEMBL626389,Rattus norvegicus,Bioavailability in rat,,4884,N,,Intermediate,,,,,,1,1,,BAO_0000218,10093,In vivo,50597
A,10116.0,,CHEMBL626390,Rattus norvegicus,Bioavailability in rat,,4905,N,,Intermediate,,,,,,1,1,,BAO_0000218,10094,In vivo,50597
A,10116.0,,CHEMBL626391,Rattus norvegicus,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,,4884,N,,Intermediate,,,,,,1,1,,BAO_0000218,10095,In vivo,50597
A,10116.0,,CHEMBL626392,Rattus norvegicus,Bioavailability in rat,,6850,N,,Intermediate,,,,,,1,1,,BAO_0000218,10096,In vivo,50597
A,10116.0,,CHEMBL626393,Rattus norvegicus,Oral bioavailability in rat,,2864,N,,Intermediate,,,,,,1,1,,BAO_0000218,10097,In vivo,50597
A,10116.0,,CHEMBL623026,Rattus norvegicus,Bioavailability was determined in rat,,5780,N,,Intermediate,,,,,,1,1,,BAO_0000218,10098,In vivo,50597
A,10116.0,,CHEMBL623027,Rattus norvegicus,Bioavailability,,1465,N,,Intermediate,,,,,,1,1,,BAO_0000218,10099,In vivo,50597
A,10116.0,,CHEMBL623028,Rattus norvegicus,Bioavailability,,5199,N,,Intermediate,,,,,,1,1,,BAO_0000218,10100,In vivo,50597
A,10116.0,,CHEMBL623029,Rattus norvegicus,Bioavailability in rat after 1 day dosing,,5765,N,,Intermediate,,,,,,1,1,,BAO_0000218,10101,In vivo,50597
A,10116.0,,CHEMBL623030,Rattus norvegicus,Bioavailability in rat after 4 day dosing,,5765,N,,Intermediate,,,,,,1,1,,BAO_0000218,10102,In vivo,50597
A,10116.0,,CHEMBL623031,Rattus norvegicus,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,10103,In vivo,50597
A,10116.0,,CHEMBL623032,Rattus norvegicus,Bioavailability after IV dosing at 1 mg/kg in rat; no data,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,10104,In vivo,50597
A,10116.0,,CHEMBL623033,Rattus norvegicus,Bioavailability after oral administration at a dose of 2 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,10105,In vivo,50597
A,10116.0,,CHEMBL623034,Rattus norvegicus,Bioavailability after oral administration at a dose of 4 mg/kg in rat,,6518,N,,Intermediate,,,,,,1,1,,BAO_0000218,10106,In vivo,50597
A,10116.0,,CHEMBL623035,Rattus norvegicus,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,,2083,N,,Intermediate,,,,,,1,1,,BAO_0000218,10107,In vivo,50597
A,10116.0,,CHEMBL623036,Rattus norvegicus,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,,17260,N,,Intermediate,,,,,,1,1,,BAO_0000218,10108,In vivo,50597
A,10116.0,,CHEMBL623037,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,4956,N,,Intermediate,,,,,,1,1,,BAO_0000218,10109,In vivo,50597
A,10116.0,,CHEMBL623038,Rattus norvegicus,Bioavailability by intravenous administration of 3.4 mg/kg in rat,,4368,N,,Intermediate,,,,,,1,1,,BAO_0000218,10110,In vivo,50597
A,10116.0,,CHEMBL874385,Rattus norvegicus,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,,17752,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10111,In vivo,50597
A,10116.0,,CHEMBL623039,Rattus norvegicus,Bioavailability in rat (Fisher) (fasted),,1446,N,,Intermediate,,,,,,1,1,,BAO_0000218,10112,In vivo,50597
A,9443.0,,CHEMBL623040,Primates,Bioavailability in monkey after po administration of 10 mg/kg dose,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,10113,In vivo,22224
A,9443.0,,CHEMBL623041,Primates,Oral bioavailability in monkey (dose 10 mg/kg),,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,10114,In vivo,22224
A,10116.0,,CHEMBL623741,Rattus norvegicus,Bioavailability in rat,,6672,N,,Intermediate,,,,,,1,1,,BAO_0000218,10115,In vivo,50597
A,10116.0,,CHEMBL623742,Rattus norvegicus,Bioavailability in rat,,6673,N,,Intermediate,,,,,,1,1,,BAO_0000218,10116,In vivo,50597
A,10116.0,,CHEMBL623743,Rattus norvegicus,Bioavailability in rat,,17655,N,,Intermediate,,,,,,1,1,,BAO_0000218,10117,In vivo,50597
A,10116.0,,CHEMBL623744,Rattus norvegicus,Bioavailability in rat,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,10118,In vivo,50597
A,10116.0,,CHEMBL623745,Rattus norvegicus,Bioavailability in rat (dose 2.0 mg/kg p.o.),,17853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10119,In vivo,50597
A,10116.0,,CHEMBL623746,Rattus norvegicus,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),,4521,N,,Intermediate,,,,,,1,1,,BAO_0000218,10120,In vivo,50597
A,10116.0,,CHEMBL623747,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg p.o.),,4940,N,,Intermediate,,,,,,1,1,,BAO_0000218,10121,In vivo,50597
A,10116.0,,CHEMBL623748,Rattus norvegicus,Bioavailability in rat after po administration of 30 mg/kg dose,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,10122,In vivo,22224
A,10116.0,,CHEMBL623916,Rattus norvegicus,Bioavailability in rat after po administration of 30 mg/kg dose,,2891,U,,Intermediate,,,,,,1,0,,BAO_0000218,10123,In vivo,22224
A,10116.0,,CHEMBL623917,Rattus norvegicus,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,,4521,N,,Intermediate,,,,,,1,1,,BAO_0000218,10124,In vivo,50597
A,10116.0,,CHEMBL623918,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg i.v.),,17686,N,,Intermediate,,,,,,1,1,,BAO_0000218,10125,In vivo,50597
A,10116.0,,CHEMBL874386,Rattus norvegicus,Bioavailability in rat,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,10126,In vivo,50597
A,10116.0,,CHEMBL623919,Rattus norvegicus,Bioavailability in rat; Only traces detected in rat plasma,,17796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10127,In vivo,50597
A,10116.0,,CHEMBL623920,Rattus norvegicus,Bioavailability in rat,,5064,N,,Intermediate,,,,,,1,1,,BAO_0000218,10128,In vivo,50597
A,10116.0,,CHEMBL623148,Rattus norvegicus,Bioavailability upon oral administration of compound,,5147,N,,Intermediate,,,,,,1,1,,BAO_0000218,10129,In vivo,50597
A,10116.0,,CHEMBL623149,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),,1916,N,,Intermediate,,,,,,1,1,,BAO_0000218,10130,In vivo,50597
A,10116.0,,CHEMBL623150,Rattus norvegicus,Bioavailability in rat,,6049,N,,Intermediate,,,,,,1,1,,BAO_0000218,10131,In vivo,50597
A,10116.0,,CHEMBL623151,Rattus norvegicus,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",,1445,N,,Intermediate,,,,,,1,1,,BAO_0000218,10132,In vivo,50597
A,10116.0,,CHEMBL623152,Rattus norvegicus,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",,1445,N,,Intermediate,,,,,,1,1,,BAO_0000218,10133,In vivo,50597
F,10116.0,,CHEMBL623153,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,,2862,N,,Expert,,,,,,1,1,,BAO_0000218,10134,,50597
F,10116.0,,CHEMBL623154,Rattus norvegicus,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,,2862,N,,Expert,,,,,,1,1,,BAO_0000218,10135,,50597
A,10116.0,,CHEMBL623155,Rattus norvegicus,In vitro and metabolic stability was determined,,4194,N,,Intermediate,,,,,,1,1,,BAO_0000218,10136,,50597
A,10116.0,,CHEMBL623156,Rattus norvegicus,In vitro metabolic stability in rat hepatocytes,,4194,N,,Intermediate,,,,,,1,1,,BAO_0000218,10137,,50597
A,10116.0,,CHEMBL623157,Rattus norvegicus,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,,5486,N,,Intermediate,,,,,,1,1,,BAO_0000218,10138,,50597
A,10116.0,,CHEMBL623158,Rattus norvegicus,Metabolic rate for compound was observed in rat hepatocytes,,17582,N,401.0,Intermediate,,,Liver,2107.0,Hepatocyte,1,1,,BAO_0000218,10139,In vitro,50597
A,10116.0,,CHEMBL623159,Rattus norvegicus,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,,5600,N,,Intermediate,,,,,,1,1,,BAO_0000218,10140,,50597
A,10116.0,,CHEMBL874390,Rattus norvegicus,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),,14294,N,,Intermediate,,,,,,1,1,,BAO_0000218,10141,,50597
A,10116.0,,CHEMBL623160,Rattus norvegicus,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),,14294,N,,Intermediate,,,,,,1,1,,BAO_0000218,10142,,50597
A,10116.0,,CHEMBL623161,Rattus norvegicus,Metabolism of compound in rat S9 microsomes; Trace,,14294,N,,Intermediate,,,,,,1,1,,BAO_0000218,10143,,50597
A,10116.0,,CHEMBL623162,Rattus norvegicus,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,,17847,N,,Intermediate,,,,,,1,1,,BAO_0000218,10144,,50597
A,10116.0,,CHEMBL623163,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10145,,50597
A,10116.0,,CHEMBL623164,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10146,,50597
A,10116.0,,CHEMBL623165,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10147,,50597
A,10116.0,,CHEMBL623166,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10148,,50597
A,10116.0,,CHEMBL624983,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10149,,50597
A,10116.0,,CHEMBL624984,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10150,,50597
A,10116.0,,CHEMBL624985,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10151,,50597
A,10116.0,,CHEMBL622970,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10152,,50597
A,10116.0,,CHEMBL622971,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10153,,50597
A,10116.0,,CHEMBL622972,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10154,,50597
A,10116.0,,CHEMBL622973,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10155,,50597
A,10116.0,,CHEMBL622974,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10156,,50597
A,10116.0,,CHEMBL622975,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10157,,50597
A,10116.0,,CHEMBL622976,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10158,,50597
A,10116.0,,CHEMBL622977,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10159,,50597
A,10116.0,,CHEMBL624351,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10160,,50597
A,10116.0,,CHEMBL624352,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10161,,50597
A,10116.0,,CHEMBL624353,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10162,,50597
A,10116.0,,CHEMBL622397,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10163,,50597
A,10116.0,,CHEMBL622398,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10164,,50597
A,10116.0,,CHEMBL622399,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10165,,50597
A,10116.0,,CHEMBL622400,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10166,,50597
A,10116.0,,CHEMBL628428,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10167,,50597
A,10116.0,,CHEMBL628590,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10168,,50597
A,10116.0,,CHEMBL628591,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10169,,50597
A,10116.0,,CHEMBL628592,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10170,,50597
A,10116.0,,CHEMBL628593,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10171,,50597
A,10116.0,,CHEMBL875333,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10172,,50597
A,10116.0,,CHEMBL628594,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10173,,50597
A,10116.0,,CHEMBL628595,Rattus norvegicus,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,,4969,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10174,,50597
A,10116.0,,CHEMBL628596,Rattus norvegicus,Stability in rat plasma was determined,,6737,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10175,,50597
A,10116.0,,CHEMBL628597,Rattus norvegicus,Stability in rat plasma was determined; ND= no data,,6737,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10176,,50597
A,10116.0,,CHEMBL628598,Rattus norvegicus,Tested for plasma half life period in rat (0-8 hr),,5089,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10177,,50597
A,10116.0,,CHEMBL628599,Rattus norvegicus,Tested for plasma half life period in rat (0-8 hr); Not determined,,5089,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10178,,50597
A,10116.0,,CHEMBL628600,Rattus norvegicus,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,10179,In vivo,50597
A,10116.0,,CHEMBL628601,Rattus norvegicus,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,10180,In vivo,50597
A,10116.0,,CHEMBL628602,Rattus norvegicus,Tested for the half life in rat,,4950,N,,Intermediate,,,,,,1,1,,BAO_0000218,10181,,50597
A,10116.0,,CHEMBL628603,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,,2412,N,,Intermediate,,,,,,1,1,,BAO_0000218,10182,In vitro,50597
A,10116.0,,CHEMBL628604,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,,2412,N,,Intermediate,,,,,,1,1,,BAO_0000218,10183,In vitro,50597
A,10116.0,,CHEMBL628605,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,,2412,N,,Intermediate,,,,,,1,1,,BAO_0000218,10184,In vitro,50597
A,10116.0,,CHEMBL628606,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,,2412,N,,Intermediate,,,,,,1,1,,BAO_0000218,10185,In vitro,50597
A,10116.0,,CHEMBL628607,Rattus norvegicus,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,,2412,N,,Intermediate,,,,,,1,1,,BAO_0000218,10186,In vitro,50597
A,10116.0,,CHEMBL628608,Rattus norvegicus,The biological half life the compound was measured at the dose of 100 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,10187,,50597
A,10116.0,,CHEMBL628609,Rattus norvegicus,The biological half life the compound was measured at the dose of 30 umol/kg,,15022,N,,Intermediate,,,,,,1,1,,BAO_0000218,10188,,50597
A,10116.0,,CHEMBL628610,Rattus norvegicus,The compound was evaluated for plasma half life period in rat,,406,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10189,,50597
A,10116.0,,CHEMBL873819,Rattus norvegicus,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,10190,In vivo,50597
A,10116.0,,CHEMBL628611,Rattus norvegicus,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,10191,In vivo,50597
A,10116.0,,CHEMBL628612,Rattus norvegicus,The pharmacokinetic parameter half-life period in vivo in rats,,5247,N,,Intermediate,,,,,,1,1,,BAO_0000218,10192,In vivo,50597
A,10116.0,,CHEMBL628613,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined",,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10193,In vivo,50597
A,10116.0,,CHEMBL628614,Rattus norvegicus,"The pharmacokinetic property, Half-life in rat in vivo",,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10194,In vivo,50597
A,10116.0,,CHEMBL628615,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined; ND denotes no data",,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10195,In vivo,50597
A,10116.0,,CHEMBL628616,Rattus norvegicus,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10196,In vivo,50597
A,10116.0,,CHEMBL627924,Rattus norvegicus,The plasma half life period in rats,,3918,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10197,,50597
A,10116.0,,CHEMBL627925,Rattus norvegicus,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,,2906,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10198,,50597
A,10116.0,,CHEMBL627926,Rattus norvegicus,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,,6467,N,,Intermediate,,,,,,1,1,,BAO_0000218,10199,In vivo,50597
A,10116.0,,CHEMBL627927,Rattus norvegicus,t1/2 (apparent elimination)of the compound was determined,,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,10200,,50597
A,10116.0,,CHEMBL627928,Rattus norvegicus,t1/2 value in rat,,3788,N,,Intermediate,,,,,,1,1,,BAO_0000218,10201,,50597
A,10116.0,,CHEMBL627539,Rattus norvegicus,Half life in rat,,17796,N,,Intermediate,,,,,,1,1,,BAO_0000218,10202,,50597
A,10116.0,,CHEMBL876790,Rattus norvegicus,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",,12873,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10203,In vivo,50597
A,10116.0,,CHEMBL858186,Rattus norvegicus,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,10204,In vivo,50597
A,10116.0,,CHEMBL627540,Rattus norvegicus,Half-life period in fasted rats,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,10205,,50597
A,10116.0,,CHEMBL627541,Rattus norvegicus,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,10206,In vivo,50597
A,10116.0,,CHEMBL627715,Rattus norvegicus,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,10207,In vivo,50597
A,10116.0,,CHEMBL627716,Rattus norvegicus,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,,429,N,,Intermediate,,,,,,1,1,,BAO_0000218,10208,In vivo,50597
A,10116.0,,CHEMBL627717,Rattus norvegicus,Maximum time required to achieve Cmax was determined in rat,,17655,N,,Intermediate,,,,,,1,1,,BAO_0000218,10209,,50597
A,10116.0,,CHEMBL627718,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10210,In vivo,50597
A,10116.0,,CHEMBL627719,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10211,In vivo,50597
A,10116.0,,CHEMBL627720,Rattus norvegicus,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10212,In vivo,50597
A,10116.0,,CHEMBL627721,Rattus norvegicus,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,10213,In vivo,50597
A,10116.0,,CHEMBL627722,Rattus norvegicus,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,10214,In vivo,50597
A,10116.0,,CHEMBL627723,Rattus norvegicus,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10215,In vivo,50597
A,10116.0,,CHEMBL626058,Rattus norvegicus,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10216,In vivo,50597
A,10116.0,,CHEMBL626059,Rattus norvegicus,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10217,In vivo,50597
A,10116.0,,CHEMBL626060,Rattus norvegicus,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10218,In vivo,50597
A,10116.0,,CHEMBL626061,Rattus norvegicus,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10219,In vivo,50597
A,10116.0,,CHEMBL876791,Rattus norvegicus,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,10220,In vivo,50597
A,10116.0,,CHEMBL626062,Rattus norvegicus,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,,4723,N,,Intermediate,,,,,,1,1,,BAO_0000218,10221,In vivo,50597
A,10116.0,,CHEMBL626063,Rattus norvegicus,Tmax at the dose of 2 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,10222,In vivo,50597
A,10116.0,,CHEMBL626064,Rattus norvegicus,Tmax at the dose of 5 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,10223,In vivo,50597
A,10116.0,,CHEMBL626065,Rattus norvegicus,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10224,In vivo,50597
A,10116.0,,CHEMBL626066,Rattus norvegicus,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,,17720,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10225,In vivo,50597
A,10116.0,,CHEMBL626067,Rattus norvegicus,tmax upon peroral administration of 10.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,10226,In vivo,50597
F,10116.0,,CHEMBL626068,Rattus norvegicus,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10227,,50597
F,10116.0,,CHEMBL626069,Rattus norvegicus,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10228,,50597
F,10116.0,,CHEMBL626070,Rattus norvegicus,Percent total excretion of 3-methoxyacetaminophen glucuronide,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10229,,50597
F,10116.0,,CHEMBL626071,Rattus norvegicus,Percent total excretion of N-methoxyacetaminophen glucuronide,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10230,,50597
F,10116.0,,CHEMBL626072,Rattus norvegicus,Percent total excretion of N-methoxyacetaminophen sulfate,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10231,,50597
F,10116.0,,CHEMBL626073,Rattus norvegicus,Percent total excretion of acetaminophen,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10232,,50597
A,10116.0,,CHEMBL626741,Rattus norvegicus,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",,7768,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,10233,,50597
A,10116.0,,CHEMBL626742,Rattus norvegicus,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",,17655,N,,Intermediate,,,,,,1,1,,BAO_0000218,10234,,50597
A,10116.0,,CHEMBL626743,Rattus norvegicus,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,,17735,N,,Intermediate,,,,,,1,1,,BAO_0000218,10235,,50597
A,10116.0,,CHEMBL876792,Rattus norvegicus,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,10236,,50597
A,10116.0,,CHEMBL626744,Rattus norvegicus,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,,17735,N,,Intermediate,,,,,,1,1,,BAO_0000218,10237,,50597
A,10116.0,,CHEMBL626745,Rattus norvegicus,Compound was tested for antidiuretic activity in rats,,7116,N,,Intermediate,,,,,,1,1,,BAO_0000218,10238,,50597
A,10116.0,,CHEMBL626746,Rattus norvegicus,AUC in rat after 3mg/kg oral dose,,4878,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10239,In vivo,50597
A,10116.0,,CHEMBL626747,Rattus norvegicus,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,10240,,50597
A,10116.0,,CHEMBL626748,Rattus norvegicus,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,10241,,50597
A,10116.0,,CHEMBL626749,Rattus norvegicus,Bioavailability administered orally at a dose of 10 mg/kg to rats,,16367,N,,Intermediate,,,,,,1,1,,BAO_0000218,10242,,50597
A,10116.0,,CHEMBL626750,Rattus norvegicus,Oral Bioavailability was determined,,16366,N,,Intermediate,,,,,,1,1,,BAO_0000218,10243,,50597
A,10116.0,,CHEMBL626751,Rattus norvegicus,Oral bioavailability in rat,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,10244,,50597
A,10116.0,,CHEMBL626913,Rattus norvegicus,Oral bioavailability in rat; Not performed.,,4426,N,,Intermediate,,,,,,1,1,,BAO_0000218,10245,,50597
A,10116.0,,CHEMBL626914,Rattus norvegicus,Bioavailability,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10246,,50597
A,10116.0,,CHEMBL626915,Rattus norvegicus,Bioavailability was determined; ND denotes no data,,5041,N,,Intermediate,,,,,,1,1,,BAO_0000218,10247,,50597
A,10116.0,,CHEMBL626916,Rattus norvegicus,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,,1500,N,,Intermediate,,,,,,1,1,,BAO_0000218,10248,,50597
A,10116.0,,CHEMBL626917,Rattus norvegicus,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,,1500,N,,Intermediate,,,,,,1,1,,BAO_0000218,10249,,50597
A,10116.0,,CHEMBL626918,Rattus norvegicus,Binding towards rat plasma protein at 10 uM,,17409,N,,Intermediate,,,,,,1,1,,BAO_0000218,10250,,50597
A,10116.0,,CHEMBL626919,Rattus norvegicus,Binding towards rat plasma protein at 100 uM,,17409,N,,Intermediate,,,,,,1,1,,BAO_0000218,10251,,50597
A,10116.0,,CHEMBL626920,Rattus norvegicus,Bioavailability in rat (dose 20 mg/kg p.o.),,2959,N,,Intermediate,,,,,,1,1,,BAO_0000218,10252,In vivo,50597
A,10116.0,,CHEMBL621976,Rattus norvegicus,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,,13501,N,,Intermediate,,,,,,1,1,,BAO_0000218,10253,In vivo,50597
A,10116.0,,CHEMBL877599,Rattus norvegicus,Bioavailability in rat after 5 mg/kg oral gavage,,6567,N,,Intermediate,,,,,,1,1,,BAO_0000218,10254,In vivo,50597
A,10116.0,,CHEMBL621977,Rattus norvegicus,Bioavailability in rat,,6571,N,,Intermediate,,,,,,1,1,,BAO_0000218,10255,In vivo,50597
A,10116.0,,CHEMBL621978,Rattus norvegicus,Bioavailability in rat (dose 1 mg/kg i.v.),,6715,N,,Intermediate,,,,,,1,1,,BAO_0000218,10256,In vivo,50597
A,10116.0,,CHEMBL621979,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg p.o.),,6715,N,,Intermediate,,,,,,1,1,,BAO_0000218,10257,In vivo,50597
A,10116.0,,CHEMBL621980,Rattus norvegicus,Oral bioavailability in rat,,2932,N,,Intermediate,,,,,,1,1,,BAO_0000218,10258,In vivo,50597
A,10116.0,,CHEMBL621981,Rattus norvegicus,Bioavailability of the compound in rats after administration of 30 mg/kg,,4171,N,,Intermediate,,,,,,1,1,,BAO_0000218,10259,In vivo,50597
A,10116.0,,CHEMBL621982,Rattus norvegicus,Bioavailability after administration of 10 mg/kg in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,10260,In vivo,50597
A,10116.0,,CHEMBL882953,Rattus norvegicus,Bioavailability after administration of 2 mg/kg in rats,,17509,N,,Intermediate,,,,,,1,1,,BAO_0000218,10261,In vivo,50597
A,10116.0,,CHEMBL621983,Rattus norvegicus,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,,4527,N,,Intermediate,,,,,,1,1,,BAO_0000218,10262,In vivo,50597
A,10116.0,,CHEMBL621984,Rattus norvegicus,Bioavailability in dogs was determined; high,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,10263,In vivo,50597
A,10116.0,,CHEMBL621985,Rattus norvegicus,Bioavailability in monkey after intravenous administration at 1 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10264,In vivo,50597
A,10116.0,,CHEMBL621986,Rattus norvegicus,Bioavailability in monkey after peroral administration at 10 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10265,In vivo,50597
A,10116.0,,CHEMBL621987,Rattus norvegicus,Bioavailability in rat after intravenous administration at 1 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10266,In vivo,50597
F,10116.0,,CHEMBL877600,Rattus norvegicus,Bioavailability in rat after intravenous administration at 2 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10267,In vivo,50597
A,10116.0,,CHEMBL621988,Rattus norvegicus,Bioavailability in rat after peroral administration at 30 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10268,In vivo,50597
F,10116.0,,CHEMBL621989,Rattus norvegicus,Bioavailability in rat after peroral administration at at 100 mpk,,6659,N,,Intermediate,,,,,,1,1,,BAO_0000218,10269,In vivo,50597
A,10116.0,,CHEMBL621990,Rattus norvegicus,Bioavailability in rats was evaluated,,6597,N,,Intermediate,,,,,,1,1,,BAO_0000218,10270,In vivo,50597
A,10116.0,,CHEMBL621991,Rattus norvegicus,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,,1202,N,,Intermediate,,,,,,1,1,,BAO_0000218,10271,In vivo,50597
A,10116.0,,CHEMBL621992,Rattus norvegicus,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,,1202,N,,Intermediate,,,,,,1,1,,BAO_0000218,10272,In vivo,50597
A,10116.0,,CHEMBL621993,Rattus norvegicus,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,,1202,N,,Intermediate,,,,,,1,1,,BAO_0000218,10273,In vivo,50597
A,10116.0,,CHEMBL621994,Rattus norvegicus,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,,1202,N,,Intermediate,,,,,,1,1,,BAO_0000218,10274,In vivo,50597
A,10116.0,,CHEMBL621995,Rattus norvegicus,Bioavailability in rat,,5207,N,,Intermediate,,,,,,1,1,,BAO_0000218,10275,In vivo,50597
A,10116.0,,CHEMBL621996,Rattus norvegicus,Bioavailability in rat,,5970,N,,Intermediate,,,,,,1,1,,BAO_0000218,10276,In vivo,50597
A,10116.0,,CHEMBL621997,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),,17538,N,,Intermediate,,,,,,1,1,,BAO_0000218,10277,In vivo,50597
A,10116.0,,CHEMBL621998,Rattus norvegicus,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,,17538,N,,Intermediate,,,,,,1,1,,BAO_0000218,10278,In vivo,50597
A,10116.0,,CHEMBL621999,Rattus norvegicus,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,,1466,N,,Intermediate,,,,,,1,1,,BAO_0000218,10279,In vivo,50597
A,10116.0,,CHEMBL622000,Rattus norvegicus,Oral bioavailability in rat,,2879,N,,Intermediate,,,,,,1,1,,BAO_0000218,10280,In vivo,50597
A,10116.0,,CHEMBL622001,Rattus norvegicus,Bioavailability was measured in rat after oral administration; 2-4,,2879,N,,Intermediate,,,,,,1,1,,BAO_0000218,10281,In vivo,50597
A,10116.0,,CHEMBL622002,Rattus norvegicus,Bioavailability was measured in rat after oral administration; 3-7,,2879,N,,Intermediate,,,,,,1,1,,BAO_0000218,10282,In vivo,50597
A,10116.0,,CHEMBL622003,Rattus norvegicus,Bioavailability in rat (intraduodenal administration),,3777,N,,Intermediate,,,,,,1,1,,BAO_0000218,10283,In vivo,50597
A,10116.0,,CHEMBL877601,Rattus norvegicus,Bioavailability in rat (intraduodenal administration),,3777,N,,Intermediate,,,,,,1,1,,BAO_0000218,10284,In vivo,50597
A,10116.0,,CHEMBL624871,Rattus norvegicus,Oral bioavailability in rat,,3777,N,,Intermediate,,,,,,1,1,,BAO_0000218,10285,In vivo,50597
A,10116.0,,CHEMBL622004,Rattus norvegicus,Oral bioavailability in rat,,3777,N,,Intermediate,,,,,,1,1,,BAO_0000218,10286,In vivo,50597
A,10116.0,,CHEMBL882954,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),,5423,N,,Intermediate,,,,,,1,1,,BAO_0000218,10287,In vivo,50597
A,10116.0,,CHEMBL622005,Rattus norvegicus,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,10288,In vivo,50597
A,10116.0,,CHEMBL622006,Rattus norvegicus,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,,16365,N,,Intermediate,,,,,,1,1,,BAO_0000218,10289,In vivo,50597
A,10116.0,,CHEMBL622007,Rattus norvegicus,Bioavailability was measured in rat,,4239,N,,Intermediate,,,,,,1,1,,BAO_0000218,10290,In vivo,50597
A,10116.0,,CHEMBL622008,Rattus norvegicus,Bioavailability was reported,,5438,N,,Intermediate,,,,,,1,1,,BAO_0000218,10291,In vivo,50597
A,10116.0,,CHEMBL622009,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,10292,In vivo,50597
A,10116.0,,CHEMBL622010,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,10293,In vivo,50597
A,10116.0,,CHEMBL622011,Rattus norvegicus,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,10294,In vivo,50597
A,10116.0,,CHEMBL622012,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,10295,In vivo,50597
A,10116.0,,CHEMBL622013,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),,4199,N,,Intermediate,,,,,,1,1,,BAO_0000218,10296,In vivo,50597
A,10116.0,,CHEMBL622014,Rattus norvegicus,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,,4890,N,,Intermediate,,,,,,1,1,,BAO_0000218,10297,In vivo,50597
A,10116.0,,CHEMBL624749,Rattus norvegicus,Bioavailability was determined at 3 mg/kg po dose in rats,,2792,N,,Intermediate,,,,,,1,1,,BAO_0000218,10298,In vivo,50597
A,10116.0,,CHEMBL624750,Rattus norvegicus,Oral bioavailability in rat (dose 2 mg/kg),,5529,N,,Intermediate,,,,,,1,1,,BAO_0000218,10299,In vivo,50597
A,10116.0,,CHEMBL624751,Rattus norvegicus,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,10300,In vivo,50597
A,10116.0,,CHEMBL624752,Rattus norvegicus,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,10301,In vivo,50597
A,10116.0,,CHEMBL624753,Rattus norvegicus,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",,6685,N,,Intermediate,,,,,,1,1,,BAO_0000218,10302,In vivo,50597
A,10116.0,,CHEMBL624754,Rattus norvegicus,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,,6005,N,,Intermediate,,,,,,1,1,,BAO_0000218,10303,In vivo,50597
A,10116.0,,CHEMBL624755,Rattus norvegicus,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,10304,In vivo,50597
A,10116.0,,CHEMBL624756,Rattus norvegicus,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,10305,In vivo,50597
A,10116.0,,CHEMBL624757,Rattus norvegicus,Bioavailability in rat,,6103,N,,Intermediate,,,,,,1,1,,BAO_0000218,10306,In vivo,50597
A,10116.0,,CHEMBL624758,Rattus norvegicus,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,10307,In vivo,50597
A,10116.0,,CHEMBL622270,Rattus norvegicus,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,,6410,N,,Intermediate,,,,,,1,1,,BAO_0000218,10308,In vivo,50597
A,10116.0,,CHEMBL622271,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley),,5353,N,,Intermediate,,,,,,1,1,,BAO_0000218,10309,In vivo,50597
A,10116.0,,CHEMBL622272,Rattus norvegicus,Bioavailability in rat at the dose of 2 mg/kg,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,10310,In vivo,50597
A,10116.0,,CHEMBL622273,Rattus norvegicus,Oral bioavailability in rat,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,10311,In vivo,50597
A,10116.0,,CHEMBL622274,Rattus norvegicus,Bioavailability in rat (cannulated) (dose 2 mg/kg),,5809,N,,Intermediate,,,,,,1,1,,BAO_0000218,10312,In vivo,50597
A,10116.0,,CHEMBL622275,Rattus norvegicus,Bioavailability value of compound in rats was determined after peroral administration,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,10313,In vivo,50597
A,10116.0,,CHEMBL622276,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg),,3634,N,,Intermediate,,,,,,1,1,,BAO_0000218,10314,In vivo,50597
A,10116.0,,CHEMBL622277,Rattus norvegicus,Oral bioavailability in rat,,3341,N,,Intermediate,,,,,,1,1,,BAO_0000218,10315,In vivo,50597
A,10116.0,,CHEMBL622278,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg),,2690,N,,Intermediate,,,,,,1,1,,BAO_0000218,10316,In vivo,50597
A,10116.0,,CHEMBL622279,Rattus norvegicus,Oral bioavailability in rat,,3184,N,,Intermediate,,,,,,1,1,,BAO_0000218,10317,In vivo,50597
A,10116.0,,CHEMBL622280,Rattus norvegicus,Oral bioavailability in rat,,740,N,,Intermediate,,,,,,1,1,,BAO_0000218,10318,In vivo,50597
A,10116.0,,CHEMBL624083,Rattus norvegicus,Compound was evaluated for oral bioavailability in rats; 15-27 %,,1806,N,,Intermediate,,,,,,1,1,,BAO_0000218,10319,In vivo,50597
A,10116.0,,CHEMBL624084,Rattus norvegicus,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,,4891,N,,Intermediate,,,,,,1,1,,BAO_0000218,10320,In vivo,50597
A,10116.0,,CHEMBL624085,Rattus norvegicus,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),,3634,N,,Intermediate,,,,,,1,1,,BAO_0000218,10321,In vivo,50597
A,10116.0,,CHEMBL624086,Rattus norvegicus,Compound was tested for bioavailability in rats,,64,N,,Intermediate,,,,,,1,1,,BAO_0000218,10322,In vivo,50597
A,10116.0,,CHEMBL624087,Rattus norvegicus,Bioavailability in rat,,4839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10323,In vivo,50597
A,10116.0,,CHEMBL624088,Rattus norvegicus,Oral bioavailability in rat,,1094,N,,Intermediate,,,,,,1,1,,BAO_0000218,10324,In vivo,50597
A,9544.0,,CHEMBL624089,Macaca mulatta,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,,5005,U,,Intermediate,,,,,,1,0,,BAO_0000218,10325,In vivo,22224
A,10116.0,,CHEMBL624090,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),,5005,U,,Intermediate,,,,,,1,0,,BAO_0000218,10326,In vivo,22224
A,10116.0,,CHEMBL624091,Rattus norvegicus,Evaluated for the bioavailability in rat (in vivo),,4687,N,,Intermediate,,,,,,1,1,,BAO_0000218,10327,In vivo,50597
A,10116.0,,CHEMBL624092,Rattus norvegicus,F value of compound in rats was determined after peroral administration,,17804,N,,Intermediate,,,,,,1,1,,BAO_0000218,10328,In vivo,50597
A,10116.0,,CHEMBL624093,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10329,In vivo,50597
A,10116.0,,CHEMBL624094,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10330,In vivo,50597
A,10116.0,,CHEMBL624095,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10331,In vivo,50597
A,10116.0,,CHEMBL624096,Rattus norvegicus,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,,5974,N,,Intermediate,,,,,,1,1,,BAO_0000218,10332,In vivo,50597
A,10116.0,,CHEMBL624097,Rattus norvegicus,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",,1088,N,,Intermediate,,,,,,1,1,,BAO_0000218,10333,In vivo,50597
A,10116.0,,CHEMBL624098,Rattus norvegicus,Maximum fall in carotid flow in rat,,1742,N,,Intermediate,,,,,,1,1,,BAO_0000218,10334,In vivo,50597
A,10116.0,,CHEMBL874392,Rattus norvegicus,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,,4689,N,,Intermediate,,,,,,1,1,,BAO_0000218,10335,In vivo,50597
A,10116.0,,CHEMBL624099,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg),,2463,N,,Intermediate,,,,,,1,1,,BAO_0000218,10336,In vivo,50597
A,10116.0,,CHEMBL624100,Rattus norvegicus,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,10337,In vivo,50597
A,10116.0,,CHEMBL624101,Rattus norvegicus,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,,5654,N,,Intermediate,,,,,,1,1,,BAO_0000218,10338,In vivo,50597
A,10116.0,,CHEMBL624102,Rattus norvegicus,Oral bioavailability in rat (male Wistar),,6874,N,,Intermediate,,,,,,1,1,,BAO_0000218,10339,In vivo,50597
A,10116.0,,CHEMBL624103,Rattus norvegicus,Oral bioavailability after administration (30 mg/kg) in rat; good,,5633,N,,Intermediate,,,,,,1,1,,BAO_0000218,10340,In vivo,50597
A,10116.0,,CHEMBL624104,Rattus norvegicus,Oral bioavailability at the dose of 2 mg/kg in rat,,5496,N,,Intermediate,,,,,,1,1,,BAO_0000218,10341,In vivo,50597
A,10116.0,,CHEMBL624105,Rattus norvegicus,Oral bioavailability determined in rats,,2358,N,,Intermediate,,,,,,1,1,,BAO_0000218,10342,In vivo,50597
A,10116.0,,CHEMBL624106,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),,16456,N,,Intermediate,,,,,,1,1,,BAO_0000218,10343,In vivo,50597
A,10116.0,,CHEMBL624107,Rattus norvegicus,Oral bioavailability in rat (dose single 10 mg/kg),,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,10344,In vivo,50597
A,10116.0,,CHEMBL623943,Rattus norvegicus,Oral bioavailability in rat (dose single 10 mg/kg),,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,10345,In vivo,50597
A,10116.0,,CHEMBL623944,Rattus norvegicus,Oral bioavailability in rat (dose 5 mg/kg,,5302,N,,Intermediate,,,,,,1,1,,BAO_0000218,10346,In vivo,50597
A,10116.0,,CHEMBL623945,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10347,,50597
A,10116.0,,CHEMBL623946,Rattus norvegicus,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10348,,50597
A,10116.0,,CHEMBL623947,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10349,,50597
A,10116.0,,CHEMBL623948,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10350,,50597
A,10116.0,,CHEMBL623949,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10351,,50597
A,10116.0,,CHEMBL623950,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10352,,50597
A,10116.0,,CHEMBL874398,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10353,,50597
A,10116.0,,CHEMBL623951,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10354,,50597
A,10116.0,,CHEMBL623952,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10355,,50597
A,10116.0,,CHEMBL623953,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10356,,50597
A,10116.0,,CHEMBL623954,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10357,,50597
A,10116.0,,CHEMBL623955,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10358,,50597
A,10116.0,,CHEMBL623956,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10359,,50597
A,10116.0,,CHEMBL627807,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10360,,50597
A,10116.0,,CHEMBL627808,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10361,,50597
A,10116.0,,CHEMBL627809,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10362,,50597
A,10116.0,,CHEMBL627810,Rattus norvegicus,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10363,,50597
A,10116.0,,CHEMBL627811,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10364,,50597
A,10116.0,,CHEMBL627812,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10365,,50597
A,10116.0,,CHEMBL627813,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10366,,50597
A,10116.0,,CHEMBL627814,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10367,,50597
A,10116.0,,CHEMBL875336,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10368,,50597
A,10116.0,,CHEMBL627815,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10369,,50597
A,10116.0,,CHEMBL627816,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10370,,50597
A,10116.0,,CHEMBL627817,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10371,,50597
A,10116.0,,CHEMBL627818,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10372,,50597
A,10116.0,,CHEMBL627819,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10373,,50597
A,10116.0,,CHEMBL627820,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10374,,50597
A,10116.0,,CHEMBL627821,Rattus norvegicus,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10375,,50597
A,10116.0,,CHEMBL628464,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10376,,50597
A,10116.0,,CHEMBL626239,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10377,,50597
A,10116.0,,CHEMBL626240,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10378,,50597
A,10116.0,,CHEMBL626241,Rattus norvegicus,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10379,,50597
A,10116.0,,CHEMBL626242,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10380,,50597
A,10116.0,,CHEMBL626243,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10381,,50597
A,10116.0,,CHEMBL626244,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10382,,50597
A,10116.0,,CHEMBL626907,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10383,,50597
A,10116.0,,CHEMBL626908,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10384,,50597
A,10116.0,,CHEMBL626909,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10385,,50597
A,10116.0,,CHEMBL626910,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10386,,50597
F,10116.0,,CHEMBL875342,Rattus norvegicus,Percent total excretion of acetaminophen cysteine conjugate,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10387,,50597
F,10116.0,,CHEMBL626911,Rattus norvegicus,Percent total excretion of acetaminophen glucuronide,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10388,,50597
F,10116.0,,CHEMBL626912,Rattus norvegicus,Percent total excretion of acetaminophen sulfate,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10389,,50597
F,10116.0,,CHEMBL627065,Rattus norvegicus,Percent total excretion of acetaminophen-mercapturic acid,,7449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10390,,50597
A,10116.0,,CHEMBL627066,Rattus norvegicus,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,,3172,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,10391,,50597
A,10116.0,,CHEMBL627067,Rattus norvegicus,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,,16456,N,,Intermediate,,,,,,1,1,,BAO_0000218,10392,In vivo,50597
A,8656.0,,CHEMBL627068,ratrat,Biodistribution of compound in rat muscle after 5 min of administration,,10839,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,10393,In vivo,22224
A,8656.0,,CHEMBL627069,ratrat,Biodistribution of compound in rat muscle after 5 min of administration.,,10839,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,10394,In vivo,22224
A,9940.0,,CHEMBL627070,Ovis aries,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10395,In vivo,22224
A,9940.0,,CHEMBL627071,Ovis aries,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10396,In vivo,22224
A,9940.0,,CHEMBL627072,Ovis aries,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10397,In vivo,22224
A,9940.0,,CHEMBL627073,Ovis aries,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10398,In vivo,22224
A,9940.0,,CHEMBL625387,Ovis aries,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10399,In vivo,22224
A,9940.0,,CHEMBL625388,Ovis aries,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,,,,1,0,,BAO_0000218,10400,In vivo,22224
A,9940.0,,CHEMBL625389,Ovis aries,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10401,In vivo,22224
A,9940.0,,CHEMBL875343,Ovis aries,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),,5334,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10402,In vivo,22224
A,8570.0,,CHEMBL876795,Serpentes,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),,1735,N,,Intermediate,,,,,,1,1,,BAO_0000218,10403,,50497
A,8570.0,,CHEMBL626552,Serpentes,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,,1469,N,,Intermediate,,,,,,1,1,,BAO_0000218,10404,,50497
A,8570.0,,CHEMBL626553,Serpentes,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,,1336,N,,Intermediate,,,,,,1,1,,BAO_0000218,10405,,50497
A,9606.0,,CHEMBL626554,Homo sapiens,The human biological plasma half life of the compound,,12403,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000366,10406,,22224
A,10116.0,,CHEMBL626555,Rattus norvegicus,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,10407,,50597
A,10116.0,,CHEMBL626556,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10408,,50597
A,10116.0,,CHEMBL626557,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10409,,50597
A,10116.0,,CHEMBL626558,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10410,,50597
A,10116.0,,CHEMBL626559,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10411,,50597
A,10116.0,,CHEMBL626560,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10412,,50597
A,10116.0,,CHEMBL876803,Rattus norvegicus,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10413,,50597
A,10116.0,,CHEMBL627964,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10414,,50597
A,10116.0,,CHEMBL627965,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10415,,50597
A,10116.0,,CHEMBL627966,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10416,,50597
A,10116.0,,CHEMBL627967,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10417,,50597
A,10116.0,,CHEMBL627968,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10418,,50597
A,10116.0,,CHEMBL627969,Rattus norvegicus,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10419,,50597
A,10116.0,,CHEMBL627970,Rattus norvegicus,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,,8004,N,,Intermediate,,,,,,1,1,,BAO_0000218,10420,,50597
A,10116.0,,CHEMBL627971,Rattus norvegicus,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,,8004,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10421,,50597
A,10116.0,,CHEMBL627972,Rattus norvegicus,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,,8004,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10422,,50597
B,9606.0,,CHEMBL856029,Homo sapiens,Dissociation constant against binding to human cyclophilin A,,15917,D,,Expert,,,,,,1,9,,BAO_0000357,10423,,180
B,9913.0,,CHEMBL627973,Bos taurus,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,,12396,H,,Expert,,,,,,1,8,,BAO_0000019,10424,,11591
A,,,CHEMBL627974,,-Log C was determined by performing the electroshock minimum test,,7065,U,,Autocuration,,,,,,1,0,,BAO_0000019,10425,,22224
A,,,CHEMBL627975,,-Log C was determined by performing the foot shock test,,7065,U,,Autocuration,,,,,,1,0,,BAO_0000019,10426,,22224
A,,,CHEMBL627976,,-Log C was determined by performing the incl screen test,,7065,U,,Autocuration,,,,,,1,0,,BAO_0000019,10427,,22224
A,,,CHEMBL627977,,-Log C was determined by performing the maximum electroshock test,,7065,U,,Autocuration,,,,,,1,0,,BAO_0000019,10428,,22224
A,,,CHEMBL627978,,-Log C was determined by performing the pentylenetetrazole test,,7065,U,,Autocuration,,,,,,1,0,,BAO_0000019,10429,,22224
A,,,CHEMBL627979,,Tested for experimental arotinoid inhibitory dose,,12415,U,,Autocuration,,,,,,1,0,,BAO_0000019,10430,,22224
A,,,CHEMBL876804,,Negative log transformed activity,,10256,U,,Autocuration,,,,,,1,0,,BAO_0000019,10431,,22224
A,,,CHEMBL627980,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,7991,U,,Autocuration,,,,,,1,0,,BAO_0000019,10432,,22224
A,10141.0,,CHEMBL627981,Cavia porcellus,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,,14342,N,,Intermediate,,,,,,1,1,,BAO_0000218,10433,,50512
A,10141.0,,CHEMBL627982,Cavia porcellus,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,,14342,N,,Intermediate,,,,,,1,1,,BAO_0000218,10434,,50512
A,10141.0,,CHEMBL627983,Cavia porcellus,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,,14342,N,,Intermediate,,,,,,1,1,,BAO_0000218,10435,,50512
A,10141.0,,CHEMBL627984,Cavia porcellus,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,,14342,N,,Intermediate,,,Ileum,2116.0,,1,1,,BAO_0000218,10436,,50512
P,,,CHEMBL627985,,Solubility in water was determined; values expressed as -log,,6047,U,,Autocuration,,,,,,1,0,,BAO_0000100,10437,,22229
A,,,CHEMBL627986,,Ratio of Kcat to that of Km was determined,,17269,U,,Autocuration,,,,,,1,0,,BAO_0000019,10438,,22224
A,,,CHEMBL627987,,Observed first order rate constant,,10026,U,,Autocuration,,,,,,1,0,,BAO_0000019,10439,,22224
A,,,CHEMBL627988,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,14583,U,,Autocuration,,,,,,1,0,,BAO_0000019,10440,,22224
A,10116.0,,CHEMBL627989,Rattus norvegicus,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,10441,In vivo,50597
A,10116.0,,CHEMBL627990,Rattus norvegicus,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,,2661,N,,Intermediate,,,,,,1,1,,BAO_0000218,10442,In vivo,50597
A,10116.0,,CHEMBL876805,Rattus norvegicus,Oral Bioavailability after administration of 10 mg/kg in male rat,,4029,N,,Intermediate,,,,,,1,1,,BAO_0000218,10443,In vivo,50597
A,10116.0,,CHEMBL627991,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),,17735,N,,Intermediate,,,,,,1,1,,BAO_0000218,10444,In vivo,50597
A,10116.0,,CHEMBL627992,Rattus norvegicus,Oral bioavailability in rat,,4576,N,,Intermediate,,,,,,1,1,,BAO_0000218,10445,In vivo,50597
A,10116.0,,CHEMBL627993,Rattus norvegicus,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,,17582,N,,Intermediate,,,,,,1,1,,BAO_0000218,10446,In vivo,50597
A,10116.0,,CHEMBL622817,Rattus norvegicus,Oral bioavailability at 1 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,10447,In vivo,50597
A,10116.0,,CHEMBL622818,Rattus norvegicus,Oral bioavailability at 10 mg/kg was determined in rat,,17651,N,,Intermediate,,,,,,1,1,,BAO_0000218,10448,In vivo,50597
A,10116.0,,CHEMBL622819,Rattus norvegicus,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",,17670,N,,Intermediate,,,,,,1,1,,BAO_0000218,10449,In vivo,50597
A,10116.0,,CHEMBL872267,Rattus norvegicus,Oral bioavailability in rat,,5045,N,,Intermediate,,,,,,1,1,,BAO_0000218,10450,In vivo,50597
A,10116.0,,CHEMBL622820,Rattus norvegicus,Oral bioavailability in rat,,1696,N,,Intermediate,,,,,,1,1,,BAO_0000218,10451,In vivo,50597
A,10116.0,,CHEMBL622821,Rattus norvegicus,Oral bioavailability after intravenous administration in rats at 24 uM/kg,,17764,N,,Intermediate,,,,,,1,1,,BAO_0000218,10452,In vivo,50597
A,10116.0,,CHEMBL622822,Rattus norvegicus,Oral bioavailability in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,10453,In vivo,50597
A,10116.0,,CHEMBL622823,Rattus norvegicus,Oral bioavailability in rat,,6596,N,,Intermediate,,,,,,1,1,,BAO_0000218,10454,In vivo,50597
A,10116.0,,CHEMBL622824,Rattus norvegicus,Oral bioavailability in rat,,17547,N,,Intermediate,,,,,,1,1,,BAO_0000218,10455,In vivo,50597
A,10116.0,,CHEMBL622825,Rattus norvegicus,Oral bioavailability in rat at a dose of 3 mg/kg,,17771,N,,Intermediate,,,,,,1,1,,BAO_0000218,10456,In vivo,50597
A,10116.0,,CHEMBL622901,Rattus norvegicus,Oral bioavailability in rat after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,10457,In vivo,50597
A,10116.0,,CHEMBL622902,Rattus norvegicus,Oral bioavailability in rat,,4558,N,,Intermediate,,,,,,1,1,,BAO_0000218,10458,In vivo,50597
A,10116.0,,CHEMBL621844,Rattus norvegicus,Oral bioavailability in rat,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,10459,In vivo,50597
A,10116.0,,CHEMBL621845,Rattus norvegicus,Oral bioavailability in Dawley rats,,6827,N,,Intermediate,,,,,,1,1,,BAO_0000218,10460,In vivo,50597
A,10116.0,,CHEMBL621846,Rattus norvegicus,Oral bioavailability,,4026,N,,Intermediate,,,,,,1,1,,BAO_0000218,10461,In vivo,50597
A,10116.0,,CHEMBL621847,Rattus norvegicus,Oral bioavailability in rat (dose 30 mg/kg),,10,N,,Intermediate,,,,,,1,1,,BAO_0000218,10462,In vivo,50597
A,10116.0,,CHEMBL877609,Rattus norvegicus,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10463,In vivo,50597
A,10116.0,,CHEMBL621848,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg i.v.),,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10464,In vivo,50597
A,10116.0,,CHEMBL621849,Rattus norvegicus,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10465,In vivo,50597
A,10116.0,,CHEMBL622030,Rattus norvegicus,Oral bioavailability in rat (dose 60 mg/kg p.o.),,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10466,In vivo,50597
A,10116.0,,CHEMBL622031,Rattus norvegicus,Percent oral bioavailability determined in rats,,4796,N,,Intermediate,,,,,,1,1,,BAO_0000218,10467,In vivo,50597
A,10116.0,,CHEMBL622032,Rattus norvegicus,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,10468,In vivo,50597
A,10116.0,,CHEMBL622033,Rattus norvegicus,The compound was evaluated for bioavailability in rats; 32-51,,2137,N,,Intermediate,,,,,,1,1,,BAO_0000218,10469,In vivo,50597
A,10116.0,,CHEMBL622034,Rattus norvegicus,Bioavailability in rat (dose 20 mg/kg p.o.),,2959,N,,Intermediate,,,,,,1,1,,BAO_0000218,10470,In vivo,50597
A,10116.0,,CHEMBL622035,Rattus norvegicus,Oral bioavailability in rat,,1361,N,,Intermediate,,,,,,1,1,,BAO_0000218,10471,In vivo,50597
A,10116.0,,CHEMBL882966,Rattus norvegicus,Bioavailability percent in rat at the dose of 2 mg/kg,,4727,N,,Intermediate,,,,,,1,1,,BAO_0000218,10472,In vivo,50597
A,10116.0,,CHEMBL622036,Rattus norvegicus,Bioavailability was evaluated after 20 uM/kg of peroral administration,,16423,N,,Intermediate,,,,,,1,1,,BAO_0000218,10473,In vivo,50597
A,10116.0,,CHEMBL622037,Rattus norvegicus,Oral bioavailability in rat,,5206,N,,Intermediate,,,,,,1,1,,BAO_0000218,10474,In vivo,50597
A,10116.0,,CHEMBL622038,Rattus norvegicus,Oral bioavailability in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,10475,In vivo,50597
A,10116.0,,CHEMBL622039,Rattus norvegicus,Bioavailability in rats,,17723,N,,Intermediate,,,,,,1,1,,BAO_0000218,10476,In vivo,50597
A,10116.0,,CHEMBL622040,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10477,In vivo,50597
A,10116.0,,CHEMBL622041,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10478,In vivo,50597
A,10116.0,,CHEMBL622042,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10479,In vivo,50597
A,10116.0,,CHEMBL622043,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10480,In vivo,50597
A,10116.0,,CHEMBL622044,Rattus norvegicus,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10481,In vivo,50597
A,10116.0,,CHEMBL622045,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,10482,In vivo,50597
A,10116.0,,CHEMBL622046,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,10483,In vivo,50597
A,10116.0,,CHEMBL622047,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,10484,In vivo,50597
A,10116.0,,CHEMBL877610,Rattus norvegicus,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,10485,In vivo,50597
A,10116.0,,CHEMBL622048,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10486,In vivo,50597
A,10116.0,,CHEMBL622049,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10487,In vivo,50597
A,10116.0,,CHEMBL622050,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10488,In vivo,50597
A,10116.0,,CHEMBL622051,Rattus norvegicus,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10489,In vivo,50597
A,10116.0,,CHEMBL622052,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,,,,1,1,,BAO_0000218,10490,In vivo,50597
A,10116.0,,CHEMBL622053,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,,,,1,1,,BAO_0000218,10491,In vivo,50597
A,10116.0,,CHEMBL622054,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,,,,1,1,,BAO_0000218,10492,In vivo,50597
A,10116.0,,CHEMBL622055,Rattus norvegicus,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,,,,1,1,,BAO_0000218,10493,In vivo,50597
A,10116.0,,CHEMBL622056,Rattus norvegicus,Oral bioavailability in rats was determined; High,,5237,N,,Intermediate,,,,,,1,1,,BAO_0000218,10494,In vivo,50597
A,10116.0,,CHEMBL622057,Rattus norvegicus,Oral bioavailability in the rat was determined,,5503,N,,Intermediate,,,,,,1,1,,BAO_0000218,10495,In vivo,50597
A,10116.0,,CHEMBL628008,Rattus norvegicus,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,,15765,N,,Intermediate,,,,,,1,1,,BAO_0000218,10496,In vivo,50597
A,10116.0,,CHEMBL622058,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),,15660,N,,Intermediate,,,,,,1,1,,BAO_0000218,10497,In vivo,50597
A,10116.0,,CHEMBL622059,Rattus norvegicus,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10498,In vivo,50597
A,10116.0,,CHEMBL622060,Rattus norvegicus,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10499,In vivo,50597
A,10116.0,,CHEMBL622061,Rattus norvegicus,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10500,In vivo,50597
A,10116.0,,CHEMBL622062,Rattus norvegicus,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,,5978,N,,Intermediate,,,,,,1,1,,BAO_0000218,10501,In vivo,50597
A,10116.0,,CHEMBL622063,Rattus norvegicus,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,10502,In vivo,50597
A,10116.0,,CHEMBL877611,Rattus norvegicus,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,,3598,N,,Expert,,,,,,1,1,,BAO_0000218,10503,In vivo,50597
A,10116.0,,CHEMBL622064,Rattus norvegicus,Oral bioavailability of compound in Sprague Dawley rats,,4216,N,,Intermediate,,,,,,1,1,,BAO_0000218,10504,In vivo,50597
A,10116.0,,CHEMBL622065,Rattus norvegicus,Oral bioavailability of compound in rat,,17839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10505,In vivo,50597
A,10116.0,,CHEMBL622066,Rattus norvegicus,Oral bioavailability in rat (dose 2 mg/kg),,6570,N,,Intermediate,,,,,,1,1,,BAO_0000218,10506,In vivo,50597
A,10116.0,,CHEMBL622067,Rattus norvegicus,Oral bioavailability of compound in rat was determined,,5334,N,,Intermediate,,,,,,1,1,,BAO_0000218,10507,In vivo,50597
A,10116.0,,CHEMBL622068,Rattus norvegicus,Oral bioavailability of compound in rats,,6886,N,,Intermediate,,,,,,1,1,,BAO_0000218,10508,In vivo,50597
A,10116.0,,CHEMBL622069,Rattus norvegicus,Oral bioavailability of compound was determined in rats,,5210,N,,Intermediate,,,,,,1,1,,BAO_0000218,10509,In vivo,50597
A,10116.0,,CHEMBL624796,Rattus norvegicus,Oral bioavailability at a dose of 30 mg/kg in rats,,4170,N,,Intermediate,,,,,,1,1,,BAO_0000218,10510,In vivo,50597
A,10116.0,,CHEMBL624797,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),,6028,N,,Intermediate,,,,,,1,1,,BAO_0000218,10511,In vivo,50597
A,10116.0,,CHEMBL623053,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),,6028,N,,Intermediate,,,,,,1,1,,BAO_0000218,10512,In vivo,50597
A,10116.0,,CHEMBL623054,Rattus norvegicus,Oral bioavailability evaluated in rat,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,10513,In vivo,50597
A,10116.0,,CHEMBL623055,Rattus norvegicus,Oral bioavailability in fasted rat,,6168,N,,Intermediate,,,,,,1,1,,BAO_0000218,10514,In vivo,50597
A,10116.0,,CHEMBL623056,Rattus norvegicus,Oral bioavailability in fed rat,,6168,N,,Intermediate,,,,,,1,1,,BAO_0000218,10515,In vivo,50597
A,10116.0,,CHEMBL623057,Rattus norvegicus,Oral bioavailability in rat (mature male) (dose 30 mg/kg),,5160,N,,Intermediate,,,,,,1,1,,BAO_0000218,10516,In vivo,50597
A,10116.0,,CHEMBL623058,Rattus norvegicus,Oral bioavailability in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,10517,In vivo,50597
A,10116.0,,CHEMBL623059,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o.),,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,10518,In vivo,50597
A,10116.0,,CHEMBL623060,Rattus norvegicus,Oral bioavailability in rat after administration of 10 mg/kg po,,6535,N,,Intermediate,,,,,,1,1,,BAO_0000218,10519,In vivo,50597
A,10116.0,,CHEMBL623061,Rattus norvegicus,Oral bioavailability in rat,,4194,N,,Intermediate,,,,,,1,1,,BAO_0000218,10520,In vivo,50597
A,10116.0,,CHEMBL623062,Rattus norvegicus,Oral bioavailability in rat,,6230,N,,Intermediate,,,,,,1,1,,BAO_0000218,10521,In vivo,50597
A,10116.0,,CHEMBL623063,Rattus norvegicus,Oral bioavailability in rat,,6619,N,,Intermediate,,,,,,1,1,,BAO_0000218,10522,In vivo,50597
A,10116.0,,CHEMBL623064,Rattus norvegicus,Oral bioavailability in rat,,17607,N,,Intermediate,,,,,,1,1,,BAO_0000218,10523,In vivo,50597
A,10116.0,,CHEMBL623065,Rattus norvegicus,Oral bioavailability in ratrs,,4942,N,,Intermediate,,,,,,1,1,,BAO_0000218,10524,In vivo,50597
A,10116.0,,CHEMBL623066,Rattus norvegicus,Oral bioavailability in rat,,4942,N,,Intermediate,,,,,,1,1,,BAO_0000218,10525,In vivo,50597
A,10116.0,,CHEMBL623067,Rattus norvegicus,Oral bioavailability in rat,,6646,N,,Intermediate,,,,,,1,1,,BAO_0000218,10526,In vivo,50597
A,10116.0,,CHEMBL623068,Rattus norvegicus,Oral bioavailability in rats was determined; High,,5237,N,,Intermediate,,,,,,1,1,,BAO_0000218,10527,In vivo,50597
A,10116.0,,CHEMBL623069,Rattus norvegicus,Oral bioavailability in rat,,6646,N,,Intermediate,,,,,,1,1,,BAO_0000218,10528,In vivo,50597
A,10116.0,,CHEMBL623070,Rattus norvegicus,Oral bioavailability in rat,,4449,N,,Intermediate,,,,,,1,1,,BAO_0000218,10529,In vivo,50597
A,10116.0,,CHEMBL623071,Rattus norvegicus,Oral bioavailability was calculated in rat,,6057,N,,Intermediate,,,,,,1,1,,BAO_0000218,10530,In vivo,50597
A,10116.0,,CHEMBL623072,Rattus norvegicus,Oral bioavailability,,2552,N,,Intermediate,,,,,,1,1,,BAO_0000218,10531,In vivo,50597
A,10116.0,,CHEMBL623073,Rattus norvegicus,Oral bioavailability,,5496,N,,Intermediate,,,,,,1,1,,BAO_0000218,10532,In vivo,50597
A,10116.0,,CHEMBL623074,Rattus norvegicus,Oral bioavailability,,6484,N,,Intermediate,,,,,,1,1,,BAO_0000218,10533,In vivo,50597
A,10116.0,,CHEMBL623075,Rattus norvegicus,Oral bioavailability,,6485,N,,Intermediate,,,,,,1,1,,BAO_0000218,10534,In vivo,50597
A,10116.0,,CHEMBL623076,Rattus norvegicus,Oral bioavailability after i.v. administration,,6616,N,,Intermediate,,,,,,1,1,,BAO_0000218,10535,In vivo,50597
A,10116.0,,CHEMBL623077,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,4969,N,,Intermediate,,,,,,1,1,,BAO_0000218,10536,In vivo,50597
A,10116.0,,CHEMBL623078,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),,5862,N,,Intermediate,,,,,,1,1,,BAO_0000218,10537,In vivo,50597
A,10116.0,,CHEMBL623079,Rattus norvegicus,Oral bioavailability in Sprague-Dawley rats,,4514,N,,Intermediate,,,,,,1,1,,BAO_0000218,10538,In vivo,50597
A,10116.0,,CHEMBL623080,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,4514,N,,Intermediate,,,,,,1,1,,BAO_0000218,10539,In vivo,50597
A,10116.0,,CHEMBL623081,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,4514,N,,Intermediate,,,,,,1,1,,BAO_0000218,10540,In vivo,50597
A,10116.0,,CHEMBL623082,Rattus norvegicus,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,,5546,N,,Intermediate,,,,,,1,1,,BAO_0000218,10541,In vivo,50597
A,10116.0,,CHEMBL874400,Rattus norvegicus,Oral bioavailability in fasted rat,,6168,N,,Intermediate,,,,,,1,1,,BAO_0000218,10542,In vivo,50597
A,10116.0,,CHEMBL623083,Rattus norvegicus,Oral bioavailability in fed rat,,6168,N,,Intermediate,,,,,,1,1,,BAO_0000218,10543,In vivo,50597
A,10116.0,,CHEMBL623084,Rattus norvegicus,Oral bioavailability in rat,,3624,N,,Intermediate,,,,,,1,1,,BAO_0000218,10544,In vivo,50597
A,10116.0,,CHEMBL623085,Rattus norvegicus,Oral bioavailability in rat,,5213,N,,Intermediate,,,,,,1,1,,BAO_0000218,10545,In vivo,50597
A,10116.0,,CHEMBL623086,Rattus norvegicus,Oral bioavailability in rat,,5496,N,,Intermediate,,,,,,1,1,,BAO_0000218,10546,In vivo,50597
A,10116.0,,CHEMBL623087,Rattus norvegicus,Oral bioavailability in rat,,5553,N,,Intermediate,,,,,,1,1,,BAO_0000218,10547,In vivo,50597
A,10116.0,,CHEMBL623088,Rattus norvegicus,Oral bioavailability in rat,,5833,N,,Intermediate,,,,,,1,1,,BAO_0000218,10548,In vivo,50597
A,10116.0,,CHEMBL623089,Rattus norvegicus,Oral bioavailability in rat,,5836,N,,Intermediate,,,,,,1,1,,BAO_0000218,10549,In vivo,50597
A,10116.0,,CHEMBL623090,Rattus norvegicus,Oral bioavailability in rat,,5865,N,,Intermediate,,,,,,1,1,,BAO_0000218,10550,In vivo,50597
A,10116.0,,CHEMBL623091,Rattus norvegicus,Oral bioavailability in rat,,5960,N,,Intermediate,,,,,,1,1,,BAO_0000218,10551,In vivo,50597
A,10116.0,,CHEMBL623092,Rattus norvegicus,Oral bioavailability in rat,,6249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10552,In vivo,50597
A,10116.0,,CHEMBL623093,Rattus norvegicus,Oral bioavailability in rat,,6448,N,,Intermediate,,,,,,1,1,,BAO_0000218,10553,In vivo,50597
A,10116.0,,CHEMBL874401,Rattus norvegicus,Oral bioavailability in rat,,6453,N,,Intermediate,,,,,,1,1,,BAO_0000218,10554,In vivo,50597
A,10116.0,,CHEMBL623094,Rattus norvegicus,Oral bioavailability in rat,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,10555,In vivo,50597
A,10116.0,,CHEMBL623095,Rattus norvegicus,Oral bioavailability in rat,,17607,N,,Intermediate,,,,,,1,1,,BAO_0000218,10556,In vivo,50597
A,10116.0,,CHEMBL623096,Rattus norvegicus,Oral bioavailability in rat after peroral administration at 10 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,10557,In vivo,50597
A,10116.0,,CHEMBL624913,Rattus norvegicus,Oral bioavailability in rat after peroral administration at 5 mg/kg,,5939,N,,Intermediate,,,,,,1,1,,BAO_0000218,10558,In vivo,50597
A,10116.0,,CHEMBL624914,Rattus norvegicus,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),,6281,N,,Intermediate,,,,,,1,1,,BAO_0000218,10559,In vivo,50597
A,10116.0,,CHEMBL624915,Rattus norvegicus,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,,5874,N,,Intermediate,,,,,,1,1,,BAO_0000218,10560,In vivo,50597
A,10116.0,,CHEMBL624916,Rattus norvegicus,Oral bioavailability in rat; Not measured,,5213,N,,Intermediate,,,,,,1,1,,BAO_0000218,10561,In vivo,50597
A,10116.0,,CHEMBL624917,Rattus norvegicus,Oral bioavailability in rat,,4964,N,,Intermediate,,,,,,1,1,,BAO_0000218,10562,In vivo,50597
A,10116.0,,CHEMBL625157,Rattus norvegicus,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,,11020,N,,Intermediate,,,,,,1,1,,BAO_0000218,10563,,50597
A,10116.0,,CHEMBL625158,Rattus norvegicus,In vitro metabolic potential in rat liver microsomes,,6251,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10564,,50597
A,10116.0,,CHEMBL625159,Rattus norvegicus,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",,1568,N,,Intermediate,,,,,,1,1,,BAO_0000218,10565,In vivo,50597
A,10116.0,,CHEMBL625160,Rattus norvegicus,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",,3032,N,,Intermediate,,,,,,1,1,,BAO_0000218,10566,In vivo,50597
A,10116.0,,CHEMBL625161,Rattus norvegicus,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,,3748,N,,Intermediate,,,,,,1,1,,BAO_0000218,10567,In vivo,50597
A,10116.0,,CHEMBL625162,Rattus norvegicus,Oral bioavailability in rat,,401,N,,Intermediate,,,,,,1,1,,BAO_0000218,10568,In vivo,50597
A,10116.0,,CHEMBL625163,Rattus norvegicus,Oral bioavailability in rat,,6512,N,,Intermediate,,,,,,1,1,,BAO_0000218,10569,In vivo,50597
A,10116.0,,CHEMBL625164,Rattus norvegicus,Oral bioavailability in rats at 10 mg/kg,,17617,N,,Intermediate,,,,,,1,1,,BAO_0000218,10570,In vivo,50597
A,10116.0,,CHEMBL625165,Rattus norvegicus,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,,6679,N,,Intermediate,,,,,,1,1,,BAO_0000218,10571,In vivo,50597
A,10116.0,,CHEMBL625166,Rattus norvegicus,Oral bioavailability in rat,,6742,N,,Intermediate,,,,,,1,1,,BAO_0000218,10572,In vivo,50597
A,10116.0,,CHEMBL625167,Rattus norvegicus,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,,589,N,,Intermediate,,,,,,1,1,,BAO_0000218,10573,,50597
A,10116.0,,CHEMBL625168,Rattus norvegicus,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,,589,N,,Intermediate,,,,,,1,1,,BAO_0000218,10574,,50597
A,10116.0,,CHEMBL625169,Rattus norvegicus,Plasma clearance of the compound,,3185,N,,Intermediate,,,,,,1,1,,BAO_0000218,10575,In vivo,50597
A,10116.0,,CHEMBL626264,Rattus norvegicus,Plasma clearance at 10 mg/kg in rat upon intravenous administration,,17596,N,,Intermediate,,,,,,1,1,,BAO_0000218,10576,In vivo,50597
A,10116.0,,CHEMBL626265,Rattus norvegicus,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,,2713,N,,Intermediate,,,,,,1,1,,BAO_0000218,10577,In vivo,50597
A,10116.0,,CHEMBL626266,Rattus norvegicus,The compound was tested for plasma clearance in rat,,12500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10578,In vivo,50597
A,10116.0,,CHEMBL626267,Rattus norvegicus,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,,12500,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10579,In vivo,50597
A,10116.0,,CHEMBL626268,Rattus norvegicus,Plasma concentration upon oral administration of 1 mg/Kg in rats,,2713,N,,Intermediate,,,,,,1,1,,BAO_0000218,10580,,50597
A,10116.0,,CHEMBL626269,Rattus norvegicus,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,,1446,N,,Intermediate,,,,,,1,1,,BAO_0000218,10581,,50597
A,10116.0,,CHEMBL626270,Rattus norvegicus,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,,6227,N,,Intermediate,,,,,,1,1,,BAO_0000218,10582,,50597
A,10116.0,,CHEMBL626271,Rattus norvegicus,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,,4709,N,,Intermediate,,,,,,1,1,,BAO_0000218,10583,,50597
A,10116.0,,CHEMBL626272,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,10584,,50597
A,10116.0,,CHEMBL626273,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,10585,,50597
A,10116.0,,CHEMBL875346,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,10586,,50597
A,10116.0,,CHEMBL626274,Rattus norvegicus,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",,5510,N,,Intermediate,,,,,,1,1,,BAO_0000218,10587,,50597
A,10116.0,,CHEMBL626275,Rattus norvegicus,Compound was tested for protein binding in rat plasma,,4514,N,,Intermediate,,,,,,1,1,,BAO_0000218,10588,,50597
A,10116.0,,CHEMBL624646,Rattus norvegicus,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,,2713,N,,Intermediate,,,,,,1,1,,BAO_0000218,10589,,50597
A,10116.0,,CHEMBL624647,Rattus norvegicus,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,,2713,N,,Intermediate,,,,,,1,1,,BAO_0000218,10590,,50597
A,10116.0,,CHEMBL624648,Rattus norvegicus,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,,5340,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10591,,50597
A,10116.0,,CHEMBL624649,Rattus norvegicus,Area under curve ratio was determined (po/iv) in rat,,12058,N,,Intermediate,,,,,,1,1,,BAO_0000218,10592,,50597
A,10116.0,,CHEMBL624650,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,,11195,N,,Intermediate,,,,,,1,1,,BAO_0000218,10593,,50597
A,10116.0,,CHEMBL624651,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,,11195,N,,Intermediate,,,,,,1,1,,BAO_0000218,10594,,50597
A,10116.0,,CHEMBL624652,Rattus norvegicus,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,,11195,N,,Intermediate,,,,,,1,1,,BAO_0000218,10595,,50597
A,10116.0,,CHEMBL624653,Rattus norvegicus,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,,6495,N,,Intermediate,,,,,,1,1,,BAO_0000218,10596,,50597
A,10116.0,,CHEMBL624654,Rattus norvegicus,Ratio of AUCbrain to AUCplasma,,6078,N,,Intermediate,,,,,,1,1,,BAO_0000218,10597,,50597
A,10116.0,,CHEMBL624655,Rattus norvegicus,Ratio of brain to plasma,,5656,N,,Intermediate,,,,,,1,1,,BAO_0000218,10598,,50597
A,10116.0,,CHEMBL624656,Rattus norvegicus,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10599,,50597
A,10116.0,,CHEMBL624657,Rattus norvegicus,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10600,,50597
A,10116.0,,CHEMBL624658,Rattus norvegicus,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10601,,50597
A,10116.0,,CHEMBL624659,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,10602,,50597
A,10116.0,,CHEMBL624660,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,10603,,50597
A,10116.0,,CHEMBL624661,Rattus norvegicus,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,,10130,N,,Intermediate,,,,,,1,1,,BAO_0000218,10604,,50597
A,10116.0,,CHEMBL624662,Rattus norvegicus,Steady state brain :blood ratio was determined,,5213,N,,Intermediate,,,,,,1,1,,BAO_0000218,10605,,50597
A,10116.0,,CHEMBL625199,Rattus norvegicus,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10606,,50597
A,10116.0,,CHEMBL625200,Rattus norvegicus,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10607,,50597
A,10116.0,,CHEMBL625201,Rattus norvegicus,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10608,,50597
A,10116.0,,CHEMBL625202,Rattus norvegicus,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,,4910,N,,Intermediate,,,,,,1,1,,BAO_0000218,10609,,50597
A,10116.0,,CHEMBL625203,Rattus norvegicus,Percentage recovery after 3h incubation with rat hapatocytes was determined,,2083,N,,Intermediate,,,,,,1,1,,BAO_0000218,10610,,50597
A,10116.0,,CHEMBL625204,Rattus norvegicus,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,,2082,N,,Intermediate,,,,,,1,1,,BAO_0000218,10611,,50597
A,10116.0,,CHEMBL625205,Rattus norvegicus,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,,2082,N,,Intermediate,,,,,,1,1,,BAO_0000218,10612,,50597
A,10116.0,,CHEMBL625206,Rattus norvegicus,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,,6351,N,,Intermediate,,,,,,1,1,,BAO_0000218,10613,,50597
A,,,CHEMBL625207,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,14583,U,,Autocuration,,,,,,1,0,,BAO_0000019,10614,,22224
A,,,CHEMBL625208,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,14583,U,,Autocuration,,,,,,1,0,,BAO_0000019,10615,,22224
A,9606.0,,CHEMBL625209,Homo sapiens,In vivo absorption in Caco-2 cell line monolayers was determined,,4608,N,495.0,Intermediate,,,,,Caco-2,1,1,,BAO_0000218,10616,,50587
P,,,CHEMBL625210,,Calculated partition coefficient (clogP),,13668,U,,Autocuration,,,,,,1,0,,BAO_0000100,10617,,22229
A,10116.0,,CHEMBL625211,Rattus norvegicus,Area under curve was determine after peroral administration at 10 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,10618,,50597
A,9544.0,,CHEMBL625212,Macaca mulatta,Area under curve was determine after peroral administration at 10 mpk in Rhesus,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,10619,,50797
A,10116.0,,CHEMBL625213,Rattus norvegicus,Area under curve was determine after peroral administration at 160 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,10620,,50597
A,10116.0,,CHEMBL625214,Rattus norvegicus,Area under curve was determine after peroral administration at 20 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,10621,,50597
A,10116.0,,CHEMBL874542,Rattus norvegicus,Area under curve was determine after peroral administration at 50 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,10622,,50597
P,,,CHEMBL625215,,Calculated partition coefficient (clogP) (AlogP),,6472,U,,Autocuration,,,,,,1,0,,BAO_0000100,10623,,22229
A,,,CHEMBL625216,,Activated partial thromboplastin time measured,,15106,U,,Autocuration,,,,,,1,0,,BAO_0000019,10624,,22224
P,,,CHEMBL625217,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,15207,U,,Autocuration,,,,,,1,0,,BAO_0000100,10625,,22224
P,,,CHEMBL625218,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,15207,U,,Autocuration,,,,,,1,0,,BAO_0000100,10626,,22224
A,9615.0,,CHEMBL622864,Canis lupus familiaris,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10627,,50588
A,10116.0,,CHEMBL622865,Rattus norvegicus,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10628,,50597
A,10116.0,,CHEMBL622866,Rattus norvegicus,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10629,,50597
A,9615.0,,CHEMBL622867,Canis lupus familiaris,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10630,,50588
A,10141.0,,CHEMBL876808,Cavia porcellus,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,,15240,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10631,,50512
A,,,CHEMBL627725,,AUC in brain,,10655,U,,Autocuration,,,Brain,955.0,,1,0,,BAO_0000019,10632,,22224
A,,,CHEMBL627726,,AUC in serum,,10655,U,,Autocuration,,,Serum,1977.0,,1,0,,BAO_0000019,10633,,22224
A,,,CHEMBL627727,,AUC was determined,,6504,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10634,,22224
A,,,CHEMBL627728,,AUC of the compound.,,10615,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10635,,22224
A,,,CHEMBL627729,,AUC value (0-4 hr),,10353,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10636,,22224
A,,,CHEMBL627730,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,14907,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10637,,22224
A,,,CHEMBL627731,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,14907,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10638,,22224
A,,,CHEMBL627732,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,14907,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10639,,22224
A,,,CHEMBL627733,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,14907,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,10640,,22224
A,10116.0,,CHEMBL627734,Rattus norvegicus,AUC(area under curve) was determined after intravenous administration in rats,,16359,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10641,,50597
A,10116.0,,CHEMBL627735,Rattus norvegicus,AUC(area under curve) was determined after oral administration in rats,,16359,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10642,,50597
A,10141.0,,CHEMBL627736,Cavia porcellus,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,,15240,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10643,,50512
A,10116.0,,CHEMBL876809,Rattus norvegicus,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,,15240,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10644,,50597
A,,,CHEMBL627737,,Area Under Curve after oral dosing of 100 uM/Kg,,15469,U,,Autocuration,,,,,,1,0,,BAO_0000019,10645,,22224
A,,,CHEMBL627738,,Area Under Curve after oral dosing of 30 uM/Kg,,15469,U,,Autocuration,,,,,,1,0,,BAO_0000019,10646,,22224
A,,,CHEMBL627739,,Area Under Curve was measured by ploting the graph between concentration verses time,,13520,U,,Autocuration,,,,,,1,0,,BAO_0000019,10647,,22224
A,9615.0,,CHEMBL626143,Canis lupus familiaris,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,10648,,50588
A,314293.0,,CHEMBL626144,Simiiformes,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,,17025,U,,Autocuration,,,,,,1,0,,BAO_0000218,10649,,22224
A,9986.0,,CHEMBL626145,Oryctolagus cuniculus,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,10650,,50592
A,10116.0,,CHEMBL626146,Rattus norvegicus,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,10651,,50597
A,10116.0,,CHEMBL626147,Rattus norvegicus,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,,12032,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10652,,50597
A,,,CHEMBL626148,,Area under curve (AUC) was determined,,10291,U,,Autocuration,,,,,,1,0,,BAO_0000019,10653,,22224
A,,,CHEMBL626149,,Area under curve (AUC) following ip administration at 1 mg/kg,,5767,U,,Autocuration,,,,,,1,0,,BAO_0000218,10654,,22224
A,,,CHEMBL626150,,Area under curve (AUC) was determined; ND is Not determined,,1434,U,,Autocuration,,,,,,1,0,,BAO_0000019,10655,,22224
A,9615.0,,CHEMBL626151,Canis lupus familiaris,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,,14925,N,,Intermediate,,,,,,1,1,,BAO_0000218,10656,,50588
A,9615.0,,CHEMBL626152,Canis lupus familiaris,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,,14925,N,,Intermediate,,,,,,1,1,,BAO_0000218,10657,,50588
A,9615.0,,CHEMBL626153,Canis lupus familiaris,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,,14925,N,,Intermediate,,,,,,1,1,,BAO_0000218,10658,,50588
A,,,CHEMBL626154,,Area under curve (AUR) was determined,,1434,U,,Autocuration,,,,,,1,0,,BAO_0000019,10659,,22224
A,,,CHEMBL626155,,Area under curve at 1 uM/dg administered intravenously,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000019,10660,,22224
A,,,CHEMBL626156,,Area under curve at 10 uM/dg administered perorally,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000019,10661,,22224
A,,,CHEMBL626157,,Area under curve at 2 uM/dg administered intravenously,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000019,10662,,22224
A,,,CHEMBL626158,,Area under curve at 20 uM/dg administered perorally,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000019,10663,,22224
A,9615.0,,CHEMBL626159,Canis lupus familiaris,Area under curve at a peroral dose of 3 mg/kg in dog,,15233,N,,Intermediate,,,,,,1,1,,BAO_0000218,10664,,50588
A,10116.0,,CHEMBL626160,Rattus norvegicus,Area under curve at a peroral dose of 3 mg/kg in rat,,15233,N,,Intermediate,,,,,,1,1,,BAO_0000218,10665,,50597
A,9615.0,,CHEMBL626161,Canis lupus familiaris,Area under curve at an iv dose of 1 mg/kg in dog,,15233,N,,Intermediate,,,,,,1,1,,BAO_0000218,10666,,50588
A,10116.0,,CHEMBL626162,Rattus norvegicus,Area under curve at an iv dose of 1 mg/kg in rat,,15233,N,,Intermediate,,,,,,1,1,,BAO_0000218,10667,,50597
A,,,CHEMBL626163,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,12978,U,,Autocuration,,,,,,1,0,,BAO_0000019,10668,,22224
A,,,CHEMBL626164,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,12978,U,,Autocuration,,,,,,1,0,,BAO_0000019,10669,,22224
A,10090.0,,CHEMBL626165,Mus musculus,Area under curve measured as conc vs time after intravenous administration to mice.,,11355,N,,Intermediate,,,,,,1,1,,BAO_0000218,10670,,50594
A,10090.0,,CHEMBL626166,Mus musculus,Area under curve measured as conc vs time after peroral administration to mice.,,11355,N,,Intermediate,,,,,,1,1,,BAO_0000218,10671,,50594
A,9615.0,,CHEMBL626167,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,,12923,N,,Intermediate,,,,,,1,1,,BAO_0000218,10672,,50588
A,9615.0,,CHEMBL626168,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,,12923,N,,Intermediate,,,,,,1,1,,BAO_0000218,10673,,50588
A,9615.0,,CHEMBL877463,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,,12923,N,,Intermediate,,,,,,1,1,,BAO_0000218,10674,,50588
A,9615.0,,CHEMBL626169,Canis lupus familiaris,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,,12923,N,,Intermediate,,,,,,1,1,,BAO_0000218,10675,,50588
A,10116.0,,CHEMBL626170,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10676,In vivo,50597
A,10116.0,,CHEMBL626171,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10677,In vivo,50597
A,10116.0,,CHEMBL626172,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10678,In vivo,50597
A,10116.0,,CHEMBL626173,Rattus norvegicus,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10679,In vivo,50597
A,10116.0,,CHEMBL626174,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10680,In vivo,50597
A,10116.0,,CHEMBL626175,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10681,In vivo,50597
A,10116.0,,CHEMBL626176,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10682,In vivo,50597
A,10116.0,,CHEMBL626177,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10683,In vivo,50597
A,10116.0,,CHEMBL622499,Rattus norvegicus,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10684,In vivo,50597
A,10116.0,,CHEMBL622500,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10685,In vivo,50597
A,10116.0,,CHEMBL622501,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10686,In vivo,50597
A,10116.0,,CHEMBL622502,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10687,In vivo,50597
A,10116.0,,CHEMBL622503,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10688,In vivo,50597
A,10116.0,,CHEMBL877614,Rattus norvegicus,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10689,In vivo,50597
A,10116.0,,CHEMBL624839,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10690,In vivo,50597
A,10116.0,,CHEMBL624840,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10691,In vivo,50597
A,10116.0,,CHEMBL624841,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10692,In vivo,50597
A,10116.0,,CHEMBL624842,Rattus norvegicus,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10693,In vivo,50597
A,10116.0,,CHEMBL624843,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10694,In vivo,50597
A,10116.0,,CHEMBL624844,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10695,In vivo,50597
A,10116.0,,CHEMBL624845,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10696,In vivo,50597
A,10116.0,,CHEMBL621904,Rattus norvegicus,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,,17738,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10697,In vivo,50597
A,10116.0,,CHEMBL621905,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,,11195,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10698,In vivo,50597
A,10116.0,,CHEMBL874382,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,,11195,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10699,In vivo,50597
A,10116.0,,CHEMBL621906,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,,11195,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10700,In vivo,50597
A,10116.0,,CHEMBL621907,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,,11195,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10701,In vivo,50597
A,10116.0,,CHEMBL622096,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,,11195,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10702,In vivo,50597
A,10116.0,,CHEMBL622097,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,,11195,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,10703,In vivo,50597
A,10116.0,,CHEMBL622098,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,,11195,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10704,In vivo,50597
A,10116.0,,CHEMBL622099,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,,11195,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10705,In vivo,50597
A,10116.0,,CHEMBL622100,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,,11195,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10706,In vivo,50597
A,10116.0,,CHEMBL622101,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,,11195,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10707,In vivo,50597
A,10116.0,,CHEMBL622102,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,,11195,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10708,In vivo,50597
A,10116.0,,CHEMBL622103,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,,11195,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10709,In vivo,50597
A,10116.0,,CHEMBL622104,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,,11195,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10710,In vivo,50597
A,10116.0,,CHEMBL622105,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,,11195,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10711,In vivo,50597
A,10116.0,,CHEMBL622106,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,,11195,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10712,In vivo,50597
A,10116.0,,CHEMBL622107,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,,11195,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10713,In vivo,50597
A,10116.0,,CHEMBL622108,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,,11195,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10714,In vivo,50597
A,10116.0,,CHEMBL622109,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,,11195,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,10715,In vivo,50597
A,10116.0,,CHEMBL622110,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,,11195,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10716,In vivo,50597
A,10116.0,,CHEMBL622111,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,,11195,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10717,In vivo,50597
A,10116.0,,CHEMBL874383,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,,11195,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,10718,In vivo,50597
A,10116.0,,CHEMBL622112,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,,11195,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,10719,In vivo,50597
A,10116.0,,CHEMBL622113,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,,11195,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,10720,In vivo,50597
A,10116.0,,CHEMBL622114,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,,11195,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,10721,In vivo,50597
A,10116.0,,CHEMBL622115,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,,11195,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,10722,In vivo,50597
A,10116.0,,CHEMBL622116,Rattus norvegicus,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,,11195,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,10723,In vivo,50597
A,10116.0,,CHEMBL622117,Rattus norvegicus,Oral bioavailability in rat,,6193,N,,Intermediate,,,,,,1,1,,BAO_0000218,10724,In vivo,50597
A,10116.0,,CHEMBL622118,Rattus norvegicus,Oral bioavailability in rat,,6803,N,,Intermediate,,,,,,1,1,,BAO_0000218,10725,In vivo,50597
A,10116.0,,CHEMBL622119,Rattus norvegicus,Oral bioavailability in rats at 6 mg/kg,,6647,N,,Intermediate,,,,,,1,1,,BAO_0000218,10726,In vivo,50597
A,10116.0,,CHEMBL622120,Rattus norvegicus,Oral bioavailability in rat (dose 6 mg/kg),,6647,N,,Intermediate,,,,,,1,1,,BAO_0000218,10727,In vivo,50597
A,10116.0,,CHEMBL622121,Rattus norvegicus,Oral bioavailability in rats at 6 mg/kg dose; Not tested,,6647,N,,Intermediate,,,,,,1,1,,BAO_0000218,10728,In vivo,50597
A,10116.0,,CHEMBL622122,Rattus norvegicus,Oral bioavailability in rat,,6640,N,,Intermediate,,,,,,1,1,,BAO_0000218,10729,In vivo,50597
A,10116.0,,CHEMBL622123,Rattus norvegicus,Oral bioavailability in rat,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,10730,In vivo,50597
A,10116.0,,CHEMBL622124,Rattus norvegicus,Oral bioavailability in rat,,6641,N,,Intermediate,,,,,,1,1,,BAO_0000218,10731,In vivo,50597
A,10116.0,,CHEMBL622125,Rattus norvegicus,Bioavailability in rat,,6642,N,,Intermediate,,,,,,1,1,,BAO_0000218,10732,In vivo,50597
A,10116.0,,CHEMBL622126,Rattus norvegicus,Oral bioavailability,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,10733,In vivo,50597
A,10116.0,,CHEMBL620455,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,6141,N,,Intermediate,,,,,,1,1,,BAO_0000218,10734,In vivo,50597
A,10116.0,,CHEMBL620456,Rattus norvegicus,Oral bioavailability in rat,,4390,N,,Intermediate,,,,,,1,1,,BAO_0000218,10735,In vivo,50597
A,10116.0,,CHEMBL620457,Rattus norvegicus,Oral bioavailability in rat,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,10736,In vivo,50597
A,10116.0,,CHEMBL620458,Rattus norvegicus,Oral bioavailability was evaluated; Not tested,,5472,N,,Intermediate,,,,,,1,1,,BAO_0000218,10737,In vivo,50597
A,10116.0,,CHEMBL620459,Rattus norvegicus,Oral bioavailability,,5438,N,,Intermediate,,,,,,1,1,,BAO_0000218,10738,In vivo,50597
A,10116.0,,CHEMBL620460,Rattus norvegicus,Oral bioavailability in rat by oral dosing,,4883,N,,Intermediate,,,,,,1,1,,BAO_0000218,10739,In vivo,50597
A,10116.0,,CHEMBL620461,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg p.o.),,1908,N,,Intermediate,,,,,,1,1,,BAO_0000218,10740,In vivo,50597
A,10116.0,,CHEMBL620462,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10741,In vivo,50597
A,10116.0,,CHEMBL620463,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10742,In vivo,50597
A,10116.0,,CHEMBL620464,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10743,In vivo,50597
A,10116.0,,CHEMBL620465,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10744,In vivo,50597
A,10116.0,,CHEMBL620466,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10745,In vivo,50597
A,10116.0,,CHEMBL620467,Rattus norvegicus,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10746,In vivo,50597
A,10116.0,,CHEMBL620468,Rattus norvegicus,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,,4853,N,,Intermediate,,,,,,1,1,,BAO_0000218,10747,In vivo,50597
A,10116.0,,CHEMBL620469,Rattus norvegicus,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,,12873,N,,Intermediate,,,,,,1,1,,BAO_0000218,10748,In vivo,50597
A,10116.0,,CHEMBL620470,Rattus norvegicus,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,,12873,N,,Intermediate,,,,,,1,1,,BAO_0000218,10749,In vivo,50597
A,10116.0,,CHEMBL620471,Rattus norvegicus,Oral bioavailability in rat,,3169,N,,Intermediate,,,,,,1,1,,BAO_0000218,10750,In vivo,50597
A,10116.0,,CHEMBL620472,Rattus norvegicus,Oral bioavailability in rat,,6305,N,,Intermediate,,,,,,1,1,,BAO_0000218,10751,In vivo,50597
A,10116.0,,CHEMBL620473,Rattus norvegicus,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,,4762,N,,Intermediate,,,,,,1,1,,BAO_0000218,10752,In vivo,50597
A,10116.0,,CHEMBL620474,Rattus norvegicus,Oral bioavailability in rat,,17847,N,,Intermediate,,,,,,1,1,,BAO_0000218,10753,In vivo,50597
A,10116.0,,CHEMBL620475,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),,6211,N,,Intermediate,,,,,,1,1,,BAO_0000218,10754,In vivo,50597
A,10116.0,,CHEMBL620476,Rattus norvegicus,Oral bioavailability in rat,,6011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10755,In vivo,50597
A,10116.0,,CHEMBL620477,Rattus norvegicus,Oral bioavailability in rat,,6317,N,,Intermediate,,,,,,1,1,,BAO_0000218,10756,In vivo,50597
A,10116.0,,CHEMBL620478,Rattus norvegicus,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,10757,In vivo,50597
A,10116.0,,CHEMBL618768,Rattus norvegicus,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,10758,In vivo,50597
A,10116.0,,CHEMBL618769,Rattus norvegicus,Oral bioavailability in rat after oral administration at 13 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,10759,In vivo,50597
A,10116.0,,CHEMBL618770,Rattus norvegicus,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,,6644,N,,Intermediate,,,,,,1,1,,BAO_0000218,10760,In vivo,50597
A,10116.0,,CHEMBL618771,Rattus norvegicus,Oral bioavailability (dose 20 mg/kg p.o.),,6113,N,,Intermediate,,,,,,1,1,,BAO_0000218,10761,In vivo,50597
A,10116.0,,CHEMBL618772,Rattus norvegicus,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,,5937,N,,Intermediate,,,,,,1,1,,BAO_0000218,10762,In vivo,50597
A,10116.0,,CHEMBL618773,Rattus norvegicus,Oral bioavailability in rat at 10 mg/kg of the compound,,5711,N,,Intermediate,,,,,,1,1,,BAO_0000218,10763,In vivo,50597
A,10116.0,,CHEMBL875842,Rattus norvegicus,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10764,In vivo,50597
A,10116.0,,CHEMBL618774,Rattus norvegicus,Bioavailability in rat (dose 3 mg/kg i.v.),,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10765,In vivo,50597
A,10116.0,,CHEMBL618775,Rattus norvegicus,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10766,In vivo,50597
A,10116.0,,CHEMBL618776,Rattus norvegicus,Oral bioavailability in rat (dose 60 mg/kg p.o.),,17717,N,,Intermediate,,,,,,1,1,,BAO_0000218,10767,In vivo,50597
A,10116.0,,CHEMBL618777,Rattus norvegicus,Percent bioavailability (F) in rats after iv administration,,4722,N,,Intermediate,,,,,,1,1,,BAO_0000218,10768,In vivo,50597
A,10116.0,,CHEMBL618778,Rattus norvegicus,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,,4722,N,,Intermediate,,,,,,1,1,,BAO_0000218,10769,In vivo,50597
A,10116.0,,CHEMBL618779,Rattus norvegicus,Bioavailability in rat (dose 5 uM/kg p.o.),,4353,N,,Intermediate,,,,,,1,1,,BAO_0000218,10770,In vivo,50597
A,10116.0,,CHEMBL618780,Rattus norvegicus,Oral bioavailability,,15662,N,,Intermediate,,,,,,1,1,,BAO_0000218,10771,In vivo,50597
A,10116.0,,CHEMBL618781,Rattus norvegicus,Bioavailability in rat (dose 2 mg/kg p.o.),,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,10772,In vivo,50597
A,10116.0,,CHEMBL618782,Rattus norvegicus,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,,4756,N,,Intermediate,,,,,,1,1,,BAO_0000218,10773,In vivo,50597
A,10116.0,,CHEMBL618783,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg),,3436,N,,Intermediate,,,,,,1,1,,BAO_0000218,10774,In vivo,50597
A,10116.0,,CHEMBL618784,Rattus norvegicus,Oral bioavailability in rat,,17800,N,,Intermediate,,,,,,1,1,,BAO_0000218,10775,In vivo,50597
A,10116.0,,CHEMBL618785,Rattus norvegicus,Percent oral bioavailability evaluated in rat,,15762,N,,Intermediate,,,,,,1,1,,BAO_0000218,10776,In vivo,50597
A,10116.0,,CHEMBL618786,Rattus norvegicus,Oral bioavailability in rat,,5089,N,,Intermediate,,,,,,1,1,,BAO_0000218,10777,In vivo,50597
A,10116.0,,CHEMBL618787,Rattus norvegicus,Percent oral bioavailability in rat; Not determined,,5089,N,,Intermediate,,,,,,1,1,,BAO_0000218,10778,In vivo,50597
A,10116.0,,CHEMBL618788,Rattus norvegicus,Oral bioavailability in rat,,3185,N,,Intermediate,,,,,,1,1,,BAO_0000218,10779,In vivo,50597
A,10116.0,,CHEMBL618789,Rattus norvegicus,Bioavailability in rat,,5145,N,,Intermediate,,,,,,1,1,,BAO_0000218,10780,In vivo,50597
A,10116.0,,CHEMBL618790,Rattus norvegicus,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),,3457,N,,Intermediate,,,,,,1,1,,BAO_0000218,10781,In vivo,50597
A,10116.0,,CHEMBL618791,Rattus norvegicus,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),,3457,N,,Intermediate,,,,,,1,1,,BAO_0000218,10782,In vivo,50597
A,10116.0,,CHEMBL875843,Rattus norvegicus,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,,5983,N,,Intermediate,,,,,,1,1,,BAO_0000218,10783,In vivo,50597
A,10116.0,,CHEMBL618792,Rattus norvegicus,Oral bioavailability in rat (dose 20 mg/kg p.o.),,5739,N,,Intermediate,,,,,,1,1,,BAO_0000218,10784,In vivo,50597
A,10116.0,,CHEMBL623395,Rattus norvegicus,Cmax at a dose of 30 mg/kg in rat,,3579,N,,Intermediate,,,,,,1,1,,BAO_0000218,10785,In vivo,50597
A,314293.0,,CHEMBL623396,Simiiformes,Cmax in monkeys at a dose of 1 mg/kg,,17788,U,,Autocuration,,,,,,1,0,,BAO_0000218,10786,In vivo,22224
A,10116.0,,CHEMBL623397,Rattus norvegicus,Cmax in rat,,14956,N,,Intermediate,,,,,,1,1,,BAO_0000218,10787,In vivo,50597
A,10116.0,,CHEMBL623398,Rattus norvegicus,Cmax in rats at a dose of 1 mg/kg,,17788,N,,Intermediate,,,,,,1,1,,BAO_0000218,10788,In vivo,50597
A,10090.0,,CHEMBL623399,Mus musculus,Cmax was measured in mice after an oral dose of 50 mg/kg.,,9750,N,,Intermediate,,,,,,1,1,,BAO_0000218,10789,In vivo,50594
A,,,CHEMBL623400,,"Cmax value at a dose of 12.7 uM/kg, po",,12767,U,,Autocuration,,,,,,1,0,,BAO_0000218,10790,In vivo,22224
A,,,CHEMBL623401,,"Cmax value at a dose of 6.3 uM/kg, iv",,12767,U,,Autocuration,,,,,,1,0,,BAO_0000218,10791,In vivo,22224
A,,,CHEMBL623402,,"Cmax value at a dose of 7.1 uM/kg, iv",,12767,U,,Autocuration,,,,,,1,0,,BAO_0000218,10792,In vivo,22224
A,,,CHEMBL623403,,Cmax value of compound was determined after 1 hr,,12703,U,,Autocuration,,,,,,1,0,,BAO_0000218,10793,In vivo,22224
A,,,CHEMBL623404,,Cmax value of the compound,,15778,U,,Autocuration,,,,,,1,0,,BAO_0000218,10794,In vivo,22224
A,10116.0,,CHEMBL625997,Rattus norvegicus,Cmax value administered intraintestinal in rats.,,12818,N,,Intermediate,,,,,,1,1,,BAO_0000218,10795,In vivo,50597
A,10116.0,,CHEMBL625998,Rattus norvegicus,Cmax value administered perorally was determined in rat; Not determined,,14964,N,,Intermediate,,,,,,1,1,,BAO_0000218,10796,In vivo,50597
A,,,CHEMBL625999,,Cmax value at the dose of 2.3 mg/kg,,15808,U,,Autocuration,,,,,,1,0,,BAO_0000218,10797,In vivo,22224
A,,,CHEMBL626000,,Cmax value at the dose of 5 mg/kg,,15808,U,,Autocuration,,,,,,1,0,,BAO_0000218,10798,In vivo,22224
A,,,CHEMBL626001,,Cmax value in the period of 8 hr after dosing. ,,15778,U,,Autocuration,,,,,,1,0,,BAO_0000218,10799,In vivo,22224
A,,,CHEMBL626002,,Cmax value at a oral dose of 20 mg/kg; Not tested,,3715,U,,Autocuration,,,,,,1,0,,BAO_0000218,10800,In vivo,22224
A,,,CHEMBL626003,,Cmax value at a oral dose of 20 mg/kg,,3715,U,,Autocuration,,,,,,1,0,,BAO_0000218,10801,In vivo,22224
A,10116.0,,CHEMBL626004,Rattus norvegicus,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,,1446,N,,Intermediate,,,,,,1,1,,BAO_0000218,10802,In vivo,50597
A,10141.0,,CHEMBL626005,Cavia porcellus,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,,15240,N,,Intermediate,,,,,,1,1,,BAO_0000218,10803,In vivo,50512
A,10116.0,,CHEMBL626006,Rattus norvegicus,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,,15240,N,,Intermediate,,,,,,1,1,,BAO_0000218,10804,In vivo,50597
A,10116.0,,CHEMBL626007,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,,14810,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10805,In vivo,50597
A,10090.0,,CHEMBL626008,Mus musculus,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,,14239,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10806,In vivo,50594
A,9615.0,,CHEMBL626009,Canis lupus familiaris,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,,12555,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10807,In vivo,50588
A,9615.0,,CHEMBL626010,Canis lupus familiaris,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,,10754,N,,Intermediate,,,,,,1,1,,BAO_0000218,10808,In vivo,50588
A,10090.0,,CHEMBL626011,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10809,In vivo,50594
A,10090.0,,CHEMBL626012,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10810,In vivo,50594
A,10090.0,,CHEMBL626013,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10811,In vivo,50594
A,10090.0,,CHEMBL626014,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10812,In vivo,50594
A,10090.0,,CHEMBL877496,Mus musculus,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,,10754,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10813,In vivo,50594
F,9615.0,,CHEMBL626015,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,,14600,N,,Intermediate,,,,,,1,1,,BAO_0000218,10814,In vivo,50588
F,9615.0,,CHEMBL626016,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,,14600,N,,Intermediate,,,,,,1,1,,BAO_0000218,10815,In vivo,50588
F,9615.0,,CHEMBL626017,Canis lupus familiaris,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,,14600,N,,Intermediate,,,,,,1,1,,BAO_0000218,10816,In vivo,50588
A,9615.0,,CHEMBL626018,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs,,13543,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10817,In vivo,50588
A,9615.0,,CHEMBL626692,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs,,13543,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10818,In vivo,50588
A,10116.0,,CHEMBL626693,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats,,13543,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10819,In vivo,50597
A,10116.0,,CHEMBL626694,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats,,13543,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10820,In vivo,22224
A,9615.0,,CHEMBL626695,Canis lupus familiaris,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10821,In vivo,50588
A,9615.0,,CHEMBL626696,Canis lupus familiaris,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10822,In vivo,50588
A,9615.0,,CHEMBL626697,Canis lupus familiaris,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10823,In vivo,50588
A,9615.0,,CHEMBL626859,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10824,In vivo,50588
A,9615.0,,CHEMBL626860,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10825,In vivo,50588
A,9615.0,,CHEMBL626861,Canis lupus familiaris,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,,14600,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,10826,In vivo,50588
A,10116.0,,CHEMBL626296,Rattus norvegicus,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,,14681,N,,Intermediate,,,,,,1,1,,BAO_0000218,10827,In vivo,50597
A,,,CHEMBL626297,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,15905,U,,Autocuration,,,,,,1,0,,BAO_0000218,10828,In vivo,22224
A,,,CHEMBL626298,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,15905,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10829,In vivo,22224
A,10116.0,,CHEMBL626299,Rattus norvegicus,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",,13304,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10830,In vivo,50597
A,10116.0,,CHEMBL626300,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10831,In vivo,50597
A,10116.0,,CHEMBL626301,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10832,In vivo,50597
A,10116.0,,CHEMBL626962,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10833,In vivo,50597
A,10116.0,,CHEMBL626963,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10834,In vivo,50597
A,10116.0,,CHEMBL626964,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10835,In vivo,50597
A,9541.0,,CHEMBL626965,Macaca fascicularis,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10836,In vivo,100710
A,10090.0,,CHEMBL626966,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10837,In vivo,50594
A,10090.0,,CHEMBL626967,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10838,In vivo,50594
A,9541.0,,CHEMBL626968,Macaca fascicularis,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10839,In vivo,100710
A,10116.0,,CHEMBL626969,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10840,,50597
A,10116.0,,CHEMBL627126,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10841,,50597
A,10116.0,,CHEMBL631276,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10842,,50597
A,10116.0,,CHEMBL631277,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10843,,50597
A,10116.0,,CHEMBL631278,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10844,,50597
A,10116.0,,CHEMBL874457,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10845,,50597
A,10116.0,,CHEMBL631279,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10846,,50597
A,10116.0,,CHEMBL631280,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10847,,50597
A,10116.0,,CHEMBL631281,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10848,,50597
A,10116.0,,CHEMBL631968,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10849,,50597
A,10116.0,,CHEMBL631969,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10850,,50597
A,10116.0,,CHEMBL631970,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10851,,50597
A,10116.0,,CHEMBL631971,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10852,,50597
A,10116.0,,CHEMBL631972,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10853,,50597
A,10116.0,,CHEMBL630435,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10854,,50597
A,10116.0,,CHEMBL630436,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10855,,50597
A,10116.0,,CHEMBL630437,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10856,,50597
A,10116.0,,CHEMBL630438,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10857,,50597
A,10116.0,,CHEMBL630439,Rattus norvegicus,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,,8418,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,10858,,50597
A,10116.0,,CHEMBL630440,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10859,,50597
A,10116.0,,CHEMBL630441,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10860,,50597
A,10116.0,,CHEMBL630442,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10861,,50597
A,10116.0,,CHEMBL625234,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10862,,50597
A,10116.0,,CHEMBL625235,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10863,,50597
A,10116.0,,CHEMBL625236,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10864,,50597
A,10116.0,,CHEMBL625237,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10865,,50597
A,10116.0,,CHEMBL626125,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10866,,50597
A,10116.0,,CHEMBL626126,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10867,,50597
A,10116.0,,CHEMBL626127,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10868,,50597
A,10116.0,,CHEMBL626128,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10869,,50597
A,10116.0,,CHEMBL626129,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10870,,50597
A,10116.0,,CHEMBL626130,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10871,,50597
A,10116.0,,CHEMBL626131,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10872,,50597
A,10116.0,,CHEMBL626132,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10873,,50597
A,10116.0,,CHEMBL626752,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10874,,50597
A,10116.0,,CHEMBL626753,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10875,,50597
A,10116.0,,CHEMBL626754,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10876,,50597
A,10116.0,,CHEMBL626755,Rattus norvegicus,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,,8418,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,10877,,50597
A,10116.0,,CHEMBL626756,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10878,,50597
A,10116.0,,CHEMBL626757,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10879,,50597
A,10116.0,,CHEMBL626758,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10880,,50597
A,10116.0,,CHEMBL626759,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10881,,50597
A,10116.0,,CHEMBL626760,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,10882,,50597
A,9615.0,,CHEMBL626394,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10883,,50588
A,9615.0,,CHEMBL626395,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10884,,50588
A,9615.0,,CHEMBL626396,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10885,,50588
A,9615.0,,CHEMBL626397,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10886,,50588
A,9615.0,,CHEMBL626398,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10887,,50588
A,9615.0,,CHEMBL626399,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10888,,50588
A,10116.0,,CHEMBL874653,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10889,,50597
A,10116.0,,CHEMBL626400,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10890,,50597
A,10116.0,,CHEMBL626401,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10891,,50597
A,10116.0,,CHEMBL626402,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10892,,50597
A,10116.0,,CHEMBL626403,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10893,,50597
A,10116.0,,CHEMBL626404,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10894,,50597
A,10116.0,,CHEMBL626405,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10895,,50597
A,10116.0,,CHEMBL625529,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10896,,50597
A,10116.0,,CHEMBL625530,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10897,,50597
A,10116.0,,CHEMBL625531,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10898,,50597
A,10116.0,,CHEMBL625532,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10899,,50597
A,10116.0,,CHEMBL625533,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10900,,50597
A,10116.0,,CHEMBL875474,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10901,,50597
A,10116.0,,CHEMBL625534,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10902,,50597
A,10116.0,,CHEMBL625535,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10903,,50597
A,10116.0,,CHEMBL625536,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10904,,50597
A,10116.0,,CHEMBL625537,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10905,,50597
A,10116.0,,CHEMBL625538,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10906,,50597
A,10116.0,,CHEMBL625539,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10907,,50597
A,10116.0,,CHEMBL625540,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10908,,50597
A,10116.0,,CHEMBL625541,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10909,,50597
A,10116.0,,CHEMBL625542,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10910,,50597
A,10116.0,,CHEMBL625543,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10911,,50597
A,10116.0,,CHEMBL625544,Rattus norvegicus,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10912,,50597
A,9615.0,,CHEMBL625545,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10913,,50588
A,9615.0,,CHEMBL625546,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10914,,50588
A,9615.0,,CHEMBL625547,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10915,,50588
A,9615.0,,CHEMBL625548,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10916,,50588
A,9615.0,,CHEMBL625549,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10917,,50588
A,9615.0,,CHEMBL625550,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10918,,50588
A,9615.0,,CHEMBL625551,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10919,,50588
A,9615.0,,CHEMBL875475,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10920,,50588
A,9615.0,,CHEMBL625552,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10921,,50588
A,9615.0,,CHEMBL625553,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10922,,50588
A,9615.0,,CHEMBL625554,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10923,,50588
A,9615.0,,CHEMBL625555,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10924,,50588
A,9615.0,,CHEMBL625556,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10925,,50588
A,9615.0,,CHEMBL624986,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10926,,50588
A,9615.0,,CHEMBL624987,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10927,,50588
A,9615.0,,CHEMBL624988,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,10928,,50588
A,9615.0,,CHEMBL624989,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10929,In vivo,50588
A,9615.0,,CHEMBL624990,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10930,In vivo,50588
A,9615.0,,CHEMBL874391,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10931,In vivo,50588
A,9615.0,,CHEMBL624991,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10932,In vivo,50588
A,9615.0,,CHEMBL624992,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10933,In vivo,50588
A,9615.0,,CHEMBL624993,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10934,In vivo,50588
A,9615.0,,CHEMBL624994,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10935,In vivo,50588
A,9615.0,,CHEMBL624995,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10936,In vivo,50588
A,9615.0,,CHEMBL624996,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10937,In vivo,50588
A,9615.0,,CHEMBL624997,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10938,In vivo,50588
A,9615.0,,CHEMBL624998,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10939,In vivo,50588
A,9615.0,,CHEMBL624999,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10940,In vivo,50588
A,9615.0,,CHEMBL882955,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10941,In vivo,50588
A,9615.0,,CHEMBL625000,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10942,In vivo,50588
A,9615.0,,CHEMBL625001,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10943,In vivo,50588
A,9615.0,,CHEMBL625089,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10944,In vivo,50588
A,9615.0,,CHEMBL625090,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10945,In vivo,50588
A,9615.0,,CHEMBL625091,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10946,In vivo,50588
A,9615.0,,CHEMBL625092,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10947,In vivo,50588
A,9615.0,,CHEMBL625093,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10948,In vivo,50588
A,9615.0,,CHEMBL625094,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10949,In vivo,50588
A,9615.0,,CHEMBL625095,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,10950,In vivo,50588
A,9615.0,,CHEMBL625096,Canis lupus familiaris,Compound was evaluated for its bioavailability in the dogs,,2249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10951,In vivo,50588
A,10116.0,,CHEMBL625097,Rattus norvegicus,Compound was evaluated for its bioavailability in the rats,,2249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10952,In vivo,50597
A,,,CHEMBL882956,,Compound was evaluated for oral bioavailability,,17515,U,,Autocuration,,,,,,1,0,,BAO_0000218,10953,In vivo,22224
A,10116.0,,CHEMBL625098,Rattus norvegicus,Compound was evaluated for percentage of Oral bioavailability in rats,,14541,N,,Intermediate,,,,,,1,1,,BAO_0000218,10954,In vivo,50597
A,10141.0,,CHEMBL625099,Cavia porcellus,Bioavailability in guinea pig,,12797,U,,Autocuration,,,,,,1,0,,BAO_0000218,10955,In vivo,22224
A,10116.0,,CHEMBL625100,Rattus norvegicus,Compound was evaluated for the oral bioavailability in rat,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,10956,In vivo,50597
A,9615.0,,CHEMBL625101,Canis lupus familiaris,Compound was evaluated for the oral bioavailability in dog,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,10957,In vivo,50588
A,10116.0,,CHEMBL874396,Rattus norvegicus,Compound was evaluated for the oral bioavailability in rat,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,10958,In vivo,50597
F,9615.0,,CHEMBL625102,Canis lupus familiaris,Bioavailability in dog (dosed i.v.),,11727,U,,Autocuration,,,,,,1,0,,BAO_0000218,10959,In vivo,22224
A,9615.0,,CHEMBL625103,Canis lupus familiaris,Compound was tested for in vivo bioavailability in dog,,13249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10960,In vivo,50588
A,10026.0,,CHEMBL625104,Cricetinae,Compound was tested for in vivo bioavailability in hamsters,,13249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10961,In vivo,100712
A,314293.0,,CHEMBL625105,Simiiformes,Compound was tested for in vivo bioavailability in monkey,,13249,U,,Autocuration,,,,,,1,0,,BAO_0000218,10962,In vivo,22224
A,10116.0,,CHEMBL625106,Rattus norvegicus,Compound was tested for in vivo bioavailability in rat,,13249,N,,Intermediate,,,,,,1,1,,BAO_0000218,10963,In vivo,50597
A,10090.0,,CHEMBL625107,Mus musculus,Oral bioavailability in mouse,,9552,U,,Autocuration,,,,,,1,0,,BAO_0000218,10964,In vivo,22224
A,10090.0,,CHEMBL625108,Mus musculus,Compound was tested for percent of oral bioavailability in mice; 56-74,,9552,N,,Intermediate,,,,,,1,1,,BAO_0000218,10965,In vivo,50594
A,10090.0,,CHEMBL625109,Mus musculus,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),,14839,U,,Autocuration,,,,,,1,0,,BAO_0000218,10966,In vivo,22224
A,9541.0,,CHEMBL625110,Macaca fascicularis,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),,14839,U,,Autocuration,,,,,,1,0,,BAO_0000218,10967,In vivo,22224
A,9541.0,,CHEMBL625111,Macaca fascicularis,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),,14839,U,,Autocuration,,,,,,1,0,,BAO_0000218,10968,In vivo,22224
A,10090.0,,CHEMBL625112,Mus musculus,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10969,In vivo,50594
A,10090.0,,CHEMBL875334,Mus musculus,Oral bioavailability in nude mice,,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10970,In vivo,50594
A,9443.0,,CHEMBL628617,Primates,Bioavailability in monkey (i.d. dosing),,11219,U,,Autocuration,,,,,,1,0,,BAO_0000218,10971,In vivo,22224
A,10116.0,,CHEMBL628618,Rattus norvegicus,Bioavailability in rat,,9552,U,,Autocuration,,,,,,1,0,,BAO_0000218,10972,In vivo,22224
A,,,CHEMBL628619,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,10973,In vivo,22224
A,,,CHEMBL628620,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,10974,In vivo,22224
A,9541.0,,CHEMBL628621,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10975,In vivo,100710
A,9541.0,,CHEMBL628622,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10976,In vivo,100710
A,9541.0,,CHEMBL628623,Macaca fascicularis,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,10977,In vivo,100710
A,9541.0,,CHEMBL628624,Macaca fascicularis,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10978,In vivo,100710
A,10090.0,,CHEMBL628625,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10979,In vivo,50594
A,9541.0,,CHEMBL628626,Macaca fascicularis,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10980,In vivo,100710
A,10090.0,,CHEMBL627041,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10981,In vivo,50594
A,10090.0,,CHEMBL627042,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10982,In vivo,50594
A,10090.0,,CHEMBL627043,Mus musculus,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,,14839,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10983,In vivo,50594
A,,,CHEMBL627044,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,13932,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10984,In vivo,22224
A,10090.0,,CHEMBL627045,Mus musculus,Cmax in mouse plasma,,11637,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10985,In vivo,50594
A,,,CHEMBL627046,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,11637,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,10986,In vivo,22224
A,10116.0,,CHEMBL627047,Rattus norvegicus,Maximal plasma concentration in rat,,13960,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10987,In vivo,50597
A,10116.0,,CHEMBL627048,Rattus norvegicus,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,,15905,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,10988,In vivo,50597
A,10116.0,,CHEMBL627049,Rattus norvegicus,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10989,In vivo,50597
A,10116.0,,CHEMBL627050,Rattus norvegicus,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10990,In vivo,50597
A,10116.0,,CHEMBL627051,Rattus norvegicus,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10991,In vivo,50597
A,10116.0,,CHEMBL627052,Rattus norvegicus,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10992,In vivo,50597
A,10116.0,,CHEMBL627053,Rattus norvegicus,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10993,In vivo,50597
A,10116.0,,CHEMBL627054,Rattus norvegicus,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,10994,In vivo,50597
A,10090.0,,CHEMBL627055,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10995,In vivo,50594
A,10090.0,,CHEMBL627056,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10996,In vivo,50594
A,10090.0,,CHEMBL627057,Mus musculus,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10997,In vivo,50594
A,10090.0,,CHEMBL627058,Mus musculus,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10998,In vivo,50594
A,10090.0,,CHEMBL626211,Mus musculus,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,10999,In vivo,50594
A,,,CHEMBL626212,,Maximum Concentration of the compound.,,10291,U,,Autocuration,,,,,,1,0,,BAO_0000218,11000,In vivo,22224
A,9615.0,,CHEMBL626213,Canis lupus familiaris,Maximum Concentration was measured after iv administration into Beagle dog,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,11001,In vivo,50588
A,9615.0,,CHEMBL626214,Canis lupus familiaris,Maximum Concentration was measured after iv administration into Beagle dog.,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,11002,In vivo,50588
A,9615.0,,CHEMBL626215,Canis lupus familiaris,Maximum Concentration was measured after po administration into Beagle dog,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,11003,In vivo,50588
A,9615.0,,CHEMBL626216,Canis lupus familiaris,Maximum Concentration was measured after po administration into Beagle dog.,,14599,N,,Intermediate,,,,,,1,1,,BAO_0000218,11004,In vivo,50588
A,,,CHEMBL626217,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11005,In vivo,22224
A,,,CHEMBL626218,,Maximum blood level reached after an iv dose of 12.2 uM/kg,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11006,In vivo,22224
A,,,CHEMBL626219,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11007,In vivo,22224
A,,,CHEMBL626220,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11008,In vivo,22224
A,,,CHEMBL626221,,Maximum blood level reached after an oral dose of 5.0 mg/kg,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11009,In vivo,22224
A,,,CHEMBL626222,,Maximum blood level reached at dose of 10.6 uM/kg orally,,12767,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11010,In vivo,22224
A,10141.0,,CHEMBL626223,Cavia porcellus,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,,14706,N,,Intermediate,,,,,,1,1,,BAO_0000218,11011,In vivo,50512
A,10141.0,,CHEMBL626224,Cavia porcellus,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,,14706,N,,Intermediate,,,,,,1,1,,BAO_0000218,11012,In vivo,50512
A,10116.0,,CHEMBL626225,Rattus norvegicus,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11013,In vivo,50597
A,10116.0,,CHEMBL626226,Rattus norvegicus,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11014,In vivo,50597
A,10116.0,,CHEMBL626227,Rattus norvegicus,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,,14793,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11015,In vivo,50597
A,10116.0,,CHEMBL626228,Rattus norvegicus,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11016,In vivo,50597
A,10116.0,,CHEMBL626229,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,11017,In vivo,50597
A,10116.0,,CHEMBL626921,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,11018,In vivo,50597
A,10116.0,,CHEMBL876793,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,11019,In vivo,50597
A,10116.0,,CHEMBL625309,Rattus norvegicus,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,,,,1,1,,BAO_0000218,11020,In vivo,50597
A,1423.0,,CHEMBL625310,Bacillus subtilis,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),,10524,N,,Intermediate,,,,,,1,1,,BAO_0000218,11021,In vivo,50278
A,314293.0,,CHEMBL625311,Simiiformes,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,,11871,U,,Autocuration,,,,,,1,0,,BAO_0000218,11022,In vivo,22224
A,10116.0,,CHEMBL625312,Rattus norvegicus,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,,11871,N,,Intermediate,,,,,,1,1,,BAO_0000218,11023,In vivo,50597
A,,,CHEMBL625313,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,3437,U,,Autocuration,,,,,,1,0,,BAO_0000218,11024,In vivo,22224
A,10090.0,,CHEMBL625314,Mus musculus,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,,12038,N,,Intermediate,,,,,,1,1,,BAO_0000218,11025,In vivo,50594
A,10116.0,,CHEMBL625315,Rattus norvegicus,Maximum concentration in male rats after iv administration of 20 mg/kg,,12038,N,,Intermediate,,,,,,1,1,,BAO_0000218,11026,In vivo,50597
A,10116.0,,CHEMBL625316,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11027,,50597
A,10116.0,,CHEMBL625317,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11028,,50597
A,10116.0,,CHEMBL625318,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11029,,50597
A,10116.0,,CHEMBL625319,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11030,,50597
A,10116.0,,CHEMBL625320,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11031,,50597
A,10116.0,,CHEMBL625321,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11032,,50597
A,10116.0,,CHEMBL625322,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11033,,50597
A,10116.0,,CHEMBL876801,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11034,,50597
A,10116.0,,CHEMBL625323,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11035,,50597
A,10116.0,,CHEMBL625324,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11036,,50597
A,10116.0,,CHEMBL625325,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11037,,50597
A,10116.0,,CHEMBL625326,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11038,,50597
A,10116.0,,CHEMBL625327,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11039,,50597
A,10116.0,,CHEMBL625328,Rattus norvegicus,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,,8418,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11040,,50597
A,10116.0,,CHEMBL625329,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11041,,50597
A,10116.0,,CHEMBL625330,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11042,,50597
A,10116.0,,CHEMBL627774,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11043,,50597
A,10116.0,,CHEMBL627775,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11044,,50597
A,10116.0,,CHEMBL627949,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11045,,50597
A,10116.0,,CHEMBL627950,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11046,,50597
A,10116.0,,CHEMBL627951,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11047,,50597
A,10116.0,,CHEMBL627952,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11048,,50597
A,10116.0,,CHEMBL627953,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11049,,50597
A,10116.0,,CHEMBL627954,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11050,,50597
A,10116.0,,CHEMBL627955,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11051,,50597
A,10116.0,,CHEMBL627956,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11052,,50597
A,10116.0,,CHEMBL876802,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11053,,50597
A,10116.0,,CHEMBL627957,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11054,,50597
A,10116.0,,CHEMBL627958,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11055,,50597
A,10116.0,,CHEMBL627959,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11056,,50597
A,10116.0,,CHEMBL627960,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11057,,50597
A,10116.0,,CHEMBL627961,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11058,,50597
A,10116.0,,CHEMBL627962,Rattus norvegicus,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,,8418,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11059,,50597
A,10116.0,,CHEMBL627963,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,,,,1,1,,BAO_0000218,11060,,50597
A,10116.0,,CHEMBL624759,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,,,,1,1,,BAO_0000218,11061,,50597
A,10116.0,,CHEMBL624760,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,,,,1,1,,BAO_0000218,11062,,50597
A,10116.0,,CHEMBL624761,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,,,,1,1,,BAO_0000218,11063,,50597
A,10116.0,,CHEMBL877607,Rattus norvegicus,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,,,,1,1,,BAO_0000218,11064,,50597
A,10116.0,,CHEMBL624762,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11065,,50597
A,10116.0,,CHEMBL624763,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11066,,50597
A,10116.0,,CHEMBL624764,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11067,,50597
A,10116.0,,CHEMBL624765,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11068,,50597
A,10116.0,,CHEMBL624766,Rattus norvegicus,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11069,,50597
A,9615.0,,CHEMBL624767,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11070,,50588
A,9615.0,,CHEMBL624768,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11071,,50588
A,9615.0,,CHEMBL624769,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11072,,50588
A,9615.0,,CHEMBL624770,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11073,,50588
A,9615.0,,CHEMBL624771,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11074,,50588
A,9615.0,,CHEMBL624772,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11075,,50588
A,10116.0,,CHEMBL624773,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11076,,50597
A,10116.0,,CHEMBL624774,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11077,,50597
A,10116.0,,CHEMBL624775,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11078,,50597
A,10116.0,,CHEMBL624776,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11079,,50597
A,10116.0,,CHEMBL624777,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11080,,50597
A,10116.0,,CHEMBL624778,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11081,,50597
A,10116.0,,CHEMBL624779,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11082,,50597
A,10116.0,,CHEMBL624780,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11083,,50597
A,10116.0,,CHEMBL624781,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11084,,50597
A,10116.0,,CHEMBL877608,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11085,,50597
A,10116.0,,CHEMBL624782,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11086,,50597
A,10116.0,,CHEMBL624783,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11087,,50597
A,10116.0,,CHEMBL624784,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11088,,50597
A,10116.0,,CHEMBL624785,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11089,,50597
A,10116.0,,CHEMBL624786,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11090,,50597
A,10116.0,,CHEMBL624787,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11091,,50597
A,10116.0,,CHEMBL628676,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11092,,50597
A,10116.0,,CHEMBL621842,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11093,,50597
A,10116.0,,CHEMBL621843,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11094,,50597
A,10116.0,,CHEMBL623873,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11095,,50597
A,10116.0,,CHEMBL623874,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11096,,50597
A,10116.0,,CHEMBL623875,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11097,,50597
A,10116.0,,CHEMBL623876,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11098,,50597
A,9615.0,,CHEMBL623877,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11099,,50588
A,9615.0,,CHEMBL623878,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11100,,50588
A,9615.0,,CHEMBL623879,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11101,,50588
A,9615.0,,CHEMBL623880,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11102,,50588
A,9615.0,,CHEMBL623881,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11103,,50588
A,9615.0,,CHEMBL623957,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11104,,50588
A,9615.0,,CHEMBL623958,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11105,,50588
A,9615.0,,CHEMBL623959,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11106,,50588
A,9615.0,,CHEMBL623960,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11107,,50588
A,9615.0,,CHEMBL623961,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11108,,50588
A,9615.0,,CHEMBL623962,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11109,,50588
A,9615.0,,CHEMBL624676,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11110,,50588
A,9615.0,,CHEMBL624677,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11111,,50588
A,9615.0,,CHEMBL624678,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11112,,50588
A,9615.0,,CHEMBL624679,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11113,,50588
A,9615.0,,CHEMBL624680,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11114,,50588
A,,,CHEMBL624849,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,11115,In vivo,22224
A,,,CHEMBL624850,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,11116,In vivo,22224
A,,,CHEMBL874399,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,11117,In vivo,22224
A,,,CHEMBL624851,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,11118,In vivo,22224
A,,,CHEMBL624852,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,11732,U,,Autocuration,,,,,,1,0,,BAO_0000218,11119,In vivo,22224
A,10116.0,,CHEMBL624853,Rattus norvegicus,Oral bioavailability in rat (dose 10 mg/kg),,13359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11120,In vivo,22224
A,10116.0,,CHEMBL624854,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley),,16618,U,,Autocuration,,,,,,1,0,,BAO_0000218,11121,In vivo,22224
A,10116.0,,CHEMBL624855,Rattus norvegicus,Oral bioavailability in rat,,13960,U,,Autocuration,,,,,,1,0,,BAO_0000218,11122,In vivo,22224
A,10116.0,,CHEMBL624856,Rattus norvegicus,Oral bioavailability in rats was determined in vivo,,13917,U,,Autocuration,,,,,,1,0,,BAO_0000218,11123,In vivo,22224
A,9615.0,,CHEMBL882957,Canis lupus familiaris,Oral bioavailability in dog,,14266,U,,Autocuration,,,,,,1,0,,BAO_0000218,11124,In vivo,22224
A,314293.0,,CHEMBL624857,Simiiformes,Oral bioavailability of compound in monkey,,12359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11125,In vivo,22224
A,10116.0,,CHEMBL622202,Rattus norvegicus,Oral bioavailability of compound in rat,,12359,N,,Intermediate,,,,,,1,1,,BAO_0000218,11126,In vivo,50597
A,10116.0,,CHEMBL622203,Rattus norvegicus,Bioavailability in rat of PMEA prodrug,,12359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11127,In vivo,22224
A,10116.0,,CHEMBL625522,Rattus norvegicus,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,,12359,N,,Intermediate,,,,,,1,1,,BAO_0000218,11128,In vivo,50597
A,9544.0,,CHEMBL622868,Macaca mulatta,Serum conc at 3 hours following 25 mg/kg dose,,10791,U,,Autocuration,,,,,,1,0,,BAO_0000218,11129,In vivo,22224
A,9544.0,,CHEMBL622869,Macaca mulatta,Urine conc 0-5 hours following 25 mg/kg dose,,10791,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,11130,In vivo,22224
A,9544.0,,CHEMBL622870,Macaca mulatta,Urine conc 0-24 hours following 25 mg/kg dose,,10791,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,11131,In vivo,22224
A,9534.0,,CHEMBL622871,Chlorocebus aethiops,Oral bioavailability in African green monkeys; 20-25,,138,U,,Autocuration,,,,,,1,0,,BAO_0000218,11132,In vivo,22224
A,9541.0,,CHEMBL620560,Macaca fascicularis,Oral bioavailability in cynomolgus monkey.,,14521,N,,Intermediate,,,,,,1,1,,BAO_0000218,11133,In vivo,100710
A,9615.0,,CHEMBL620561,Canis lupus familiaris,Oral bioavailability in dog,,13953,U,,Autocuration,,,,,,1,0,,BAO_0000218,11134,In vivo,22224
A,9615.0,,CHEMBL620562,Canis lupus familiaris,Oral bioavailability in dog at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,11135,In vivo,50588
A,10026.0,,CHEMBL620563,Cricetinae,Oral bioavailability in hamster at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,11136,In vivo,100712
A,10116.0,,CHEMBL620564,Rattus norvegicus,Oral bioavailability in rat at 10 mg/kg oral dose,,12836,N,,Intermediate,,,,,,1,1,,BAO_0000218,11137,In vivo,50597
A,10116.0,,CHEMBL872265,Rattus norvegicus,Oral bioavailability in rat,,14521,U,,Autocuration,,,,,,1,0,,BAO_0000218,11138,In vivo,22224
A,10116.0,,CHEMBL620565,Rattus norvegicus,Oral bioavailability in rat,,13953,U,,Autocuration,,,,,,1,0,,BAO_0000218,11139,In vivo,22224
A,9347.0,,CHEMBL620566,Eutheria,Oral bioavailability,,6799,U,,Autocuration,,,,,,1,0,,BAO_0000218,11140,In vivo,22224
A,,,CHEMBL620567,,Oral bioavailability was determined; range 49-102%,,11311,U,,Autocuration,,,,,,1,0,,BAO_0000218,11141,In vivo,22224
A,9615.0,,CHEMBL620568,Canis lupus familiaris,Oral bioavailability was determined in dogs,,4013,N,,Intermediate,,,,,,1,1,,BAO_0000218,11142,In vivo,50588
A,10116.0,,CHEMBL620569,Rattus norvegicus,Oral bioavailability in rat,,4013,U,,Autocuration,,,,,,1,0,,BAO_0000218,11143,In vivo,22224
A,9347.0,,CHEMBL620570,Eutheria,Oral bioavailability,,17591,U,,Autocuration,,,,,,1,0,,BAO_0000218,11144,In vivo,22224
A,,,CHEMBL620571,,Oral bioavailability was determined; Not orally available,,17591,U,,Autocuration,,,,,,1,0,,BAO_0000218,11145,In vivo,22224
A,10090.0,,CHEMBL620572,Mus musculus,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),,15011,N,,Intermediate,,,,,,1,1,,BAO_0000218,11146,In vivo,50594
A,10090.0,,CHEMBL620573,Mus musculus,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),,15011,U,,Autocuration,,,,,,1,0,,BAO_0000218,11147,In vivo,22224
A,10090.0,,CHEMBL620574,Mus musculus,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,,15011,U,,Autocuration,,,,,,1,0,,BAO_0000218,11148,In vivo,22224
A,9544.0,,CHEMBL620575,Macaca mulatta,Oral bioavailability in Rhesus monkey,,9552,U,,Autocuration,,,,,,1,0,,BAO_0000218,11149,In vivo,22224
A,9615.0,,CHEMBL620576,Canis lupus familiaris,Oral bioavailability in dog (female mongrel),,9552,U,,Autocuration,,,,,,1,0,,BAO_0000218,11150,In vivo,22224
A,,,CHEMBL875846,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,3639,U,,Autocuration,,,,,,1,0,,BAO_0000218,11151,In vivo,22224
A,9615.0,,CHEMBL620577,Canis lupus familiaris,Oral bioavailability in dog,,13397,U,,Autocuration,,,,,,1,0,,BAO_0000218,11152,In vivo,22224
A,,,CHEMBL620578,,Percentage Bioavailability was evaluated.,,3031,U,,Autocuration,,,,,,1,0,,BAO_0000218,11153,In vivo,22224
A,10116.0,,CHEMBL620579,Rattus norvegicus,Bioavailability in rat administered i.d.,,12818,U,,Autocuration,,,,,,1,0,,BAO_0000218,11154,In vivo,22224
A,9347.0,,CHEMBL621248,Eutheria,Bioavailability,,4847,U,,Autocuration,,,,,,1,0,,BAO_0000218,11155,In vivo,22224
A,9615.0,,CHEMBL625390,Canis lupus familiaris,Bioavailability in dog (male Beagle) i.v. administration,,12421,U,,Autocuration,,,,,,1,0,,BAO_0000218,11156,In vivo,22224
A,10116.0,,CHEMBL625391,Rattus norvegicus,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",,11966,U,,Autocuration,,,,,,1,0,,BAO_0000218,11157,In vivo,22224
A,9443.0,,CHEMBL872266,Primates,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),,11218,U,,Autocuration,,,,,,1,0,,BAO_0000218,11158,In vivo,22224
A,10116.0,,CHEMBL625392,Rattus norvegicus,Oral bioavailability in rat (Sprague-Dawley) (male),,13129,U,,Autocuration,,,,,,1,0,,BAO_0000218,11159,In vivo,22224
A,10116.0,,CHEMBL625393,Rattus norvegicus,The oral bioavailability was measured on rats after oral administration,,12350,N,,Intermediate,,,,,,1,1,,BAO_0000218,11160,In vivo,50597
A,10116.0,,CHEMBL625394,Rattus norvegicus,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,2231,N,,Intermediate,,,,,,1,1,,BAO_0000218,11161,In vivo,50597
A,9544.0,,CHEMBL625395,Macaca mulatta,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,2231,N,,Intermediate,,,,,,1,1,,BAO_0000218,11162,In vivo,50797
A,10116.0,,CHEMBL625396,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg i.d.),,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,11163,In vivo,22224
A,9615.0,,CHEMBL625397,Canis lupus familiaris,Bioavailability in dog (male Beagle) i.v. administration,,12421,U,,Autocuration,,,,,,1,0,,BAO_0000218,11164,In vivo,22224
A,10090.0,,CHEMBL625398,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11165,In vivo,50594
A,10090.0,,CHEMBL625399,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11166,In vivo,50594
A,10090.0,,CHEMBL626074,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11167,In vivo,50594
A,10090.0,,CHEMBL626075,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11168,In vivo,50594
A,10116.0,,CHEMBL626076,Rattus norvegicus,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,,2231,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11169,In vivo,50597
A,9544.0,,CHEMBL626077,Macaca mulatta,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,,2231,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11170,In vivo,50797
A,10116.0,,CHEMBL626078,Rattus norvegicus,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),,12178,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11171,In vivo,50597
A,,,CHEMBL625846,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,12178,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11172,In vivo,22224
A,,,CHEMBL625847,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,12178,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11173,In vivo,22224
A,10116.0,,CHEMBL625848,Rattus norvegicus,Maximum concentration observed in rats at an oral dose of 50 mg/kg,,15633,N,,Expert,,,,,,1,1,,BAO_0000218,11174,In vivo,50597
A,10116.0,,CHEMBL625849,Rattus norvegicus,Maximum concentration of compound in plasma administered orally to rats,,14258,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11175,In vivo,50597
A,9615.0,,CHEMBL626023,Canis lupus familiaris,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11176,In vivo,50588
A,9615.0,,CHEMBL626024,Canis lupus familiaris,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11177,In vivo,50588
A,9615.0,,CHEMBL626025,Canis lupus familiaris,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11178,In vivo,50588
A,,,CHEMBL626026,,Maximum concentration after 10 mg/kg by oral administration,,5566,U,,Autocuration,,,,,,1,0,,BAO_0000218,11179,In vivo,22224
A,,,CHEMBL626027,,Maximum concentration at a dose of 1.5 mg/kg,,16935,U,,Autocuration,,,,,,1,0,,BAO_0000218,11180,In vivo,22224
A,,,CHEMBL626028,,Maximum concentration at a dose of 2.0 mg/kg,,16935,U,,Autocuration,,,,,,1,0,,BAO_0000218,11181,In vivo,22224
A,9615.0,,CHEMBL626029,Canis lupus familiaris,Maximum concentration in dog plasma,,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11182,In vivo,50588
A,,,CHEMBL626030,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,12536,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11183,In vivo,22224
A,,,CHEMBL626031,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,12536,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11184,In vivo,22224
A,,,CHEMBL626032,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,12536,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11185,In vivo,22224
A,,,CHEMBL626033,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,12536,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11186,In vivo,22224
A,,,CHEMBL626034,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,12536,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11187,In vivo,22224
A,9615.0,,CHEMBL626035,Canis lupus familiaris,Maximum concentration in plasma after oral administration in dog (25 mg/kg),,9994,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11188,In vivo,50588
A,,,CHEMBL626036,,Maximum concentration in plasma at Tmax,,1434,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11189,In vivo,22224
A,9615.0,,CHEMBL626037,Canis lupus familiaris,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,,12836,N,,Expert,,,Plasma,1969.0,,1,1,,BAO_0000218,11190,In vivo,50588
A,10026.0,,CHEMBL626038,Cricetinae,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,,12836,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11191,In vivo,100712
A,10116.0,,CHEMBL626039,Rattus norvegicus,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,,12836,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11192,In vivo,50597
A,10116.0,,CHEMBL626040,Rattus norvegicus,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,,12545,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11193,In vivo,50597
A,9986.0,,CHEMBL626041,Oryctolagus cuniculus,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,,13856,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11194,In vivo,50592
A,,,CHEMBL626042,,Maximum concentration was calculated,,3550,U,,Autocuration,,,,,,1,0,,BAO_0000218,11195,In vivo,22224
A,,,CHEMBL626043,,Maximum concentration was calculated.,,2632,U,,Autocuration,,,,,,1,0,,BAO_0000218,11196,In vivo,22224
A,,,CHEMBL626044,,Maximum concentration at a peroral dose of 10 mg/kg,,5566,U,,Autocuration,,,,,,1,0,,BAO_0000218,11197,In vivo,22224
A,,,CHEMBL626045,,Maximum concentration of the drug at 10 uM/dg administered perorally,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000218,11198,In vivo,22224
A,,,CHEMBL626046,,Maximum concentration of the drug at 2 uM/dg administered intravenously,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000218,11199,In vivo,22224
A,9615.0,,CHEMBL626047,Canis lupus familiaris,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",,14122,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11200,In vivo,50588
A,10026.0,,CHEMBL626048,Cricetinae,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",,14122,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11201,In vivo,100712
A,10116.0,,CHEMBL626049,Rattus norvegicus,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",,14122,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11202,In vivo,50597
A,10116.0,,CHEMBL626050,Rattus norvegicus,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,,12542,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11203,In vivo,50597
A,9615.0,,CHEMBL874541,Canis lupus familiaris,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,,12542,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11204,In vivo,50588
A,10026.0,,CHEMBL622826,Cricetinae,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,,12542,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11205,In vivo,100712
A,10026.0,,CHEMBL622827,Cricetinae,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,,12542,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11206,In vivo,100712
A,10116.0,,CHEMBL622828,Rattus norvegicus,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,,12542,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11207,In vivo,50597
A,10116.0,,CHEMBL622829,Rattus norvegicus,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,,14080,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11208,In vivo,50597
A,10116.0,,CHEMBL876806,Rattus norvegicus,Maximum concentration reached following intravenous administration in male rat,,11911,N,,Intermediate,,,,,,1,1,,BAO_0000218,11209,In vivo,50597
A,9615.0,,CHEMBL622830,Canis lupus familiaris,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,,13204,N,,Intermediate,,,,,,1,1,,BAO_0000218,11210,In vivo,50588
A,10116.0,,CHEMBL622831,Rattus norvegicus,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,,13204,N,,Intermediate,,,,,,1,1,,BAO_0000218,11211,In vivo,50597
A,9615.0,,CHEMBL626794,Canis lupus familiaris,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,11212,In vivo,50588
A,10116.0,,CHEMBL626795,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,11213,In vivo,50597
A,10116.0,,CHEMBL626796,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,11214,In vivo,50597
A,10116.0,,CHEMBL626797,Rattus norvegicus,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,,,,1,1,,BAO_0000218,11215,In vivo,50597
A,10116.0,,CHEMBL626798,Rattus norvegicus,Maximum drug concentration is determined after oral dosing in rats.,,14127,N,,Intermediate,,,,,,1,1,,BAO_0000218,11216,In vivo,50597
A,9615.0,,CHEMBL626799,Canis lupus familiaris,Maximum observed concentration in oral (5 mg/kg) fasted dogs,,14339,N,,Intermediate,,,,,,1,1,,BAO_0000218,11217,In vivo,50588
A,9615.0,,CHEMBL626800,Canis lupus familiaris,Maximum observed concentration in oral (5 mg/kg) fed dogs,,14339,N,,Intermediate,,,,,,1,1,,BAO_0000218,11218,In vivo,50588
A,,,CHEMBL626801,,Maximum plasma concentration,,13494,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11219,In vivo,22224
A,10116.0,,CHEMBL876816,Rattus norvegicus,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,,14925,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11220,In vivo,50597
A,10116.0,,CHEMBL626802,Rattus norvegicus,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,,14474,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11221,In vivo,50597
A,9615.0,,CHEMBL626803,Canis lupus familiaris,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,,14474,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11222,In vivo,50588
A,,,CHEMBL626804,,Maximum plasma concentration following oral administration of 30 umol/kg,,13917,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11223,In vivo,22224
A,10116.0,,CHEMBL626805,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,,9796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11224,,50597
A,10116.0,,CHEMBL626309,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11225,,50597
A,10116.0,,CHEMBL626310,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11226,,50597
A,10116.0,,CHEMBL626311,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11227,,50597
A,10116.0,,CHEMBL626312,Rattus norvegicus,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11228,,50597
A,10116.0,,CHEMBL626313,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11229,,50597
A,10116.0,,CHEMBL626314,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11230,,50597
A,10116.0,,CHEMBL626315,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11231,,50597
A,10116.0,,CHEMBL626316,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11232,,50597
A,10116.0,,CHEMBL626317,Rattus norvegicus,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,,9796,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11233,,50597
A,10116.0,,CHEMBL626318,Rattus norvegicus,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11234,,50597
A,10116.0,,CHEMBL626319,Rattus norvegicus,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11235,,50597
A,10116.0,,CHEMBL626320,Rattus norvegicus,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11236,,50597
A,10116.0,,CHEMBL875053,Rattus norvegicus,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11237,,50597
A,10116.0,,CHEMBL626321,Rattus norvegicus,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11238,,50597
A,10116.0,,CHEMBL626322,Rattus norvegicus,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11239,,50597
A,10116.0,,CHEMBL626323,Rattus norvegicus,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11240,,50597
A,10116.0,,CHEMBL626324,Rattus norvegicus,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11241,,50597
A,10116.0,,CHEMBL626325,Rattus norvegicus,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11242,,50597
A,10116.0,,CHEMBL626326,Rattus norvegicus,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11243,,50597
A,10116.0,,CHEMBL626327,Rattus norvegicus,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11244,,50597
A,10116.0,,CHEMBL626328,Rattus norvegicus,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),,8363,N,,Intermediate,,,,,,1,1,,BAO_0000218,11245,,50597
A,10116.0,,CHEMBL626329,Rattus norvegicus,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11246,,50597
A,10116.0,,CHEMBL626330,Rattus norvegicus,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11247,,50597
A,10116.0,,CHEMBL626331,Rattus norvegicus,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11248,,50597
A,10116.0,,CHEMBL626332,Rattus norvegicus,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11249,,50597
A,10116.0,,CHEMBL626333,Rattus norvegicus,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11250,,50597
A,10116.0,,CHEMBL626334,Rattus norvegicus,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11251,,50597
A,10116.0,,CHEMBL626335,Rattus norvegicus,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11252,,50597
A,10116.0,,CHEMBL624798,Rattus norvegicus,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11253,,50597
A,10116.0,,CHEMBL624799,Rattus norvegicus,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11254,,50597
A,10116.0,,CHEMBL624800,Rattus norvegicus,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11255,,50597
A,10116.0,,CHEMBL624801,Rattus norvegicus,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11256,,50597
A,10116.0,,CHEMBL624802,Rattus norvegicus,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11257,,50597
A,10116.0,,CHEMBL624803,Rattus norvegicus,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11258,,50597
A,10116.0,,CHEMBL624804,Rattus norvegicus,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11259,,50597
A,10116.0,,CHEMBL624805,Rattus norvegicus,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11260,,50597
A,10116.0,,CHEMBL624806,Rattus norvegicus,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",,8684,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11261,,50597
A,10116.0,,CHEMBL624807,Rattus norvegicus,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11262,,50597
A,10116.0,,CHEMBL624808,Rattus norvegicus,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11263,,50597
A,10116.0,,CHEMBL624809,Rattus norvegicus,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11264,,50597
A,10116.0,,CHEMBL624810,Rattus norvegicus,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11265,,50597
A,10116.0,,CHEMBL877618,Rattus norvegicus,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11266,,50597
A,10116.0,,CHEMBL624811,Rattus norvegicus,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11267,,50597
A,10116.0,,CHEMBL624812,Rattus norvegicus,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11268,,50597
A,10116.0,,CHEMBL624813,Rattus norvegicus,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11269,,50597
A,10116.0,,CHEMBL624814,Rattus norvegicus,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11270,,50597
A,10116.0,,CHEMBL624815,Rattus norvegicus,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11271,,50597
A,10116.0,,CHEMBL624816,Rattus norvegicus,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11272,,50597
A,10116.0,,CHEMBL624817,Rattus norvegicus,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11273,,50597
A,9615.0,,CHEMBL624818,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11274,,50588
A,9615.0,,CHEMBL624819,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11275,,50588
A,9615.0,,CHEMBL624820,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11276,,50588
A,9615.0,,CHEMBL624821,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11277,,50588
A,9615.0,,CHEMBL624822,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11278,,50588
A,9615.0,,CHEMBL624823,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,11279,,50588
A,562.0,,CHEMBL624824,Escherichia coli,Observed diffusion coefficient in organic solvent for Escherichia coli,,15599,N,,Intermediate,,,,,,1,1,,BAO_0000218,11280,,50212
A,10116.0,,CHEMBL624825,Rattus norvegicus,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11281,,50597
A,10116.0,,CHEMBL624826,Rattus norvegicus,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11282,,50597
A,10116.0,,CHEMBL876817,Rattus norvegicus,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,Cardiac atrium,2081.0,,1,1,,BAO_0000218,11283,,50597
A,10116.0,,CHEMBL624827,Rattus norvegicus,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,Cardiac atrium,2081.0,,1,1,,BAO_0000218,11284,,50597
A,10116.0,,CHEMBL624828,Rattus norvegicus,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,11285,,50597
A,10116.0,,CHEMBL624829,Rattus norvegicus,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,11286,,50597
A,10116.0,,CHEMBL624830,Rattus norvegicus,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11287,,50597
A,10116.0,,CHEMBL624831,Rattus norvegicus,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11288,,50597
A,10116.0,,CHEMBL624832,Rattus norvegicus,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,Cardiac atrium,2081.0,,1,1,,BAO_0000218,11289,,50597
A,10116.0,,CHEMBL624833,Rattus norvegicus,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,Cardiac atrium,2081.0,,1,1,,BAO_0000218,11290,,50597
A,10116.0,,CHEMBL624834,Rattus norvegicus,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,11291,,50597
A,10116.0,,CHEMBL624835,Rattus norvegicus,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,11292,,50597
A,10116.0,,CHEMBL624836,Rattus norvegicus,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",,9614,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11293,,50597
A,10116.0,,CHEMBL624837,Rattus norvegicus,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",,9614,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11294,,50597
A,10116.0,,CHEMBL624838,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11295,,50597
A,10116.0,,CHEMBL622188,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,,9071,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11296,,50597
A,10116.0,,CHEMBL622189,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11297,,50597
A,10116.0,,CHEMBL622190,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,,9071,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11298,,50597
A,10116.0,,CHEMBL625170,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,,9071,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11299,,50597
A,10116.0,,CHEMBL625171,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11300,,50597
A,10116.0,,CHEMBL625172,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11301,,50597
A,10116.0,,CHEMBL625173,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,,9071,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11302,,50597
A,10116.0,,CHEMBL625174,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11303,,50597
A,10116.0,,CHEMBL625175,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,,9071,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11304,,50597
A,10116.0,,CHEMBL625176,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,,9071,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11305,,50597
A,10116.0,,CHEMBL625177,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11306,,50597
A,10116.0,,CHEMBL625178,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,,9071,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11307,,50597
A,10116.0,,CHEMBL625179,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,,9071,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11308,,50597
A,10116.0,,CHEMBL625180,Rattus norvegicus,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,,9071,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11309,,50597
A,,,CHEMBL625181,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,10677,U,,Autocuration,,,,,,1,0,,BAO_0000218,11310,,22224
A,10090.0,,CHEMBL625182,Mus musculus,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,,9750,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11311,,50594
A,10116.0,,CHEMBL625183,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11312,,50597
A,10116.0,,CHEMBL875848,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11313,,50597
A,10116.0,,CHEMBL622260,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11314,,50597
A,10116.0,,CHEMBL622261,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11315,,50597
A,10116.0,,CHEMBL622262,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11316,,50597
A,10116.0,,CHEMBL622263,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11317,,50597
A,10116.0,,CHEMBL622418,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11318,,50597
A,10116.0,,CHEMBL622419,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11319,,50597
A,10090.0,,CHEMBL623388,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11320,In vivo,50594
A,10090.0,,CHEMBL623389,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11321,In vivo,50594
A,10090.0,,CHEMBL623390,Mus musculus,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11322,In vivo,50594
A,10090.0,,CHEMBL623391,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11323,In vivo,50594
A,10090.0,,CHEMBL623392,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11324,In vivo,50594
A,10090.0,,CHEMBL623393,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11325,In vivo,50594
A,10090.0,,CHEMBL623394,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11326,In vivo,50594
A,10090.0,,CHEMBL618885,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11327,In vivo,50594
A,10090.0,,CHEMBL618886,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11328,In vivo,50594
A,10090.0,,CHEMBL618887,Mus musculus,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11329,In vivo,50594
A,10090.0,,CHEMBL619535,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11330,In vivo,50594
A,10090.0,,CHEMBL619536,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11331,In vivo,50594
A,10090.0,,CHEMBL619537,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11332,In vivo,50594
A,10090.0,,CHEMBL619705,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11333,In vivo,50594
A,10090.0,,CHEMBL619706,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11334,In vivo,50594
A,10090.0,,CHEMBL619707,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11335,In vivo,50594
A,10090.0,,CHEMBL619708,Mus musculus,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11336,In vivo,50594
A,10090.0,,CHEMBL625219,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11337,In vivo,50594
A,10090.0,,CHEMBL625220,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11338,In vivo,50594
A,10090.0,,CHEMBL625221,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11339,In vivo,50594
A,10090.0,,CHEMBL625222,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11340,In vivo,50594
A,10090.0,,CHEMBL625223,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11341,In vivo,50594
A,10090.0,,CHEMBL625224,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11342,In vivo,50594
A,10090.0,,CHEMBL625225,Mus musculus,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),,13256,N,,Intermediate,,,,,,1,1,,BAO_0000218,11343,In vivo,50594
A,10116.0,,CHEMBL625226,Rattus norvegicus,Biodistribution in Rat blood after 24 hours of iv administration,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11344,In vivo,50597
A,10116.0,,CHEMBL625227,Rattus norvegicus,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11345,In vivo,50597
A,10116.0,,CHEMBL625228,Rattus norvegicus,Biodistribution in Rat blood after 30 minutes of iv administration,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11346,In vivo,50597
A,10116.0,,CHEMBL875354,Rattus norvegicus,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11347,In vivo,50597
A,10116.0,,CHEMBL625229,Rattus norvegicus,Biodistribution in Rat blood after 5 minutes of iv administration,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11348,In vivo,50597
A,10116.0,,CHEMBL625230,Rattus norvegicus,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11349,In vivo,50597
A,10116.0,,CHEMBL625231,Rattus norvegicus,Biodistribution in Rat heart after 24 hours of iv administration,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11350,In vivo,50597
A,10116.0,,CHEMBL625900,Rattus norvegicus,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11351,In vivo,50597
A,10116.0,,CHEMBL625901,Rattus norvegicus,Biodistribution in Rat heart after 30 minutes of iv administration,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11352,In vivo,50597
A,10116.0,,CHEMBL625902,Rattus norvegicus,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11353,In vivo,50597
A,10116.0,,CHEMBL625903,Rattus norvegicus,Biodistribution in Rat heart after 5 minutes of iv administration,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11354,In vivo,50597
A,10116.0,,CHEMBL625904,Rattus norvegicus,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11355,In vivo,50597
A,10116.0,,CHEMBL625905,Rattus norvegicus,Biodistribution in Rat liver after 24 hours of iv administration,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11356,In vivo,50597
A,10116.0,,CHEMBL627861,Rattus norvegicus,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11357,In vivo,50597
A,10116.0,,CHEMBL627862,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11358,In vivo,50597
A,10116.0,,CHEMBL627863,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11359,In vivo,50597
A,10116.0,,CHEMBL627769,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11360,In vivo,50597
A,9615.0,,CHEMBL627770,Canis lupus familiaris,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,13249,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11361,In vivo,50588
A,9541.0,,CHEMBL627771,Macaca fascicularis,Cmax in cynomolgus monkey (PO dose),,13622,N,,Intermediate,,,,,,1,1,,BAO_0000218,11362,In vivo,100710
A,10116.0,,CHEMBL627772,Rattus norvegicus,Cmax in rat (PO dose),,13622,N,,Intermediate,,,,,,1,1,,BAO_0000218,11363,In vivo,50597
A,10116.0,,CHEMBL627773,Rattus norvegicus,Cmax in rat (PO dose),,13622,N,,Intermediate,,,,,,1,1,,BAO_0000218,11364,In vivo,50597
A,10116.0,,CHEMBL621922,Rattus norvegicus,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,,13494,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11365,In vivo,50597
A,10116.0,,CHEMBL621923,Rattus norvegicus,Cmax in rat plasma after oral dose (10 mg/kg),,12170,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11366,In vivo,50597
A,,,CHEMBL621924,,Cmax in plasma after oral dose (10 mg/kg),,12170,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11367,In vivo,22224
A,9615.0,,CHEMBL621925,Canis lupus familiaris,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,,17025,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11368,In vivo,50588
A,314293.0,,CHEMBL621926,Simiiformes,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,,17025,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11369,In vivo,22224
A,9986.0,,CHEMBL621927,Oryctolagus cuniculus,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,,17025,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11370,In vivo,50592
A,10116.0,,CHEMBL621928,Rattus norvegicus,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,,17025,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11371,In vivo,50597
A,10116.0,,CHEMBL621929,Rattus norvegicus,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,,14187,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11372,In vivo,50597
A,10090.0,,CHEMBL621930,Mus musculus,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,,14816,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11373,In vivo,50594
A,10116.0,,CHEMBL621931,Rattus norvegicus,Maximum plasma concentration after oral dosing in rat,,17820,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11374,In vivo,50597
A,,,CHEMBL621932,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11375,In vivo,22224
A,,,CHEMBL621933,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11376,In vivo,22224
A,9615.0,,CHEMBL621934,Canis lupus familiaris,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,,14691,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11377,In vivo,50588
A,9615.0,,CHEMBL621935,Canis lupus familiaris,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,,14691,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11378,In vivo,50588
A,10116.0,,CHEMBL621936,Rattus norvegicus,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,,13375,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11379,In vivo,50597
A,,,CHEMBL621937,,Maximum plasma concentration was determined,,6236,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11380,In vivo,22224
A,,,CHEMBL621938,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11381,In vivo,22224
A,,,CHEMBL621939,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11382,In vivo,22224
A,,,CHEMBL621940,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11383,In vivo,22224
A,,,CHEMBL621941,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11384,In vivo,22224
A,,,CHEMBL621942,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11385,In vivo,22224
A,,,CHEMBL626178,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11386,In vivo,22224
A,,,CHEMBL626179,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11387,In vivo,22224
A,,,CHEMBL626180,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11388,In vivo,22224
A,10116.0,,CHEMBL626181,Rattus norvegicus,Plasma Cmax in rat (PO dose),,13622,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11389,In vivo,50597
A,10116.0,,CHEMBL626182,Rattus norvegicus,Maximum serum concentration after po dose of 5.22 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,11390,In vivo,50597
A,10116.0,,CHEMBL626183,Rattus norvegicus,Maximum serum concentration after po dose of 5.46 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,11391,In vivo,50597
A,10116.0,,CHEMBL626184,Rattus norvegicus,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,11392,In vivo,50597
A,10116.0,,CHEMBL626185,Rattus norvegicus,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,,15372,N,,Intermediate,,,,,,1,1,,BAO_0000218,11393,In vivo,50597
A,9615.0,,CHEMBL626186,Canis lupus familiaris,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,,14925,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11394,In vivo,50588
A,9615.0,,CHEMBL877589,Canis lupus familiaris,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,,14925,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11395,In vivo,50588
A,,,CHEMBL626187,,Maximum concentration of the drug at 1 uM/dg administered intravenously,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000218,11396,In vivo,22224
A,,,CHEMBL626188,,Maximum concentration of the drug at 20 uM/dg administered perorally,,11883,U,,Autocuration,,,,,,1,0,,BAO_0000218,11397,In vivo,22224
A,,,CHEMBL626189,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,13391,U,,Autocuration,,,,,,1,0,,BAO_0000218,11398,In vivo,22224
A,,,CHEMBL626855,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11399,In vivo,22224
A,,,CHEMBL623781,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11400,In vivo,22224
A,,,CHEMBL623782,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11401,In vivo,22224
A,10116.0,,CHEMBL623783,Rattus norvegicus,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,,16360,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11402,In vivo,50597
A,9615.0,,CHEMBL623784,Canis lupus familiaris,Cmax in dog plasma after 1mg/kg oral dose,,3673,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11403,In vivo,50588
A,9615.0,,CHEMBL623785,Canis lupus familiaris,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,,14431,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11404,In vivo,50588
A,10116.0,,CHEMBL623786,Rattus norvegicus,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,,14431,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11405,In vivo,50597
A,10116.0,,CHEMBL623787,Rattus norvegicus,Oral maximum concentration in rat,,14964,N,,Intermediate,,,,,,1,1,,BAO_0000218,11406,In vivo,50597
A,10116.0,,CHEMBL623788,Rattus norvegicus,Oral maximum concentration in rat,,14964,N,,Intermediate,,,,,,1,1,,BAO_0000218,11407,In vivo,50597
A,10090.0,,CHEMBL623789,Mus musculus,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,,14209,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11408,In vivo,50594
A,10090.0,,CHEMBL623790,Mus musculus,Peak concentration in blood after intravenous administration to mice,,11355,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11409,In vivo,50594
A,10090.0,,CHEMBL623791,Mus musculus,Peak concentration in blood after peroral administration to mice,,11355,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11410,In vivo,50594
A,10116.0,,CHEMBL623792,Rattus norvegicus,Peak concentration in rat plasma was determined,,11966,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11411,In vivo,50597
A,314293.0,,CHEMBL623793,Simiiformes,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,,8918,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11412,In vivo,22224
A,10090.0,,CHEMBL623794,Mus musculus,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,,8918,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11413,In vivo,50594
A,10116.0,,CHEMBL623795,Rattus norvegicus,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,,8918,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11414,In vivo,50597
A,10116.0,,CHEMBL623796,Rattus norvegicus,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11415,,50597
A,10116.0,,CHEMBL623797,Rattus norvegicus,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11416,,50597
A,10116.0,,CHEMBL623798,Rattus norvegicus,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11417,,50597
A,10116.0,,CHEMBL623799,Rattus norvegicus,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11418,,50597
A,10116.0,,CHEMBL624490,Rattus norvegicus,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11419,,50597
A,10116.0,,CHEMBL624491,Rattus norvegicus,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11420,,50597
A,10116.0,,CHEMBL624492,Rattus norvegicus,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11421,,50597
A,10116.0,,CHEMBL624493,Rattus norvegicus,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11422,,50597
A,10116.0,,CHEMBL877595,Rattus norvegicus,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11423,,50597
A,10116.0,,CHEMBL624494,Rattus norvegicus,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11424,,50597
A,10116.0,,CHEMBL624495,Rattus norvegicus,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11425,,50597
A,10116.0,,CHEMBL624681,Rattus norvegicus,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,11426,,50597
A,10116.0,,CHEMBL624682,Rattus norvegicus,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11427,,50597
A,10116.0,,CHEMBL624683,Rattus norvegicus,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11428,,50597
A,10116.0,,CHEMBL624684,Rattus norvegicus,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11429,,50597
A,10116.0,,CHEMBL624685,Rattus norvegicus,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11430,,50597
A,10116.0,,CHEMBL624686,Rattus norvegicus,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11431,,50597
A,10116.0,,CHEMBL624687,Rattus norvegicus,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11432,,50597
A,10116.0,,CHEMBL624688,Rattus norvegicus,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11433,,50597
A,10116.0,,CHEMBL627161,Rattus norvegicus,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11434,,50597
A,10116.0,,CHEMBL622127,Rattus norvegicus,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11435,,50597
A,10116.0,,CHEMBL622128,Rattus norvegicus,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11436,,50597
A,10116.0,,CHEMBL874384,Rattus norvegicus,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11437,,50597
A,10116.0,,CHEMBL624898,Rattus norvegicus,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11438,,50597
A,10116.0,,CHEMBL624899,Rattus norvegicus,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11439,,50597
A,10116.0,,CHEMBL624900,Rattus norvegicus,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11440,,50597
A,10116.0,,CHEMBL624901,Rattus norvegicus,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11441,,50597
A,10116.0,,CHEMBL624902,Rattus norvegicus,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11442,,50597
A,10116.0,,CHEMBL624903,Rattus norvegicus,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11443,,50597
A,10116.0,,CHEMBL624904,Rattus norvegicus,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11444,,50597
A,10116.0,,CHEMBL624905,Rattus norvegicus,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11445,,50597
A,10116.0,,CHEMBL624906,Rattus norvegicus,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11446,,50597
A,10116.0,,CHEMBL624907,Rattus norvegicus,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11447,,50597
A,10116.0,,CHEMBL624908,Rattus norvegicus,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11448,,50597
A,10116.0,,CHEMBL624909,Rattus norvegicus,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11449,,50597
A,10116.0,,CHEMBL624910,Rattus norvegicus,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11450,,50597
A,10116.0,,CHEMBL624911,Rattus norvegicus,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11451,,50597
A,10116.0,,CHEMBL874388,Rattus norvegicus,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11452,,50597
A,10116.0,,CHEMBL624912,Rattus norvegicus,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11453,,50597
A,10116.0,,CHEMBL622930,Rattus norvegicus,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11454,,50597
A,10116.0,,CHEMBL623121,Rattus norvegicus,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11455,,50597
A,10116.0,,CHEMBL623122,Rattus norvegicus,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11456,,50597
A,10116.0,,CHEMBL623123,Rattus norvegicus,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11457,,50597
A,10116.0,,CHEMBL623124,Rattus norvegicus,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11458,,50597
A,10116.0,,CHEMBL623125,Rattus norvegicus,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11459,,50597
A,10116.0,,CHEMBL623126,Rattus norvegicus,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11460,,50597
A,10116.0,,CHEMBL623127,Rattus norvegicus,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11461,,50597
A,10116.0,,CHEMBL623128,Rattus norvegicus,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11462,,50597
A,10116.0,,CHEMBL623129,Rattus norvegicus,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11463,,50597
A,10116.0,,CHEMBL623130,Rattus norvegicus,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11464,,50597
A,10116.0,,CHEMBL623131,Rattus norvegicus,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11465,,50597
A,10116.0,,CHEMBL623132,Rattus norvegicus,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11466,,50597
A,10116.0,,CHEMBL623133,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11467,,50597
A,10116.0,,CHEMBL623134,Rattus norvegicus,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11468,,50597
A,10116.0,,CHEMBL874389,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11469,,50597
A,10116.0,,CHEMBL623135,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11470,,50597
A,10116.0,,CHEMBL623136,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11471,,50597
A,10116.0,,CHEMBL623137,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11472,,50597
A,10116.0,,CHEMBL623138,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11473,,50597
A,10116.0,,CHEMBL623139,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11474,,50597
A,10116.0,,CHEMBL623140,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11475,,50597
A,10116.0,,CHEMBL623141,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11476,,50597
A,10116.0,,CHEMBL623142,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11477,,50597
A,10116.0,,CHEMBL623143,Rattus norvegicus,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11478,,50597
A,10090.0,,CHEMBL623144,Mus musculus,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,,14571,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11479,,50594
A,10116.0,,CHEMBL623405,Rattus norvegicus,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,,14571,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11480,,50597
A,10116.0,,CHEMBL624074,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11481,,50597
A,10116.0,,CHEMBL624075,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11482,,50597
A,10116.0,,CHEMBL624076,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11483,,50597
A,10116.0,,CHEMBL624077,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11484,,50597
A,10116.0,,CHEMBL624078,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11485,,50597
A,10116.0,,CHEMBL624079,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11486,,50597
A,10116.0,,CHEMBL624261,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11487,,50597
A,10116.0,,CHEMBL624262,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11488,,50597
A,10116.0,,CHEMBL624263,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11489,,50597
A,10116.0,,CHEMBL624264,Rattus norvegicus,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11490,,50597
A,10116.0,,CHEMBL624265,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11491,,50597
A,10116.0,,CHEMBL624266,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11492,,50597
A,10116.0,,CHEMBL624267,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11493,,50597
A,10116.0,,CHEMBL624268,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11494,,50597
A,10116.0,,CHEMBL875227,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11495,,50597
A,10116.0,,CHEMBL624269,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11496,,50597
A,10116.0,,CHEMBL624270,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11497,,50597
A,10116.0,,CHEMBL624271,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11498,,50597
A,10116.0,,CHEMBL624272,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11499,,50597
A,10116.0,,CHEMBL624273,Rattus norvegicus,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,,8319,N,,Intermediate,,,,,,1,1,,BAO_0000218,11500,,50597
A,10116.0,,CHEMBL624274,Rattus norvegicus,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11501,,50597
A,10116.0,,CHEMBL624275,Rattus norvegicus,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11502,,50597
A,10116.0,,CHEMBL624276,Rattus norvegicus,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11503,,50597
A,10116.0,,CHEMBL624277,Rattus norvegicus,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,,12038,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,11504,,50597
A,,,CHEMBL624278,,% dose converted to 2-amino-5-chlorophenyl sulfate,,14314,U,,Autocuration,,,,,,1,0,,BAO_0000019,11505,,22224
A,,,CHEMBL624279,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,14314,U,,Autocuration,,,,,,1,0,,BAO_0000019,11506,,22224
A,10116.0,,CHEMBL624280,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11488,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,11507,,50597
A,10116.0,,CHEMBL624281,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11488,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,11508,,50597
A,10116.0,,CHEMBL622933,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11488,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,11509,,50597
A,10116.0,,CHEMBL622934,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11488,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,11510,,50597
A,10116.0,,CHEMBL622935,Rattus norvegicus,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11511,In vivo,50597
A,10116.0,,CHEMBL622936,Rattus norvegicus,Biodistribution in Rat liver after 5 minutes of iv administration,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11512,In vivo,50597
A,10116.0,,CHEMBL875228,Rattus norvegicus,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11513,In vivo,50597
A,10116.0,,CHEMBL622937,Rattus norvegicus,Biodistribution in Rat lung after 24 hours of iv administration,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11514,In vivo,50597
A,10116.0,,CHEMBL622938,Rattus norvegicus,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11515,In vivo,50597
A,10116.0,,CHEMBL619736,Rattus norvegicus,Biodistribution in Rat lung after 30 minutes of iv administration,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11516,In vivo,50597
A,10116.0,,CHEMBL625117,Rattus norvegicus,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11517,In vivo,50597
A,10116.0,,CHEMBL625118,Rattus norvegicus,Biodistribution in Rat lung after 5 minutes of iv administration,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11518,In vivo,50597
A,10116.0,,CHEMBL625119,Rattus norvegicus,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,,8829,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11519,In vivo,50597
A,10116.0,,CHEMBL625120,Rattus norvegicus,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",,14972,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11520,In vivo,50597
A,10116.0,,CHEMBL625121,Rattus norvegicus,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",,14972,N,,Intermediate,,,,,,1,1,,BAO_0000218,11521,In vivo,50597
A,10116.0,,CHEMBL625122,Rattus norvegicus,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",,14972,N,,Intermediate,,,Thalamus,10000006.0,,1,1,,BAO_0000218,11522,In vivo,50597
A,10116.0,,CHEMBL622204,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11523,In vivo,50597
A,10116.0,,CHEMBL877503,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11524,In vivo,50597
A,10116.0,,CHEMBL627127,Rattus norvegicus,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11525,In vivo,50597
A,,,CHEMBL627128,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,U,,Autocuration,,,Hippocampus,10000000.0,,1,0,,BAO_0000218,11526,In vivo,22224
A,,,CHEMBL627129,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,U,,Autocuration,,,Hippocampus,10000000.0,,1,0,,BAO_0000218,11527,In vivo,22224
A,,,CHEMBL627130,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,U,,Autocuration,,,Hippocampus,10000000.0,,1,0,,BAO_0000218,11528,In vivo,22224
A,10116.0,,CHEMBL627131,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11529,In vivo,50597
A,10116.0,,CHEMBL627132,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11530,In vivo,50597
A,10116.0,,CHEMBL627133,Rattus norvegicus,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11531,In vivo,50597
A,10116.0,,CHEMBL627134,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11532,In vivo,50597
A,10116.0,,CHEMBL627135,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11533,In vivo,50597
A,10116.0,,CHEMBL627136,Rattus norvegicus,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,11534,In vivo,50597
A,10116.0,,CHEMBL628435,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11535,In vivo,50597
A,10116.0,,CHEMBL628436,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11536,In vivo,50597
A,10116.0,,CHEMBL628437,Rattus norvegicus,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11537,In vivo,50597
A,10116.0,,CHEMBL628438,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11538,In vivo,50597
A,10116.0,,CHEMBL628439,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11539,In vivo,50597
A,10116.0,,CHEMBL628440,Rattus norvegicus,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,11540,In vivo,50597
A,10116.0,,CHEMBL628441,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,11541,In vivo,50597
A,10116.0,,CHEMBL628442,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,11542,In vivo,50597
A,10116.0,,CHEMBL628443,Rattus norvegicus,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,11543,In vivo,50597
A,10116.0,,CHEMBL628444,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11544,In vivo,50597
A,10116.0,,CHEMBL628445,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11545,In vivo,50597
A,10116.0,,CHEMBL877504,Rattus norvegicus,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11546,In vivo,50597
A,10116.0,,CHEMBL628446,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11547,In vivo,50597
A,10116.0,,CHEMBL626874,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11548,In vivo,50597
A,10116.0,,CHEMBL626875,Rattus norvegicus,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11549,In vivo,50597
A,10116.0,,CHEMBL626876,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11550,In vivo,50597
A,10116.0,,CHEMBL626877,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11551,In vivo,50597
A,10116.0,,CHEMBL626878,Rattus norvegicus,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11552,In vivo,50597
A,10116.0,,CHEMBL626879,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11553,In vivo,50597
A,314293.0,,CHEMBL626880,Simiiformes,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,,8918,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11554,In vivo,22224
A,10090.0,,CHEMBL626881,Mus musculus,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,,8918,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11555,In vivo,50594
A,10116.0,,CHEMBL626882,Rattus norvegicus,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,,8918,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11556,In vivo,50597
A,9615.0,,CHEMBL626883,Canis lupus familiaris,Peak plasma concentration was measured in dogs,,14470,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11557,In vivo,50588
A,10116.0,,CHEMBL626884,Rattus norvegicus,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,11558,In vivo,50597
A,10116.0,,CHEMBL626885,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,11559,In vivo,50597
A,10116.0,,CHEMBL626886,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,11560,In vivo,50597
A,10116.0,,CHEMBL626887,Rattus norvegicus,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,11561,In vivo,50597
A,10116.0,,CHEMBL626888,Rattus norvegicus,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,11562,In vivo,50597
A,9615.0,,CHEMBL626889,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11563,In vivo,50588
A,314293.0,,CHEMBL626761,Simiiformes,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,,13465,U,,Autocuration,,,,,,1,0,,BAO_0000218,11564,In vivo,22224
A,9615.0,,CHEMBL626762,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11565,In vivo,50588
A,9615.0,,CHEMBL626763,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11566,In vivo,50588
A,10116.0,,CHEMBL626764,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11567,In vivo,50597
A,10116.0,,CHEMBL626765,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11568,In vivo,50597
A,9615.0,,CHEMBL626766,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11569,In vivo,50588
A,10116.0,,CHEMBL626767,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11570,In vivo,50597
A,10116.0,,CHEMBL626768,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11571,In vivo,50597
A,9615.0,,CHEMBL626769,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11572,In vivo,50588
A,9615.0,,CHEMBL874463,Canis lupus familiaris,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11573,In vivo,50588
A,314293.0,,CHEMBL626770,Simiiformes,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,,13465,U,,Autocuration,,,,,,1,0,,BAO_0000218,11574,In vivo,22224
A,314293.0,,CHEMBL626771,Simiiformes,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,,13465,U,,Autocuration,,,,,,1,0,,BAO_0000218,11575,In vivo,22224
A,10116.0,,CHEMBL626772,Rattus norvegicus,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,,13465,N,,Intermediate,,,,,,1,1,,BAO_0000218,11576,In vivo,50597
A,9541.0,,CHEMBL626773,Macaca fascicularis,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,11577,In vivo,100710
A,10090.0,,CHEMBL626774,Mus musculus,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,11578,In vivo,50594
A,9615.0,,CHEMBL626775,Canis lupus familiaris,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,,13376,N,,Intermediate,,,,,,1,1,,BAO_0000218,11579,In vivo,50588
A,9615.0,,CHEMBL626776,Canis lupus familiaris,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,,13376,N,,Intermediate,,,,,,1,1,,BAO_0000218,11580,In vivo,50588
A,10116.0,,CHEMBL626777,Rattus norvegicus,Maximum concentration (Cmax) in rat when administered orally,,14443,N,,Intermediate,,,,,,1,1,,BAO_0000218,11581,In vivo,50597
A,314293.0,,CHEMBL626778,Simiiformes,Maximal concentration in monkey plasma after 25 mg/kg oral dose,,13465,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11582,In vivo,22224
A,10116.0,,CHEMBL626779,Rattus norvegicus,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",,16359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11583,In vivo,22224
A,10116.0,,CHEMBL626780,Rattus norvegicus,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",,16359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11584,In vivo,22224
A,,,CHEMBL626781,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,15618,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11585,In vivo,22224
A,10116.0,,CHEMBL632164,Rattus norvegicus,Pharmacokinetic profile Cmax was evaluated in rats,,14554,N,,Intermediate,,,,,,1,1,,BAO_0000218,11586,In vivo,50597
A,9615.0,,CHEMBL632165,Canis lupus familiaris,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,11587,In vivo,50588
A,10090.0,,CHEMBL632166,Mus musculus,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,11588,In vivo,50594
A,9615.0,,CHEMBL632167,Canis lupus familiaris,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,11589,In vivo,50588
A,10090.0,,CHEMBL632168,Mus musculus,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,11590,In vivo,50594
A,10116.0,,CHEMBL632169,Rattus norvegicus,Cmax in rat plasma,,2021,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11591,In vivo,22224
A,9615.0,,CHEMBL632170,Canis lupus familiaris,Cmax in dog plasma after 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11592,In vivo,50588
A,10116.0,,CHEMBL632171,Rattus norvegicus,Cmax in rat plasma after 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11593,In vivo,50597
A,10116.0,,CHEMBL632172,Rattus norvegicus,Plasma level in rats at 30 mg/kg,,17320,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11594,In vivo,50597
A,10090.0,,CHEMBL632173,Mus musculus,Tested for maximum plasma concentration in mice,,15831,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11595,In vivo,50594
A,10116.0,,CHEMBL632174,Rattus norvegicus,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,11596,In vivo,50597
A,10116.0,,CHEMBL632175,Rattus norvegicus,The Cmax values in female wistar rats.,,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,11597,In vivo,50597
A,9615.0,,CHEMBL632176,Canis lupus familiaris,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,,15343,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11598,In vivo,50588
A,10116.0,,CHEMBL632177,Rattus norvegicus,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,,15343,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11599,In vivo,50597
A,10116.0,,CHEMBL632178,Rattus norvegicus,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,,14856,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11600,In vivo,50597
A,10116.0,,CHEMBL632179,Rattus norvegicus,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,,13129,N,,Intermediate,,,,,,1,1,,BAO_0000218,11601,In vivo,50597
A,10116.0,,CHEMBL632180,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,,13098,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11602,In vivo,50597
A,10116.0,,CHEMBL632181,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,,13098,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11603,In vivo,50597
A,10116.0,,CHEMBL632182,Rattus norvegicus,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,,13098,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11604,In vivo,50597
A,10090.0,,CHEMBL632183,Mus musculus,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,,15478,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11605,In vivo,22224
A,9615.0,,CHEMBL632184,Canis lupus familiaris,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,11606,In vivo,50588
A,10116.0,,CHEMBL874470,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,11607,In vivo,50597
A,10116.0,,CHEMBL631302,Rattus norvegicus,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11608,,50597
A,10116.0,,CHEMBL631303,Rattus norvegicus,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11609,,50597
A,10116.0,,CHEMBL631304,Rattus norvegicus,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11610,,50597
A,10116.0,,CHEMBL631305,Rattus norvegicus,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11611,,50597
A,10116.0,,CHEMBL631306,Rattus norvegicus,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11612,,50597
A,10116.0,,CHEMBL631307,Rattus norvegicus,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11613,,50597
A,10116.0,,CHEMBL631308,Rattus norvegicus,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11614,,50597
A,10116.0,,CHEMBL625557,Rattus norvegicus,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,,,,1,1,,BAO_0000218,11615,,50597
A,10116.0,,CHEMBL625558,Rattus norvegicus,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11616,,50597
A,10116.0,,CHEMBL625559,Rattus norvegicus,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11617,,50597
A,10116.0,,CHEMBL625560,Rattus norvegicus,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11618,,50597
A,10116.0,,CHEMBL625561,Rattus norvegicus,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11619,,50597
A,10116.0,,CHEMBL625562,Rattus norvegicus,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11620,,50597
A,10116.0,,CHEMBL875320,Rattus norvegicus,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11621,,50597
A,10116.0,,CHEMBL625563,Rattus norvegicus,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11622,,50597
A,10116.0,,CHEMBL625564,Rattus norvegicus,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11623,,50597
A,10116.0,,CHEMBL625565,Rattus norvegicus,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11624,,50597
A,10116.0,,CHEMBL625566,Rattus norvegicus,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11625,,50597
A,10116.0,,CHEMBL625567,Rattus norvegicus,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11626,,50597
A,10116.0,,CHEMBL625568,Rattus norvegicus,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11627,,50597
A,10116.0,,CHEMBL628217,Rattus norvegicus,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11628,,50597
A,10116.0,,CHEMBL628218,Rattus norvegicus,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11629,,50597
A,10116.0,,CHEMBL628219,Rattus norvegicus,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11630,,50597
A,10116.0,,CHEMBL628220,Rattus norvegicus,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",,8684,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,11631,,50597
A,,,CHEMBL628221,,Distribution in the blood after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11632,,22224
A,,,CHEMBL628222,,Distribution in the blood after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11633,,22224
A,,,CHEMBL628223,,Distribution in the blood after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11634,,22224
A,,,CHEMBL628224,,Distribution in the blood after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11635,,22224
A,,,CHEMBL628225,,Distribution in the blood after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11636,,22224
A,,,CHEMBL628226,,Distribution in the blood after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11637,,22224
A,,,CHEMBL628227,,Distribution in the bone after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11638,,22224
A,,,CHEMBL875481,,Distribution in the bone after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11639,,22224
A,,,CHEMBL628228,,Distribution in the bone after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11640,,22224
A,,,CHEMBL628229,,Distribution in the bone after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11641,,22224
A,,,CHEMBL628230,,Distribution in the bone after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11642,,22224
A,,,CHEMBL628231,,Distribution in the bone after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11643,,22224
A,,,CHEMBL628232,,Distribution in the heart after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11644,,22224
A,,,CHEMBL628233,,Distribution in the heart after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11645,,22224
A,,,CHEMBL628234,,Distribution in the heart after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11646,,22224
A,,,CHEMBL628235,,Distribution in the heart after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11647,,22224
A,,,CHEMBL628236,,Distribution in the heart after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11648,,22224
A,,,CHEMBL628237,,Distribution in the heart after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11649,,22224
A,,,CHEMBL628238,,Distribution in the kidneys after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11650,,22224
A,,,CHEMBL628239,,Distribution in the kidneys after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11651,,22224
A,,,CHEMBL628240,,Distribution in the kidneys after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11652,,22224
A,,,CHEMBL628241,,Distribution in the kidneys after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11653,,22224
A,,,CHEMBL628242,,Distribution in the kidneys after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11654,,22224
A,,,CHEMBL875482,,Distribution in the kidneys after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11655,,22224
A,,,CHEMBL628243,,Distribution in the liver after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11656,,22224
A,,,CHEMBL628244,,Distribution in the liver after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11657,,22224
A,,,CHEMBL628245,,Distribution in the liver after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11658,,22224
A,,,CHEMBL628246,,Distribution in the liver after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11659,,22224
A,,,CHEMBL628247,,Distribution in the liver after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11660,,22224
A,,,CHEMBL628248,,Distribution in the liver after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11661,,22224
A,,,CHEMBL628249,,Distribution in the lung after 120 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11662,,22224
A,10090.0,,CHEMBL625452,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,11663,,50594
A,10090.0,,CHEMBL625453,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,11664,,50594
A,10090.0,,CHEMBL625454,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,11665,,50594
A,10090.0,,CHEMBL623844,Mus musculus,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",,14839,N,,Intermediate,,,,,,1,1,,BAO_0000218,11666,,50594
A,10116.0,,CHEMBL623845,Rattus norvegicus,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,,12178,N,,Intermediate,,,,,,1,1,,BAO_0000218,11667,,50597
A,10116.0,,CHEMBL623846,Rattus norvegicus,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,,12178,N,,Intermediate,,,,,,1,1,,BAO_0000218,11668,,50597
A,,,CHEMBL623847,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,12178,U,,Autocuration,,,,,,1,0,,BAO_0000218,11669,,22224
A,9541.0,,CHEMBL623848,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,11670,,100710
A,9541.0,,CHEMBL623849,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,11671,,100710
A,9541.0,,CHEMBL623850,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,11672,,100710
A,9541.0,,CHEMBL623851,Macaca fascicularis,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,11673,,100710
A,314293.0,,CHEMBL623852,Simiiformes,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,11674,,22224
A,9669.0,,CHEMBL624551,Mustela putorius furo,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,11675,,50506
A,9669.0,,CHEMBL624552,Mustela putorius furo,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,11676,,50506
A,314293.0,,CHEMBL624553,Simiiformes,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,11677,,22224
A,314293.0,,CHEMBL624554,Simiiformes,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,11678,,22224
A,10116.0,,CHEMBL624555,Rattus norvegicus,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,11679,,50597
A,10116.0,,CHEMBL624741,Rattus norvegicus,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,11680,,50597
A,9615.0,,CHEMBL624742,Canis lupus familiaris,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11681,,50588
A,10026.0,,CHEMBL624743,Cricetinae,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11682,,100712
A,10116.0,,CHEMBL877606,Rattus norvegicus,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11683,,50597
A,,,CHEMBL624744,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,13391,U,,Autocuration,,,,,,1,0,,BAO_0000218,11684,,22224
A,,,CHEMBL624745,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11685,,22224
A,,,CHEMBL624746,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11686,,22224
A,,,CHEMBL624747,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,13391,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,11687,,22224
A,,,CHEMBL624748,,Oral absorption expressed as Area under curve was determined,,16360,U,,Autocuration,,,,,,1,0,,BAO_0000019,11688,,22224
A,9615.0,,CHEMBL622504,Canis lupus familiaris,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,,3673,N,,Intermediate,,,,,,1,1,,BAO_0000218,11689,,50588
A,9615.0,,CHEMBL622505,Canis lupus familiaris,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11690,,50588
A,10026.0,,CHEMBL622506,Cricetinae,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11691,,100712
A,10026.0,,CHEMBL622507,Cricetinae,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11692,,100712
A,10116.0,,CHEMBL622508,Rattus norvegicus,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",,14122,N,,Intermediate,,,,,,1,1,,BAO_0000218,11693,,50597
A,,,CHEMBL622509,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,13889,U,,Autocuration,,,,,,1,0,,BAO_0000019,11694,,22224
A,10116.0,,CHEMBL622510,Rattus norvegicus,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,11695,,50597
A,10116.0,,CHEMBL622511,Rattus norvegicus,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),,17279,N,,Intermediate,,,,,,1,1,,BAO_0000218,11696,,50597
A,9541.0,,CHEMBL622512,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11697,,100710
A,9541.0,,CHEMBL622513,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11698,,100710
A,9541.0,,CHEMBL622514,Macaca fascicularis,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11699,,100710
A,9615.0,,CHEMBL622515,Canis lupus familiaris,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11700,,50588
A,9615.0,,CHEMBL622516,Canis lupus familiaris,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11701,,50588
A,10116.0,,CHEMBL622517,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11702,,50597
A,10116.0,,CHEMBL622518,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11703,,50597
A,10116.0,,CHEMBL622519,Rattus norvegicus,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,11704,,50597
A,10116.0,,CHEMBL622520,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11705,In vivo,50597
A,10116.0,,CHEMBL622521,Rattus norvegicus,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11706,In vivo,50597
A,10090.0,,CHEMBL625113,Mus musculus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,11707,In vivo,50594
A,10116.0,,CHEMBL625114,Rattus norvegicus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,11708,In vivo,50597
A,10116.0,,CHEMBL874397,Rattus norvegicus,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,11709,In vivo,50597
A,10116.0,,CHEMBL625115,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11710,In vivo,50597
A,10116.0,,CHEMBL625116,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11711,In vivo,50597
A,10116.0,,CHEMBL623932,Rattus norvegicus,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11712,In vivo,50597
A,10116.0,,CHEMBL623933,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,11713,In vivo,50597
A,10116.0,,CHEMBL623934,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,11714,In vivo,50597
A,10116.0,,CHEMBL623935,Rattus norvegicus,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,11715,In vivo,50597
A,10116.0,,CHEMBL623936,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,,14608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,11716,In vivo,50597
A,10116.0,,CHEMBL623937,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,,14608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,11717,In vivo,50597
A,10116.0,,CHEMBL623938,Rattus norvegicus,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,,14608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,11718,In vivo,50597
A,10090.0,,CHEMBL623939,Mus musculus,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11719,,50594
A,10090.0,,CHEMBL623940,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11720,,50594
A,10090.0,,CHEMBL623941,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11721,,50594
A,10090.0,,CHEMBL627216,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11722,,50594
A,10090.0,,CHEMBL623942,Mus musculus,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11723,,50594
A,10090.0,,CHEMBL618793,Mus musculus,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11724,,50594
A,10090.0,,CHEMBL618794,Mus musculus,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11725,,50594
A,10090.0,,CHEMBL618795,Mus musculus,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11726,,50594
A,10090.0,,CHEMBL618796,Mus musculus,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11727,,50594
A,10090.0,,CHEMBL618797,Mus musculus,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11728,,50594
A,10090.0,,CHEMBL618798,Mus musculus,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11729,,50594
A,10090.0,,CHEMBL618799,Mus musculus,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11730,,50594
A,10090.0,,CHEMBL618800,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11731,,50594
A,10090.0,,CHEMBL618801,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11732,,50594
A,10090.0,,CHEMBL618802,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11733,,50594
A,10090.0,,CHEMBL618803,Mus musculus,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11734,,50594
A,10090.0,,CHEMBL618804,Mus musculus,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11735,,50594
A,10090.0,,CHEMBL618805,Mus musculus,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11736,,50594
A,10090.0,,CHEMBL618806,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11737,,50594
A,10090.0,,CHEMBL618807,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11738,,50594
A,10090.0,,CHEMBL618808,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11739,,50594
A,10090.0,,CHEMBL618809,Mus musculus,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11740,,50594
A,10090.0,,CHEMBL618810,Mus musculus,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11741,,50594
A,10090.0,,CHEMBL618811,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,,15383,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11742,,50594
A,10090.0,,CHEMBL875844,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11743,,50594
A,10090.0,,CHEMBL618812,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11744,,50594
A,10090.0,,CHEMBL618813,Mus musculus,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11745,,50594
A,10090.0,,CHEMBL618814,Mus musculus,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11746,,50594
A,10090.0,,CHEMBL618815,Mus musculus,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11747,,50594
A,10090.0,,CHEMBL618816,Mus musculus,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11748,,50594
A,10090.0,,CHEMBL618817,Mus musculus,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11749,,50594
A,10090.0,,CHEMBL620544,Mus musculus,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11750,,50594
A,10116.0,,CHEMBL626230,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,11751,In vivo,50597
A,10116.0,,CHEMBL626231,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,11752,In vivo,50597
A,10116.0,,CHEMBL626232,Rattus norvegicus,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,11753,In vivo,50597
A,9615.0,,CHEMBL626233,Canis lupus familiaris,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,,14906,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11754,In vivo,50588
A,10116.0,,CHEMBL626234,Rattus norvegicus,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,,14906,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11755,In vivo,50597
A,10116.0,,CHEMBL875341,Rattus norvegicus,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,,14906,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11756,In vivo,50597
A,9606.0,,CHEMBL626235,Homo sapiens,The maximum plasma concentration (100 mg/kg) administered orally in human,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11757,In vivo,50587
A,9481.0,,CHEMBL626236,Callithrix,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,,14215,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11758,In vivo,22224
A,314293.0,,CHEMBL626237,Simiiformes,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,,14215,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11759,In vivo,22224
A,9615.0,,CHEMBL626238,Canis lupus familiaris,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11760,In vivo,50588
A,9606.0,,CHEMBL622412,Homo sapiens,The maximum plasma concentration (200 mg/kg) administered orally in human,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11761,In vivo,50587
A,10116.0,,CHEMBL623114,Rattus norvegicus,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11762,In vivo,50597
A,9481.0,,CHEMBL623115,Callithrix,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,,14215,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11763,In vivo,22224
A,314293.0,,CHEMBL623116,Simiiformes,The maximum plasma concentration (25 mg/kg) administered orally in monkey,,14215,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11764,In vivo,22224
A,9615.0,,CHEMBL623117,Canis lupus familiaris,The maximum plasma concentration (30 mg/kg) administered orally in dog,,14215,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11765,In vivo,22224
A,9606.0,,CHEMBL623118,Homo sapiens,The maximum plasma concentration (400 mg/kg) administered orally in human,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11766,In vivo,50587
A,10116.0,,CHEMBL623119,Rattus norvegicus,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11767,In vivo,50597
A,10116.0,,CHEMBL623120,Rattus norvegicus,The maximum plasma concentration (50 mg/kg) administered orally in rat,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11768,In vivo,50597
A,9606.0,,CHEMBL623286,Homo sapiens,The maximum plasma concentration (800 mg/kg) administered orally in human,,14215,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11769,In vivo,50587
A,10116.0,,CHEMBL623287,Rattus norvegicus,The maximum plasma concentration was measured on rats,,14067,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11770,In vivo,50597
A,10116.0,,CHEMBL623288,Rattus norvegicus,The maximum plasma concentration was measured on rats after oral administration,,12350,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11771,In vivo,50597
A,10116.0,,CHEMBL623289,Rattus norvegicus,Plasma drug Cmax in rat (PO dose),,14813,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11772,In vivo,50597
A,,,CHEMBL623290,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,12536,U,,Autocuration,,,,,,1,0,,BAO_0000218,11773,In vivo,22224
A,9615.0,,CHEMBL623291,Canis lupus familiaris,maximum Plasma concentration in Dog was determined after Peroral administration,,14169,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11774,In vivo,50588
A,10116.0,,CHEMBL623292,Rattus norvegicus,maximum Plasma concentration in Rats was determined after Peroral administration,,14169,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11775,In vivo,50597
A,9615.0,,CHEMBL623293,Canis lupus familiaris,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,15604,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11776,In vivo,50588
A,314293.0,,CHEMBL623294,Simiiformes,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,15604,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,11777,In vivo,22224
A,10116.0,,CHEMBL623295,Rattus norvegicus,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,15604,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11778,In vivo,50597
A,10090.0,,CHEMBL623296,Mus musculus,maximum concentration was measured when administered through oral route in mice,,14387,N,,Intermediate,,,,,,1,1,,BAO_0000218,11779,In vivo,50594
A,10090.0,,CHEMBL875349,Mus musculus,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,,15115,N,,Intermediate,,,,,,1,1,,BAO_0000218,11780,,50594
A,314293.0,,CHEMBL623297,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,,15115,U,,Autocuration,,,,,,1,0,,BAO_0000019,11781,,22224
A,314293.0,,CHEMBL623298,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,,15115,U,,Autocuration,,,,,,1,0,,BAO_0000019,11782,,22224
A,314293.0,,CHEMBL623299,Simiiformes,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,,15115,U,,Autocuration,,,,,,1,0,,BAO_0000019,11783,,22224
A,10116.0,,CHEMBL623300,Rattus norvegicus,Pharmacokinetic parameter was evaluated in rats,,16359,N,,Intermediate,,,,,,1,1,,BAO_0000218,11784,,50597
A,10090.0,,CHEMBL623301,Mus musculus,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,12829,N,,Intermediate,,,,,,1,1,,BAO_0000218,11785,,50594
A,10090.0,,CHEMBL623302,Mus musculus,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,,12829,N,,Intermediate,,,,,,1,1,,BAO_0000218,11786,,50594
A,10090.0,,CHEMBL623303,Mus musculus,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,,12829,N,,Intermediate,,,,,,1,1,,BAO_0000218,11787,,50594
A,10090.0,,CHEMBL623304,Mus musculus,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,,12829,N,,Intermediate,,,,,,1,1,,BAO_0000218,11788,,50594
A,10090.0,,CHEMBL623305,Mus musculus,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,,12829,N,,Intermediate,,,,,,1,1,,BAO_0000218,11789,,50594
A,10116.0,,CHEMBL623306,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11790,,50597
A,10116.0,,CHEMBL623307,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11791,,50597
A,10116.0,,CHEMBL623308,Rattus norvegicus,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11792,,50597
A,10090.0,,CHEMBL623309,Mus musculus,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,,15137,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,11793,,50594
A,10090.0,,CHEMBL623310,Mus musculus,Plasma Concentration after 120 min of oral administration to mice,,13509,N,,Intermediate,,,,,,1,1,,BAO_0000218,11794,,50594
A,10090.0,,CHEMBL623311,Mus musculus,Plasma Concentration after 30 min of oral administration to mice,,13509,N,,Intermediate,,,,,,1,1,,BAO_0000218,11795,,50594
A,9541.0,,CHEMBL623312,Macaca fascicularis,Plasma Concentration after 60 min of oral administration to mice,,13509,N,,Intermediate,,,,,,1,1,,BAO_0000218,11796,,100710
A,10090.0,,CHEMBL875350,Mus musculus,Plasma Concentration after 60 min of oral administration to mice; Not determined,,13509,N,,Intermediate,,,,,,1,1,,BAO_0000218,11797,,50594
A,10090.0,,CHEMBL628635,Mus musculus,Plasma Concentration after 90 min of oral administration to mice,,13509,N,,Intermediate,,,,,,1,1,,BAO_0000218,11798,,50594
A,10116.0,,CHEMBL628636,Rattus norvegicus,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,,,,1,1,,BAO_0000218,11799,,50597
A,10116.0,,CHEMBL628637,Rattus norvegicus,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,,,,1,1,,BAO_0000218,11800,,50597
A,10116.0,,CHEMBL628058,Rattus norvegicus,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,,12064,N,,Intermediate,,,,,,1,1,,BAO_0000218,11801,,50597
A,10116.0,,CHEMBL628059,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11802,,50597
A,10116.0,,CHEMBL628060,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11803,,50597
A,,,CHEMBL628061,,Distribution in the lung after 15 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11804,,22224
A,,,CHEMBL628062,,Distribution in the lung after 30 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11805,,22224
A,,,CHEMBL628063,,Distribution in the lung after 5 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11806,,22224
A,,,CHEMBL628064,,Distribution in the lung after 60 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11807,,22224
A,,,CHEMBL628065,,Distribution in the lung after 90 min of intravenous administration,,8926,U,,Autocuration,,,,,,1,0,,BAO_0000019,11808,,22224
A,,,CHEMBL628066,,Distribution in the muscle after 120 min of intravenous administration,,8926,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000019,11809,,22224
A,,,CHEMBL628067,,Distribution in the muscle after 15 min of intravenous administration,,8926,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000019,11810,,22224
A,10090.0,,CHEMBL874646,Mus musculus,Distribution in the muscle after 30 min of intravenous administration,,8926,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11811,,50594
A,,,CHEMBL628068,,Distribution in the muscle after 5 min of intravenous administration,,8926,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000019,11812,,22224
A,,,CHEMBL628069,,Distribution in the muscle after 60 min of intravenous administration,,8926,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000019,11813,,22224
A,,,CHEMBL628070,,Distribution in the muscle after 90 min of intravenous administration,,8926,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000019,11814,,22224
A,,,CHEMBL628071,,Distribution in the spleen after 120 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11815,,22224
A,,,CHEMBL628072,,Distribution in the spleen after 15 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11816,,22224
A,,,CHEMBL628073,,Distribution in the spleen after 30 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11817,,22224
A,,,CHEMBL628074,,Distribution in the spleen after 5 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11818,,22224
A,,,CHEMBL628075,,Distribution in the spleen after 60 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11819,,22224
A,,,CHEMBL628076,,Distribution in the spleen after 90 min of intravenous administration,,8926,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000019,11820,,22224
A,10116.0,,CHEMBL628077,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,,7570,N,,Intermediate,,,Adrenal cortex,1235.0,,1,1,,BAO_0000218,11821,,50597
A,10116.0,,CHEMBL628078,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,,7570,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11822,,50597
A,10116.0,,CHEMBL628079,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,,7570,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11823,,50597
A,10116.0,,CHEMBL628080,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,,7570,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,11824,,50597
A,10116.0,,CHEMBL628081,Rattus norvegicus,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,,7570,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,11825,,50597
A,10116.0,,CHEMBL628082,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,,7570,N,,Intermediate,,,Adrenal cortex,1235.0,,1,1,,BAO_0000218,11826,,50597
A,10116.0,,CHEMBL874647,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,,7570,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11827,,50597
A,10116.0,,CHEMBL626406,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,,7570,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11828,,50597
A,10116.0,,CHEMBL626407,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,,7570,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,11829,,50597
A,10116.0,,CHEMBL626408,Rattus norvegicus,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,,7570,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,11830,,50597
A,10116.0,,CHEMBL626409,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11831,,50597
A,10116.0,,CHEMBL626410,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11832,,50597
A,10116.0,,CHEMBL626411,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11833,,50597
A,10116.0,,CHEMBL626412,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11834,,50597
A,10116.0,,CHEMBL626413,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11835,,50597
A,10116.0,,CHEMBL626414,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11836,,50597
A,10116.0,,CHEMBL626415,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11837,,50597
A,10116.0,,CHEMBL626416,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11838,,50597
A,10116.0,,CHEMBL627062,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11839,,50597
A,10116.0,,CHEMBL627063,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11840,,50597
A,10116.0,,CHEMBL627064,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11841,,50597
A,10116.0,,CHEMBL627227,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11842,,50597
A,10116.0,,CHEMBL627228,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11843,,50597
A,10116.0,,CHEMBL627229,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11844,,50597
A,10116.0,,CHEMBL625792,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11845,,50597
A,10116.0,,CHEMBL625793,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11846,,50597
A,10116.0,,CHEMBL625794,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11847,,50597
A,10116.0,,CHEMBL625795,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",,8608,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11848,,50597
A,10090.0,,CHEMBL625796,Mus musculus,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,,13792,N,,Intermediate,,,,,,1,1,,BAO_0000218,11849,,50594
A,9615.0,,CHEMBL625797,Canis lupus familiaris,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,,13376,N,,Intermediate,,,,,,1,1,,BAO_0000218,11850,,50588
A,9615.0,,CHEMBL625798,Canis lupus familiaris,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,,13376,N,,Intermediate,,,,,,1,1,,BAO_0000218,11851,,50588
A,,,CHEMBL875613,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11852,,22224
A,,,CHEMBL625799,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11853,,22224
A,,,CHEMBL625800,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11854,,22224
A,,,CHEMBL625801,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11855,,22224
A,,,CHEMBL625802,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11856,,22224
A,,,CHEMBL625803,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11857,,22224
A,,,CHEMBL625804,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000019,11858,,22224
A,,,CHEMBL622530,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,14380,U,,Autocuration,,,,,,1,0,,BAO_0000218,11859,,22224
A,10090.0,,CHEMBL622531,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11860,,50594
A,10090.0,,CHEMBL622532,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11861,,50594
A,10090.0,,CHEMBL623176,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11862,,50594
A,10090.0,,CHEMBL623177,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11863,,50594
A,10090.0,,CHEMBL623178,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11864,,50594
A,10090.0,,CHEMBL623179,Mus musculus,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11865,,50594
A,10090.0,,CHEMBL623180,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11866,,50594
A,10090.0,,CHEMBL623181,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11867,,50594
A,10090.0,,CHEMBL624131,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11868,,50594
A,10090.0,,CHEMBL624132,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11869,,50594
A,10090.0,,CHEMBL624133,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11870,,50594
A,10090.0,,CHEMBL624846,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11871,,50594
A,10090.0,,CHEMBL624847,Mus musculus,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11872,,50594
A,10090.0,,CHEMBL624848,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11873,,50594
A,10090.0,,CHEMBL625012,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11874,,50594
A,10090.0,,CHEMBL625013,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11875,,50594
A,10090.0,,CHEMBL625014,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11876,,50594
A,10090.0,,CHEMBL625015,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11877,,50594
A,10090.0,,CHEMBL625016,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11878,,50594
A,10090.0,,CHEMBL625017,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11879,,50594
A,10090.0,,CHEMBL625018,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11880,,50594
A,10090.0,,CHEMBL625019,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11881,,50594
A,10090.0,,CHEMBL625020,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11882,,50594
A,10090.0,,CHEMBL625021,Mus musculus,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,11883,,50594
A,10116.0,,CHEMBL625022,Rattus norvegicus,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,11884,,50597
A,10090.0,,CHEMBL625023,Mus musculus,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,11885,,50594
A,9541.0,,CHEMBL625024,Macaca fascicularis,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,11886,,100710
A,9541.0,,CHEMBL627626,Macaca fascicularis,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,11887,,100710
A,,,CHEMBL627627,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,13758,U,,Autocuration,,,Brain,955.0,,1,0,,BAO_0000218,11888,,22224
A,,,CHEMBL627628,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,13758,U,,Autocuration,,,Serum,1977.0,,1,0,,BAO_0000218,11889,,22224
A,,,CHEMBL627629,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,13758,U,,Autocuration,,,Brain,955.0,,1,0,,BAO_0000218,11890,,22224
A,,,CHEMBL627630,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,13758,U,,Autocuration,,,Serum,1977.0,,1,0,,BAO_0000218,11891,,22224
A,,,CHEMBL627631,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,16359,U,,Autocuration,,,,,,1,0,,BAO_0000019,11892,,22224
A,,,CHEMBL629515,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,16359,U,,Autocuration,,,,,,1,0,,BAO_0000218,11893,,22224
A,10090.0,,CHEMBL629516,Mus musculus,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11894,,50594
A,10090.0,,CHEMBL629517,Mus musculus,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11895,,50594
A,10090.0,,CHEMBL629518,Mus musculus,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,11896,,50594
A,10090.0,,CHEMBL877499,Mus musculus,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11897,,50594
A,10090.0,,CHEMBL629519,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11898,,50594
A,10090.0,,CHEMBL629520,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11899,,50594
A,10090.0,,CHEMBL629521,Mus musculus,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,,15383,N,,Intermediate,,,,,,1,1,,BAO_0000218,11900,,50594
A,10090.0,,CHEMBL629522,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11901,,50594
A,10090.0,,CHEMBL629523,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11902,,50594
A,10090.0,,CHEMBL629524,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11903,,50594
A,10090.0,,CHEMBL629525,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11904,,50594
A,10090.0,,CHEMBL629526,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11905,,50594
A,10090.0,,CHEMBL629527,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11906,,50594
A,10090.0,,CHEMBL629528,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11907,,50594
A,10090.0,,CHEMBL629529,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11908,,50594
A,10090.0,,CHEMBL629530,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11909,,50594
A,10090.0,,CHEMBL629531,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11910,,50594
A,10090.0,,CHEMBL628656,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11911,,50594
A,10090.0,,CHEMBL628657,Mus musculus,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,11912,,50594
A,10116.0,,CHEMBL628658,Rattus norvegicus,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11913,In vivo,50597
A,10116.0,,CHEMBL628659,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11914,In vivo,50597
A,10116.0,,CHEMBL877500,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11915,In vivo,50597
A,10116.0,,CHEMBL628660,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11916,In vivo,50597
A,10116.0,,CHEMBL628661,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11917,In vivo,50597
A,10116.0,,CHEMBL628662,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11918,In vivo,50597
A,10116.0,,CHEMBL628663,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11919,In vivo,50597
A,10116.0,,CHEMBL628664,Rattus norvegicus,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,11920,In vivo,50597
A,10116.0,,CHEMBL628665,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11921,In vivo,50597
A,10116.0,,CHEMBL628666,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11922,In vivo,50597
A,10116.0,,CHEMBL628667,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11923,In vivo,50597
A,10116.0,,CHEMBL628668,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11924,In vivo,50597
A,10116.0,,CHEMBL628669,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11925,In vivo,50597
A,10116.0,,CHEMBL628670,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11926,In vivo,50597
A,10116.0,,CHEMBL628671,Rattus norvegicus,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11927,In vivo,50597
A,10116.0,,CHEMBL628672,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,11928,In vivo,50597
A,10116.0,,CHEMBL630300,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,11929,In vivo,50597
A,10116.0,,CHEMBL629787,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,11930,In vivo,50597
A,10116.0,,CHEMBL629788,Rattus norvegicus,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,11931,In vivo,50597
A,10116.0,,CHEMBL629789,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11932,In vivo,50597
A,10116.0,,CHEMBL629790,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11933,In vivo,50597
A,10116.0,,CHEMBL629791,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11934,In vivo,50597
A,10116.0,,CHEMBL629792,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11935,In vivo,50597
A,10116.0,,CHEMBL629793,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11936,In vivo,50597
A,10116.0,,CHEMBL629794,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11937,In vivo,50597
A,10116.0,,CHEMBL874459,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11938,,50597
A,10116.0,,CHEMBL629795,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11939,,50597
A,10116.0,,CHEMBL629796,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11940,,50597
A,10116.0,,CHEMBL629797,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11941,,50597
A,10116.0,,CHEMBL629798,Rattus norvegicus,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,,10677,N,,Intermediate,,,,,,1,1,,BAO_0000218,11942,,50597
A,10116.0,,CHEMBL629799,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Adrenal gland,2369.0,,1,1,,BAO_0000218,11943,In vivo,50597
A,10116.0,,CHEMBL629800,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Adrenal gland,2369.0,,1,1,,BAO_0000218,11944,In vivo,50597
A,10116.0,,CHEMBL629801,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Adrenal gland,2369.0,,1,1,,BAO_0000218,11945,In vivo,50597
A,10116.0,,CHEMBL629802,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,,10911,N,,Intermediate,,,Adrenal gland,2369.0,,1,1,,BAO_0000218,11946,In vivo,50597
A,10116.0,,CHEMBL629803,Rattus norvegicus,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Adrenal gland,2369.0,,1,1,,BAO_0000218,11947,In vivo,50597
A,10116.0,,CHEMBL629804,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11948,In vivo,50597
A,10116.0,,CHEMBL629805,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11949,In vivo,50597
A,10116.0,,CHEMBL629806,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11950,In vivo,50597
A,10116.0,,CHEMBL629807,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11951,In vivo,50597
A,10116.0,,CHEMBL629808,Rattus norvegicus,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,11952,In vivo,50597
A,10116.0,,CHEMBL629809,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11953,In vivo,50597
A,10116.0,,CHEMBL629810,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11954,In vivo,50597
A,10116.0,,CHEMBL629811,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11955,In vivo,50597
A,10116.0,,CHEMBL629812,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11956,In vivo,50597
A,10116.0,,CHEMBL629813,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11957,In vivo,50597
A,10116.0,,CHEMBL874460,Rattus norvegicus,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,11958,In vivo,50597
A,10116.0,,CHEMBL629814,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,,,,1,1,,BAO_0000218,11959,In vivo,50597
A,10116.0,,CHEMBL629815,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,,,,1,1,,BAO_0000218,11960,In vivo,50597
A,10116.0,,CHEMBL629816,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,,,,1,1,,BAO_0000218,11961,In vivo,50597
A,10116.0,,CHEMBL629817,Rattus norvegicus,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,,,,1,1,,BAO_0000218,11962,In vivo,50597
A,10116.0,,CHEMBL626643,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11963,In vivo,50597
A,10116.0,,CHEMBL626644,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11964,In vivo,50597
A,10116.0,,CHEMBL626806,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11965,In vivo,50597
A,10116.0,,CHEMBL626807,Rattus norvegicus,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,11966,In vivo,50597
A,10116.0,,CHEMBL627261,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11967,In vivo,50597
A,10116.0,,CHEMBL627262,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11968,In vivo,50597
A,10116.0,,CHEMBL627263,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11969,In vivo,50597
A,10116.0,,CHEMBL627264,Rattus norvegicus,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,11970,In vivo,50597
A,10116.0,,CHEMBL627265,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11971,In vivo,50597
A,10116.0,,CHEMBL627266,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11972,In vivo,50597
A,10116.0,,CHEMBL627267,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11973,In vivo,50597
A,10116.0,,CHEMBL627268,Rattus norvegicus,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,11974,In vivo,50597
A,10116.0,,CHEMBL627269,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11975,In vivo,50597
A,10116.0,,CHEMBL627270,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,11976,In vivo,50597
A,10116.0,,CHEMBL627271,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11977,,50597
A,10116.0,,CHEMBL627946,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11978,,50597
A,10116.0,,CHEMBL875472,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11979,,50597
A,10116.0,,CHEMBL627947,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11980,,50597
A,10116.0,,CHEMBL627948,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11981,,50597
A,10116.0,,CHEMBL628113,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11982,,50597
A,10116.0,,CHEMBL628114,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11983,,50597
A,10116.0,,CHEMBL628115,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11984,,50597
A,10116.0,,CHEMBL628116,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11985,,50597
A,10116.0,,CHEMBL628117,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11986,,50597
A,10116.0,,CHEMBL628118,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11987,,50597
A,10116.0,,CHEMBL628119,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11988,,50597
A,10116.0,,CHEMBL628120,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11989,,50597
A,10116.0,,CHEMBL628121,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11990,,50597
A,10116.0,,CHEMBL628122,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11991,,50597
A,10116.0,,CHEMBL627297,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11992,,50597
A,10116.0,,CHEMBL627298,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11993,,50597
A,10116.0,,CHEMBL627299,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11994,,50597
A,10116.0,,CHEMBL627300,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11995,,50597
A,10116.0,,CHEMBL627301,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11996,,50597
A,10116.0,,CHEMBL627302,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11997,,50597
A,10116.0,,CHEMBL627303,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11998,,50597
A,10116.0,,CHEMBL627304,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,11999,,50597
A,10116.0,,CHEMBL627305,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12000,,50597
A,10116.0,,CHEMBL627306,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12001,,50597
A,10116.0,,CHEMBL623982,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12002,,50597
A,10116.0,,CHEMBL623983,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12003,,50597
A,10116.0,,CHEMBL623984,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12004,,50597
A,10116.0,,CHEMBL623985,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12005,,50597
A,10116.0,,CHEMBL623986,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12006,,50597
A,10116.0,,CHEMBL623987,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12007,,50597
A,10116.0,,CHEMBL623988,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12008,,50597
A,10116.0,,CHEMBL623989,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12009,,50597
A,10116.0,,CHEMBL622215,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12010,,50597
A,10116.0,,CHEMBL622216,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12011,,50597
A,10116.0,,CHEMBL877481,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",,8608,N,,Intermediate,,,,,,1,1,,BAO_0000218,12012,,50597
A,,,CHEMBL622217,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,16359,U,,Autocuration,,,,,,1,0,,BAO_0000218,12013,,22224
A,10090.0,,CHEMBL622218,Mus musculus,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),,13701,N,,Intermediate,,,,,,1,1,,BAO_0000218,12014,,50594
A,10116.0,,CHEMBL622219,Rattus norvegicus,Pharmacokinetic profile AUC was evaluated in rats,,14554,N,,Intermediate,,,,,,1,1,,BAO_0000218,12015,,50597
A,,,CHEMBL622220,,Pharmacokinetic property (Area under curve),,6241,U,,Autocuration,,,,,,1,0,,BAO_0000019,12016,,22224
A,9615.0,,CHEMBL622221,Canis lupus familiaris,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,12017,,50588
A,10090.0,,CHEMBL622222,Mus musculus,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,12018,,50594
A,9615.0,,CHEMBL622223,Canis lupus familiaris,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,12019,,50588
A,10090.0,,CHEMBL622224,Mus musculus,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",,11537,N,,Intermediate,,,,,,1,1,,BAO_0000218,12020,,50594
A,,,CHEMBL622225,,Plasma concentration (AUC) was determined,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,12021,,22224
A,,,CHEMBL622226,,Plasma concentration (AUC) was determined; Not detectable,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,12022,,22224
A,10141.0,,CHEMBL624154,Cavia porcellus,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),,9562,N,,Intermediate,,,,,,1,1,,BAO_0000218,12023,,50512
A,10116.0,,CHEMBL624155,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,,10363,N,,Intermediate,,,,,,1,1,,BAO_0000218,12024,,50597
A,10116.0,,CHEMBL624156,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,,10363,N,,Intermediate,,,,,,1,1,,BAO_0000218,12025,,50597
A,10116.0,,CHEMBL624157,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,,10363,N,,Intermediate,,,,,,1,1,,BAO_0000218,12026,,50597
A,10116.0,,CHEMBL624158,Rattus norvegicus,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,,10363,N,,Intermediate,,,,,,1,1,,BAO_0000218,12027,,50597
A,10116.0,,CHEMBL624159,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,12028,,50597
A,10116.0,,CHEMBL624160,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,12029,,50597
A,10116.0,,CHEMBL624161,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,12030,,50597
A,10116.0,,CHEMBL624162,Rattus norvegicus,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,12031,,50597
A,9615.0,,CHEMBL624163,Canis lupus familiaris,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,,13317,N,,Intermediate,,,,,,1,1,,BAO_0000218,12032,,50588
A,10116.0,,CHEMBL624164,Rattus norvegicus,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,12033,,50597
A,10116.0,,CHEMBL624165,Rattus norvegicus,The AUC(0-infinity) values in female wistar rats.,,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,12034,,50597
A,10116.0,,CHEMBL624166,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,12035,,50597
A,10116.0,,CHEMBL624167,Rattus norvegicus,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,12036,,50597
A,10116.0,,CHEMBL624168,Rattus norvegicus,The AUC(0-t)values in female wistar rats.,,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,12037,,50597
A,10116.0,,CHEMBL624169,Rattus norvegicus,The Area under the concentration time curve of compound was measured on rats,,14067,N,,Intermediate,,,,,,1,1,,BAO_0000218,12038,,50597
A,9606.0,,CHEMBL624170,Homo sapiens,The area under curve (100 mg/kg) administered orally in humans,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12039,,50587
A,9481.0,,CHEMBL624171,Callithrix,The area under curve (12.5 mg/kg) administered intravenously in marmoset,,14215,U,,Autocuration,,,,,,1,0,,BAO_0000218,12040,,22224
A,314293.0,,CHEMBL624172,Simiiformes,The area under curve (12.5 mg/kg) administered intravenously in monkey,,14215,U,,Autocuration,,,,,,1,0,,BAO_0000218,12041,,22224
A,9615.0,,CHEMBL624173,Canis lupus familiaris,The area under curve (15 mg/kg) administered intravenously in dog,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12042,,50588
A,9606.0,,CHEMBL877488,Homo sapiens,The area under curve (200 mg/kg) administered orally in humans,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12043,,50587
A,10116.0,,CHEMBL624174,Rattus norvegicus,The area under curve (25 mg/kg) administered intravenously in rat,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12044,,50597
A,9481.0,,CHEMBL624175,Callithrix,The area under curve (25 mg/kg) administered orally in marmoset,,14215,U,,Autocuration,,,,,,1,0,,BAO_0000218,12045,,22224
A,314293.0,,CHEMBL624176,Simiiformes,The area under curve (25 mg/kg) administered orally in monkey,,14215,U,,Autocuration,,,,,,1,0,,BAO_0000218,12046,,22224
A,9615.0,,CHEMBL624177,Canis lupus familiaris,The area under curve (30 mg/kg) administered orally in dog,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12047,,50588
A,9606.0,,CHEMBL624178,Homo sapiens,The area under curve (400 mg/kg) administered orally in humans,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12048,,50587
A,10116.0,,CHEMBL624179,Rattus norvegicus,The area under curve (50 mg/kg) administered orally in fasted rat,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12049,,50597
A,10116.0,,CHEMBL627689,Rattus norvegicus,The area under curve (50 mg/kg) administered orally in rat,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12050,,50597
A,9606.0,,CHEMBL627690,Homo sapiens,The area under curve (800 mg/kg) administered orally in humans,,14215,N,,Intermediate,,,,,,1,1,,BAO_0000218,12051,,50587
A,,,CHEMBL627691,,The compound was evaluated for area under the curve,,11324,U,,Autocuration,,,,,,1,0,,BAO_0000019,12052,,22224
A,9481.0,,CHEMBL627692,Callithrix,The compound was evaluated for area under the curve in marmosets,,11324,U,,Autocuration,,,,,,1,0,,BAO_0000019,12053,,22224
A,9481.0,,CHEMBL627693,Callithrix,The compound was evaluated for area under the curve in marmosets,,11324,U,,Autocuration,,,,,,1,0,,BAO_0000019,12054,,22224
A,10116.0,,CHEMBL627694,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,N,,Intermediate,,,,,,1,1,,BAO_0000218,12055,,50597
A,10116.0,,CHEMBL627695,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,N,,Intermediate,,,,,,1,1,,BAO_0000218,12056,,50597
A,,,CHEMBL627696,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,13875,U,,Autocuration,,,,,,1,0,,BAO_0000218,12057,,22224
A,10116.0,,CHEMBL627697,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,N,,Intermediate,,,,,,1,1,,BAO_0000218,12058,,50597
A,10116.0,,CHEMBL627698,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,N,,Intermediate,,,,,,1,1,,BAO_0000218,12059,,50597
A,10116.0,,CHEMBL627699,Rattus norvegicus,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,,13875,N,,Intermediate,,,,,,1,1,,BAO_0000218,12060,,50597
A,10116.0,,CHEMBL627700,Rattus norvegicus,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,,13807,N,,Intermediate,,,,,,1,1,,BAO_0000218,12061,,50597
A,10116.0,,CHEMBL627701,Rattus norvegicus,Total drug exposure is determined after oral dosing in rats.,,14127,N,,Intermediate,,,,,,1,1,,BAO_0000218,12062,,50597
A,,,CHEMBL627702,,Total drug exposure (5 mg/kg) when administered intravenously,,15116,U,,Autocuration,,,,,,1,0,,BAO_0000218,12063,,22224
A,,,CHEMBL627703,,Total drug exposure (5 mg/kg) when administered orally,,15116,U,,Autocuration,,,,,,1,0,,BAO_0000218,12064,,22224
A,314293.0,,CHEMBL626873,Simiiformes,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,15604,U,,Autocuration,,,,,,1,0,,BAO_0000218,12065,,22224
A,10116.0,,CHEMBL629583,Rattus norvegicus,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,15604,N,,Intermediate,,,,,,1,1,,BAO_0000218,12066,,50597
A,9615.0,,CHEMBL629584,Canis lupus familiaris,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,15604,N,,Intermediate,,,,,,1,1,,BAO_0000218,12067,,50588
A,9615.0,,CHEMBL629585,Canis lupus familiaris,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,,15604,N,,Intermediate,,,,,,1,1,,BAO_0000218,12068,,50588
A,10116.0,,CHEMBL629586,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12069,In vivo,50597
A,10116.0,,CHEMBL629587,Rattus norvegicus,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12070,In vivo,50597
A,10116.0,,CHEMBL629588,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12071,In vivo,50597
A,10116.0,,CHEMBL629589,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12072,In vivo,50597
A,10116.0,,CHEMBL629590,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12073,In vivo,50597
A,10116.0,,CHEMBL629591,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12074,In vivo,50597
A,10116.0,,CHEMBL629592,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12075,In vivo,50597
A,10116.0,,CHEMBL629593,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12076,In vivo,50597
A,10116.0,,CHEMBL629594,Rattus norvegicus,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12077,In vivo,50597
A,10116.0,,CHEMBL629595,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12078,In vivo,50597
A,10116.0,,CHEMBL630290,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12079,In vivo,50597
A,10116.0,,CHEMBL627137,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12080,In vivo,50597
A,10116.0,,CHEMBL627138,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12081,In vivo,50597
A,10116.0,,CHEMBL627139,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12082,In vivo,50597
A,10116.0,,CHEMBL627140,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12083,In vivo,50597
A,10116.0,,CHEMBL627141,Rattus norvegicus,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12084,In vivo,50597
A,10116.0,,CHEMBL627142,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12085,In vivo,50597
A,10116.0,,CHEMBL627143,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12086,In vivo,50597
A,10116.0,,CHEMBL874449,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12087,In vivo,50597
A,10116.0,,CHEMBL627144,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12088,In vivo,50597
A,10116.0,,CHEMBL627145,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12089,In vivo,50597
A,10116.0,,CHEMBL627146,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12090,In vivo,50597
A,10116.0,,CHEMBL627147,Rattus norvegicus,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12091,In vivo,50597
A,10116.0,,CHEMBL627148,Rattus norvegicus,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12092,In vivo,50597
A,10116.0,,CHEMBL627149,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12093,In vivo,50597
A,10116.0,,CHEMBL632160,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12094,In vivo,50597
A,10116.0,,CHEMBL632161,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12095,In vivo,50597
A,10116.0,,CHEMBL632162,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12096,In vivo,50597
A,10116.0,,CHEMBL632163,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12097,In vivo,50597
A,10116.0,,CHEMBL874469,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12098,In vivo,50597
A,10116.0,,CHEMBL627182,Rattus norvegicus,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12099,In vivo,50597
A,10116.0,,CHEMBL627183,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12100,In vivo,50597
A,10116.0,,CHEMBL627184,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12101,In vivo,50597
A,10116.0,,CHEMBL627185,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12102,In vivo,50597
A,10116.0,,CHEMBL627186,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12103,In vivo,50597
A,10116.0,,CHEMBL627187,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12104,In vivo,50597
A,10116.0,,CHEMBL627188,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12105,In vivo,50597
A,10116.0,,CHEMBL627189,Rattus norvegicus,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12106,In vivo,50597
A,10116.0,,CHEMBL627190,Rattus norvegicus,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,,,,1,1,,BAO_0000218,12107,In vivo,50597
A,10116.0,,CHEMBL627191,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12108,In vivo,50597
A,10116.0,,CHEMBL627192,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12109,In vivo,50597
A,10116.0,,CHEMBL627193,Rattus norvegicus,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12110,In vivo,50597
A,10116.0,,CHEMBL874590,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12111,In vivo,50597
A,10116.0,,CHEMBL627194,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12112,In vivo,50597
A,10116.0,,CHEMBL627195,Rattus norvegicus,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12113,In vivo,50597
A,10116.0,,CHEMBL627196,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,12114,In vivo,50597
A,10116.0,,CHEMBL627197,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,12115,In vivo,50597
A,10116.0,,CHEMBL627198,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,12116,In vivo,50597
A,10116.0,,CHEMBL627199,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,,10911,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,12117,In vivo,50597
A,10116.0,,CHEMBL627200,Rattus norvegicus,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Female gonad,992.0,,1,1,,BAO_0000218,12118,In vivo,50597
A,10116.0,,CHEMBL627201,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12119,In vivo,50597
A,10116.0,,CHEMBL627202,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12120,In vivo,50597
A,10116.0,,CHEMBL627203,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12121,In vivo,50597
A,10116.0,,CHEMBL627204,Rattus norvegicus,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12122,In vivo,50597
A,10116.0,,CHEMBL627205,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12123,In vivo,50597
A,10116.0,,CHEMBL627206,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12124,In vivo,50597
A,10116.0,,CHEMBL627207,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12125,In vivo,50597
A,10116.0,,CHEMBL627208,Rattus norvegicus,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12126,In vivo,50597
A,10116.0,,CHEMBL627209,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12127,In vivo,50597
A,10116.0,,CHEMBL627210,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12128,In vivo,50597
A,10116.0,,CHEMBL627211,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12129,In vivo,50597
A,10116.0,,CHEMBL627212,Rattus norvegicus,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12130,In vivo,50597
A,10116.0,,CHEMBL627213,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12131,In vivo,50597
A,10116.0,,CHEMBL626599,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12132,In vivo,50597
A,10116.0,,CHEMBL626600,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12133,In vivo,50597
A,10116.0,,CHEMBL626601,Rattus norvegicus,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,,10911,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12134,In vivo,50597
A,,,CHEMBL627484,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,8081,U,,Autocuration,,,,,,1,0,,BAO_0000019,12135,,22224
A,9541.0,,CHEMBL627485,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12136,,100710
A,9541.0,,CHEMBL628147,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12137,,100710
A,9541.0,,CHEMBL628148,Macaca fascicularis,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12138,,100710
A,9615.0,,CHEMBL628149,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12139,,50588
A,9615.0,,CHEMBL628150,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12140,,50588
A,9615.0,,CHEMBL628318,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12141,,50588
A,9615.0,,CHEMBL628319,Canis lupus familiaris,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,,17248,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12142,,50588
A,9615.0,,CHEMBL875609,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,15592,N,,Intermediate,,,,,,1,1,,BAO_0000218,12143,,50588
A,,,CHEMBL628320,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12144,,22224
A,,,CHEMBL628321,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12145,,22224
A,,,CHEMBL628322,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12146,,22224
A,,,CHEMBL628323,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12147,,22224
A,,,CHEMBL628324,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12148,,22224
A,,,CHEMBL628325,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12149,,22224
A,,,CHEMBL628326,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,7040,U,,Autocuration,,,,,,1,0,,BAO_0000019,12150,,22224
A,9615.0,,CHEMBL628327,Canis lupus familiaris,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12151,,50588
A,9615.0,,CHEMBL628328,Canis lupus familiaris,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",,9614,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12152,,50588
A,9615.0,,CHEMBL628329,Canis lupus familiaris,"Concentration of compound in blood of dog 1, after administering intravenously",,9614,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12153,,50588
A,10116.0,,CHEMBL628330,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12154,,50597
A,10116.0,,CHEMBL628331,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12155,,50597
A,10116.0,,CHEMBL628332,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12156,,50597
A,10116.0,,CHEMBL628333,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12157,,50597
A,10116.0,,CHEMBL628334,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12158,,50597
A,10116.0,,CHEMBL628335,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12159,,50597
A,10116.0,,CHEMBL628336,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12160,,50597
A,10116.0,,CHEMBL628337,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12161,,50597
A,10116.0,,CHEMBL628338,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12162,,50597
A,10116.0,,CHEMBL875610,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12163,,50597
A,10116.0,,CHEMBL628339,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12164,,50597
A,10116.0,,CHEMBL628340,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12165,,50597
A,10116.0,,CHEMBL628341,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12166,,50597
A,10116.0,,CHEMBL622214,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12167,,50597
A,10116.0,,CHEMBL623167,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12168,,50597
A,10116.0,,CHEMBL623168,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12169,,50597
A,10116.0,,CHEMBL623169,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12170,,50597
A,10116.0,,CHEMBL623170,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",,8608,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12171,,50597
A,10116.0,,CHEMBL627224,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12172,,50597
A,10116.0,,CHEMBL875634,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12173,,50597
A,10116.0,,CHEMBL627225,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12174,,50597
A,10116.0,,CHEMBL627226,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12175,,50597
A,10116.0,,CHEMBL626083,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12176,,50597
A,10116.0,,CHEMBL626084,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12177,,50597
A,10116.0,,CHEMBL626085,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12178,,50597
A,10116.0,,CHEMBL626086,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12179,,50597
A,10116.0,,CHEMBL626087,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12180,,50597
A,10116.0,,CHEMBL626088,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12181,,50597
A,10116.0,,CHEMBL626089,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12182,,50597
A,10116.0,,CHEMBL626090,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12183,,50597
A,10116.0,,CHEMBL626091,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12184,,50597
A,10116.0,,CHEMBL626092,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12185,,50597
A,10116.0,,CHEMBL626093,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12186,,50597
A,10116.0,,CHEMBL626094,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12187,,50597
A,10116.0,,CHEMBL626095,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12188,,50597
A,10116.0,,CHEMBL626096,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",,8608,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12189,,50597
A,314293.0,,CHEMBL626097,Simiiformes,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,,15604,U,,Autocuration,,,,,,1,0,,BAO_0000218,12190,,22224
A,10116.0,,CHEMBL626098,Rattus norvegicus,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,,15604,N,,Intermediate,,,,,,1,1,,BAO_0000218,12191,,50597
A,,,CHEMBL626099,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,1806,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,12192,,22224
A,,,CHEMBL626100,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,1806,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,12193,,22224
A,9615.0,,CHEMBL626101,Canis lupus familiaris,AUC 0-inf in dog,,17237,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12194,,50588
A,10141.0,,CHEMBL626102,Cavia porcellus,AUC 0-inf in guinea pig,,17237,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12195,,50512
A,9615.0,,CHEMBL626103,Canis lupus familiaris,AUC 0-t in dog,,17237,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12196,,50588
A,10141.0,,CHEMBL628391,Cavia porcellus,AUC 0-t in guinea pig,,17237,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12197,,50512
A,10116.0,,CHEMBL628392,Rattus norvegicus,The compound was tested for brain to plasma partition in rat,,15194,N,,Intermediate,,,,,,1,1,,BAO_0000218,12198,,50597
A,10116.0,,CHEMBL628393,Rattus norvegicus,The compound was tested for brain to plasma partition in rat.,,15194,N,,Intermediate,,,,,,1,1,,BAO_0000218,12199,,50597
A,,,CHEMBL628394,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,8787,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000019,12200,,22224
A,9615.0,,CHEMBL628395,Canis lupus familiaris,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12201,,50588
A,314293.0,,CHEMBL628396,Simiiformes,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,,17025,U,,Autocuration,,,,,,1,0,,BAO_0000218,12202,,22224
A,9986.0,,CHEMBL628397,Oryctolagus cuniculus,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12203,,50592
A,10116.0,,CHEMBL628398,Rattus norvegicus,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12204,,50597
A,9544.0,,CHEMBL628399,Macaca mulatta,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,,4236,N,,Intermediate,,,,,,1,1,,BAO_0000218,12205,,50797
A,9615.0,,CHEMBL628400,Canis lupus familiaris,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,,15343,N,,Intermediate,,,,,,1,1,,BAO_0000218,12206,,50588
A,10116.0,,CHEMBL874907,Rattus norvegicus,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,,15343,N,,Intermediate,,,,,,1,1,,BAO_0000218,12207,,50597
A,,,CHEMBL628401,,Area under curve of the compound was determined,,17720,U,,Autocuration,,,,,,1,0,,BAO_0000019,12208,,22224
A,314293.0,,CHEMBL628402,Simiiformes,AUC in monkeys at a dose of 1 mg/kg,,17788,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,12209,,22224
A,10116.0,,CHEMBL628403,Rattus norvegicus,AUC in rats at a dose of 1 mg/kg,,17788,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12210,,50597
A,,,CHEMBL628404,,Compound was evaluated for the overall absorbance loss at pH of 2,,8778,U,,Autocuration,,,,,,1,0,,BAO_0000019,12211,,22224
A,,,CHEMBL628405,,Compound was evaluated for the overall absorbance loss at pH of 4,,8778,U,,Autocuration,,,,,,1,0,,BAO_0000019,12212,,22224
A,,,CHEMBL628406,,Compound was evaluated for the overall absorbance loss at pH of 7,,8778,U,,Autocuration,,,,,,1,0,,BAO_0000019,12213,,22224
A,10116.0,,CHEMBL628407,Rattus norvegicus,Compound was evaluated for its absorption in the rats,,2249,N,,Intermediate,,,,,,1,1,,BAO_0000218,12214,,50597
A,10116.0,,CHEMBL628408,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,8881,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12215,,50597
A,10116.0,,CHEMBL629171,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,,8881,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12216,,50597
A,10116.0,,CHEMBL629172,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,,8881,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12217,,50597
A,10116.0,,CHEMBL629173,Rattus norvegicus,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,,8881,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12218,,50597
A,10116.0,,CHEMBL629174,Rattus norvegicus,In vitro percent permeability into rat ileum,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12219,,50597
A,10116.0,,CHEMBL629175,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-17,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12220,,50597
A,10116.0,,CHEMBL629176,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-18,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12221,,50597
A,10116.0,,CHEMBL629177,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 10-19,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12222,,50597
A,10116.0,,CHEMBL629178,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 12-15,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12223,,50597
A,10116.0,,CHEMBL631869,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 13-19,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12224,,50597
A,10116.0,,CHEMBL631870,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 14-17,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12225,,50597
A,10116.0,,CHEMBL631871,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 15-18,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12226,,50597
A,10116.0,,CHEMBL631872,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 2-5,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12227,,50597
A,,,CHEMBL875775,,In vitro percent permeability into rat ileum; Range is 23-42,,15286,U,,Autocuration,,,Ileum,2116.0,,1,0,,BAO_0000221,12228,,22224
A,10116.0,,CHEMBL631873,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 28-36,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12229,,50597
A,10116.0,,CHEMBL631874,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 29-35,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12230,,50597
A,10116.0,,CHEMBL631875,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 46-66,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12231,,50597
A,10116.0,,CHEMBL631876,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 50-68,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12232,,50597
A,10116.0,,CHEMBL631877,Rattus norvegicus,In vitro percent permeability into rat ileum; Range is 78-81,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12233,,50597
A,10116.0,,CHEMBL631878,Rattus norvegicus,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12234,,50597
A,10116.0,,CHEMBL631879,Rattus norvegicus,In vitro percent permeability into rat ileum; nd indicates not detected,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12235,,50597
A,10116.0,,CHEMBL631880,Rattus norvegicus,In vitro percent permeability into rat ileum; nt indicates not detected,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12236,,50597
A,10116.0,,CHEMBL631881,Rattus norvegicus,In vitro percent permeability into rat ileum; nt indicates not tested,,15286,N,,Intermediate,,,,,,1,1,,BAO_0000218,12237,,50597
A,10116.0,,CHEMBL631882,Rattus norvegicus,Compound was tested for oral absorption in bile-duct cannulated rats,,13770,N,,Intermediate,,,,,,1,1,,BAO_0000218,12238,,50597
A,10116.0,,CHEMBL630749,Rattus norvegicus,Compound was tested for oral absorption in bile-duct cannulated rats.,,13770,N,,Intermediate,,,,,,1,1,,BAO_0000218,12239,,50597
A,9606.0,,CHEMBL630750,Homo sapiens,Oral absorption using Caco-2 cell monolayers.,,5202,N,,Intermediate,,,,,,1,1,,BAO_0000218,12240,,50587
A,9606.0,,CHEMBL630253,Homo sapiens,Percent of the drug absorbed after administration to humans was determined,,14920,N,,Intermediate,,,,,,1,1,,BAO_0000218,12241,,50587
A,10116.0,,CHEMBL630254,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12242,,50597
A,10116.0,,CHEMBL630255,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12243,,50597
A,10116.0,,CHEMBL630256,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12244,,50597
A,10116.0,,CHEMBL875781,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12245,In vivo,50597
A,10116.0,,CHEMBL630257,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12246,In vivo,50597
A,10116.0,,CHEMBL630258,Rattus norvegicus,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",,13751,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12247,In vivo,50597
A,10116.0,,CHEMBL630259,Rattus norvegicus,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",,15807,N,,Intermediate,,,,,,1,1,,BAO_0000218,12248,,50597
A,10116.0,,CHEMBL630260,Rattus norvegicus,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",,15807,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,12249,,50597
A,10116.0,,CHEMBL630261,Rattus norvegicus,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",,15807,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,12250,,50597
A,10116.0,,CHEMBL630262,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12251,,50597
A,10116.0,,CHEMBL630263,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12252,,50597
A,10116.0,,CHEMBL630264,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12253,,50597
A,10116.0,,CHEMBL630265,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12254,,50597
A,10116.0,,CHEMBL630266,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12255,,50597
A,10116.0,,CHEMBL630267,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,,14950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12256,,50597
A,10116.0,,CHEMBL630268,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,,14950,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12257,,50597
A,10116.0,,CHEMBL630269,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12258,,50597
A,10116.0,,CHEMBL630270,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12259,,50597
A,10116.0,,CHEMBL630141,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,,14950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12260,,50597
A,10116.0,,CHEMBL630142,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,,14950,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12261,,50597
A,10116.0,,CHEMBL630143,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,,14950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12262,,50597
A,10116.0,,CHEMBL630144,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,,14950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12263,,50597
A,10116.0,,CHEMBL630145,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,,14950,N,,Intermediate,,,Prostate gland,2367.0,,1,1,,BAO_0000218,12264,,50597
A,10116.0,,CHEMBL630146,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,,14950,N,,Intermediate,,,Prostate gland,2367.0,,1,1,,BAO_0000218,12265,,50597
A,10116.0,,CHEMBL630147,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12266,,50597
A,10116.0,,CHEMBL630148,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12267,,50597
A,10116.0,,CHEMBL630149,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12268,,50597
A,10116.0,,CHEMBL630150,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,,14950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12269,,50597
A,10116.0,,CHEMBL630151,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,,14950,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12270,,50597
A,10116.0,,CHEMBL632031,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,,14950,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12271,,50597
A,10116.0,,CHEMBL632032,Rattus norvegicus,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,,14950,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12272,,50597
A,10116.0,,CHEMBL632033,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12273,,50597
A,10116.0,,CHEMBL632034,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12274,,50597
A,10116.0,,CHEMBL632035,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,,14950,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12275,,50597
A,10116.0,,CHEMBL632036,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,,14950,N,,Intermediate,,,,,,1,1,,BAO_0000218,12276,,50597
A,10116.0,,CHEMBL632037,Rattus norvegicus,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,,14950,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12277,,50597
A,10116.0,,CHEMBL632038,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12278,,50597
A,10116.0,,CHEMBL632039,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12279,,50597
A,10116.0,,CHEMBL632040,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12280,,50597
A,10116.0,,CHEMBL632041,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12281,,50597
A,9615.0,,CHEMBL632042,Canis lupus familiaris,"Concentration of compound in blood of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12282,,50588
A,9615.0,,CHEMBL632043,Canis lupus familiaris,"Concentration of compound in left ventricle of dog 1, after administering intravenously",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,12283,,50588
A,9615.0,,CHEMBL632044,Canis lupus familiaris,"Concentration of compound in left ventricle of dog 2, after administering intravenously",,9614,N,,Intermediate,,,,,,1,1,,BAO_0000218,12284,,50588
A,9615.0,,CHEMBL632045,Canis lupus familiaris,"Concentration of compound in liver of dog 1, after administering intravenously",,9614,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12285,,50588
A,9615.0,,CHEMBL632046,Canis lupus familiaris,"Concentration of compound in liver of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12286,,50588
A,9615.0,,CHEMBL632047,Canis lupus familiaris,"Concentration of compound in lung of dog 1, after administering intravenously",,9614,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12287,,50588
A,9615.0,,CHEMBL632048,Canis lupus familiaris,"Concentration of compound in lung of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12288,,50588
A,9615.0,,CHEMBL632049,Canis lupus familiaris,"Concentration of compound in muscle of dog 1, after administering intravenously",,9614,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12289,,50588
A,9615.0,,CHEMBL876418,Canis lupus familiaris,"Concentration of compound in muscle of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12290,,50588
A,9615.0,,CHEMBL632050,Canis lupus familiaris,"Concentration of compound in spleen of dog 1,after administering intravenously",,9614,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12291,,50588
A,9615.0,,CHEMBL632051,Canis lupus familiaris,"Concentration of compound in spleen of dog 2, after administering intravenously",,9614,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12292,,50588
F,,,CHEMBL632052,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,10353,U,,Autocuration,,,,,,1,0,,BAO_0000218,12293,,22224
F,,,CHEMBL632053,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,10353,U,,Autocuration,,,,,,1,0,,BAO_0000218,12294,,22224
A,,,CHEMBL632054,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,10353,U,,Autocuration,,,,,,1,0,,BAO_0000218,12295,,22224
F,,,CHEMBL632055,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,10353,U,,Autocuration,,,,,,1,0,,BAO_0000218,12296,,22224
F,,,CHEMBL631181,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,10353,U,,Autocuration,,,,,,1,0,,BAO_0000218,12297,,22224
A,,,CHEMBL631182,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12298,,22224
A,,,CHEMBL631183,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12299,,22224
A,,,CHEMBL631184,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12300,,22224
A,,,CHEMBL629774,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12301,,22224
A,,,CHEMBL629775,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12302,,22224
A,,,CHEMBL876549,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12303,,22224
A,,,CHEMBL628172,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12304,,22224
A,,,CHEMBL628173,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12305,,22224
A,,,CHEMBL628174,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12306,,22224
A,,,CHEMBL628175,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12307,,22224
A,,,CHEMBL628176,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12308,,22224
A,,,CHEMBL628177,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12309,,22224
A,,,CHEMBL628178,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12310,,22224
A,,,CHEMBL628179,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12311,,22224
A,,,CHEMBL628180,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12312,,22224
A,,,CHEMBL628181,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12313,,22224
A,,,CHEMBL628182,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12314,,22224
A,,,CHEMBL628183,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12315,,22224
A,,,CHEMBL628184,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12316,,22224
A,,,CHEMBL628185,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12317,,22224
A,,,CHEMBL875617,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12318,,22224
A,,,CHEMBL628186,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12319,,22224
A,,,CHEMBL628187,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12320,,22224
A,,,CHEMBL628188,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12321,,22224
A,,,CHEMBL628189,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12322,,22224
A,,,CHEMBL628190,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12323,,22224
A,,,CHEMBL628191,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12324,,22224
A,,,CHEMBL626513,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12325,,22224
A,10116.0,,CHEMBL626514,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12326,,50597
A,10116.0,,CHEMBL626515,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12327,,50597
A,10116.0,,CHEMBL626516,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12328,,50597
A,10116.0,,CHEMBL626517,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12329,,50597
A,10116.0,,CHEMBL626518,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12330,,50597
A,10116.0,,CHEMBL626519,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12331,,50597
A,10116.0,,CHEMBL626520,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12332,,50597
A,10116.0,,CHEMBL626521,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12333,,50597
A,10116.0,,CHEMBL626522,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12334,,50597
A,10116.0,,CHEMBL626523,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12335,,50597
A,10116.0,,CHEMBL626524,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12336,,50597
A,10116.0,,CHEMBL626688,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12337,,50597
A,10116.0,,CHEMBL626689,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12338,,50597
A,10116.0,,CHEMBL626690,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12339,,50597
A,10116.0,,CHEMBL626691,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12340,,50597
A,10116.0,,CHEMBL627319,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12341,,50597
A,10116.0,,CHEMBL624052,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12342,,50597
A,10116.0,,CHEMBL624053,Rattus norvegicus,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",,8608,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12343,,50597
A,10116.0,,CHEMBL624054,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,,,,1,1,,BAO_0000218,12344,,50597
A,10116.0,,CHEMBL624055,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,,,,1,1,,BAO_0000218,12345,,50597
A,10116.0,,CHEMBL624056,Rattus norvegicus,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,,,,1,1,,BAO_0000218,12346,,50597
A,10116.0,,CHEMBL624057,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12347,,50597
A,10116.0,,CHEMBL622281,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12348,,50597
A,10116.0,,CHEMBL622282,Rattus norvegicus,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12349,,50597
A,10116.0,,CHEMBL622283,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12350,,50597
A,10116.0,,CHEMBL622284,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12351,,50597
A,10116.0,,CHEMBL622285,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12352,,50597
A,10116.0,,CHEMBL622286,Rattus norvegicus,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,,8085,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,12353,,50597
P,,,CHEMBL622287,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,7657,U,,Autocuration,,,,,,1,0,,BAO_0000100,12354,,22224
A,10090.0,,CHEMBL622288,Mus musculus,Partition coefficient (logD7.4),,8935,N,,Intermediate,,,,,,1,1,,BAO_0000218,12355,,50594
A,10090.0,,CHEMBL622289,Mus musculus,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,13792,N,,Intermediate,,,,,,1,1,,BAO_0000218,12356,,50594
A,10090.0,,CHEMBL622290,Mus musculus,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12357,,50594
A,10090.0,,CHEMBL622291,Mus musculus,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,13792,N,,Intermediate,,,,,,1,1,,BAO_0000218,12358,,50594
A,10090.0,,CHEMBL622292,Mus musculus,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12359,,50594
A,10090.0,,CHEMBL622293,Mus musculus,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",,13792,N,,Intermediate,,,,,,1,1,,BAO_0000218,12360,,50594
A,10090.0,,CHEMBL622294,Mus musculus,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12361,,50594
A,10090.0,,CHEMBL622295,Mus musculus,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,,13792,N,,Intermediate,,,,,,1,1,,BAO_0000218,12362,,50594
A,10116.0,,CHEMBL622296,Rattus norvegicus,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12363,,50597
A,10116.0,,CHEMBL874409,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12364,,50597
A,10116.0,,CHEMBL622297,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12365,,50597
A,10116.0,,CHEMBL622298,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12366,,50597
A,10116.0,,CHEMBL622299,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12367,,50597
A,10116.0,,CHEMBL622300,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12368,,50597
A,10116.0,,CHEMBL622301,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12369,,50597
A,10116.0,,CHEMBL622302,Rattus norvegicus,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12370,,50597
A,10116.0,,CHEMBL622303,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12371,,50597
A,10116.0,,CHEMBL622304,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12372,,50597
A,10116.0,,CHEMBL622305,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12373,,50597
A,10116.0,,CHEMBL622306,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12374,,50597
A,10116.0,,CHEMBL626864,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12375,,50597
A,10116.0,,CHEMBL626865,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12376,,50597
A,10116.0,,CHEMBL626866,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12377,,50597
A,10116.0,,CHEMBL626867,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12378,,50597
A,10116.0,,CHEMBL626868,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12379,,50597
A,10116.0,,CHEMBL626869,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12380,,50597
A,10116.0,,CHEMBL626870,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12381,,50597
A,10116.0,,CHEMBL626871,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12382,,50597
A,10116.0,,CHEMBL626872,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12383,,50597
A,10116.0,,CHEMBL632185,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12384,,50597
A,10116.0,,CHEMBL632186,Rattus norvegicus,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,,14103,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12385,,50597
A,,,CHEMBL629310,,Amount of acetic acid produced by the compound,,12904,U,,Autocuration,,,,,,1,0,,BAO_0000019,12386,,22224
A,,,CHEMBL629311,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,12904,U,,Autocuration,,,,,,1,0,,BAO_0000019,12387,,22224
A,10116.0,,CHEMBL629312,Rattus norvegicus,Log of (Cbrain/Cblood) in rats,,9663,N,,Intermediate,,,,,,1,1,,BAO_0000218,12388,,50597
A,,,CHEMBL629313,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000221,12389,,22224
A,,,CHEMBL629314,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000221,12390,,22224
A,,,CHEMBL629315,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000221,12391,,22224
B,,,CHEMBL629316,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000219,12392,,22224
A,,,CHEMBL629317,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000221,12393,,22224
A,,,CHEMBL629318,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12394,,22224
A,,,CHEMBL877497,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12395,,22224
A,,,CHEMBL629319,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12396,,22224
A,,,CHEMBL629320,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12397,,22224
A,,,CHEMBL629496,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12398,,22224
A,,,CHEMBL629497,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12399,,22224
A,,,CHEMBL629498,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12400,,22224
A,,,CHEMBL629499,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12401,,22224
A,,,CHEMBL629500,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12402,,22224
A,,,CHEMBL629501,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12403,,22224
A,,,CHEMBL629502,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,7652,U,,Autocuration,,,,,,1,0,,BAO_0000019,12404,,22224
F,,,CHEMBL629503,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,8267,U,,Autocuration,,,,,,1,0,,BAO_0000218,12405,In vivo,22224
A,9615.0,,CHEMBL629504,Canis lupus familiaris,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,,8267,N,,Intermediate,,,,,,1,1,,BAO_0000218,12406,,50588
A,,,CHEMBL629505,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,14479,U,,Autocuration,,,,,,1,0,,BAO_0000019,12407,,22224
A,,,CHEMBL629506,,Compound was evaluated for total body clearance,,17515,U,,Autocuration,,,,,,1,0,,BAO_0000019,12408,,22224
A,,,CHEMBL629507,,Compound was evaluated for volume of distribution at steady state,,17515,U,,Autocuration,,,,,,1,0,,BAO_0000019,12409,,22224
A,,,CHEMBL877498,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,8142,U,,Autocuration,,,,,,1,0,,BAO_0000019,12410,,22224
A,,,CHEMBL629508,,Percentage of the diamine which is monoprotonated at pH 7.4,,14849,U,,Autocuration,,,,,,1,0,,BAO_0000019,12411,,22224
A,,,CHEMBL629509,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,7653,U,,Autocuration,,,,,,1,0,,BAO_0000019,12412,,22224
A,10116.0,,CHEMBL629510,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12413,,50597
A,10116.0,,CHEMBL629511,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12414,,50597
A,10116.0,,CHEMBL629512,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12415,,50597
A,10116.0,,CHEMBL629513,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12416,,50597
A,10116.0,,CHEMBL629514,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12417,,50597
A,10116.0,,CHEMBL628447,Rattus norvegicus,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12418,,50597
A,10116.0,,CHEMBL628448,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12419,,50597
A,10116.0,,CHEMBL628449,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12420,,50597
A,10116.0,,CHEMBL631119,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12421,,50597
A,10116.0,,CHEMBL631120,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12422,,50597
A,10116.0,,CHEMBL631121,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12423,,50597
A,10116.0,,CHEMBL874458,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12424,,50597
A,10116.0,,CHEMBL631122,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12425,,50597
A,10116.0,,CHEMBL631123,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12426,,50597
A,10116.0,,CHEMBL631124,Rattus norvegicus,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12427,,50597
A,10116.0,,CHEMBL631125,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12428,,50597
A,10116.0,,CHEMBL631290,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12429,,50597
A,10116.0,,CHEMBL631291,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12430,,50597
A,10116.0,,CHEMBL631292,Rattus norvegicus,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12431,,50597
A,10116.0,,CHEMBL631293,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12432,,50597
A,10116.0,,CHEMBL631294,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12433,,50597
A,10116.0,,CHEMBL631295,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12434,,50597
A,10116.0,,CHEMBL631296,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12435,,50597
A,10116.0,,CHEMBL631297,Rattus norvegicus,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,,8631,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12436,,50597
A,,,CHEMBL631298,,Maximum biodistribution (Bmax) was determined.,,10263,U,,Autocuration,,,,,,1,0,,BAO_0000218,12437,,22224
A,10090.0,,CHEMBL631299,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,,12364,N,,Intermediate,,,,,,1,1,,BAO_0000218,12438,,50594
A,10090.0,,CHEMBL631300,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,,12364,N,,Intermediate,,,,,,1,1,,BAO_0000218,12439,,50594
A,10090.0,,CHEMBL631301,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,,12364,N,,Intermediate,,,,,,1,1,,BAO_0000218,12440,,50594
A,10090.0,,CHEMBL630291,Mus musculus,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,,12364,N,,Intermediate,,,,,,1,1,,BAO_0000218,12441,,50594
A,,,CHEMBL630292,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12442,,22224
A,,,CHEMBL630293,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12443,,22224
A,,,CHEMBL630294,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12444,,22224
A,,,CHEMBL630295,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12445,,22224
A,,,CHEMBL630296,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12446,,22224
A,,,CHEMBL626782,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12447,,22224
A,,,CHEMBL626783,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12448,,22224
A,,,CHEMBL626784,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12449,,22224
A,,,CHEMBL626785,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12450,,22224
A,,,CHEMBL626786,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12451,,22224
A,,,CHEMBL626787,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12452,,22224
A,,,CHEMBL626788,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12453,,22224
A,,,CHEMBL625927,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12454,,22224
A,10116.0,,CHEMBL625928,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12455,,50597
A,10116.0,,CHEMBL625929,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12456,,50597
A,10116.0,,CHEMBL625930,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12457,,50597
A,10116.0,,CHEMBL625931,Rattus norvegicus,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12458,,50597
A,10116.0,,CHEMBL627230,Rattus norvegicus,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12459,,50597
A,10116.0,,CHEMBL627231,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12460,,50597
A,10116.0,,CHEMBL627232,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12461,,50597
A,10116.0,,CHEMBL627233,Rattus norvegicus,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12462,,50597
A,10116.0,,CHEMBL875470,Rattus norvegicus,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12463,,50597
A,10116.0,,CHEMBL627234,Rattus norvegicus,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12464,,50597
A,10116.0,,CHEMBL627235,Rattus norvegicus,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12465,,50597
A,10116.0,,CHEMBL627236,Rattus norvegicus,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12466,,50597
A,10116.0,,CHEMBL627237,Rattus norvegicus,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12467,,50597
A,10116.0,,CHEMBL627238,Rattus norvegicus,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12468,,50597
A,10116.0,,CHEMBL627239,Rattus norvegicus,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12469,,50597
A,10116.0,,CHEMBL627240,Rattus norvegicus,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12470,,50597
A,10116.0,,CHEMBL627241,Rattus norvegicus,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12471,,50597
A,10116.0,,CHEMBL627242,Rattus norvegicus,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12472,,50597
A,10116.0,,CHEMBL627243,Rattus norvegicus,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12473,,50597
A,10116.0,,CHEMBL627244,Rattus norvegicus,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12474,,50597
A,10116.0,,CHEMBL627245,Rattus norvegicus,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12475,,50597
A,10116.0,,CHEMBL627246,Rattus norvegicus,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12476,,50597
A,10116.0,,CHEMBL627247,Rattus norvegicus,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12477,,50597
A,10116.0,,CHEMBL627248,Rattus norvegicus,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12478,,50597
A,10116.0,,CHEMBL627249,Rattus norvegicus,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12479,,50597
A,10116.0,,CHEMBL625569,Rattus norvegicus,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12480,,50597
A,10116.0,,CHEMBL625570,Rattus norvegicus,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12481,,50597
A,10116.0,,CHEMBL625571,Rattus norvegicus,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12482,,50597
A,10116.0,,CHEMBL625572,Rattus norvegicus,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12483,,50597
A,10116.0,,CHEMBL625573,Rattus norvegicus,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12484,,50597
A,10116.0,,CHEMBL625574,Rattus norvegicus,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12485,,50597
A,10116.0,,CHEMBL626245,Rattus norvegicus,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12486,,50597
A,10116.0,,CHEMBL626246,Rattus norvegicus,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12487,,50597
A,,,CHEMBL626247,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12488,,22224
A,,,CHEMBL626248,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12489,,22224
A,,,CHEMBL626249,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12490,,22224
A,,,CHEMBL626420,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12491,,22224
A,,,CHEMBL626421,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12492,,22224
A,,,CHEMBL626422,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12493,,22224
A,,,CHEMBL626423,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12494,,22224
A,,,CHEMBL626424,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12495,,22224
A,9615.0,,CHEMBL626425,Canis lupus familiaris,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,,12023,N,,Intermediate,,,,,,1,1,,BAO_0000218,12496,,50588
A,10116.0,,CHEMBL875476,Rattus norvegicus,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,,12023,N,,Intermediate,,,,,,1,1,,BAO_0000218,12497,,50597
A,9541.0,,CHEMBL626426,Macaca fascicularis,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,,12023,N,,Intermediate,,,,,,1,1,,BAO_0000218,12498,,100710
P,,,CHEMBL626427,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,10580,U,,Autocuration,,,,,,1,0,,BAO_0000100,12499,,22224
P,,,CHEMBL626428,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,10580,U,,Autocuration,,,,,,1,0,,BAO_0000100,12500,,22224
A,,,CHEMBL626429,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,16032,U,,Autocuration,,,,,,1,0,,BAO_0000019,12501,,22224
A,,,CHEMBL625025,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,16032,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,12502,,22224
A,10116.0,,CHEMBL625026,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12503,,50597
A,10116.0,,CHEMBL625027,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12504,,50597
A,10116.0,,CHEMBL874410,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12505,,50597
A,10116.0,,CHEMBL625028,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12506,,50597
A,10116.0,,CHEMBL625029,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12507,,50597
A,10116.0,,CHEMBL625030,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12508,,50597
A,10116.0,,CHEMBL625031,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12509,,50597
A,10116.0,,CHEMBL625032,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12510,,50597
A,10116.0,,CHEMBL625033,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12511,,50597
A,10116.0,,CHEMBL625034,Rattus norvegicus,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12512,,50597
A,10116.0,,CHEMBL624872,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12513,,50597
A,10116.0,,CHEMBL624873,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12514,,50597
A,10116.0,,CHEMBL624874,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12515,,50597
A,10116.0,,CHEMBL624875,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12516,,50597
A,10116.0,,CHEMBL624876,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12517,,50597
A,10116.0,,CHEMBL624877,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12518,,50597
A,10116.0,,CHEMBL624878,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12519,,50597
A,10116.0,,CHEMBL624879,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12520,,50597
A,10116.0,,CHEMBL624880,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12521,,50597
A,10116.0,,CHEMBL624881,Rattus norvegicus,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12522,,50597
A,10116.0,,CHEMBL624882,Rattus norvegicus,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12523,,50597
A,10116.0,,CHEMBL624883,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12524,,50597
A,10116.0,,CHEMBL624884,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12525,,50597
A,10116.0,,CHEMBL624885,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12526,,50597
A,10116.0,,CHEMBL624886,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12527,,50597
A,10116.0,,CHEMBL624887,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12528,,50597
A,10116.0,,CHEMBL624888,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12529,,50597
A,10116.0,,CHEMBL624889,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12530,,50597
A,10116.0,,CHEMBL624890,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12531,,50597
A,10116.0,,CHEMBL621964,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12532,,50597
A,10116.0,,CHEMBL621965,Rattus norvegicus,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12533,,50597
A,10116.0,,CHEMBL621966,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12534,,50597
A,10116.0,,CHEMBL621967,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12535,,50597
A,10116.0,,CHEMBL622164,Rattus norvegicus,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12536,,50597
A,,,CHEMBL623097,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,7653,U,,Autocuration,,,,,,1,0,,BAO_0000019,12537,,22224
A,,,CHEMBL623098,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,7653,U,,Autocuration,,,,,,1,0,,BAO_0000019,12538,,22224
A,,,CHEMBL623099,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,7653,U,,Autocuration,,,,,,1,0,,BAO_0000019,12539,,22224
A,,,CHEMBL623100,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,7653,U,,Autocuration,,,,,,1,0,,BAO_0000019,12540,,22224
A,10116.0,,CHEMBL628673,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12541,,50597
A,10116.0,,CHEMBL628674,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12542,,50597
A,10116.0,,CHEMBL628675,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12543,,50597
A,10116.0,,CHEMBL627644,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12544,,50597
A,10116.0,,CHEMBL627645,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12545,,50597
A,10116.0,,CHEMBL627646,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12546,,50597
A,10116.0,,CHEMBL627647,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12547,,50597
A,10116.0,,CHEMBL627648,Rattus norvegicus,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",,9104,N,,Intermediate,,,,,,1,1,,BAO_0000218,12548,,50597
A,10116.0,,CHEMBL627649,Rattus norvegicus,Free level in rat plasma,,12902,N,,Intermediate,,,,,,1,1,,BAO_0000218,12549,,50597
A,,,CHEMBL628313,,Level reaching in blood plasma of rat or human was determined,,6614,U,,Autocuration,,,,,,1,0,,BAO_0000019,12550,,22224
A,10116.0,,CHEMBL628314,Rattus norvegicus,Log (Cbrain/Cblood) in rats,,9663,N,,Intermediate,,,,,,1,1,,BAO_0000218,12551,,50597
A,,,CHEMBL628315,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,17658,U,,Autocuration,,,,,,1,0,,BAO_0000019,12552,,22224
A,,,CHEMBL628316,,Mean percentage of compound transport through membrane; expressed as membrane transport,,17658,U,,Autocuration,,,,,,1,0,,BAO_0000019,12553,,22224
A,,,CHEMBL628317,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,14314,U,,Autocuration,,,,,,1,0,,BAO_0000218,12554,,22224
A,,,CHEMBL628473,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,7385,U,,Autocuration,,,,,,1,0,,BAO_0000019,12555,,22224
A,,,CHEMBL628474,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,7385,U,,Autocuration,,,,,,1,0,,BAO_0000019,12556,,22224
A,,,CHEMBL628475,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,7385,U,,Autocuration,,,,,,1,0,,BAO_0000019,12557,,22224
A,,,CHEMBL628476,,Net water uptake by a carrier mediated transport (%cm) mechanism,,1329,U,,Autocuration,,,,,,1,0,,BAO_0000019,12558,,22224
A,314293.0,,CHEMBL628477,Simiiformes,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,12559,,22224
A,9669.0,,CHEMBL628478,Mustela putorius furo,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,12560,,50506
A,9669.0,,CHEMBL628479,Mustela putorius furo,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,12561,,50506
A,314293.0,,CHEMBL628480,Simiiformes,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,12562,,22224
A,314293.0,,CHEMBL628481,Simiiformes,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,12563,,22224
A,10116.0,,CHEMBL628482,Rattus norvegicus,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,12564,,50597
A,10116.0,,CHEMBL628483,Rattus norvegicus,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,12565,,50597
A,10116.0,,CHEMBL628484,Rattus norvegicus,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12566,,50597
A,10116.0,,CHEMBL628485,Rattus norvegicus,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12567,,50597
A,9541.0,,CHEMBL628486,Macaca fascicularis,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12568,,100710
A,9606.0,,CHEMBL628487,Homo sapiens,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12569,,50587
A,10116.0,,CHEMBL628488,Rattus norvegicus,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12570,,50597
A,10116.0,,CHEMBL628489,Rattus norvegicus,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12571,,50597
A,10116.0,,CHEMBL628490,Rattus norvegicus,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",,9278,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12572,,50597
A,9541.0,,CHEMBL628491,Macaca fascicularis,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,12573,,100710
A,9541.0,,CHEMBL877507,Macaca fascicularis,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,12574,,100710
A,,,CHEMBL628492,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,12186,U,,Autocuration,,,,,,1,0,,BAO_0000218,12575,,22224
A,314293.0,,CHEMBL628493,Simiiformes,% metabolized in monkey S-9 after 2 hours (10 ug/mL),,12041,U,,Autocuration,,,,,,1,0,,BAO_0000019,12576,,22224
A,314293.0,,CHEMBL628494,Simiiformes,% metabolized in monkey S-9 after 2 hours (1 ug/ml),,12041,U,,Autocuration,,,,,,1,0,,BAO_0000019,12577,,22224
A,314293.0,,CHEMBL628495,Simiiformes,% metabolized in monkey S-9 after 2 hours (10 ug/ml),,12041,U,,Autocuration,,,,,,1,0,,BAO_0000019,12578,,22224
A,9606.0,,CHEMBL628496,Homo sapiens,Permeability in Caco-2 assay at 10E-6,,6737,N,,Intermediate,,,,,,1,1,,BAO_0000218,12579,,50587
A,,,CHEMBL628497,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,13758,U,,Autocuration,,,Brain,955.0,,1,0,,BAO_0000218,12580,,22224
A,,,CHEMBL628498,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,13758,U,,Autocuration,,,Brain,955.0,,1,0,,BAO_0000218,12581,,22224
A,,,CHEMBL628499,,Plasma protein binding was determined,,5676,U,,Autocuration,,,,,,1,0,,BAO_0000019,12582,,22224
A,,,CHEMBL627656,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12583,,22224
A,,,CHEMBL627657,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12584,,22224
A,,,CHEMBL626808,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12585,,22224
A,,,CHEMBL626809,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12586,,22224
A,,,CHEMBL626810,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12587,,22224
A,,,CHEMBL626811,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12588,,22224
A,,,CHEMBL874465,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12589,,22224
A,,,CHEMBL626812,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12590,,22224
A,,,CHEMBL626813,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12591,,22224
A,,,CHEMBL626814,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,12592,,22224
A,,,CHEMBL626815,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,14000,U,,Autocuration,,,,,,1,0,,BAO_0000019,12593,,22224
A,,,CHEMBL628566,,Partition coefficient (logP),,5948,U,,Autocuration,,,,,,1,0,,BAO_0000019,12594,,22224
P,,,CHEMBL628567,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,U,,Autocuration,,,,,,1,0,,BAO_0000100,12595,,22229
P,,,CHEMBL628568,,Calculated partition coefficient (clogP),,10778,U,,Autocuration,,,,,,1,0,,BAO_0000100,12596,,22229
A,9615.0,,CHEMBL628569,Canis lupus familiaris,C max in dog,,17237,N,,Intermediate,,,,,,1,1,,BAO_0000218,12597,In vivo,50588
A,10141.0,,CHEMBL628570,Cavia porcellus,C max in guinea pig,,17237,N,,Intermediate,,,,,,1,1,,BAO_0000218,12598,In vivo,50512
A,,,CHEMBL628571,,C max value was evaluated,,2809,U,,Autocuration,,,,,,1,0,,BAO_0000218,12599,In vivo,22224
A,,,CHEMBL628572,,Cmax value after oral dose of 0.1 mg//kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12600,In vivo,22224
A,,,CHEMBL628573,,Cmax value after oral dose of 0.3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12601,In vivo,22224
A,,,CHEMBL628574,,Cmax value after oral dose of 1 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12602,In vivo,22224
A,,,CHEMBL628575,,Cmax value after oral dose of 10 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12603,In vivo,22224
A,,,CHEMBL628576,,Cmax value after oral dose of 23.4 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12604,In vivo,22224
A,,,CHEMBL628577,,Cmax value after oral dose of 3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12605,In vivo,22224
A,,,CHEMBL628578,,Cmax value after oral dose of 3.87 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,12606,In vivo,22224
A,9615.0,,CHEMBL874466,Canis lupus familiaris,Cmax value in female Beagle dogs,,12768,N,,Intermediate,,,,,,1,1,,BAO_0000218,12607,In vivo,50588
A,10116.0,,CHEMBL628579,Rattus norvegicus,Cmax value in male rats,,12768,N,,Intermediate,,,,,,1,1,,BAO_0000218,12608,In vivo,50597
A,10116.0,,CHEMBL628580,Rattus norvegicus,Cmax value in rat plasma when administered 20 mg/kg perorally,,12780,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12609,In vivo,50597
A,9615.0,,CHEMBL628581,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,15592,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12610,In vivo,50588
A,9615.0,,CHEMBL628582,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,15592,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12611,In vivo,50588
A,9615.0,,CHEMBL628583,Canis lupus familiaris,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12612,,50588
A,314293.0,,CHEMBL625782,Simiiformes,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,,17025,U,,Autocuration,,,,,,1,0,,BAO_0000218,12613,,22224
A,9986.0,,CHEMBL625783,Oryctolagus cuniculus,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12614,,50592
A,10116.0,,CHEMBL625784,Rattus norvegicus,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12615,,50597
A,9544.0,,CHEMBL625785,Macaca mulatta,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,,4236,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12616,,50797
A,10116.0,,CHEMBL625786,Rattus norvegicus,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,,15791,N,,Intermediate,,,,,,1,1,,BAO_0000218,12617,,50597
A,,,CHEMBL874467,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,11149,U,,Autocuration,,,,,,1,0,,BAO_0000019,12618,,22224
A,9615.0,,CHEMBL625787,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",,15592,N,,Intermediate,,,,,,1,1,,BAO_0000218,12619,,50588
A,12721.0,,CHEMBL625964,Human immunodeficiency virus,cytotoxicity against HIV protease enzyme.,,15778,N,,Intermediate,,,,,,1,1,,BAO_0000218,12620,,50677
A,10090.0,,CHEMBL625965,Mus musculus,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,12621,,50594
A,10090.0,,CHEMBL625966,Mus musculus,Apparent clearance in mice after oral administration of 100 mg/kg of dose,,12745,N,,Intermediate,,,,,,1,1,,BAO_0000218,12622,,50594
A,9615.0,,CHEMBL625967,Canis lupus familiaris,The plasma clearance in dog.,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12623,In vivo,50588
A,10116.0,,CHEMBL625968,Rattus norvegicus,The plasma clearance in rat.,,13941,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12624,In vivo,50597
A,10116.0,,CHEMBL625969,Rattus norvegicus,Clearance from plasma in male Sprague-Dawley rats,,16449,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12625,In vivo,50597
A,9541.0,,CHEMBL625970,Macaca fascicularis,Clearance from plasma in male cynomolgus monkeys,,16449,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12626,In vivo,100710
A,9615.0,,CHEMBL625971,Canis lupus familiaris,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12627,In vivo,50588
A,9615.0,,CHEMBL625972,Canis lupus familiaris,Clearance of compound in dog plasma,,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12628,In vivo,50588
A,9606.0,,CHEMBL625973,Homo sapiens,Clearance of compound in human plasma,,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12629,In vivo,50587
A,9615.0,,CHEMBL625974,Canis lupus familiaris,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,,14317,N,,Intermediate,,,,,,1,1,,BAO_0000218,12630,In vivo,50588
A,9615.0,,CHEMBL625975,Canis lupus familiaris,Clearance of compound when administered intravenously as an individual dose to a single dog.,,14317,N,,Intermediate,,,,,,1,1,,BAO_0000218,12631,In vivo,50588
A,9615.0,,CHEMBL625976,Canis lupus familiaris,"Clearance (10 mg/kg, intravenously) in dog plasma",,14224,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12632,In vivo,50588
A,9615.0,,CHEMBL625977,Canis lupus familiaris,Clearance value in dog,,17237,N,,Intermediate,,,,,,1,1,,BAO_0000218,12633,In vivo,50588
A,10141.0,,CHEMBL625978,Cavia porcellus,Clearance value in guinea pig,,17237,N,,Intermediate,,,,,,1,1,,BAO_0000218,12634,In vivo,50512
A,10116.0,,CHEMBL874468,Rattus norvegicus,Clearance values in rats after iv administration.,,14187,N,,Intermediate,,,,,,1,1,,BAO_0000218,12635,In vivo,50597
A,,,CHEMBL625421,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,4806,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,12636,In vivo,22224
A,9986.0,,CHEMBL625422,Oryctolagus cuniculus,In vivo clearance (5 mg/kg) was determined in rabbits,,15025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12637,In vivo,50592
A,10116.0,,CHEMBL625423,Rattus norvegicus,Plasma Clearance rate was determined for the compound in rats,,13197,N,,Intermediate,,,,,,1,1,,BAO_0000218,12638,In vivo,50597
A,9520.0,,CHEMBL625424,Saimiri,Plasma Clearance rate was determined for the compound in squirrel monkeys,,13197,U,,Autocuration,,,,,,1,0,,BAO_0000218,12639,In vivo,22224
A,10116.0,,CHEMBL625425,Rattus norvegicus,Plasma clearance in rat,,13960,N,,Intermediate,,,,,,1,1,,BAO_0000218,12640,In vivo,50597
A,,,CHEMBL625426,,Plasma clearance of the compound,,17820,U,,Autocuration,,,,,,1,0,,BAO_0000218,12641,In vivo,22224
A,10141.0,,CHEMBL625427,Cavia porcellus,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,,14706,N,,Intermediate,,,,,,1,1,,BAO_0000218,12642,In vivo,50512
A,10141.0,,CHEMBL625428,Cavia porcellus,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,,14706,N,,Intermediate,,,,,,1,1,,BAO_0000218,12643,In vivo,50512
A,,,CHEMBL625429,,Plasma clearance was determined,,6504,U,,Autocuration,,,,,,1,0,,BAO_0000218,12644,In vivo,22224
A,9615.0,,CHEMBL625430,Canis lupus familiaris,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,,14925,N,,Intermediate,,,,,,1,1,,BAO_0000218,12645,In vivo,50588
A,10116.0,,CHEMBL625431,Rattus norvegicus,Plasma clearance rate was determined for the compound in rats,,13197,N,,Intermediate,,,,,,1,1,,BAO_0000218,12646,In vivo,50597
A,9520.0,,CHEMBL627307,Saimiri,Plasma clearance rate was determined for the compound in squirrel monkeys,,13197,U,,Autocuration,,,,,,1,0,,BAO_0000218,12647,In vivo,22224
A,,,CHEMBL627308,,Slow clearance (CL) was determined,,3437,U,,Autocuration,,,,,,1,0,,BAO_0000218,12648,In vivo,22224
A,,,CHEMBL627309,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12649,,22224
A,,,CHEMBL627310,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12650,,22224
A,,,CHEMBL627311,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12651,,22224
A,,,CHEMBL627312,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12652,,22224
A,,,CHEMBL627313,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12653,,22224
A,,,CHEMBL627314,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12654,,22224
A,,,CHEMBL627315,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12655,,22224
A,,,CHEMBL627316,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12656,,22224
A,,,CHEMBL627317,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12657,,22224
A,,,CHEMBL627318,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12658,,22224
A,,,CHEMBL627999,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12659,,22224
A,,,CHEMBL628000,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12660,,22224
A,,,CHEMBL628001,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12661,,22224
A,,,CHEMBL628002,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12662,,22224
A,,,CHEMBL625610,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12663,,22224
A,,,CHEMBL625611,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12664,,22224
A,,,CHEMBL625612,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12665,,22224
A,,,CHEMBL625613,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12666,,22224
A,,,CHEMBL875479,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12667,,22224
A,,,CHEMBL625614,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12668,,22224
A,,,CHEMBL625615,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12669,,22224
A,,,CHEMBL626302,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,9196,U,,Autocuration,,,,,,1,0,,BAO_0000218,12670,,22224
A,10116.0,,CHEMBL626303,Rattus norvegicus,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12671,,50597
A,10116.0,,CHEMBL627420,Rattus norvegicus,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,,8374,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12672,,50597
A,10116.0,,CHEMBL627421,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12673,,50597
A,10116.0,,CHEMBL625695,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12674,,50597
A,10116.0,,CHEMBL625696,Rattus norvegicus,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12675,,50597
A,10090.0,,CHEMBL875606,Mus musculus,Distribution of compound in mice brain was measured after 1 hr,,10009,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12676,,50594
A,10090.0,,CHEMBL625697,Mus musculus,Distribution of compound in mice brain was measured after 24 hr r,,10009,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12677,,50594
A,10090.0,,CHEMBL625698,Mus musculus,Distribution of compound in mice brain was measured after 2 hr,,10009,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12678,,50594
A,10090.0,,CHEMBL625699,Mus musculus,Distribution of compound in mice brain was measured after 3 hr,,10009,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12679,,50594
A,10090.0,,CHEMBL625700,Mus musculus,Distribution of compound in mice brain was measured after 6 hr,,10009,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,12680,,50594
A,10090.0,,CHEMBL625701,Mus musculus,Distribution of compound in mice liver was measured after 1 hr,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,12681,,50594
A,10090.0,,CHEMBL625702,Mus musculus,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,12682,,50594
A,10090.0,,CHEMBL625703,Mus musculus,Distribution of compound in mice liver was measured after 2 hr,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,12683,,50594
A,10090.0,,CHEMBL625704,Mus musculus,Distribution of compound in mice liver was measured after 3 hr,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,12684,,50594
A,10090.0,,CHEMBL625705,Mus musculus,Distribution of compound in mice liver was measured after 6 hr,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,12685,,50594
A,9615.0,,CHEMBL625706,Canis lupus familiaris,Distribution in dog adrenal medulla 30 min after administration.,,8170,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12686,,50588
A,9615.0,,CHEMBL625707,Canis lupus familiaris,Distribution in dog adrenal medulla 72 hours after administration.,,8170,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12687,,50588
A,9615.0,,CHEMBL625708,Canis lupus familiaris,Distribution in female dog Ovary 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12688,,50588
A,9615.0,,CHEMBL625709,Canis lupus familiaris,Distribution in female dog Ovary 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12689,,50588
A,9615.0,,CHEMBL624180,Canis lupus familiaris,Distribution in female dog adipose 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12690,,50588
A,9615.0,,CHEMBL624181,Canis lupus familiaris,Distribution in female dog adipose 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12691,,50588
A,9615.0,,CHEMBL624182,Canis lupus familiaris,Distribution in female dog adrenal cortex 72 hours after administration.,,8170,N,,Intermediate,,,Adrenal cortex,1235.0,,1,1,,BAO_0000218,12692,,50588
A,9615.0,,CHEMBL624183,Canis lupus familiaris,Distribution in female dog adrenal cortex 72 hours after administration.,,8170,N,,Intermediate,,,Adrenal cortex,1235.0,,1,1,,BAO_0000218,12693,,50588
A,10116.0,,CHEMBL624184,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12694,,50597
A,10116.0,,CHEMBL877489,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12695,,50597
A,10116.0,,CHEMBL624185,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12696,,50597
A,10116.0,,CHEMBL624186,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12697,,50597
A,10116.0,,CHEMBL624187,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12698,,50597
A,10116.0,,CHEMBL624188,Rattus norvegicus,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12699,,50597
A,10116.0,,CHEMBL624189,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12700,,50597
A,10116.0,,CHEMBL624190,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12701,,50597
A,10116.0,,CHEMBL624191,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12702,,50597
A,10116.0,,CHEMBL624192,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12703,,50597
A,10116.0,,CHEMBL624193,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12704,,50597
A,10116.0,,CHEMBL624194,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12705,,50597
A,10116.0,,CHEMBL624891,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12706,,50597
A,10116.0,,CHEMBL624892,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12707,,50597
A,10116.0,,CHEMBL624893,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12708,,50597
A,10116.0,,CHEMBL627632,Rattus norvegicus,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12709,,50597
A,10116.0,,CHEMBL627633,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12710,,50597
A,10116.0,,CHEMBL627634,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12711,,50597
A,10116.0,,CHEMBL627635,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12712,,50597
A,10116.0,,CHEMBL627636,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12713,,50597
A,10116.0,,CHEMBL626816,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12714,,50597
A,10116.0,,CHEMBL626817,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12715,,50597
A,10116.0,,CHEMBL626818,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12716,,50597
A,10116.0,,CHEMBL626819,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12717,,50597
A,10116.0,,CHEMBL626820,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12718,,50597
A,10116.0,,CHEMBL626821,Rattus norvegicus,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12719,,50597
A,10116.0,,CHEMBL626822,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12720,,50597
A,10116.0,,CHEMBL626823,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12721,,50597
A,10116.0,,CHEMBL626824,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12722,,50597
A,10116.0,,CHEMBL626825,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12723,,50597
A,10116.0,,CHEMBL626826,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12724,,50597
A,10116.0,,CHEMBL626827,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12725,,50597
A,10116.0,,CHEMBL626828,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12726,,50597
A,10116.0,,CHEMBL626829,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12727,,50597
A,10116.0,,CHEMBL626830,Rattus norvegicus,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12728,,50597
A,10116.0,,CHEMBL627150,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12729,,50597
A,10116.0,,CHEMBL627151,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12730,,50597
A,10116.0,,CHEMBL627152,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12731,,50597
A,10116.0,,CHEMBL627153,Rattus norvegicus,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12732,,50597
A,,,CHEMBL627154,,Rate of acetate production by the compound was determined,,12904,U,,Autocuration,,,,,,1,0,,BAO_0000019,12733,,22224
A,,,CHEMBL627155,,Rate of acetate production by the compound was determined; Not determined,,12904,U,,Autocuration,,,,,,1,0,,BAO_0000019,12734,,22224
A,,,CHEMBL627156,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,3730,U,,Autocuration,,,,,,1,0,,BAO_0000019,12735,,22224
A,,,CHEMBL627157,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,3627,U,,Autocuration,,,,,,1,0,,BAO_0000019,12736,,22224
A,9986.0,,CHEMBL627158,Oryctolagus cuniculus,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,13799,N,,Intermediate,,,,,,1,1,,BAO_0000218,12737,,50592
A,9986.0,,CHEMBL627159,Oryctolagus cuniculus,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,,13799,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12738,,50592
A,10090.0,,CHEMBL627160,Mus musculus,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,N,,Intermediate,,,,,,1,1,,BAO_0000218,12739,,50594
A,10116.0,,CHEMBL628540,Rattus norvegicus,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,N,,Intermediate,,,,,,1,1,,BAO_0000218,12740,,50597
A,10116.0,,CHEMBL628541,Rattus norvegicus,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12741,,50597
A,10116.0,,CHEMBL628542,Rattus norvegicus,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,,13799,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12742,,50597
P,,,CHEMBL628543,,Solubility after at a pH 1.2,,6629,U,,Autocuration,,,,,,1,0,,BAO_0000100,12743,,22229
P,,,CHEMBL628544,,Solubility after at pH 1.2,,6629,U,,Autocuration,,,,,,1,0,,BAO_0000100,12744,,22229
P,,,CHEMBL628545,,Solubility after injection of water,,6629,U,,Autocuration,,,,,,1,0,,BAO_0000100,12745,,22229
A,,,CHEMBL628546,,Statistical significance of IC 50 values; Expressed as R value,,14000,U,,Autocuration,,,,,,1,0,,BAO_0000019,12746,,22224
A,,,CHEMBL874455,,Systemic availability with respect to methyldopa was determined,,8267,U,,Autocuration,,,,,,1,0,,BAO_0000019,12747,,22224
A,10116.0,,CHEMBL628547,Rattus norvegicus,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,,13799,N,,Intermediate,,,,,,1,1,,BAO_0000218,12748,,50597
A,10116.0,,CHEMBL628548,Rattus norvegicus,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,,13799,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12749,,50597
A,9986.0,,CHEMBL628549,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12750,,50592
A,9986.0,,CHEMBL628550,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12751,,50592
A,9986.0,,CHEMBL628551,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12752,,50592
A,9986.0,,CHEMBL628552,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12753,,50592
A,9986.0,,CHEMBL628553,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12754,,50592
A,9986.0,,CHEMBL628554,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12755,,50592
A,9986.0,,CHEMBL628555,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12756,,50592
A,9986.0,,CHEMBL628556,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12757,,50592
A,9986.0,,CHEMBL628557,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12758,,50592
A,9986.0,,CHEMBL628558,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12759,,50592
A,9986.0,,CHEMBL628559,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12760,,50592
A,9986.0,,CHEMBL628560,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12761,,50592
A,9986.0,,CHEMBL874456,Oryctolagus cuniculus,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12762,,50592
A,9986.0,,CHEMBL628561,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12763,,50592
A,9986.0,,CHEMBL628562,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12764,,50592
A,9986.0,,CHEMBL628563,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12765,,50592
A,9986.0,,CHEMBL628564,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12766,,50592
A,9986.0,,CHEMBL628565,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12767,,50592
A,9986.0,,CHEMBL631248,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12768,,50592
A,9986.0,,CHEMBL631249,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12769,,50592
A,9986.0,,CHEMBL627214,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12770,,50592
A,9986.0,,CHEMBL874591,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12771,,50592
A,9986.0,,CHEMBL627215,Oryctolagus cuniculus,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12772,,50592
A,9986.0,,CHEMBL625471,Oryctolagus cuniculus,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,12773,,50592
A,9986.0,,CHEMBL625472,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,,7132,N,,Intermediate,,,,,,1,1,,BAO_0000218,12774,,50592
A,9986.0,,CHEMBL625473,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,,7132,N,,Intermediate,,,,,,1,1,,BAO_0000218,12775,,50592
A,9615.0,,CHEMBL625474,Canis lupus familiaris,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,,13317,N,,Intermediate,,,,,,1,1,,BAO_0000218,12776,In vivo,50588
A,9615.0,,CHEMBL625475,Canis lupus familiaris,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,12777,In vivo,50588
A,10116.0,,CHEMBL625476,Rattus norvegicus,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,12778,In vivo,50597
A,10116.0,,CHEMBL625477,Rattus norvegicus,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,12779,In vivo,50597
A,10116.0,,CHEMBL625478,Rattus norvegicus,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,,15341,N,,Intermediate,,,,,,1,1,,BAO_0000218,12780,In vivo,50597
A,10116.0,,CHEMBL625479,Rattus norvegicus,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,,12801,N,,Intermediate,,,esophageal tunica muscularis mucosae,,,1,1,,BAO_0000218,12781,In vitro,50597
A,10116.0,,CHEMBL625480,Rattus norvegicus,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,,12801,N,,Intermediate,,,esophageal tunica muscularis mucosae,,,1,1,,BAO_0000218,12782,In vitro,50597
A,10116.0,,CHEMBL625481,Rattus norvegicus,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,,14856,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12783,In vivo,50597
A,10116.0,,CHEMBL625482,Rattus norvegicus,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,12784,In vivo,50597
A,10116.0,,CHEMBL625483,Rattus norvegicus,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,12785,In vivo,50597
A,10116.0,,CHEMBL625484,Rattus norvegicus,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,12786,In vivo,50597
A,10116.0,,CHEMBL625485,Rattus norvegicus,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,,14062,N,,Intermediate,,,,,,1,1,,BAO_0000218,12787,In vivo,50597
A,9615.0,,CHEMBL625486,Canis lupus familiaris,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12788,In vivo,50588
A,10116.0,,CHEMBL625487,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12789,In vivo,50597
A,10116.0,,CHEMBL625488,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12790,In vivo,50597
A,10116.0,,CHEMBL625489,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12791,In vivo,50597
A,10116.0,,CHEMBL625490,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12792,In vivo,50597
A,9615.0,,CHEMBL625491,Canis lupus familiaris,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12793,In vivo,50588
A,10116.0,,CHEMBL625492,Rattus norvegicus,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,,14346,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12794,In vivo,50597
A,9606.0,,CHEMBL625493,Homo sapiens,plasma clearance in human,,15711,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,12795,In vivo,50587
A,10116.0,,CHEMBL625494,Rattus norvegicus,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,12796,In vivo,50597
A,10116.0,,CHEMBL625495,Rattus norvegicus,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,12797,In vivo,50597
A,10116.0,,CHEMBL625496,Rattus norvegicus,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,,14886,N,,Intermediate,,,,,,1,1,,BAO_0000218,12798,In vivo,50597
P,,,CHEMBL625497,,1-Octanol/water partition coefficient measured at 7.4,,4115,U,,Autocuration,,,,,,1,0,,BAO_0000100,12799,,22229
P,,,CHEMBL625498,,Calculated partition coefficient (clogP),,13733,U,,Autocuration,,,,,,1,0,,BAO_0000100,12800,,22229
A,,,CHEMBL625499,,Partition coefficient (logP),,12102,U,,Autocuration,,,,,,1,0,,BAO_0000019,12801,,22224
P,,,CHEMBL625500,,Calculated partition coefficient (clogP),,12676,U,,Autocuration,,,,,,1,0,,BAO_0000100,12802,,22229
P,,,CHEMBL625501,,Calculated partition coefficient (clogP),,13733,U,,Autocuration,,,,,,1,0,,BAO_0000100,12803,,22229
P,,,CHEMBL625502,,Calculated partition coefficient (clogP),,13740,U,,Autocuration,,,,,,1,0,,BAO_0000100,12804,,22229
P,,,CHEMBL625503,,Calculated partition coefficient (clogP) (relative to BAY K 8644),,12766,U,,Autocuration,,,,,,1,0,,BAO_0000100,12805,,22229
P,,,CHEMBL625504,,Calculated partition coefficient (clogP),,2764,U,,Autocuration,,,,,,1,0,,BAO_0000100,12806,,22229
P,,,CHEMBL625505,,Calculated partition coefficient (clogP),,12355,U,,Autocuration,,,,,,1,0,,BAO_0000100,12807,,22229
P,,,CHEMBL625506,,Calculated partition coefficient of the compound,,11314,U,,Autocuration,,,,,,1,0,,BAO_0000100,12808,,22229
A,,,CHEMBL625507,,Partition coefficient (logP),,12706,U,,Autocuration,,,,,,1,0,,BAO_0000019,12809,,22224
P,,,CHEMBL625508,,Calculated partition coefficient (clogP),,12645,U,,Autocuration,,,,,,1,0,,BAO_0000100,12810,,22229
P,,,CHEMBL625509,,Calculated partition coefficient (clogP),,13668,U,,Autocuration,,,,,,1,0,,BAO_0000100,12811,,22229
P,,,CHEMBL625510,,Calculated partition coefficient (clogP),,12819,U,,Autocuration,,,,,,1,0,,BAO_0000100,12812,,22229
P,,,CHEMBL883125,,Calculated partition coefficient (clogP),,13668,U,,Autocuration,,,,,,1,0,,BAO_0000100,12813,,22229
P,,,CHEMBL625511,,Calculated partition coefficient (clogP),,13017,U,,Autocuration,,,,,,1,0,,BAO_0000100,12814,,22229
A,,,CHEMBL874650,,Partition coefficient of the compound,,2448,U,,Autocuration,,,,,,1,0,,BAO_0000019,12815,,22224
A,,,CHEMBL625512,,Partition coefficient of the compound,,11526,U,,Autocuration,,,,,,1,0,,BAO_0000019,12816,,22224
A,,,CHEMBL625513,,Partition coefficient of compound was determined,,12426,U,,Autocuration,,,,,,1,0,,BAO_0000019,12817,,22224
A,,,CHEMBL625514,,Partition coefficient was determined,,2448,U,,Autocuration,,,,,,1,0,,BAO_0000019,12818,,22224
P,,,CHEMBL625515,,Calculated partition coefficient (clogP),,12001,U,,Autocuration,,,,,,1,0,,BAO_0000100,12819,,22229
P,,,CHEMBL625516,,partition coefficient of compound was determined,,12426,U,,Autocuration,,,,,,1,0,,BAO_0000100,12820,,22229
A,9615.0,,CHEMBL625517,Canis lupus familiaris,The total body administered intravenously in dog,,13204,N,,Intermediate,,,,,,1,1,,BAO_0000218,12821,In vivo,50588
A,10116.0,,CHEMBL625518,Rattus norvegicus,The total body administered intravenously in rats,,13204,N,,Intermediate,,,,,,1,1,,BAO_0000218,12822,In vivo,50597
A,10090.0,,CHEMBL625519,Mus musculus,Time taken for the administration to female NIH mice weighing 25-30 g.,,13889,N,,Intermediate,,,,,,1,1,,BAO_0000218,12823,,50594
A,,,CHEMBL625520,,Time taken for the administration,,13889,U,,Autocuration,,,,,,1,0,,BAO_0000019,12824,,22224
A,9615.0,,CHEMBL874651,Canis lupus familiaris,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12825,In vivo,50588
A,314293.0,,CHEMBL625521,Simiiformes,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,,17025,U,,Autocuration,,,,,,1,0,,BAO_0000218,12826,In vivo,22224
A,9986.0,,CHEMBL623171,Oryctolagus cuniculus,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12827,In vivo,50592
A,10116.0,,CHEMBL623853,Rattus norvegicus,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12828,In vivo,50597
A,,,CHEMBL623854,,Plasma clearance for the compound was determined.,,15067,U,,Autocuration,,,,,,1,0,,BAO_0000019,12829,,22224
P,,,CHEMBL874405,,CLog P value of the compound,,3091,U,,Autocuration,,,,,,1,0,,BAO_0000100,12830,,22224
P,,,CHEMBL623855,,Calculated partition coefficient (clogP),,15592,U,,Autocuration,,,,,,1,0,,BAO_0000100,12831,,22229
P,,,CHEMBL623856,,Calculated partition coefficient (clogP),,14738,U,,Autocuration,,,,,,1,0,,BAO_0000100,12832,,22229
P,,,CHEMBL623857,,ClogP value of the compound; nd ='no data',,14738,U,,Autocuration,,,,,,1,0,,BAO_0000100,12833,,22224
P,,,CHEMBL623858,,ClogP value of the compound; nd ='not determined',,14738,U,,Autocuration,,,,,,1,0,,BAO_0000100,12834,,22224
P,,,CHEMBL623859,,CLog P was determined,,6076,U,,Autocuration,,,,,,1,0,,BAO_0000100,12835,,22224
P,,,CHEMBL839829,,Calculated partition coefficient (clogP),,17840,U,,Autocuration,,,,,,1,0,,BAO_0000100,12836,,22229
A,,,CHEMBL623860,,CLogP was calculated,,13589,U,,Autocuration,,,,,,1,0,,BAO_0000019,12837,,22224
A,,,CHEMBL623861,,CLogP value was determined,,17655,U,,Autocuration,,,,,,1,0,,BAO_0000019,12838,,22224
A,,,CHEMBL623862,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,5867,U,,Autocuration,,,,,,1,0,,BAO_0000019,12839,,22224
P,,,CHEMBL874406,,Calculated partition coefficient (clogP),,5867,U,,Autocuration,,,,,,1,0,,BAO_0000100,12840,,22229
P,,,CHEMBL623863,,Calculated partition coefficient (clogP),,10783,U,,Autocuration,,,,,,1,0,,BAO_0000100,12841,,22229
P,,,CHEMBL624021,,Calculated partition coefficient (clogP),,14849,U,,Autocuration,,,,,,1,0,,BAO_0000100,12842,,22229
A,9615.0,,CHEMBL624022,Canis lupus familiaris,Distribution in female dog adrenal medulla 24 hours after administration.,,8170,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12843,,50588
A,9615.0,,CHEMBL624023,Canis lupus familiaris,Distribution in female dog adrenal medulla 72 hours after administration.,,8170,N,,Intermediate,,,Adrenal medulla,1236.0,,1,1,,BAO_0000218,12844,,50588
A,9615.0,,CHEMBL624024,Canis lupus familiaris,Distribution in female dog bile 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12845,,50588
A,9615.0,,CHEMBL624025,Canis lupus familiaris,Distribution in female dog bile 72 hr after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12846,,50588
A,9615.0,,CHEMBL624026,Canis lupus familiaris,Distribution in female dog blood 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12847,,50588
A,9615.0,,CHEMBL624027,Canis lupus familiaris,Distribution in female dog blood 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12848,,50588
A,9615.0,,CHEMBL624028,Canis lupus familiaris,Distribution in female dog heart 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12849,,50588
A,9615.0,,CHEMBL624029,Canis lupus familiaris,Distribution in female dog heart 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12850,,50588
A,9615.0,,CHEMBL624030,Canis lupus familiaris,Distribution in female dog kidney 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12851,,50588
A,9615.0,,CHEMBL624031,Canis lupus familiaris,Distribution in female dog kidney 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12852,,50588
A,9615.0,,CHEMBL624032,Canis lupus familiaris,Distribution in female dog large intestine 24 hours after administration.,,8170,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,12853,,50588
A,9615.0,,CHEMBL874407,Canis lupus familiaris,Distribution in female dog large intestine 72 hours after administration.,,8170,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,12854,,50588
A,9615.0,,CHEMBL624033,Canis lupus familiaris,Distribution in female dog liver 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12855,,50588
A,9615.0,,CHEMBL624034,Canis lupus familiaris,Distribution in female dog liver 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12856,,50588
A,9615.0,,CHEMBL624035,Canis lupus familiaris,Distribution in female dog lung 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12857,,50588
A,9615.0,,CHEMBL624036,Canis lupus familiaris,Distribution in female dog lung 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12858,,50588
A,9615.0,,CHEMBL624037,Canis lupus familiaris,Distribution in female dog muscle 24 hours after administration.,,8170,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12859,,50588
A,9615.0,,CHEMBL624038,Canis lupus familiaris,Distribution in female dog muscle 72 hours after administration.,,8170,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12860,,50588
A,9615.0,,CHEMBL624039,Canis lupus familiaris,Distribution in female dog pancreas 24 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12861,,50588
A,9615.0,,CHEMBL624040,Canis lupus familiaris,Distribution in female dog pancreas 72 hours after administration.,,8170,N,,Intermediate,,,,,,1,1,,BAO_0000218,12862,,50588
A,9615.0,,CHEMBL624041,Canis lupus familiaris,Distribution in female dog small intestine 24 hours after administration.,,8170,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,12863,,50588
A,9615.0,,CHEMBL624042,Canis lupus familiaris,Distribution in female dog small intestine 72 hours after administration.,,8170,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,12864,,50588
A,9615.0,,CHEMBL624043,Canis lupus familiaris,Distribution in female dog spleen 24 hours after administration.,,8170,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12865,,50588
A,9615.0,,CHEMBL624044,Canis lupus familiaris,Distribution in female dog spleen 72 hours after administration.,,8170,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,12866,,50588
A,9615.0,,CHEMBL624045,Canis lupus familiaris,Distribution in female dog stomach 24 hours after administration.,,8170,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,12867,,50588
A,9615.0,,CHEMBL624046,Canis lupus familiaris,Distribution in female dog stomach 72 hours after administration.,,8170,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,12868,,50588
A,9615.0,,CHEMBL624047,Canis lupus familiaris,Distribution in female dog thyroid 24 hours after administration.,,8170,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12869,,50588
A,9615.0,,CHEMBL624048,Canis lupus familiaris,Distribution in female dog thyroid 72 hours after administration.,,8170,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12870,,50588
A,9615.0,,CHEMBL874408,Canis lupus familiaris,Distribution in female dog urine 24 hours after administration.,,8170,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12871,,50588
A,9615.0,,CHEMBL624049,Canis lupus familiaris,Distribution in female dog urine 72 hr after administration.,,8170,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,12872,,50588
A,,,CHEMBL624050,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,14283,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,12873,,22224
A,,,CHEMBL624051,,Plasma concentration at 7 hr after intravenous dosing,,5623,U,,Autocuration,,,,,,1,0,,BAO_0000019,12874,,22224
A,10116.0,,CHEMBL623278,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12875,,50597
A,10116.0,,CHEMBL623279,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12876,,50597
A,10116.0,,CHEMBL623280,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 1 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12877,,50597
A,10116.0,,CHEMBL623963,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 2 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12878,,50597
A,10116.0,,CHEMBL623964,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 4 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12879,,50597
A,10116.0,,CHEMBL623965,Rattus norvegicus,Plasma concentration of 3 mg/kg iv after 6 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12880,,50597
A,10116.0,,CHEMBL623966,Rattus norvegicus,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12881,,50597
A,10116.0,,CHEMBL874415,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12882,,50597
A,10116.0,,CHEMBL623967,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12883,,50597
A,10116.0,,CHEMBL623968,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12884,,50597
A,10116.0,,CHEMBL623969,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12885,,50597
A,10116.0,,CHEMBL628409,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12886,,50597
A,10116.0,,CHEMBL628410,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12887,,50597
A,10116.0,,CHEMBL628411,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12888,,50597
A,10116.0,,CHEMBL628412,Rattus norvegicus,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,12889,,50597
A,,,CHEMBL628413,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,12553,U,,Autocuration,,,,,,1,0,,BAO_0000019,12890,,22224
A,,,CHEMBL628414,,The concentration in plasmat; Not determined,,14548,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000019,12891,,22224
A,10116.0,,CHEMBL628415,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in blood,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,12892,,50597
A,10116.0,,CHEMBL628416,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in brown fat,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,12893,,50597
A,10116.0,,CHEMBL628417,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in heart,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,12894,,50597
A,10116.0,,CHEMBL874908,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in liver,,14393,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12895,,50597
A,10116.0,,CHEMBL628418,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in plasma,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,12896,,50597
A,10116.0,,CHEMBL628419,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,,14393,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,12897,,50597
A,10116.0,,CHEMBL628420,Rattus norvegicus,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,12898,,50597
A,,,CHEMBL628421,,Water solubility at 37 degree C.,,1629,U,,Autocuration,,,,,,1,0,,BAO_0000019,12899,,22224
P,,,CHEMBL626726,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,12900,,22229
P,,,CHEMBL626727,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,12901,,22229
A,10116.0,,CHEMBL626728,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12902,,50597
A,10116.0,,CHEMBL626729,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12903,,50597
A,10116.0,,CHEMBL626730,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12904,,50597
A,10116.0,,CHEMBL626731,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12905,,50597
A,10116.0,,CHEMBL626732,Rattus norvegicus,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,12906,,50597
A,10116.0,,CHEMBL626733,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12907,,50597
A,10116.0,,CHEMBL626734,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12908,,50597
A,10116.0,,CHEMBL626735,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12909,,50597
A,10116.0,,CHEMBL874909,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12910,,50597
A,10116.0,,CHEMBL626736,Rattus norvegicus,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,12911,,50597
A,10116.0,,CHEMBL626737,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12912,,50597
A,10116.0,,CHEMBL630999,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12913,,50597
A,10116.0,,CHEMBL631000,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12914,,50597
A,10116.0,,CHEMBL631001,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12915,,50597
A,10116.0,,CHEMBL631002,Rattus norvegicus,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,12916,,50597
A,10116.0,,CHEMBL631003,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12917,,50597
A,10116.0,,CHEMBL631004,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12918,,50597
A,10116.0,,CHEMBL631005,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12919,,50597
A,10116.0,,CHEMBL631006,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12920,,50597
A,10116.0,,CHEMBL631007,Rattus norvegicus,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,12921,,50597
A,10116.0,,CHEMBL631008,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12922,,50597
A,10116.0,,CHEMBL631009,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12923,,50597
A,10116.0,,CHEMBL631010,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12924,,50597
A,10116.0,,CHEMBL631011,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12925,,50597
A,10116.0,,CHEMBL631012,Rattus norvegicus,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,12926,,50597
A,10116.0,,CHEMBL630271,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12927,,50597
A,10116.0,,CHEMBL630272,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12928,,50597
A,10116.0,,CHEMBL630273,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12929,,50597
A,10116.0,,CHEMBL630274,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12930,,50597
A,10116.0,,CHEMBL630275,Rattus norvegicus,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,12931,,50597
A,10116.0,,CHEMBL875782,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12932,,50597
A,10116.0,,CHEMBL630276,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12933,,50597
A,10116.0,,CHEMBL630277,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12934,,50597
A,10116.0,,CHEMBL630278,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12935,,50597
A,10116.0,,CHEMBL630279,Rattus norvegicus,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,,8594,N,,Intermediate,,,,,,1,1,,BAO_0000218,12936,,50597
A,,,CHEMBL630280,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,8151,U,,Autocuration,,,,,,1,0,,BAO_0000019,12937,,22224
A,,,CHEMBL630281,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,U,,Autocuration,,,,,,1,0,,BAO_0000019,12938,,22224
A,9986.0,,CHEMBL630282,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,,7132,N,,Intermediate,,,,,,1,1,,BAO_0000218,12939,,50592
A,9986.0,,CHEMBL630283,Oryctolagus cuniculus,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,,7132,N,,Intermediate,,,,,,1,1,,BAO_0000218,12940,,50592
A,,,CHEMBL630284,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,5797,U,,Autocuration,,,,,,1,0,,BAO_0000019,12941,,22224
A,,,CHEMBL630285,,Alkylating activity was determined,,7849,U,,Autocuration,,,,,,1,0,,BAO_0000019,12942,,22224
A,,Microsomes,CHEMBL630286,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,14220,U,,Autocuration,,,,,,1,0,,BAO_0000251,12943,,22224
A,9986.0,,CHEMBL630069,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",,8650,N,,Intermediate,,,,,,1,1,,BAO_0000218,12944,,50592
A,9986.0,,CHEMBL630070,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",,8650,N,,Intermediate,,,,,,1,1,,BAO_0000218,12945,,50592
A,9986.0,,CHEMBL630071,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",,8650,N,,Intermediate,,,,,,1,1,,BAO_0000218,12946,,50592
A,9986.0,,CHEMBL630072,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",,8650,N,,Intermediate,,,,,,1,1,,BAO_0000218,12947,,50592
A,9986.0,,CHEMBL875110,Oryctolagus cuniculus,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",,8650,N,,Intermediate,,,,,,1,1,,BAO_0000218,12948,,50592
A,10116.0,,CHEMBL630073,Rattus norvegicus,Compound was tested for antidiuretic activity in rats,,7116,N,,Intermediate,,,,,,1,1,,BAO_0000218,12949,,50597
A,,,CHEMBL630074,,Compound was tested for inactivation kinetic values,,14131,U,,Autocuration,,,,,,1,0,,BAO_0000019,12950,,22224
A,,,CHEMBL630075,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,7415,U,,Autocuration,,,,,,1,0,,BAO_0000218,12951,In vivo,22224
A,,,CHEMBL630076,,Dissociation rate calculated from the first-order equation using the t1/2 value,,13178,U,,Autocuration,,,,,,1,0,,BAO_0000019,12952,,22224
P,,,CHEMBL630077,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,8815,U,,Autocuration,,,,,,1,0,,BAO_0000100,12953,,22229
P,,,CHEMBL630078,,Aqueous solubility was measured,,1450,U,,Autocuration,,,,,,1,0,,BAO_0000100,12954,,22229
P,,,CHEMBL630079,,Aqueous solubility was measured at a pH 4,,1450,U,,Autocuration,,,,,,1,0,,BAO_0000100,12955,,22229
P,,,CHEMBL630080,,Aqueous solubility (pH 7),,1450,U,,Autocuration,,,,,,1,0,,BAO_0000100,12956,,22229
P,,,CHEMBL630081,,Aqueous solubility was measured at a pH 9,,1450,U,,Autocuration,,,,,,1,0,,BAO_0000100,12957,,22229
A,,,CHEMBL630082,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,12711,U,,Autocuration,,,,,,1,0,,BAO_0000019,12958,,22224
A,,,CHEMBL630083,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12711,U,,Autocuration,,,,,,1,0,,BAO_0000019,12959,,22224
A,,,CHEMBL630084,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,12711,U,,Autocuration,,,,,,1,0,,BAO_0000019,12960,,22224
P,,,CHEMBL629198,,Aqueous solubility of the compound,,15032,U,,Autocuration,,,,,,1,0,,BAO_0000100,12961,,22229
P,,,CHEMBL629199,,Aqueous solubility at 37 degree Celsius at pH 7.38,,9964,U,,Autocuration,,,,,,1,0,,BAO_0000100,12962,,22229
P,,,CHEMBL629200,,Aqueous solubility in pH 7.4 phosphate buffer,,14962,U,,Autocuration,,,,,,1,0,,BAO_0000100,12963,,22229
A,9615.0,,CHEMBL629201,Canis lupus familiaris,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,12964,,50588
A,9615.0,,CHEMBL629202,Canis lupus familiaris,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,,12487,N,,Intermediate,,,,,,1,1,,BAO_0000218,12965,,50588
A,9606.0,,CHEMBL875111,Homo sapiens,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,,10026,N,,Intermediate,,,,,,1,1,,BAO_0000218,12966,,50587
A,9606.0,,CHEMBL629203,Homo sapiens,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,,10026,N,,Intermediate,,,,,,1,1,,BAO_0000218,12967,,50587
A,9606.0,,CHEMBL629204,Homo sapiens,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,,10026,N,,Intermediate,,,,,,1,1,,BAO_0000218,12968,,50587
A,9606.0,,CHEMBL629205,Homo sapiens,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,,10026,N,,Intermediate,,,,,,1,1,,BAO_0000218,12969,,50587
A,9606.0,,CHEMBL629206,Homo sapiens,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,,10026,N,,Intermediate,,,,,,1,1,,BAO_0000218,12970,,50587
A,,,CHEMBL631185,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,10026,U,,Autocuration,,,,,,1,0,,BAO_0000019,12971,,22224
A,10116.0,,CHEMBL631186,Rattus norvegicus,Compound was evaluated for the average bile flow rat in rats,,7415,N,,Intermediate,,,,,,1,1,,BAO_0000218,12972,,50597
A,9986.0,,CHEMBL631187,Oryctolagus cuniculus,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12973,,50592
A,9986.0,,CHEMBL631188,Oryctolagus cuniculus,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",,17025,N,,Intermediate,,,,,,1,1,,BAO_0000218,12974,,50592
A,,,CHEMBL876419,,Average half life period was determined,,10184,U,,Autocuration,,,,,,1,0,,BAO_0000019,12975,,22224
A,,,CHEMBL631189,,Average half life period was determined,,10184,U,,Autocuration,,,,,,1,0,,BAO_0000019,12976,,22224
A,10298.0,,CHEMBL631190,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12977,,50602
A,10298.0,,CHEMBL631191,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12978,,50602
A,10298.0,,CHEMBL631192,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12979,,50602
A,10298.0,,CHEMBL632400,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12980,,50602
A,10298.0,,CHEMBL630564,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12981,,50602
A,10298.0,,CHEMBL630565,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12982,,50602
A,10298.0,,CHEMBL630566,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12983,,50602
A,10298.0,,CHEMBL631229,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12984,,50602
A,10298.0,,CHEMBL631230,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,12985,,50602
P,,,CHEMBL876428,,Calculated partition coefficient (clogP),,6030,U,,Autocuration,,,,,,1,0,,BAO_0000100,12986,,22229
P,,,CHEMBL631231,,Calculated partition coefficient (clogP),,6147,U,,Autocuration,,,,,,1,0,,BAO_0000100,12987,,22229
P,,,CHEMBL631232,,Calculated partition coefficient (clogP) (MacLogP),,14556,U,,Autocuration,,,,,,1,0,,BAO_0000100,12988,,22229
A,,,CHEMBL631233,,Hydrophilicity was determined,,768,U,,Autocuration,,,,,,1,0,,BAO_0000019,12989,,22224
P,,,CHEMBL631234,,Calculated partition coefficient (clogP),,14452,U,,Autocuration,,,,,,1,0,,BAO_0000100,12990,,22229
A,,,CHEMBL883126,,Increased absorption was determined,,5237,U,,Autocuration,,,,,,1,0,,BAO_0000019,12991,,22224
P,,,CHEMBL631235,,Lipophilicity value was evaluated,,14378,U,,Autocuration,,,,,,1,0,,BAO_0000100,12992,,22224
P,,,CHEMBL631236,,Log P value of the compound.,,14418,U,,Autocuration,,,,,,1,0,,BAO_0000100,12993,,22224
A,,,CHEMBL631237,,Partition coefficient of compound was determined,,5249,U,,Autocuration,,,,,,1,0,,BAO_0000019,12994,,22224
P,,,CHEMBL631238,,Calculated partition coefficient (clogP),,14621,U,,Autocuration,,,,,,1,0,,BAO_0000100,12995,,22229
P,,,CHEMBL876429,,Calculated partition coefficient (clogP),,12542,U,,Autocuration,,,,,,1,0,,BAO_0000100,12996,,22229
A,,,CHEMBL631414,,Partition coefficient was measured by medchem software; Not calculated,,12542,U,,Autocuration,,,,,,1,0,,BAO_0000019,12997,,22224
P,,,CHEMBL631415,,Partition coefficient was measured by octanol-water using standard shake-flask method,,12542,U,,Autocuration,,,,,,1,0,,BAO_0000100,12998,,22224
P,,,CHEMBL631416,,Calculated partition coefficient (clogP),,15462,U,,Autocuration,,,,,,1,0,,BAO_0000100,12999,,22229
A,,,CHEMBL631417,,Partition coefficient (logP),,14884,U,,Autocuration,,,,,,1,0,,BAO_0000019,13000,,22224
P,,,CHEMBL631418,,Calculated partition coefficient (clogP),,16526,U,,Autocuration,,,,,,1,0,,BAO_0000100,13001,,22229
P,,,CHEMBL631419,,The Octanol/Water partition coefficient CLogP,,13693,U,,Autocuration,,,,,,1,0,,BAO_0000100,13002,,22229
A,,,CHEMBL631420,,The pharmacokinetic parameter C Log p was reported,,13693,U,,Autocuration,,,,,,1,0,,BAO_0000019,13003,,22224
P,,,CHEMBL631421,,Calculated partition coefficient (clogP),,13779,U,,Autocuration,,,,,,1,0,,BAO_0000100,13004,,22229
P,,,CHEMBL631422,,Calculated partition coefficient (clogP),,14772,U,,Autocuration,,,,,,1,0,,BAO_0000100,13005,,22229
P,,,CHEMBL631423,,Calculated partition coefficient (clogP),,14393,U,,Autocuration,,,,,,1,0,,BAO_0000100,13006,,22229
A,10116.0,,CHEMBL876430,Rattus norvegicus,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13007,In vivo,50597
A,10116.0,,CHEMBL631424,Rattus norvegicus,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13008,In vivo,50597
A,9615.0,,CHEMBL631425,Canis lupus familiaris,Compound was administered intravenously in dog to evaluate plasma clearance values,,13744,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13009,In vivo,50588
A,314293.0,,CHEMBL631426,Simiiformes,Compound was administered intravenously in monkey to evaluate plasma clearance values,,13744,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13010,In vivo,22224
A,10090.0,,CHEMBL631427,Mus musculus,Compound was administered intravenously in mouse to evaluate plasma clearance values,,13744,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13011,In vivo,50594
A,9615.0,,CHEMBL631428,Canis lupus familiaris,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,,13207,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13012,In vivo,50588
A,9544.0,Microsomes,CHEMBL631429,Macaca mulatta,Intrinsic clearance in Rhesus liver microsome,,5669,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13013,In vitro,50797
A,9615.0,Microsomes,CHEMBL631430,Canis lupus familiaris,Intrinsic clearance in dog liver microsome,,5669,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13014,In vitro,50588
A,10116.0,Microsomes,CHEMBL631431,Rattus norvegicus,Intrinsic clearance in rat liver microsome,,5669,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13015,In vitro,50597
A,9544.0,,CHEMBL631432,Macaca mulatta,Low plasma clearance was calculated in rhesus monkey,,4853,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13016,In vivo,50797
A,9615.0,,CHEMBL631433,Canis lupus familiaris,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,,16452,N,,Intermediate,,,,,,1,1,,BAO_0000218,13017,In vivo,50588
A,,,CHEMBL631434,,Plasma clearance after intravenous dose of 0.3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,13018,In vivo,22224
A,,,CHEMBL631435,,Plasma clearance after intravenous dose of 1 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,13019,In vivo,22224
A,,,CHEMBL631436,,Plasma clearance after intravenous dose of 3 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,13020,In vivo,22224
A,,,CHEMBL631437,,Plasma clearance after intravenous dose of 3.87 mg/kg,,11954,U,,Autocuration,,,,,,1,0,,BAO_0000218,13021,In vivo,22224
A,10116.0,,CHEMBL631438,Rattus norvegicus,Plasma clearance after peroral administration at 10 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13022,In vivo,50597
A,9544.0,,CHEMBL876431,Macaca mulatta,Plasma clearance after peroral administration at 10 mpk in Rhesus,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13023,In vivo,50797
A,9615.0,,CHEMBL631439,Canis lupus familiaris,Plasma clearance after peroral administration at 10 mpk in dog,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13024,In vivo,50588
A,10116.0,,CHEMBL631440,Rattus norvegicus,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,,13662,N,,Intermediate,,,,,,1,1,,BAO_0000218,13025,In vivo,50597
A,,,CHEMBL631441,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,8272,U,,Autocuration,,,,,,1,0,,BAO_0000019,13026,,22224
A,,,CHEMBL631442,,Critical Micellar concentration was determined,,13410,U,,Autocuration,,,,,,1,0,,BAO_0000019,13027,,22224
A,,,CHEMBL626525,,Critical Micellar concentration of the compound. was determined,,13410,U,,Autocuration,,,,,,1,0,,BAO_0000019,13028,,22224
A,,,CHEMBL627168,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,12628,U,,Autocuration,,,,,,1,0,,BAO_0000019,13029,,22224
A,,,CHEMBL875618,,Critical micellar concentration was measured in water by the dye solubilization method,,9675,U,,Autocuration,,,,,,1,0,,BAO_0000019,13030,,22224
B,,,CHEMBL626612,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,12628,U,,Autocuration,,,,,,1,0,,BAO_0000019,13031,,22224
A,,,CHEMBL626613,,CMR value (relative to BAY K 8644),,12766,U,,Autocuration,,,,,,1,0,,BAO_0000019,13032,,22224
A,,,CHEMBL626614,,Carbamoylating activity was determined,,7849,U,,Autocuration,,,,,,1,0,,BAO_0000019,13033,,22224
A,314293.0,,CHEMBL626615,Simiiformes,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13034,,22224
A,,,CHEMBL626616,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,2040,U,,Autocuration,,,,,,1,0,,BAO_0000019,13035,,22224
A,,,CHEMBL626617,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,2040,U,,Autocuration,,,,,,1,0,,BAO_0000019,13036,,22224
A,9615.0,,CHEMBL626618,Canis lupus familiaris,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,,14180,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13037,In vivo,50588
A,10116.0,,CHEMBL626619,Rattus norvegicus,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,,14180,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13038,In vivo,50597
A,9615.0,,CHEMBL626620,Canis lupus familiaris,"Clearance rate at 0.46 mg/kg, iv, in dogs",,14474,N,,Intermediate,,,,,,1,1,,BAO_0000218,13039,In vivo,50588
A,10116.0,,CHEMBL626621,Rattus norvegicus,"Clearance rate at 5.5 mg/kg, iv, in rat",,14474,N,,Intermediate,,,,,,1,1,,BAO_0000218,13040,In vivo,50597
A,9541.0,,CHEMBL626622,Macaca fascicularis,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,13041,In vivo,100710
A,9541.0,,CHEMBL626623,Macaca fascicularis,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,13042,In vivo,100710
A,9615.0,,CHEMBL626624,Canis lupus familiaris,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,13043,In vivo,50588
A,10116.0,,CHEMBL626625,Rattus norvegicus,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,,14548,N,,Intermediate,,,,,,1,1,,BAO_0000218,13044,In vivo,50597
A,10116.0,,CHEMBL626626,Rattus norvegicus,Clearance rate constant using isolated perfused rat liver (IPRL) assay,,6125,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13045,Ex vivo,50597
A,,,CHEMBL626627,,Tested for the total clearance of the compound,,6874,U,,Autocuration,,,,,,1,0,,BAO_0000218,13046,In vivo,22224
A,9615.0,,CHEMBL626628,Canis lupus familiaris,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,,15343,N,,Intermediate,,,,,,1,1,,BAO_0000218,13047,In vivo,50588
A,,,CHEMBL626629,,Total body clearance was determined,,6236,U,,Autocuration,,,,,,1,0,,BAO_0000218,13048,In vivo,22224
A,10116.0,,CHEMBL626630,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13049,,50597
A,10116.0,,CHEMBL626631,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13050,,50597
P,,,CHEMBL626632,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13051,,22229
P,,,CHEMBL626633,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13052,,22229
P,,,CHEMBL626634,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13053,,22229
P,,,CHEMBL626635,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13054,,22229
P,,,CHEMBL626636,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13055,,22229
P,,,CHEMBL626637,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,8194,U,,Autocuration,,,,,,1,0,,BAO_0000100,13056,,22229
A,4754.0,,CHEMBL626638,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13057,,50339
A,4754.0,,CHEMBL626639,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13058,,50339
A,4754.0,,CHEMBL626640,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13059,,50339
A,4754.0,,CHEMBL626641,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13060,,50339
A,4754.0,,CHEMBL627272,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13061,,50339
A,4754.0,,CHEMBL627273,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13062,,50339
A,4754.0,,CHEMBL627441,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13063,,50339
A,4754.0,,CHEMBL628355,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13064,,50339
A,4754.0,,CHEMBL628356,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13065,,50339
A,4754.0,,CHEMBL628357,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13066,,50339
A,4754.0,,CHEMBL628358,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13067,,50339
A,4754.0,,CHEMBL622307,Pneumocystis carinii,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),,13273,N,,Intermediate,,,,,,1,1,,BAO_0000218,13068,,50339
A,,,CHEMBL622527,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13069,,22224
A,,,CHEMBL622528,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13070,,22224
A,,,CHEMBL622529,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13071,,22224
A,,,CHEMBL622992,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13072,,22224
A,,,CHEMBL622993,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13073,,22224
A,,,CHEMBL622994,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,13118,U,,Autocuration,,,,,,1,0,,BAO_0000019,13074,,22224
A,10116.0,,CHEMBL622995,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",,10633,N,,Intermediate,,,,,,1,1,,BAO_0000218,13075,,50597
A,10116.0,,CHEMBL622996,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",,10633,N,,Intermediate,,,,,,1,1,,BAO_0000218,13076,,50597
A,10116.0,,CHEMBL622997,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",,10633,N,,Intermediate,,,,,,1,1,,BAO_0000218,13077,,50597
A,10116.0,,CHEMBL622998,Rattus norvegicus,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",,10633,N,,Intermediate,,,,,,1,1,,BAO_0000218,13078,,50597
A,,,CHEMBL622999,,Cp max following ip administration at 1 mg/kg,,5767,U,,Autocuration,,,,,,1,0,,BAO_0000218,13079,,22224
A,,,CHEMBL623000,,Maximum concentration in plasma was reported at 0.5 hour,,3302,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13080,In vivo,22224
A,,,CHEMBL623001,,Maximum concentration in plasma was reported at 2 hour,,3302,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13081,In vivo,22224
A,10090.0,,CHEMBL623002,Mus musculus,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,,12467,N,,Intermediate,,,,,,1,1,,BAO_0000218,13082,,50594
P,,,CHEMBL623003,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,11778,U,,Autocuration,,,,,,1,0,,BAO_0000100,13083,,22229
A,,,CHEMBL623004,,Steady state concentration was evaluated,,4321,U,,Autocuration,,,,,,1,0,,BAO_0000019,13084,,22224
A,,,CHEMBL623005,,Partition coefficient (logP),,14884,U,,Autocuration,,,,,,1,0,,BAO_0000019,13085,,22224
A,,,CHEMBL623006,,Partition coefficient (logD7.4),,15234,U,,Autocuration,,,,,,1,0,,BAO_0000019,13086,,22224
A,10116.0,,CHEMBL623007,Rattus norvegicus,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,,14198,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13087,In vivo,50597
A,10116.0,,CHEMBL623008,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,,14198,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,13088,In vivo,50597
A,10116.0,,CHEMBL876654,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,,14198,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13089,In vivo,50597
A,10116.0,,CHEMBL623009,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13090,In vivo,50597
A,10116.0,,CHEMBL623010,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13091,In vivo,50597
A,10116.0,,CHEMBL623011,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,,14198,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13092,In vivo,50597
A,10116.0,,CHEMBL623012,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,,14198,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,13093,In vivo,50597
A,,,CHEMBL623013,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,8151,U,,Autocuration,,,,,,1,0,,BAO_0000019,13094,,22224
A,,,CHEMBL623014,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,U,,Autocuration,,,,,,1,0,,BAO_0000019,13095,,22224
A,,,CHEMBL623015,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,8151,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13096,,22224
A,,,CHEMBL623016,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,8151,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13097,,22224
A,,,CHEMBL624858,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,8151,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13098,,22224
A,10116.0,,CHEMBL624859,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13099,,50597
A,10116.0,,CHEMBL624860,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13100,,50597
A,10116.0,,CHEMBL624861,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13101,,50597
A,10116.0,,CHEMBL624862,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13102,,50597
A,10116.0,,CHEMBL624863,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13103,,50597
A,10116.0,,CHEMBL876655,Rattus norvegicus,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,,8151,N,,Intermediate,,,,,,1,1,,BAO_0000218,13104,,50597
A,9615.0,,CHEMBL624864,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13105,,50588
A,9615.0,,CHEMBL624865,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13106,,50588
A,9615.0,,CHEMBL624866,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13107,,50588
F,9615.0,,CHEMBL624867,Canis lupus familiaris,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,,6996,N,,Expert,,,,,,1,1,,BAO_0000218,13108,,50588
A,9615.0,,CHEMBL624868,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13109,,50588
A,9615.0,,CHEMBL628450,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13110,,50588
A,9615.0,,CHEMBL628451,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13111,,50588
A,9615.0,,CHEMBL628452,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13112,,50588
A,9615.0,,CHEMBL628453,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13113,,50588
A,9615.0,,CHEMBL628454,Canis lupus familiaris,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13114,,50588
A,9615.0,,CHEMBL628455,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13115,,50588
A,9615.0,,CHEMBL628456,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13116,,50588
A,9615.0,,CHEMBL628457,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13117,,50588
A,9615.0,,CHEMBL877505,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13118,,50588
A,9615.0,,CHEMBL628458,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13119,,50588
A,9615.0,,CHEMBL628459,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13120,,50588
A,9615.0,,CHEMBL628460,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13121,,50588
A,9615.0,,CHEMBL628461,Canis lupus familiaris,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13122,,50588
B,,,CHEMBL628462,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,6996,U,,Autocuration,,,,,,1,0,,BAO_0000218,13123,,22224
A,9615.0,,CHEMBL628463,Canis lupus familiaris,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13124,,50588
F,10116.0,,CHEMBL625666,Rattus norvegicus,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",,6996,N,,Expert,,,,,,1,1,,BAO_0000218,13125,,50597
B,,,CHEMBL625667,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,U,,Autocuration,,,,,,1,0,,BAO_0000218,13126,,22224
A,10116.0,,CHEMBL625668,Rattus norvegicus,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,N,,Expert,,,,,,1,1,,BAO_0000218,13127,,50597
A,10116.0,,CHEMBL625669,Rattus norvegicus,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13128,,50597
A,,,CHEMBL625670,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,7114,U,,Autocuration,,,,,,1,0,,BAO_0000019,13129,,22224
A,10116.0,,CHEMBL625671,Rattus norvegicus,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,,7114,N,,Intermediate,,,,,,1,1,,BAO_0000218,13130,,50597
A,10298.0,,CHEMBL625672,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13131,,50602
A,10298.0,,CHEMBL625673,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13132,,50602
A,10298.0,,CHEMBL625674,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13133,,50602
A,10298.0,,CHEMBL625675,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13134,,50602
A,10298.0,,CHEMBL627637,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13135,,50602
A,10298.0,,CHEMBL627638,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13136,,50602
A,10298.0,,CHEMBL627639,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13137,,50602
A,10298.0,,CHEMBL627640,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13138,,50602
A,10298.0,,CHEMBL627641,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13139,,50602
A,10298.0,,CHEMBL627642,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13140,,50602
A,10298.0,,CHEMBL877506,Human herpesvirus 1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13141,,50602
A,10090.0,,CHEMBL627275,Mus musculus,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,13142,,50594
A,9669.0,,CHEMBL627643,Mustela putorius furo,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13143,,50506
A,9669.0,,CHEMBL631246,Mustela putorius furo,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13144,,50506
A,9669.0,,CHEMBL631247,Mustela putorius furo,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13145,,50506
A,9669.0,,CHEMBL629532,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13146,,50506
A,9669.0,,CHEMBL629533,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13147,,50506
A,9669.0,,CHEMBL629534,Mustela putorius furo,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13148,,50506
A,9669.0,,CHEMBL629535,Mustela putorius furo,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,,11219,N,,Intermediate,,,,,,1,1,,BAO_0000218,13149,,50506
A,,,CHEMBL625932,,Pharmacokinetic parameter :drug bound to plasma was reported,,14837,U,,Autocuration,,,,,,1,0,,BAO_0000019,13150,,22224
A,,,CHEMBL625933,,compound was evaluated for drug bound in plasma,,14837,U,,Autocuration,,,,,,1,0,,BAO_0000019,13151,,22224
A,10116.0,,CHEMBL625934,Rattus norvegicus,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,,15343,N,,Intermediate,,,,,,1,1,,BAO_0000218,13152,,50597
A,9347.0,,CHEMBL625935,Eutheria,Bioavailability,,13761,U,,Autocuration,,,,,,1,0,,BAO_0000218,13153,,22224
A,10116.0,,CHEMBL625936,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,,14810,N,,Intermediate,,,,,,1,1,,BAO_0000218,13154,,50597
A,10116.0,,CHEMBL625937,Rattus norvegicus,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,,14810,N,,Intermediate,,,,,,1,1,,BAO_0000218,13155,,50597
A,9615.0,,CHEMBL625938,Canis lupus familiaris,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,,13249,N,,Intermediate,,,,,,1,1,,BAO_0000218,13156,,50588
A,10116.0,,CHEMBL625939,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13157,,50597
A,10116.0,,CHEMBL625940,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13158,,50597
A,10116.0,,CHEMBL874464,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13159,,50597
A,10116.0,,CHEMBL625941,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13160,,50597
A,10116.0,,CHEMBL625942,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13161,,50597
A,10116.0,,CHEMBL625943,Rattus norvegicus,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,,9267,N,,Intermediate,,,Bile,1970.0,,1,1,,BAO_0000218,13162,,50597
A,9606.0,,CHEMBL625944,Homo sapiens,In vitro protein binding in human serum at 5 ug/ml,,15549,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,13163,,50587
A,,,CHEMBL625945,,Serum protein binding ability was measured,,10929,U,,Autocuration,,,,,,1,0,,BAO_0000019,13164,,22224
A,,,CHEMBL625946,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,15444,U,,Autocuration,,,,,,1,0,,BAO_0000019,13165,,22224
A,9615.0,,CHEMBL625947,Canis lupus familiaris,Oral bioavailability in dog,,12860,U,,Autocuration,,,,,,1,0,,BAO_0000218,13166,In vivo,22224
A,10116.0,,CHEMBL625948,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,12170,N,,Intermediate,,,,,,1,1,,BAO_0000218,13167,In vivo,50597
A,,,CHEMBL625949,,Absolute oral bioavailability at an iv dose of 14 mg/kg,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13168,In vivo,22224
A,,,CHEMBL625950,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13169,In vivo,22224
A,9347.0,,CHEMBL625951,Eutheria,Oral bioavailability (dose 15 mg/kg i.v.),,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13170,In vivo,22224
A,,,CHEMBL625952,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13171,In vivo,22224
A,,,CHEMBL625953,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13172,In vivo,22224
A,,,CHEMBL625954,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13173,In vivo,22224
A,,,CHEMBL882959,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13174,In vivo,22224
A,9615.0,,CHEMBL625955,Canis lupus familiaris,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,,11767,N,,Intermediate,,,,,,1,1,,BAO_0000218,13175,In vivo,50588
A,9669.0,,CHEMBL625956,Mustela putorius furo,Bioavailability in ferret,,11219,U,,Autocuration,,,,,,1,0,,BAO_0000218,13176,In vivo,22224
A,9541.0,,CHEMBL625957,Macaca fascicularis,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,,12186,N,,Intermediate,,,,,,1,1,,BAO_0000218,13177,In vivo,100710
A,10116.0,,CHEMBL625958,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13178,,50597
A,10116.0,,CHEMBL625959,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13179,,50597
A,10116.0,,CHEMBL626642,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13180,,50597
A,10116.0,,CHEMBL631330,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13181,,50597
A,10116.0,,CHEMBL631331,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13182,,50597
A,10116.0,,CHEMBL631332,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13183,,50597
A,10116.0,,CHEMBL631333,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13184,,50597
A,10116.0,,CHEMBL632018,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13185,,50597
A,10116.0,,CHEMBL632019,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13186,,50597
A,10116.0,,CHEMBL632020,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13187,,50597
A,10116.0,,CHEMBL632021,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13188,,50597
A,10116.0,,CHEMBL632022,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13189,,50597
A,10116.0,,CHEMBL632023,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13190,,50597
A,10116.0,,CHEMBL632024,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13191,,50597
A,10116.0,,CHEMBL874472,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13192,,50597
A,10116.0,,CHEMBL632025,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13193,,50597
A,10116.0,,CHEMBL632026,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13194,,50597
A,10116.0,,CHEMBL632027,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13195,,50597
A,10116.0,,CHEMBL632028,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13196,,50597
A,10116.0,,CHEMBL626430,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13197,,50597
A,10116.0,,CHEMBL626431,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13198,,50597
A,10116.0,,CHEMBL626432,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13199,,50597
A,10116.0,,CHEMBL626433,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13200,,50597
A,10116.0,,CHEMBL626434,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13201,,50597
A,10116.0,,CHEMBL627280,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13202,,50597
A,10116.0,,CHEMBL627281,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13203,,50597
A,10116.0,,CHEMBL627282,Rattus norvegicus,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13204,,50597
A,,,CHEMBL627283,,Total body clearance was measured at given dose,,7199,U,,Autocuration,,,,,,1,0,,BAO_0000019,13205,,22224
A,,,CHEMBL627284,,Total body clearance was measured at given dose.,,7199,U,,Autocuration,,,,,,1,0,,BAO_0000218,13206,,22224
A,10116.0,,CHEMBL627285,Rattus norvegicus,Metabolic clearance from the body in rat,,7095,N,,Intermediate,,,,,,1,1,,BAO_0000218,13207,,50597
A,,,CHEMBL627286,,Renal clearance from the body,,7095,U,,Autocuration,,,,,,1,0,,BAO_0000218,13208,In vivo,22224
A,10116.0,,CHEMBL875477,Rattus norvegicus,Renal clearance from the body in rat,,7095,N,,Intermediate,,,,,,1,1,,BAO_0000218,13209,In vivo,50597
A,10116.0,,CHEMBL627287,Rattus norvegicus,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,,12528,N,,Intermediate,,,,,,1,1,,BAO_0000218,13210,In vivo,50597
A,9615.0,,CHEMBL627288,Canis lupus familiaris,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,,12528,N,,Intermediate,,,,,,1,1,,BAO_0000218,13211,In vivo,50588
A,10116.0,,CHEMBL627289,Rattus norvegicus,Total clearance from the body in rat,,7095,N,,Intermediate,,,,,,1,1,,BAO_0000218,13212,,50597
A,10116.0,,CHEMBL627290,Rattus norvegicus,Clearance into cortex from rat plasma or PBS,,14223,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13213,In vivo,50597
A,,,CHEMBL627291,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,13569,U,,Autocuration,,,,,,1,0,,BAO_0000218,13214,In vivo,22224
A,,,CHEMBL627292,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,13569,U,,Autocuration,,,,,,1,0,,BAO_0000218,13215,In vivo,22224
A,,,CHEMBL627293,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,13569,U,,Autocuration,,,,,,1,0,,BAO_0000218,13216,In vivo,22224
A,,,CHEMBL627294,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,13569,U,,Autocuration,,,,,,1,0,,BAO_0000218,13217,In vivo,22224
A,,,CHEMBL875478,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,13569,U,,Autocuration,,,,,,1,0,,BAO_0000218,13218,In vivo,22224
A,,,CHEMBL627295,,Clearance was determined,,13979,U,,Autocuration,,,,,,1,0,,BAO_0000218,13219,In vivo,22224
A,10090.0,,CHEMBL627296,Mus musculus,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,,14315,N,,Intermediate,,,,,,1,1,,BAO_0000218,13220,In vivo,50594
A,9986.0,,CHEMBL626119,Oryctolagus cuniculus,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,,14315,N,,Intermediate,,,,,,1,1,,BAO_0000218,13221,In vivo,50592
A,10116.0,,CHEMBL626120,Rattus norvegicus,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,,14315,N,,Intermediate,,,,,,1,1,,BAO_0000218,13222,In vivo,50597
A,10116.0,,CHEMBL626121,Rattus norvegicus,Clearance in rat after iv dose (100 ug/kg),,12174,N,,Intermediate,,,,,,1,1,,BAO_0000218,13223,In vivo,50597
A,10141.0,,CHEMBL626122,Cavia porcellus,Clearance in guinea pig,,12797,U,,Autocuration,,,,,,1,0,,BAO_0000218,13224,In vivo,22224
A,10116.0,,CHEMBL626123,Rattus norvegicus,Compound was evaluated for clearance in rat,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,13225,In vivo,50597
A,9615.0,,CHEMBL623456,Canis lupus familiaris,Compound was evaluated for the clearance in dog,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,13226,In vivo,50588
A,10116.0,,CHEMBL623457,Rattus norvegicus,Compound was evaluated for the clearance in rat,,12797,N,,Intermediate,,,,,,1,1,,BAO_0000218,13227,In vivo,50597
A,10116.0,,CHEMBL623458,Rattus norvegicus,Compound was tested in vivo for clearance after iv administration in the rat,,11500,N,,Intermediate,,,,,,1,1,,BAO_0000218,13228,In vivo,50597
A,,,CHEMBL623459,,IV clearance determined at an iv dose of 14 mg/kg,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13229,In vivo,22224
A,,,CHEMBL875484,,IV clearance determined at an iv dose of 15.2 mg/kg,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13230,In vivo,22224
A,,,CHEMBL623460,,IV clearance determined at an iv dose of 15 mg/kg,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13231,In vivo,22224
A,,,CHEMBL623461,,IV clearance determined at an peroral dose of 30 mg/kg.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13232,In vivo,22224
A,,,CHEMBL623462,,IV clearance determined at an peroral dose of 30.2 mg/kg.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13233,In vivo,22224
A,,,CHEMBL627386,,IV clearance determined at an peroral dose of 30.3 mg/kg.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13234,In vivo,22224
A,10116.0,,CHEMBL627387,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,,14198,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13235,In vivo,50597
A,10116.0,,CHEMBL627388,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,,14198,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13236,In vivo,50597
A,10116.0,,CHEMBL627389,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,,14198,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13237,In vivo,50597
A,10116.0,,CHEMBL627390,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,,14198,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13238,In vivo,50597
A,10116.0,,CHEMBL627391,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,,14198,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13239,In vivo,50597
A,10116.0,,CHEMBL627392,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13240,In vivo,50597
A,10116.0,,CHEMBL627393,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,,14198,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13241,In vivo,50597
A,10116.0,,CHEMBL627394,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,,14198,N,,Intermediate,,,Trachea,3126.0,,1,1,,BAO_0000218,13242,In vivo,50597
A,10116.0,,CHEMBL627395,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,,14198,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,13243,In vivo,50597
A,10116.0,,CHEMBL875485,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,,14198,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13244,In vivo,50597
A,10116.0,,CHEMBL627396,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13245,In vivo,50597
A,10116.0,,CHEMBL627397,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13246,In vivo,50597
A,10116.0,,CHEMBL627398,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,,14198,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13247,In vivo,50597
A,10116.0,,CHEMBL627399,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,,14198,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,13248,In vivo,50597
A,10116.0,,CHEMBL627400,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,,14198,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13249,In vivo,50597
A,10116.0,,CHEMBL627401,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,,14198,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13250,In vivo,50597
A,10116.0,,CHEMBL627402,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,,14198,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13251,In vivo,50597
A,10116.0,,CHEMBL627403,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,,14198,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13252,In vivo,50597
A,10116.0,,CHEMBL627404,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,,14198,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13253,In vivo,50597
A,10116.0,,CHEMBL623101,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13254,In vivo,50597
A,10116.0,,CHEMBL877480,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,,14198,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13255,In vivo,50597
A,10116.0,,CHEMBL623102,Rattus norvegicus,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,,14198,N,,Intermediate,,,Trachea,3126.0,,1,1,,BAO_0000218,13256,In vivo,50597
A,10116.0,,CHEMBL623103,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,,14198,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,13257,In vivo,50597
A,10116.0,,CHEMBL623104,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,,14198,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13258,In vivo,50597
A,10116.0,,CHEMBL623105,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13259,In vivo,50597
A,10116.0,,CHEMBL623106,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13260,In vivo,50597
A,10116.0,,CHEMBL623107,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,,14198,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13261,In vivo,50597
A,10116.0,,CHEMBL623108,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,,14198,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,13262,In vivo,50597
A,10116.0,,CHEMBL623109,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,,14198,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13263,In vivo,50597
A,10116.0,,CHEMBL623110,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,,14198,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13264,In vivo,50597
A,10116.0,,CHEMBL623111,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,,14198,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13265,In vivo,50597
A,10116.0,,CHEMBL625060,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,,14198,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13266,In vivo,50597
A,10116.0,,CHEMBL625061,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,,14198,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13267,In vivo,50597
A,10116.0,,CHEMBL625062,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13268,In vivo,50597
A,10116.0,,CHEMBL625063,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,,14198,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13269,In vivo,50597
A,10116.0,,CHEMBL625064,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,,14198,N,,Intermediate,,,Trachea,3126.0,,1,1,,BAO_0000218,13270,In vivo,50597
A,10116.0,,CHEMBL625065,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,,14198,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,13271,In vivo,50597
A,10116.0,,CHEMBL625066,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,,14198,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13272,In vivo,50597
A,10116.0,,CHEMBL625067,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13273,In vivo,50597
A,10116.0,,CHEMBL625068,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13274,In vivo,50597
A,10116.0,,CHEMBL622159,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,,14198,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13275,In vivo,50597
A,10116.0,,CHEMBL622160,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,,14198,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,13276,In vivo,50597
A,10116.0,,CHEMBL622161,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,,14198,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13277,In vivo,50597
A,10116.0,,CHEMBL622162,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,,14198,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13278,In vivo,50597
A,10116.0,,CHEMBL622163,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,,14198,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13279,In vivo,50597
A,10116.0,,CHEMBL622313,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,,14198,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13280,In vivo,50597
A,10116.0,,CHEMBL622314,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,,14198,N,,Intermediate,,,,,,1,1,,BAO_0000218,13281,In vivo,50597
A,10116.0,,CHEMBL622315,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,,14198,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13282,In vivo,50597
A,10116.0,,CHEMBL622316,Rattus norvegicus,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,,14198,N,,Intermediate,,,Trachea,3126.0,,1,1,,BAO_0000218,13283,In vivo,50597
A,562.0,,CHEMBL877486,Escherichia coli,Normal diffusion coefficient in water for Escherichia coli,,15599,N,,Intermediate,,,,,,1,1,,BAO_0000218,13284,,50212
A,,,CHEMBL622317,,Average max percent decrease in RVR (renal vascular resistance) was determined,,8204,U,,Autocuration,,,,,,1,0,,BAO_0000019,13285,,22224
A,,,CHEMBL622318,,Average max percent decrease in RVR (renal vascular resistance) was determined.,,8204,U,,Autocuration,,,,,,1,0,,BAO_0000019,13286,,22224
A,,,CHEMBL622319,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13287,,22224
A,,,CHEMBL622320,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13288,,22224
A,,,CHEMBL622321,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13289,,22224
A,,,CHEMBL622322,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13290,,22224
A,,,CHEMBL622323,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,7114,U,,Autocuration,,,,,,1,0,,BAO_0000019,13291,,22224
A,10116.0,,CHEMBL622324,Rattus norvegicus,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,,7114,N,,Intermediate,,,,,,1,1,,BAO_0000218,13292,,50597
A,9615.0,,CHEMBL622325,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13293,,50588
A,9615.0,,CHEMBL622326,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13294,,50588
A,9615.0,,CHEMBL877487,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13295,,50588
A,9615.0,,CHEMBL622327,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13296,,50588
A,9615.0,,CHEMBL622328,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13297,,50588
A,9615.0,,CHEMBL622329,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13298,,50588
A,9615.0,,CHEMBL622330,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13299,,50588
A,9615.0,,CHEMBL622331,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13300,,50588
A,9615.0,,CHEMBL622332,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13301,,50588
A,9615.0,,CHEMBL622333,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13302,,50588
A,314293.0,,CHEMBL627658,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13303,,22224
A,314293.0,,CHEMBL630428,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13304,,22224
A,314293.0,,CHEMBL630429,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13305,,22224
A,314293.0,,CHEMBL630430,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13306,,22224
A,314293.0,,CHEMBL630431,Simiiformes,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13307,,22224
A,10116.0,,CHEMBL630432,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13308,,50597
A,10116.0,,CHEMBL630433,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13309,,50597
A,10116.0,,CHEMBL630434,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13310,,50597
A,10116.0,,CHEMBL629372,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13311,,50597
A,10116.0,,CHEMBL629553,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13312,,50597
A,10116.0,,CHEMBL629554,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13313,,50597
A,10116.0,,CHEMBL874447,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13314,,50597
A,10116.0,,CHEMBL629555,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13315,,50597
A,10116.0,,CHEMBL629556,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13316,,50597
A,10116.0,,CHEMBL629557,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13317,,50597
A,10116.0,,CHEMBL629558,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13318,,50597
A,10116.0,,CHEMBL629559,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13319,,50597
A,10116.0,,CHEMBL629560,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13320,,50597
A,9615.0,,CHEMBL629561,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13321,,50588
A,9615.0,,CHEMBL629562,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13322,,50588
A,9615.0,,CHEMBL629563,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13323,,50588
A,9615.0,,CHEMBL629564,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13324,,50588
A,9615.0,,CHEMBL629565,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13325,,50588
A,9615.0,,CHEMBL629566,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13326,,50588
A,9615.0,,CHEMBL629567,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13327,,50588
A,9615.0,,CHEMBL629568,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13328,,50588
A,9615.0,,CHEMBL629569,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13329,,50588
A,9615.0,,CHEMBL629570,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13330,,50588
A,314293.0,,CHEMBL629571,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13331,,22224
A,10116.0,,CHEMBL629572,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,12170,U,,Autocuration,,,,,,1,0,,BAO_0000218,13332,In vivo,22224
A,10116.0,,CHEMBL629573,Rattus norvegicus,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,,12170,U,,Autocuration,,,,,,1,0,,BAO_0000218,13333,In vivo,22224
A,9347.0,,CHEMBL629574,Eutheria,Bioavailability (dose 20 mg/kg),,4985,U,,Autocuration,,,,,,1,0,,BAO_0000218,13334,In vivo,22224
A,9615.0,,CHEMBL629575,Canis lupus familiaris,Bioavailability in dog,,15145,U,,Autocuration,,,,,,1,0,,BAO_0000218,13335,In vivo,22224
A,10116.0,,CHEMBL874448,Rattus norvegicus,Bioavailability in rat (Sprague-Dawley) (male),,14080,U,,Autocuration,,,,,,1,0,,BAO_0000218,13336,In vivo,22224
A,9443.0,,CHEMBL629576,Primates,Bioavailability in monkey (dose 10 mg/kg i.d.),,11219,U,,Autocuration,,,,,,1,0,,BAO_0000218,13337,In vivo,22224
A,10116.0,,CHEMBL629577,Rattus norvegicus,Bioavailability in rat,,15145,U,,Autocuration,,,,,,1,0,,BAO_0000218,13338,In vivo,22224
A,10116.0,,CHEMBL629578,Rattus norvegicus,Bioavailability in rat,,15145,U,,Autocuration,,,,,,1,0,,BAO_0000218,13339,In vivo,22224
A,9615.0,,CHEMBL629579,Canis lupus familiaris,Bioavailability in dog (dose 3.0 mg/kg p.o.),,1202,U,,Autocuration,,,,,,1,0,,BAO_0000218,13340,In vivo,22224
A,9615.0,,CHEMBL882958,Canis lupus familiaris,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,,1202,U,,Autocuration,,,,,,1,0,,BAO_0000218,13341,In vivo,22224
A,9598.0,,CHEMBL629580,Pan troglodytes,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,,1202,N,,Intermediate,,,,,,1,1,,BAO_0000218,13342,In vivo,50505
A,9347.0,,CHEMBL629581,Eutheria,Bioavailability,,4026,U,,Autocuration,,,,,,1,0,,BAO_0000218,13343,In vivo,22224
A,9520.0,,CHEMBL629582,Saimiri,Bioavailability in squirrel monkey,,1492,U,,Autocuration,,,,,,1,0,,BAO_0000218,13344,In vivo,22224
A,9615.0,,CHEMBL628522,Canis lupus familiaris,Bioavailability was evaluated in dog,,12793,N,,Intermediate,,,,,,1,1,,BAO_0000218,13345,In vivo,50588
A,10026.0,,CHEMBL625432,Cricetinae,Bioavailability was evaluated in hamster,,12793,N,,Intermediate,,,,,,1,1,,BAO_0000218,13346,In vivo,100712
A,10116.0,,CHEMBL625433,Rattus norvegicus,Bioavailability in rat,,12793,U,,Autocuration,,,,,,1,0,,BAO_0000218,13347,In vivo,22224
A,10116.0,,CHEMBL625434,Rattus norvegicus,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13348,In vivo,50597
A,10116.0,,CHEMBL625435,Rattus norvegicus,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,,14793,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13349,In vivo,50597
A,10116.0,,CHEMBL625436,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg p.o.),,14793,U,,Autocuration,,,,,,1,0,,BAO_0000218,13350,In vivo,22224
A,9541.0,,CHEMBL874588,Macaca fascicularis,Bioavailability was measured in cynomolgus monkeys.,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,13351,In vivo,100710
A,10090.0,,CHEMBL625437,Mus musculus,Bioavailability was measured in nude mice.,,14731,N,,Intermediate,,,,,,1,1,,BAO_0000218,13352,In vivo,50594
A,9669.0,,CHEMBL625438,Mustela putorius furo,Bioavailability in ferret (dose 10 mg/kg i.d.),,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13353,In vivo,22224
A,314293.0,,CHEMBL625439,Simiiformes,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13354,In vivo,22224
A,314293.0,,CHEMBL625440,Simiiformes,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13355,In vivo,22224
A,314293.0,,CHEMBL625441,Simiiformes,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13356,In vivo,22224
A,10116.0,,CHEMBL625442,Rattus norvegicus,Bioavailability in rat (dose 10 mg/kg i.d.),,12187,U,,Autocuration,,,,,,1,0,,BAO_0000218,13357,In vivo,22224
A,10116.0,,CHEMBL625443,Rattus norvegicus,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",,12187,N,,Intermediate,,,,,,1,1,,BAO_0000218,13358,In vivo,50597
A,,,CHEMBL625444,,Bioavailability was determined; extremely poor,,17431,U,,Autocuration,,,,,,1,0,,BAO_0000218,13359,In vivo,22224
A,10090.0,,CHEMBL625445,Mus musculus,% bioavailability in mice after oral administration of prodrug,,13318,N,,Intermediate,,,,,,1,1,,BAO_0000218,13360,In vivo,50594
A,9615.0,,CHEMBL625446,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13361,In vivo,50588
A,9615.0,,CHEMBL882960,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13362,In vivo,50588
A,9615.0,,CHEMBL625447,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13363,In vivo,50588
A,9615.0,,CHEMBL625448,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13364,In vivo,50588
A,9615.0,,CHEMBL625449,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13365,In vivo,50588
A,9615.0,,CHEMBL874589,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13366,In vivo,50588
A,9615.0,,CHEMBL625450,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13367,In vivo,50588
A,9615.0,,CHEMBL625451,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13368,In vivo,50588
A,9615.0,,CHEMBL626584,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13369,In vivo,50588
A,9615.0,,CHEMBL626585,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13370,In vivo,50588
A,9615.0,,CHEMBL626586,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13371,In vivo,50588
A,9615.0,,CHEMBL626587,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13372,In vivo,50588
A,9615.0,,CHEMBL626588,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13373,In vivo,50588
A,9615.0,,CHEMBL626589,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13374,In vivo,50588
A,9615.0,,CHEMBL626590,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13375,In vivo,50588
A,9615.0,,CHEMBL626591,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13376,In vivo,50588
A,9615.0,,CHEMBL627181,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13377,In vivo,50588
A,9615.0,,CHEMBL628083,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13378,In vivo,50588
A,,,CHEMBL628084,,IV clearance determined at an peroral dose of 15 mg/kg.,,15173,U,,Autocuration,,,,,,1,0,,BAO_0000218,13379,In vivo,22224
F,102285.0,,CHEMBL628085,Hymenolepis nana,Mouse oral clearance was measured against Hymenolepiasis nana.,,7732,N,,Expert,,,,,,1,1,,BAO_0000218,13380,In vivo,50064
F,6339.0,,CHEMBL628086,Heligmosomoides polygyrus,Mouse oral clearance was measured against Nematospiroides dubius,,7732,N,,Expert,,,,,,1,1,,BAO_0000218,13381,In vivo,50545
F,,,CHEMBL628087,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,7732,U,,Autocuration,,,,,,1,0,,BAO_0000218,13382,In vivo,22224
A,10090.0,,CHEMBL628088,Mus musculus,Mouse oral clearance was measured against N. nana; NT is Not Tested,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13383,In vivo,50594
B,,,CHEMBL628089,,Mouse oral clearance was measured against N. nana; NT is Not Tested,,7732,U,,Autocuration,,,,,,1,0,,BAO_0000218,13384,In vivo,22224
A,,,CHEMBL628090,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13385,In vivo,22224
A,,,CHEMBL628091,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13386,In vivo,22224
A,,,CHEMBL628092,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13387,In vivo,22224
A,,,CHEMBL628093,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13388,In vivo,22224
A,,,CHEMBL875607,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13389,In vivo,22224
A,,,CHEMBL625710,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13390,In vivo,22224
A,,,CHEMBL625711,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13391,In vivo,22224
A,,,CHEMBL625712,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13392,In vivo,22224
A,,,CHEMBL625713,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,8328,U,,Autocuration,,,,,,1,0,,BAO_0000218,13393,In vivo,22224
A,9615.0,,CHEMBL625714,Canis lupus familiaris,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,,13376,N,,Intermediate,,,,,,1,1,,BAO_0000218,13394,In vivo,50588
A,9544.0,,CHEMBL625715,Macaca mulatta,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,13395,In vivo,50797
A,10116.0,,CHEMBL625716,Rattus norvegicus,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,13396,In vivo,50597
A,10116.0,,CHEMBL625717,Rattus norvegicus,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,,13477,N,,Intermediate,,,,,,1,1,,BAO_0000218,13397,In vivo,50597
A,10116.0,,CHEMBL625718,Rattus norvegicus,Plasma clearance was determined for the compound in rats,,13313,N,,Intermediate,,,,,,1,1,,BAO_0000218,13398,In vivo,50597
A,10116.0,,CHEMBL625719,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,13399,In vivo,50597
A,10116.0,,CHEMBL625720,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,13400,In vivo,50597
A,10116.0,,CHEMBL625721,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,13401,In vivo,50597
A,10116.0,,CHEMBL625722,Rattus norvegicus,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,,12504,N,,Intermediate,,,,,,1,1,,BAO_0000218,13402,In vivo,50597
A,10116.0,,CHEMBL625723,Rattus norvegicus,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,,13129,N,,Intermediate,,,,,,1,1,,BAO_0000218,13403,In vivo,50597
A,6339.0,,CHEMBL625724,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13404,In vivo,50545
A,6339.0,,CHEMBL625725,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13405,In vivo,50545
A,6339.0,,CHEMBL625726,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13406,In vivo,50545
A,6339.0,,CHEMBL875608,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13407,In vivo,50545
A,6339.0,,CHEMBL625727,Heligmosomoides polygyrus,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,,7732,N,,Intermediate,,,,,,1,1,,BAO_0000218,13408,In vivo,50545
A,10116.0,,CHEMBL625728,Rattus norvegicus,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,,9278,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13409,In vivo,22224
A,10116.0,,CHEMBL625729,Rattus norvegicus,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,9278,U,,Autocuration,,,,,,1,0,,BAO_0000218,13410,In vivo,22224
A,10116.0,,CHEMBL625730,Rattus norvegicus,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,,9278,U,,Autocuration,,,,,,1,0,,BAO_0000218,13411,In vivo,22224
A,10116.0,,CHEMBL625731,Rattus norvegicus,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,,9278,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13412,In vivo,22224
A,10116.0,,CHEMBL626417,Rattus norvegicus,Urinary clearance was determined in rat at 25 mg/kg os dosage,,9278,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13413,In vivo,22224
A,9606.0,,CHEMBL626418,Homo sapiens,Urinary clearance was determined at 100 mg/kg oral dosage in human,,9278,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13414,In vivo,50587
A,9615.0,,CHEMBL626419,Canis lupus familiaris,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,,9278,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13415,In vivo,50588
A,9615.0,,CHEMBL626592,Canis lupus familiaris,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13416,In vivo,50588
A,10116.0,,CHEMBL626593,Rattus norvegicus,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,,5932,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13417,In vivo,50597
A,10116.0,,CHEMBL626594,Rattus norvegicus,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,,5182,N,,Intermediate,,,,,,1,1,,BAO_0000218,13418,In vivo,50597
A,9615.0,,CHEMBL625035,Canis lupus familiaris,Clearance rate in dogs,,10499,N,,Intermediate,,,,,,1,1,,BAO_0000218,13419,In vivo,50588
A,,,CHEMBL625036,,Compound was measured for intrinsic clearance,,6051,U,,Autocuration,,,,,,1,0,,BAO_0000019,13420,In vitro,22224
P,,,CHEMBL625037,,Calculated partition coefficient (clogP),,17508,U,,Autocuration,,,,,,1,0,,BAO_0000100,13421,,22229
P,,,CHEMBL625038,,Calculated partition coefficient (clogP),,6228,U,,Autocuration,,,,,,1,0,,BAO_0000100,13422,,22229
P,,,CHEMBL625039,,Calculated partition coefficient (clogP),,6231,U,,Autocuration,,,,,,1,0,,BAO_0000100,13423,,22229
P,,,CHEMBL625040,,Calculated partition coefficient (clogP),,17740,U,,Autocuration,,,,,,1,0,,BAO_0000100,13424,,22229
P,,,CHEMBL625041,,Calculated partition coefficient (clogP),,6495,U,,Autocuration,,,,,,1,0,,BAO_0000100,13425,,22229
P,,,CHEMBL625042,,Calculated partition coefficient (clogP),,2171,U,,Autocuration,,,,,,1,0,,BAO_0000100,13426,,22229
A,,,CHEMBL874411,,Partition coefficient of the compound,,3255,U,,Autocuration,,,,,,1,0,,BAO_0000019,13427,,22224
A,,,CHEMBL625043,,Permeability,,6821,U,,Autocuration,,,,,,1,0,,BAO_0000019,13428,,22224
P,,,CHEMBL625044,,Calculated partition coefficient (clogP),,2685,U,,Autocuration,,,,,,1,0,,BAO_0000100,13429,,22229
A,,,CHEMBL625045,,Partition coefficient (logD),,17584,U,,Autocuration,,,,,,1,0,,BAO_0000019,13430,,22224
P,,,CHEMBL625046,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,U,,Autocuration,,,,,,1,0,,BAO_0000100,13431,,22229
P,,,CHEMBL625047,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,13824,U,,Autocuration,,,,,,1,0,,BAO_0000100,13432,,22229
P,,,CHEMBL625048,,Calculated partition coefficient (clogP),,16479,U,,Autocuration,,,,,,1,0,,BAO_0000100,13433,,22229
P,,,CHEMBL625049,,Calculated partition coefficient (clogP),,11997,U,,Autocuration,,,,,,1,0,,BAO_0000100,13434,,22229
P,,,CHEMBL625050,,Calculated logarithm of partition coefficient (P) was determined,,2988,U,,Autocuration,,,,,,1,0,,BAO_0000100,13435,,22229
P,,,CHEMBL625051,,Calculated partition coefficient (clogP),,931,U,,Autocuration,,,,,,1,0,,BAO_0000100,13436,,22229
P,,,CHEMBL874412,,Calculated partition coefficient (clogP),,4381,U,,Autocuration,,,,,,1,0,,BAO_0000100,13437,,22229
P,,,CHEMBL625052,,Calculated partition coefficient (clogP),,4397,U,,Autocuration,,,,,,1,0,,BAO_0000100,13438,,22229
P,,,CHEMBL625053,,Calculated partition coefficient (clogP),,5889,U,,Autocuration,,,,,,1,0,,BAO_0000100,13439,,22229
A,,,CHEMBL623250,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13440,,22224
A,,,CHEMBL623251,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13441,,22224
A,,,CHEMBL623252,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13442,,22224
A,,,CHEMBL623253,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13443,,22224
A,,,CHEMBL623254,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13444,,22224
A,,,CHEMBL623255,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,6154,U,,Autocuration,,,,,,1,0,,BAO_0000019,13445,,22224
A,,,CHEMBL626831,,Percent degradation of compound at a pH of 1 over a 18 hr period,,6887,U,,Autocuration,,,,,,1,0,,BAO_0000019,13446,,22224
A,,,CHEMBL877494,,Percent degradation of compound at pH of 1 over an 18 hr period,,6887,U,,Autocuration,,,,,,1,0,,BAO_0000019,13447,,22224
A,,,CHEMBL626832,,Delta Logarithm of Partition Coefficient value was determined.,,14116,U,,Autocuration,,,,,,1,0,,BAO_0000019,13448,,22224
A,,,CHEMBL626833,,Delta logPoct-cyc,,11137,U,,Autocuration,,,,,,1,0,,BAO_0000019,13449,,22224
P,,,CHEMBL626834,,Lipophilicity estimated on reversed phase TLC,,7230,U,,Autocuration,,,,,,1,0,,BAO_0000100,13450,,22224
A,,,CHEMBL626835,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,15741,U,,Autocuration,,,,,,1,0,,BAO_0000019,13451,,22224
A,,,CHEMBL626836,,Delta logPoct-cyc,,9663,U,,Autocuration,,,,,,1,0,,BAO_0000019,13452,,22224
P,,,CHEMBL626837,,Change in logarithm of partition coefficient of the compound,,9663,U,,Autocuration,,,,,,1,0,,BAO_0000100,13453,,22229
A,,,CHEMBL626838,,Delta logD (pH 6.5),,13807,U,,Autocuration,,,,,,1,0,,BAO_0000019,13454,,22224
P,,,CHEMBL626839,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,13807,U,,Autocuration,,,,,,1,0,,BAO_0000100,13455,,22224
A,,,CHEMBL626840,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,17425,U,,Autocuration,,,,,,1,0,,BAO_0000019,13456,,22224
A,,,CHEMBL626841,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,12143,U,,Autocuration,,,,,,1,0,,BAO_0000019,13457,,22224
A,,,CHEMBL626842,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,12608,U,,Autocuration,,,,,,1,0,,BAO_0000219,13458,,22224
A,,,CHEMBL626843,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,12608,U,,Autocuration,,,,,,1,0,,BAO_0000219,13459,,22224
A,10116.0,,CHEMBL626844,Rattus norvegicus,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13460,,50597
A,10116.0,,CHEMBL877495,Rattus norvegicus,Amount of deuterium retained was reported after normal workup in rats,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13461,,50597
A,10116.0,,CHEMBL626845,Rattus norvegicus,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13462,,50597
A,10116.0,,CHEMBL626846,Rattus norvegicus,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13463,,50597
A,10116.0,,CHEMBL626847,Rattus norvegicus,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13464,,50597
A,10116.0,,CHEMBL628677,Rattus norvegicus,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13465,,50597
A,10116.0,,CHEMBL628678,Rattus norvegicus,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,,8649,N,,Intermediate,,,,,,1,1,,BAO_0000218,13466,,50597
A,,,CHEMBL628679,,Compound was subjected to electrochemical oxidation,,9659,U,,Autocuration,,,,,,1,0,,BAO_0000019,13467,,22224
A,,,CHEMBL628680,,Compound was subjected to photochemical oxidation,,9659,U,,Autocuration,,,,,,1,0,,BAO_0000019,13468,,22224
A,,,CHEMBL628681,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,9659,U,,Autocuration,,,,,,1,0,,BAO_0000019,13469,,22224
A,,,CHEMBL628682,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,9659,U,,Autocuration,,,,,,1,0,,BAO_0000019,13470,,22224
A,,,CHEMBL628683,,Oxidation of compound by methemoglobin in presence of hydroperoxide,,9659,U,,Autocuration,,,,,,1,0,,BAO_0000019,13471,,22224
A,10116.0,,CHEMBL628684,Rattus norvegicus,Percent diffusion through fuzzy rat skin after 48 h of incubation,,9607,N,,Intermediate,,,,,,1,1,,BAO_0000218,13472,,50597
P,,,CHEMBL877501,,Dissociation constant (pKa),,7057,U,,Autocuration,,,,,,1,0,,BAO_0000100,13473,,22229
P,,,CHEMBL628685,,Dissociation constant value of the compound; ND means not determined.,,7057,U,,Autocuration,,,,,,1,0,,BAO_0000100,13474,,22224
A,10116.0,,CHEMBL628686,Rattus norvegicus,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13475,,50597
A,10116.0,,CHEMBL628687,Rattus norvegicus,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13476,,50597
A,10116.0,,CHEMBL628688,Rattus norvegicus,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,,,,1,1,,BAO_0000218,13477,,50597
A,10116.0,,CHEMBL628689,Rattus norvegicus,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,,,,1,1,,BAO_0000218,13478,,50597
A,10116.0,,CHEMBL628690,Rattus norvegicus,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13479,,50597
A,10116.0,,CHEMBL629363,Rattus norvegicus,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13480,,50597
A,10116.0,,CHEMBL629364,Rattus norvegicus,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13481,,50597
A,10116.0,,CHEMBL629365,Rattus norvegicus,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13482,,50597
A,10116.0,,CHEMBL629366,Rattus norvegicus,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,,,,1,1,,BAO_0000218,13483,,50597
A,10116.0,,CHEMBL629367,Rattus norvegicus,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,,7911,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13484,,50597
A,10116.0,,CHEMBL629368,Rattus norvegicus,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,13485,,50597
A,10116.0,,CHEMBL877502,Rattus norvegicus,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,,7911,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13486,,50597
A,10090.0,,CHEMBL629369,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,,13792,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13487,,50594
A,10090.0,,CHEMBL629370,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,13488,,50594
A,314293.0,,CHEMBL629371,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13489,,22224
A,314293.0,,CHEMBL626276,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13490,,22224
A,314293.0,,CHEMBL626277,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13491,,22224
A,314293.0,,CHEMBL631250,Simiiformes,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13492,,22224
A,10116.0,,CHEMBL631251,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13493,,50597
A,10116.0,,CHEMBL631252,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13494,,50597
A,10116.0,,CHEMBL631253,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13495,,50597
A,10116.0,,CHEMBL631254,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13496,,50597
A,10116.0,,CHEMBL631255,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13497,,50597
A,10116.0,,CHEMBL631256,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13498,,50597
A,10116.0,,CHEMBL631257,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13499,,50597
A,10116.0,,CHEMBL628009,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13500,,50597
A,10116.0,,CHEMBL628010,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13501,,50597
A,10116.0,,CHEMBL628011,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13502,,50597
A,10116.0,,CHEMBL628012,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13503,,50597
A,10116.0,,CHEMBL628013,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13504,,50597
A,10116.0,,CHEMBL628014,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13505,,50597
A,9615.0,,CHEMBL628015,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13506,,50588
A,9615.0,,CHEMBL628016,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13507,,50588
A,9615.0,,CHEMBL874461,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13508,,50588
A,9615.0,,CHEMBL628017,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13509,,50588
A,9615.0,,CHEMBL628018,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13510,,50588
A,9615.0,,CHEMBL628019,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13511,,50588
A,9615.0,,CHEMBL628020,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13512,,50588
A,9615.0,,CHEMBL628021,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13513,,50588
A,9615.0,,CHEMBL628022,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13514,,50588
A,9615.0,,CHEMBL628023,Canis lupus familiaris,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13515,,50588
A,314293.0,,CHEMBL628024,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13516,,22224
A,314293.0,,CHEMBL628025,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13517,,22224
A,314293.0,,CHEMBL628026,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13518,,22224
A,314293.0,,CHEMBL628027,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13519,,22224
A,314293.0,,CHEMBL628028,Simiiformes,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",,8133,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,13520,,22224
A,10116.0,,CHEMBL628029,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13521,,50597
A,10116.0,,CHEMBL628030,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13522,,50597
A,10116.0,,CHEMBL628031,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13523,,50597
A,10116.0,,CHEMBL628032,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13524,,50597
A,10116.0,,CHEMBL628033,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13525,,50597
A,10116.0,,CHEMBL628034,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13526,,50597
A,10116.0,,CHEMBL628035,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13527,,50597
A,10116.0,,CHEMBL628036,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13528,,50597
A,10116.0,,CHEMBL874462,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13529,,50597
A,9615.0,,CHEMBL628037,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13530,In vivo,50588
A,9615.0,,CHEMBL628123,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13531,In vivo,50588
A,9615.0,,CHEMBL628124,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13532,In vivo,50588
A,9615.0,,CHEMBL628125,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13533,In vivo,50588
A,9615.0,,CHEMBL628126,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13534,In vivo,50588
A,9615.0,,CHEMBL628127,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13535,In vivo,50588
A,9615.0,,CHEMBL628128,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13536,In vivo,50588
A,9615.0,,CHEMBL628129,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13537,In vivo,50588
A,9615.0,,CHEMBL628130,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13538,In vivo,50588
A,9615.0,,CHEMBL628131,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13539,In vivo,50588
A,9615.0,,CHEMBL628132,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13540,In vivo,50588
A,9615.0,,CHEMBL628133,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13541,In vivo,50588
A,9615.0,,CHEMBL628134,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13542,In vivo,50588
A,9615.0,,CHEMBL628135,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13543,In vivo,50588
A,9615.0,,CHEMBL628136,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13544,In vivo,50588
A,9615.0,,CHEMBL628137,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13545,In vivo,50588
A,9615.0,,CHEMBL628138,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13546,In vivo,50588
A,9615.0,,CHEMBL628139,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13547,In vivo,50588
A,9615.0,,CHEMBL628140,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13548,In vivo,50588
A,9615.0,,CHEMBL628141,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13549,In vivo,50588
A,9615.0,,CHEMBL628142,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13550,In vivo,50588
A,9615.0,,CHEMBL628143,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13551,In vivo,50588
A,9615.0,,CHEMBL628144,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13552,In vivo,50588
A,9615.0,,CHEMBL628145,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13553,In vivo,50588
A,9615.0,,CHEMBL628146,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13554,In vivo,50588
A,9615.0,,CHEMBL625355,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13555,In vivo,50588
A,9615.0,,CHEMBL625356,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13556,In vivo,50588
A,9615.0,,CHEMBL625357,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13557,In vivo,50588
A,9615.0,,CHEMBL625527,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13558,In vivo,50588
A,9615.0,,CHEMBL875473,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13559,In vivo,50588
A,9615.0,,CHEMBL625528,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13560,In vivo,50588
A,10116.0,,CHEMBL626304,Rattus norvegicus,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,,9025,N,,Intermediate,,,,,,1,1,,BAO_0000218,13561,In vivo,50597
A,9615.0,,CHEMBL624138,Canis lupus familiaris,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,,9025,N,,Intermediate,,,Artery,1637.0,,1,1,,BAO_0000218,13562,In vivo,50588
P,,,CHEMBL624139,,Calculated partition coefficient (clogP),,6448,U,,Autocuration,,,,,,1,0,,BAO_0000100,13563,,22229
P,,,CHEMBL624140,,Calculated partition coefficient (clogP),,17221,U,,Autocuration,,,,,,1,0,,BAO_0000100,13564,,22229
P,,,CHEMBL624141,,Calculated partition coefficient (clogP),,6545,U,,Autocuration,,,,,,1,0,,BAO_0000100,13565,,22229
P,,,CHEMBL624142,,Calculated partition coefficient (clogP),,577,U,,Autocuration,,,,,,1,0,,BAO_0000100,13566,,22229
P,,,CHEMBL624143,,Calculated partition coefficient (clogP),,6285,U,,Autocuration,,,,,,1,0,,BAO_0000100,13567,,22229
P,,,CHEMBL624144,,Calculated partition coefficient (clogP),,6500,U,,Autocuration,,,,,,1,0,,BAO_0000100,13568,,22229
P,,,CHEMBL624145,,Calculated partition coefficient (clogP),,6716,U,,Autocuration,,,,,,1,0,,BAO_0000100,13569,,22229
P,,,CHEMBL624146,,Calculated partition coefficient (clogP),,13658,U,,Autocuration,,,,,,1,0,,BAO_0000100,13570,,22229
P,,,CHEMBL624147,,Calculated partition coefficient (clogP),,6549,U,,Autocuration,,,,,,1,0,,BAO_0000100,13571,,22229
P,,,CHEMBL883123,,Calculated partition coefficient (clogP) (MacLogP),,14685,U,,Autocuration,,,,,,1,0,,BAO_0000100,13572,,22229
A,,,CHEMBL624148,,Partition coefficient (logP),,6893,U,,Autocuration,,,,,,1,0,,BAO_0000019,13573,,22224
A,,,CHEMBL874416,,Kinetic parameter was determined,,3687,U,,Autocuration,,,,,,1,0,,BAO_0000019,13574,,22224
P,,,CHEMBL624149,,Calculated partition coefficient (clogP),,4207,U,,Autocuration,,,,,,1,0,,BAO_0000100,13575,,22229
P,,,CHEMBL624150,,Calculated partition coefficient (clogP),,4626,U,,Autocuration,,,,,,1,0,,BAO_0000100,13576,,22229
P,,,CHEMBL624151,,Lipophilicity was determined,,1021,U,,Autocuration,,,,,,1,0,,BAO_0000100,13577,,22224
P,,,CHEMBL624152,,Lipophilicity was determined,,3777,U,,Autocuration,,,,,,1,0,,BAO_0000100,13578,,22224
P,,,CHEMBL622139,,Lipophilicity was determined,,17533,U,,Autocuration,,,,,,1,0,,BAO_0000100,13579,,22224
P,,,CHEMBL622140,,Calculated partition coefficient (clogP),,6524,U,,Autocuration,,,,,,1,0,,BAO_0000100,13580,,22229
P,,,CHEMBL622141,,Lipophilicity was determined,,17533,U,,Autocuration,,,,,,1,0,,BAO_0000100,13581,,22224
P,,,CHEMBL622142,,Lipophilicity in octanol-water,,6480,U,,Autocuration,,,,,,1,0,,BAO_0000100,13582,,22224
P,,,CHEMBL622143,,Calculated partition coefficient (clogP),,17606,U,,Autocuration,,,,,,1,0,,BAO_0000100,13583,,22229
P,,,CHEMBL622144,,Octanol-water partition coefficient was determined,,6863,U,,Autocuration,,,,,,1,0,,BAO_0000100,13584,,22229
A,,,CHEMBL877473,,Partition coefficient (logP),,1356,U,,Autocuration,,,,,,1,0,,BAO_0000019,13585,,22224
P,,,CHEMBL622145,,Calculated partition coefficient (clogP),,3326,U,,Autocuration,,,,,,1,0,,BAO_0000100,13586,,22229
A,,,CHEMBL622146,,Partition coefficient was determined; ND means not determined,,1356,U,,Autocuration,,,,,,1,0,,BAO_0000019,13587,,22224
P,,,CHEMBL622147,,Calculated partition coefficient (clogP),,12984,U,,Autocuration,,,,,,1,0,,BAO_0000100,13588,,22229
A,,,CHEMBL622148,,Partition coefficient of the compound,,17363,U,,Autocuration,,,,,,1,0,,BAO_0000019,13589,,22224
A,,,CHEMBL883124,,Permeability was determined,,6827,U,,Autocuration,,,,,,1,0,,BAO_0000019,13590,,22224
P,,,CHEMBL622149,,The compound was evaluated for the partition coefficient,,261,U,,Autocuration,,,,,,1,0,,BAO_0000100,13591,,22229
A,,,CHEMBL622150,,Partition coefficient (logP),,2685,U,,Autocuration,,,,,,1,0,,BAO_0000019,13592,,22224
P,,,CHEMBL622151,,The lipophilicity was reported,,414,U,,Autocuration,,,,,,1,0,,BAO_0000100,13593,,22224
P,,,CHEMBL622152,,logarithm of the octanol-water partition coefficient for the compound,,15769,U,,Autocuration,,,,,,1,0,,BAO_0000100,13594,,22229
A,,,CHEMBL622153,,Clogp value was determined,,17248,U,,Autocuration,,,,,,1,0,,BAO_0000019,13595,,22224
A,,,CHEMBL877474,,Clp at a dose of 1.5 mg/kg,,16935,U,,Autocuration,,,,,,1,0,,BAO_0000218,13596,In vivo,22224
A,,,CHEMBL622154,,Clp at a dose of 2.0 mg/kg,,16935,U,,Autocuration,,,,,,1,0,,BAO_0000218,13597,In vivo,22224
A,,,CHEMBL622155,,"Clp, plasma clearance at a dose of 10 mg/kg",,14832,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13598,In vivo,22224
A,,,CHEMBL622156,,"Clp, plasma clearance at a dose of 50 mg/kg",,14832,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13599,In vivo,22224
A,10116.0,,CHEMBL622157,Rattus norvegicus,Compound was tested for plasma clearance in rat,,2399,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13600,In vivo,50597
A,10116.0,,CHEMBL622158,Rattus norvegicus,Compound was tested for plasma clearance in rat; Not determined,,2399,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13601,In vivo,50597
A,10116.0,,CHEMBL622807,Rattus norvegicus,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,,6227,N,,Intermediate,,,,,,1,1,,BAO_0000218,13602,In vivo,50597
A,9544.0,,CHEMBL622808,Macaca mulatta,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,,6227,N,,Intermediate,,,,,,1,1,,BAO_0000218,13603,In vivo,50797
A,,,CHEMBL622809,,Plasma clearance by iv administration at a dose 0.003 ug/mL,,5623,U,,Autocuration,,,,,,1,0,,BAO_0000218,13604,In vivo,22224
A,,,CHEMBL622810,,Plasma clearance determined,,4854,U,,Autocuration,,,,,,1,0,,BAO_0000218,13605,In vivo,22224
A,10026.0,,CHEMBL876653,Cricetinae,Plasma clearance after iv administration at 3 mg/kg in hamster,,4493,N,,Intermediate,,,,,,1,1,,BAO_0000218,13606,In vivo,100712
A,10026.0,,CHEMBL622811,Cricetinae,Plasma clearance after iv administration at 4 mg/kg in hamster,,4493,N,,Intermediate,,,,,,1,1,,BAO_0000218,13607,In vivo,100712
A,10116.0,,CHEMBL622986,Rattus norvegicus,Rate of clearance in rat was determined,,14956,N,,Intermediate,,,,,,1,1,,BAO_0000218,13608,In vivo,50597
A,10116.0,,CHEMBL622987,Rattus norvegicus,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,,15372,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13609,In vivo,50597
A,10116.0,,CHEMBL622988,Rattus norvegicus,Total plasma clearance after iv dose of 5.10 mg/kg in rats,,15372,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13610,In vivo,50597
A,10116.0,,CHEMBL622989,Rattus norvegicus,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,,15372,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13611,In vivo,50597
A,10116.0,,CHEMBL622990,Rattus norvegicus,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,,15372,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13612,In vivo,50597
A,314293.0,,CHEMBL622991,Simiiformes,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,,15604,U,,Autocuration,,,Plasma,1969.0,,1,0,,BAO_0000218,13613,In vivo,22224
A,10116.0,,CHEMBL622227,Rattus norvegicus,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,,15604,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13614,In vivo,50597
A,9615.0,,CHEMBL622228,Canis lupus familiaris,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,,15604,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,13615,In vivo,50588
A,10116.0,,CHEMBL622229,Rattus norvegicus,Clpl value in rat,,14964,N,,Intermediate,,,,,,1,1,,BAO_0000218,13616,In vivo,50597
A,10141.0,,CHEMBL622230,Cavia porcellus,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,,15240,N,,Intermediate,,,,,,1,1,,BAO_0000218,13617,In vivo,50512
A,10116.0,,CHEMBL622231,Rattus norvegicus,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,,16449,N,,Intermediate,,,,,,1,1,,BAO_0000218,13618,In vivo,50597
A,9541.0,,CHEMBL622232,Macaca fascicularis,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,,16449,N,,Intermediate,,,,,,1,1,,BAO_0000218,13619,In vivo,100710
A,,,CHEMBL622233,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13620,In vivo,22224
A,,,CHEMBL622234,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13621,In vivo,22224
A,,,CHEMBL622235,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13622,In vivo,22224
A,,,CHEMBL622236,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13623,In vivo,22224
A,,,CHEMBL622237,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13624,In vivo,22224
A,,,CHEMBL877482,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13625,In vivo,22224
A,,,CHEMBL622238,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13626,In vivo,22224
A,,,CHEMBL622239,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,12902,U,,Autocuration,,,,,,1,0,,BAO_0000218,13627,In vivo,22224
A,,,CHEMBL622240,,Cmax was calculated as maximum concentration reached in the blood,,11149,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,13628,In vivo,22224
A,,,CHEMBL622241,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,11149,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,13629,In vivo,22224
A,10116.0,,CHEMBL631013,Rattus norvegicus,Cmax was determine after peroral administration at 10 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13630,In vivo,50597
A,9544.0,,CHEMBL631014,Macaca mulatta,Cmax was determine after peroral administration at 10 mpk in Rhesus,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13631,In vivo,50797
A,9615.0,,CHEMBL631015,Canis lupus familiaris,Cmax was determine after peroral administration at 10 mpk in dog,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13632,In vivo,50588
A,10116.0,,CHEMBL631016,Rattus norvegicus,Cmax was determine after peroral administration at 160 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13633,In vivo,50597
A,10116.0,,CHEMBL631017,Rattus norvegicus,Cmax was determine after peroral administration at 20 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13634,In vivo,50597
A,10116.0,,CHEMBL631018,Rattus norvegicus,Cmax was determine after peroral administration at 50 mpk in Rat,,5669,N,,Intermediate,,,,,,1,1,,BAO_0000218,13635,In vivo,50597
A,,,CHEMBL631019,,Cmax was determined,,4236,U,,Autocuration,,,,,,1,0,,BAO_0000218,13636,In vivo,22224
A,10090.0,,CHEMBL875761,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,13637,,50594
A,10090.0,,CHEMBL631020,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,13638,,50594
A,10090.0,,CHEMBL631669,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,13639,,50594
A,10090.0,,CHEMBL631670,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,,13792,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,13640,,50594
A,10090.0,,CHEMBL631671,Mus musculus,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,,13792,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,13641,,50594
A,10116.0,,CHEMBL631672,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13642,,50597
A,10116.0,,CHEMBL631673,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13643,,50597
A,10116.0,,CHEMBL631856,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13644,,50597
A,10116.0,,CHEMBL631857,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13645,,50597
A,10116.0,,CHEMBL631858,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13646,,50597
A,10116.0,,CHEMBL631859,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13647,,50597
A,10116.0,,CHEMBL631860,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13648,,50597
A,10116.0,,CHEMBL631861,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13649,,50597
A,10116.0,,CHEMBL631862,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13650,,50597
A,10116.0,,CHEMBL631863,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13651,,50597
A,10116.0,,CHEMBL631864,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13652,,50597
A,10116.0,,CHEMBL631865,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13653,,50597
A,10116.0,,CHEMBL631866,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13654,,50597
A,10116.0,,CHEMBL629360,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13655,,50597
A,10116.0,,CHEMBL629361,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13656,,50597
A,10116.0,,CHEMBL629362,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13657,,50597
A,10116.0,,CHEMBL630740,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13658,,50597
A,10116.0,,CHEMBL630741,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13659,,50597
A,10116.0,,CHEMBL630742,Rattus norvegicus,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,,8418,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13660,,50597
A,10116.0,,CHEMBL630743,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13661,,50597
A,10116.0,,CHEMBL630744,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13662,,50597
A,10116.0,,CHEMBL630745,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13663,,50597
A,10116.0,,CHEMBL630746,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13664,,50597
A,10116.0,,CHEMBL630747,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13665,,50597
A,10116.0,,CHEMBL630748,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13666,,50597
A,10116.0,,CHEMBL632056,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13667,,50597
A,10116.0,,CHEMBL632057,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13668,,50597
A,10116.0,,CHEMBL632058,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13669,,50597
A,10116.0,,CHEMBL632059,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13670,,50597
A,10116.0,,CHEMBL632060,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13671,,50597
A,10116.0,,CHEMBL632061,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13672,,50597
A,10116.0,,CHEMBL629207,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13673,,50597
A,10116.0,,CHEMBL629208,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13674,,50597
A,10116.0,,CHEMBL629209,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13675,,50597
A,10116.0,,CHEMBL629210,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13676,,50597
A,10116.0,,CHEMBL629211,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13677,,50597
A,10116.0,,CHEMBL629212,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13678,,50597
A,10116.0,,CHEMBL629213,Rattus norvegicus,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,,8418,N,,Intermediate,,,,,,1,1,,BAO_0000218,13679,,50597
A,10116.0,,CHEMBL629214,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13680,,50597
A,10116.0,,CHEMBL629215,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13681,,50597
A,10116.0,,CHEMBL635154,Rattus norvegicus,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",,8133,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13682,,50597
A,10116.0,,CHEMBL629216,Rattus norvegicus,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13683,,50597
A,10116.0,,CHEMBL629217,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13684,,50597
A,10116.0,,CHEMBL629218,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13685,,50597
A,10116.0,,CHEMBL629219,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13686,,50597
A,10116.0,,CHEMBL629220,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13687,,50597
A,10116.0,,CHEMBL629221,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13688,,50597
A,10116.0,,CHEMBL631127,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13689,,50597
A,10116.0,,CHEMBL631128,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13690,,50597
A,10116.0,,CHEMBL631129,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13691,,50597
A,10116.0,,CHEMBL631130,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13692,,50597
A,10116.0,,CHEMBL631131,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13693,,50597
A,10116.0,,CHEMBL631132,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13694,,50597
A,10116.0,,CHEMBL631133,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13695,,50597
A,10116.0,,CHEMBL631134,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13696,,50597
A,10116.0,,CHEMBL875120,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13697,,50597
A,10116.0,,CHEMBL631135,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13698,,50597
A,10116.0,,CHEMBL631136,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13699,,50597
A,10116.0,,CHEMBL631137,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13700,,50597
A,10116.0,,CHEMBL631138,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13701,,50597
A,10116.0,,CHEMBL631139,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13702,,50597
A,10116.0,,CHEMBL631140,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13703,,50597
A,10116.0,,CHEMBL631141,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13704,,50597
A,10116.0,,CHEMBL631142,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13705,,50597
A,10116.0,,CHEMBL631143,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13706,,50597
A,10116.0,,CHEMBL631144,Rattus norvegicus,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13707,,50597
A,9615.0,,CHEMBL631145,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13708,,50588
A,9615.0,,CHEMBL631146,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13709,,50588
A,9615.0,,CHEMBL631147,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13710,,50588
A,9615.0,,CHEMBL631148,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13711,,50588
A,9615.0,,CHEMBL631149,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13712,,50588
A,9615.0,,CHEMBL631150,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13713,,50588
A,9615.0,,CHEMBL631151,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13714,,50588
A,9615.0,,CHEMBL631152,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13715,,50588
A,9615.0,,CHEMBL631443,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13716,,50588
A,9615.0,,CHEMBL631444,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13717,,50588
A,9615.0,,CHEMBL631445,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13718,,50588
A,9615.0,,CHEMBL631446,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13719,,50588
A,9615.0,,CHEMBL631447,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13720,,50588
A,9615.0,,CHEMBL631448,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13721,,50588
A,9615.0,,CHEMBL631449,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13722,,50588
A,9615.0,,CHEMBL631450,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13723,,50588
A,9615.0,,CHEMBL629724,Canis lupus familiaris,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),,6996,N,,Intermediate,,,,,,1,1,,BAO_0000218,13724,,50588
A,10090.0,,CHEMBL629725,Mus musculus,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,13725,In vivo,50594
A,10090.0,,CHEMBL629726,Mus musculus,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,13726,In vivo,50594
A,10090.0,,CHEMBL629727,Mus musculus,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13727,In vivo,50594
A,10090.0,,CHEMBL630404,Mus musculus,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13728,In vivo,50594
A,10090.0,,CHEMBL630405,Mus musculus,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13729,In vivo,50594
A,10090.0,,CHEMBL630406,Mus musculus,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13730,In vivo,50594
A,10090.0,,CHEMBL630407,Mus musculus,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,13731,In vivo,50594
A,10090.0,,CHEMBL630573,Mus musculus,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,13732,In vivo,50594
A,10090.0,,CHEMBL630574,Mus musculus,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,13733,In vivo,50594
A,10090.0,,CHEMBL630575,Mus musculus,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,13734,In vivo,50594
A,10090.0,,CHEMBL630576,Mus musculus,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,,,,1,1,,BAO_0000218,13735,In vivo,50594
A,10090.0,,CHEMBL630577,Mus musculus,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,,,,1,1,,BAO_0000218,13736,In vivo,50594
A,10090.0,,CHEMBL630578,Mus musculus,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,,,,1,1,,BAO_0000218,13737,In vivo,50594
A,10090.0,,CHEMBL630579,Mus musculus,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",,9716,N,,Intermediate,,,,,,1,1,,BAO_0000218,13738,In vivo,50594
A,10090.0,,CHEMBL630580,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),,12192,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13739,,50594
A,10090.0,,CHEMBL630581,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,,12192,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13740,,50594
A,10090.0,,CHEMBL630582,Mus musculus,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),,12192,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13741,,50594
A,10090.0,,CHEMBL630583,Mus musculus,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13742,,50594
A,10090.0,,CHEMBL630584,Mus musculus,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13743,,50594
A,10090.0,,CHEMBL630585,Mus musculus,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13744,,50594
A,10090.0,,CHEMBL630586,Mus musculus,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13745,,50594
A,10090.0,,CHEMBL630587,Mus musculus,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13746,,50594
A,10090.0,,CHEMBL630588,Mus musculus,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13747,,50594
A,10090.0,,CHEMBL630589,Mus musculus,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13748,,50594
A,10090.0,,CHEMBL630590,Mus musculus,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),,12192,N,,Intermediate,,,,,,1,1,,BAO_0000218,13749,,50594
A,,,CHEMBL630591,,Removal of 238-Plutonium(IV) in feces at 24 h,,12192,U,,Autocuration,,,Feces,1988.0,,1,0,,BAO_0000019,13750,,22224
A,,,CHEMBL630592,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,12192,U,,Autocuration,,,Feces,1988.0,,1,0,,BAO_0000019,13751,,22224
A,,,CHEMBL630593,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,12192,U,,Autocuration,,,,,,1,0,,BAO_0000019,13752,,22224
A,,,CHEMBL630594,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,12192,U,,Autocuration,,,,,,1,0,,BAO_0000019,13753,,22224
A,,,CHEMBL630595,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13754,,22224
A,,,CHEMBL630596,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13755,,22224
A,,,CHEMBL630597,,Removal of 238-Plutonium(IV) in urine after 0-24 h,,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13756,,22224
A,,,CHEMBL630598,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13757,,22224
A,,,CHEMBL630599,,Removal of 238-Plutonium(IV) in urine after 0-4 h,,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13758,,22224
A,,,CHEMBL630600,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13759,,22224
A,,,CHEMBL630601,,Removal of 238-Plutonium(IV) in urine after 4-24 h,,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13760,,22224
A,,,CHEMBL630602,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13761,,22224
A,,,CHEMBL630603,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13762,,22224
A,,,CHEMBL630604,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,12192,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000019,13763,,22224
A,10116.0,,CHEMBL624869,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13764,In vivo,50597
A,10116.0,,CHEMBL624870,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13765,In vivo,50597
A,10116.0,,CHEMBL623189,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13766,In vivo,50597
A,10116.0,,CHEMBL623190,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13767,In vivo,50597
A,10116.0,,CHEMBL623191,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13768,In vivo,50597
A,10116.0,,CHEMBL623192,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13769,In vivo,50597
A,10116.0,,CHEMBL623193,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13770,In vivo,50597
A,10116.0,,CHEMBL623194,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13771,In vivo,50597
A,10116.0,,CHEMBL623195,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13772,In vivo,50597
A,10116.0,,CHEMBL623196,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13773,In vivo,50597
A,10116.0,,CHEMBL623197,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,,11836,N,,Intermediate,,,,,,1,1,,BAO_0000218,13774,,50597
A,10116.0,,CHEMBL623198,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,,,,1,1,,BAO_0000218,13775,,50597
A,10116.0,,CHEMBL623199,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,11836,N,,Intermediate,,,,,,1,1,,BAO_0000218,13776,,50597
A,10116.0,,CHEMBL623200,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13777,,50597
A,10116.0,,CHEMBL623201,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13778,,50597
A,10116.0,,CHEMBL623202,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13779,,50597
A,10116.0,,CHEMBL623203,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13780,,50597
A,10116.0,,CHEMBL623204,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13781,,50597
A,10116.0,,CHEMBL623205,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13782,,50597
A,10116.0,,CHEMBL623206,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13783,,50597
A,10116.0,,CHEMBL623207,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13784,,50597
A,10116.0,,CHEMBL623208,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13785,,50597
A,10116.0,,CHEMBL623209,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13786,,50597
A,10116.0,,CHEMBL623210,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,,11836,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13787,,50597
A,10116.0,,CHEMBL623211,Rattus norvegicus,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,,,,1,1,,BAO_0000218,13788,,50597
A,10116.0,,CHEMBL623212,Rattus norvegicus,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,,11836,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,13789,,50597
A,,,CHEMBL623213,,Tested in vitro for intrinsic activity relative to quinpirole,,12640,U,,Autocuration,,,,,,1,0,,BAO_0000019,13790,,22224
A,,,CHEMBL623214,,"Relative ion enhancement, determined in pulsed ultrafiltration",,14218,U,,Autocuration,,,,,,1,0,,BAO_0000019,13791,,22224
A,,,CHEMBL623215,,% ionization at the pH 7.4 at 37 degree Centigrade,,11296,U,,Autocuration,,,,,,1,0,,BAO_0000019,13792,,22224
A,,,CHEMBL623216,,Percentage ionization was measured,,10929,U,,Autocuration,,,,,,1,0,,BAO_0000019,13793,,22224
A,9913.0,,CHEMBL623217,Bos taurus,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,,13841,N,,Intermediate,,,,,,1,1,,BAO_0000218,13794,,50591
A,,,CHEMBL623218,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13795,,22224
A,,,CHEMBL623913,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13796,,22224
A,,,CHEMBL623914,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13797,,22224
P,,,CHEMBL623915,,Compound was evaluated for the partition coefficient in octanol/water,,8826,U,,Autocuration,,,,,,1,0,,BAO_0000100,13798,,22229
P,,,CHEMBL624080,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,8826,U,,Autocuration,,,,,,1,0,,BAO_0000100,13799,,22229
A,,,CHEMBL624081,,Equilibrium constant measured by the pulse radiolysis at pH 7,,9884,U,,Autocuration,,,,,,1,0,,BAO_0000019,13800,,22224
A,9606.0,,CHEMBL624082,Homo sapiens,In vitro hydrolytic rate constant determined in human blood,,9827,N,,Intermediate,,,,,,1,1,,BAO_0000218,13801,,50587
A,9606.0,,CHEMBL625054,Homo sapiens,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13802,,50587
A,,,CHEMBL877485,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,10009,U,,Autocuration,,,,,,1,0,,BAO_0000019,13803,,22224
A,10090.0,,CHEMBL625055,Mus musculus,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13804,,50594
A,10090.0,,CHEMBL625056,Mus musculus,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13805,,50594
A,9606.0,,CHEMBL625057,Homo sapiens,In vitro oxidation of compound in presence of human plasma,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13806,,50587
A,,,CHEMBL625058,,In vitro oxidation of compound in presence of hydrogen peroxide,,10009,U,,Autocuration,,,,,,1,0,,BAO_0000019,13807,,22224
A,10090.0,,CHEMBL625059,Mus musculus,In vitro oxidation of compound in presence of mouse brain homogenate,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13808,,50594
A,10090.0,,CHEMBL629536,Mus musculus,In vitro oxidation of compound in presence of mouse liver homogenate,,10009,N,,Intermediate,,,,,,1,1,,BAO_0000218,13809,,50594
A,10116.0,,CHEMBL629537,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13810,,50597
A,10116.0,,CHEMBL629538,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13811,,50597
A,10116.0,,CHEMBL629539,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13812,,50597
A,10116.0,,CHEMBL874445,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13813,,50597
A,10116.0,,CHEMBL629540,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13814,,50597
A,10116.0,,CHEMBL629541,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13815,,50597
A,10116.0,,CHEMBL629542,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13816,,50597
A,10116.0,,CHEMBL630243,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13817,,50597
A,10116.0,,CHEMBL630244,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13818,,50597
A,10116.0,,CHEMBL630245,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13819,,50597
A,10116.0,,CHEMBL630246,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13820,,50597
A,10116.0,,CHEMBL630247,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13821,,50597
A,10116.0,,CHEMBL630248,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13822,,50597
A,10116.0,,CHEMBL630249,Rattus norvegicus,Biodistribution in rat blood at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13823,In vivo,50597
A,10116.0,,CHEMBL630250,Rattus norvegicus,Biodistribution in rat blood at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13824,In vivo,50597
A,10116.0,,CHEMBL630251,Rattus norvegicus,Biodistribution in rat blood at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13825,In vivo,50597
A,10116.0,,CHEMBL630252,Rattus norvegicus,Biodistribution in rat blood at 3 hr after dose administration.,,13100,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13826,In vivo,50597
A,10116.0,,CHEMBL630408,Rattus norvegicus,Biodistribution in rat blood at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,13827,In vivo,50597
A,10116.0,,CHEMBL630409,Rattus norvegicus,Biodistribution in rat cerebellum at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13828,In vivo,50597
A,10116.0,,CHEMBL874446,Rattus norvegicus,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13829,In vivo,50597
A,10116.0,,CHEMBL630410,Rattus norvegicus,Biodistribution in rat cerebellum at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13830,In vivo,50597
A,10116.0,,CHEMBL630411,Rattus norvegicus,Biodistribution in rat cerebellum at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13831,In vivo,50597
A,10116.0,,CHEMBL630412,Rattus norvegicus,Biodistribution in rat cerebellum at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13832,In vivo,50597
A,10116.0,,CHEMBL630413,Rattus norvegicus,Biodistribution in rat cerebellum at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13833,In vivo,50597
A,10116.0,,CHEMBL630414,Rattus norvegicus,Biodistribution in rat cerebellum at 3 hr after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13834,In vivo,50597
A,10116.0,,CHEMBL630415,Rattus norvegicus,Biodistribution in rat cerebellum at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,13835,In vivo,50597
A,10116.0,,CHEMBL630416,Rattus norvegicus,Biodistribution in rat cortex at 120 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13836,In vivo,50597
A,10116.0,,CHEMBL630417,Rattus norvegicus,Biodistribution in rat cortex at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13837,In vivo,50597
A,10116.0,,CHEMBL630418,Rattus norvegicus,Biodistribution in rat cortex at 15 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13838,In vivo,50597
A,10116.0,,CHEMBL630419,Rattus norvegicus,Biodistribution in rat cortex at 240 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13839,In vivo,50597
A,10116.0,,CHEMBL630420,Rattus norvegicus,Biodistribution in rat cortex at 30 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13840,In vivo,50597
A,10116.0,,CHEMBL630421,Rattus norvegicus,Biodistribution in rat cortex at 360 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13841,In vivo,50597
A,10116.0,,CHEMBL630422,Rattus norvegicus,Biodistribution in rat cortex at 3 hr after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13842,In vivo,50597
A,10116.0,,CHEMBL630423,Rattus norvegicus,Biodistribution in rat cortex at 60 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,13843,In vivo,50597
A,10116.0,,CHEMBL630424,Rattus norvegicus,Biodistribution in rat heart at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13844,In vivo,50597
A,10116.0,,CHEMBL630425,Rattus norvegicus,Biodistribution in rat heart at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13845,In vivo,50597
A,10116.0,,CHEMBL629462,Rattus norvegicus,Biodistribution in rat heart at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13846,In vivo,50597
A,10116.0,,CHEMBL630426,Rattus norvegicus,Biodistribution in rat heart at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13847,In vivo,50597
A,10116.0,,CHEMBL630427,Rattus norvegicus,Biodistribution in rat heart at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13848,In vivo,50597
A,10116.0,,CHEMBL625877,Rattus norvegicus,Biodistribution in rat heart at 3 hr after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13849,In vivo,50597
A,10116.0,,CHEMBL625878,Rattus norvegicus,Biodistribution in rat heart at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,13850,In vivo,50597
A,10116.0,,CHEMBL625879,Rattus norvegicus,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,13851,In vivo,50597
A,10116.0,,CHEMBL625880,Rattus norvegicus,Biodistribution in rat hippocampus at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,13852,In vivo,50597
A,10116.0,,CHEMBL625881,Rattus norvegicus,Biodistribution in rat hippocampus at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,13853,In vivo,50597
A,10116.0,,CHEMBL625882,Rattus norvegicus,Biodistribution in rat hippocampus at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,13854,In vivo,50597
A,10116.0,,CHEMBL625883,Rattus norvegicus,Biodistribution in rat hippocampus at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,13855,In vivo,50597
A,10116.0,,CHEMBL625884,Rattus norvegicus,Biodistribution in rat kidney at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13856,In vivo,50597
A,10116.0,,CHEMBL625885,Rattus norvegicus,Biodistribution in rat kidney at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13857,In vivo,50597
A,10116.0,,CHEMBL628649,Rattus norvegicus,Biodistribution in rat kidney at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13858,In vivo,50597
A,10116.0,,CHEMBL628650,Rattus norvegicus,Biodistribution in rat kidney at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13859,In vivo,50597
A,10116.0,,CHEMBL628651,Rattus norvegicus,Biodistribution in rat kidney at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13860,In vivo,50597
A,10116.0,,CHEMBL628652,Rattus norvegicus,Biodistribution in rat kidney at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13861,In vivo,50597
A,10116.0,,CHEMBL628653,Rattus norvegicus,Biodistribution in rat kidney at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13862,In vivo,50597
A,10116.0,,CHEMBL628654,Rattus norvegicus,Biodistribution in rat liver at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13863,In vivo,50597
A,10116.0,,CHEMBL628655,Rattus norvegicus,Biodistribution in rat liver at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13864,In vivo,50597
A,10116.0,,CHEMBL625238,Rattus norvegicus,Biodistribution in rat liver at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13865,In vivo,50597
A,10116.0,,CHEMBL625239,Rattus norvegicus,Biodistribution in rat liver at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13866,In vivo,50597
A,10116.0,,CHEMBL625240,Rattus norvegicus,Biodistribution in rat liver at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13867,In vivo,50597
A,10116.0,,CHEMBL625241,Rattus norvegicus,Biodistribution in rat liver at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13868,In vivo,50597
A,10116.0,,CHEMBL625242,Rattus norvegicus,Biodistribution in rat liver at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13869,In vivo,50597
A,10116.0,,CHEMBL874587,Rattus norvegicus,Biodistribution in rat lung at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13870,In vivo,50597
A,10116.0,,CHEMBL625405,Rattus norvegicus,Biodistribution in rat lung at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13871,In vivo,50597
A,10116.0,,CHEMBL625406,Rattus norvegicus,Biodistribution in rat lung at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13872,In vivo,50597
A,10116.0,,CHEMBL625407,Rattus norvegicus,Biodistribution in rat lung at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13873,In vivo,50597
A,10116.0,,CHEMBL625408,Rattus norvegicus,Biodistribution in rat lung at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13874,In vivo,50597
A,10116.0,,CHEMBL625409,Rattus norvegicus,Biodistribution in rat lung at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13875,In vivo,50597
A,10116.0,,CHEMBL625410,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13876,,50597
A,10116.0,,CHEMBL625411,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13877,,50597
A,10116.0,,CHEMBL625412,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13878,,50597
A,10116.0,,CHEMBL625413,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13879,,50597
A,10116.0,,CHEMBL625414,Rattus norvegicus,Percent of maximal contractile response to compound in rat thoracic aorta strips v,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13880,,50597
A,10116.0,,CHEMBL625415,Rattus norvegicus,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13881,,50597
A,10116.0,,CHEMBL625416,Rattus norvegicus,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,,12361,N,,Intermediate,,,Thoracic aorta,1515.0,,1,1,,BAO_0000218,13882,,50597
A,10116.0,,CHEMBL625417,Rattus norvegicus,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,,12712,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13883,,50597
A,10116.0,,CHEMBL625418,Rattus norvegicus,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,,7415,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,13884,,50597
A,10116.0,,CHEMBL625419,Rattus norvegicus,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,,7415,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13885,,50597
A,10116.0,,CHEMBL625420,Rattus norvegicus,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,,7415,N,,Intermediate,,,,,,1,1,,BAO_0000218,13886,,50597
A,10116.0,,CHEMBL626996,Rattus norvegicus,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,,7415,N,,Intermediate,,,,,,1,1,,BAO_0000218,13887,,50597
A,10116.0,,CHEMBL626997,Rattus norvegicus,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",,7415,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,13888,,50597
A,10116.0,,CHEMBL626998,Rattus norvegicus,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",,7415,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13889,,50597
A,10116.0,,CHEMBL626999,Rattus norvegicus,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",,7415,N,,Intermediate,,,,,,1,1,,BAO_0000218,13890,,50597
A,10090.0,,CHEMBL627000,Mus musculus,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,,8050,N,,Intermediate,,,,,,1,1,,BAO_0000218,13891,,50594
A,10090.0,,CHEMBL627001,Mus musculus,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,,8050,N,,Intermediate,,,,,,1,1,,BAO_0000218,13892,,50594
A,10090.0,,CHEMBL627002,Mus musculus,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,,8050,N,,Intermediate,,,,,,1,1,,BAO_0000218,13893,,50594
A,10090.0,,CHEMBL627003,Mus musculus,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,,8050,N,,Intermediate,,,,,,1,1,,BAO_0000218,13894,,50594
A,10090.0,,CHEMBL627004,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13895,,50594
A,10090.0,,CHEMBL627005,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13896,,50594
A,10090.0,,CHEMBL874594,Mus musculus,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13897,,50594
A,10090.0,,CHEMBL627006,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13898,,50594
A,10090.0,,CHEMBL627007,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13899,,50594
A,10090.0,,CHEMBL627884,Mus musculus,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13900,,50594
A,10090.0,,CHEMBL627885,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13901,,50594
A,10090.0,,CHEMBL627886,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13902,,50594
A,10090.0,,CHEMBL627887,Mus musculus,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13903,,50594
A,10090.0,,CHEMBL627888,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13904,,50594
A,10090.0,,CHEMBL628057,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13905,,50594
A,10090.0,,CHEMBL627405,Mus musculus,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,,8050,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13906,,50594
A,9615.0,,CHEMBL627406,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13907,,50588
A,9615.0,,CHEMBL627407,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13908,,50588
A,9615.0,,CHEMBL627408,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13909,,50588
A,9615.0,,CHEMBL627409,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13910,,50588
A,9615.0,,CHEMBL875486,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13911,,50588
A,9615.0,,CHEMBL627410,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13912,,50588
A,9615.0,,CHEMBL627411,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13913,,50588
A,9615.0,,CHEMBL627412,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13914,,50588
A,9615.0,,CHEMBL627413,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13915,,50588
A,9615.0,,CHEMBL627414,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13916,,50588
A,9615.0,,CHEMBL627415,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13917,,50588
A,9615.0,,CHEMBL627416,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13918,,50588
A,9615.0,,CHEMBL627417,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13919,,50588
A,9615.0,,CHEMBL627418,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13920,,50588
A,9615.0,,CHEMBL627419,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13921,,50588
A,9615.0,,CHEMBL627320,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13922,,50588
A,9615.0,,CHEMBL627321,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,13923,,50588
A,10116.0,,CHEMBL627322,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13924,In vivo,50597
A,10116.0,,CHEMBL627323,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13925,In vivo,50597
A,10116.0,,CHEMBL627491,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13926,In vivo,50597
A,10116.0,,CHEMBL627492,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13927,In vivo,50597
A,10116.0,,CHEMBL627493,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,13928,In vivo,50597
A,10116.0,,CHEMBL627494,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13929,In vivo,50597
A,10116.0,,CHEMBL627495,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13930,In vivo,50597
A,10116.0,,CHEMBL627496,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13931,In vivo,50597
A,10116.0,,CHEMBL627497,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13932,In vivo,50597
A,10116.0,,CHEMBL627498,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,13933,In vivo,50597
A,10116.0,,CHEMBL627499,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13934,In vivo,50597
A,10116.0,,CHEMBL627500,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13935,In vivo,50597
A,10116.0,,CHEMBL627501,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13936,In vivo,50597
A,10116.0,,CHEMBL625616,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13937,In vivo,50597
A,10116.0,,CHEMBL625617,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,13938,In vivo,50597
A,10116.0,,CHEMBL625618,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13939,In vivo,50597
A,10116.0,,CHEMBL625619,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13940,In vivo,50597
A,10116.0,,CHEMBL625620,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13941,In vivo,50597
A,10116.0,,CHEMBL625621,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13942,In vivo,50597
A,10116.0,,CHEMBL625622,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,13943,In vivo,50597
A,10116.0,,CHEMBL625788,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13944,In vivo,50597
A,10116.0,,CHEMBL625789,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13945,In vivo,50597
A,10116.0,,CHEMBL625790,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13946,In vivo,50597
A,10116.0,,CHEMBL625791,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13947,In vivo,50597
A,10116.0,,CHEMBL622334,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13948,In vivo,50597
A,10116.0,,CHEMBL622335,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,13949,In vivo,50597
A,10116.0,,CHEMBL622336,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,13950,In vivo,50597
A,10116.0,,CHEMBL622337,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,13951,In vivo,50597
A,10116.0,,CHEMBL622338,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,13952,In vivo,50597
A,10116.0,,CHEMBL622339,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,13953,In vivo,50597
A,10116.0,,CHEMBL624153,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13954,In vivo,50597
A,10116.0,,CHEMBL628430,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13955,In vivo,50597
A,10116.0,,CHEMBL628431,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13956,In vivo,50597
A,10116.0,,CHEMBL628432,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13957,In vivo,50597
A,10116.0,,CHEMBL628433,Rattus norvegicus,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,13958,In vivo,50597
A,10116.0,,CHEMBL628434,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13959,In vivo,50597
A,10116.0,,CHEMBL626789,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13960,In vivo,50597
A,10116.0,,CHEMBL626790,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13961,In vivo,50597
A,10116.0,,CHEMBL626791,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13962,In vivo,50597
A,10116.0,,CHEMBL626792,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13963,In vivo,50597
A,10116.0,,CHEMBL626793,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,13964,In vivo,50597
A,10116.0,,CHEMBL627436,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13965,,50597
A,10116.0,,CHEMBL627437,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13966,,50597
A,10116.0,,CHEMBL627438,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13967,,50597
A,10116.0,,CHEMBL627439,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13968,,50597
A,10116.0,,CHEMBL627440,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13969,,50597
A,10116.0,,CHEMBL627602,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13970,,50597
A,10116.0,,CHEMBL627603,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13971,,50597
A,10116.0,,CHEMBL627604,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13972,,50597
A,10116.0,,CHEMBL627605,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13973,,50597
A,10116.0,,CHEMBL627606,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13974,,50597
A,10116.0,,CHEMBL627607,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13975,,50597
A,10116.0,,CHEMBL627608,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13976,,50597
A,10116.0,,CHEMBL627609,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13977,,50597
A,10116.0,,CHEMBL627610,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13978,,50597
A,10116.0,,CHEMBL627611,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13979,,50597
A,10116.0,,CHEMBL627612,Rattus norvegicus,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,13980,,50597
P,,,CHEMBL627613,,Octanol:water partition coefficient is evaluated,,8362,U,,Autocuration,,,,,,1,0,,BAO_0000100,13981,,22229
P,,,CHEMBL627614,,Partition coefficient in 1-octanol/water system,,8257,U,,Autocuration,,,,,,1,0,,BAO_0000100,13982,,22224
P,,,CHEMBL627615,,Partition coefficient in 1-octanol/water system measured using radio active compounds,,8257,U,,Autocuration,,,,,,1,0,,BAO_0000100,13983,,22224
P,,,CHEMBL627616,,Partition coefficient in octanol/water system was determined,,9468,U,,Autocuration,,,,,,1,0,,BAO_0000100,13984,,22224
P,,,CHEMBL627617,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,9468,U,,Autocuration,,,,,,1,0,,BAO_0000100,13985,,22224
A,,,CHEMBL627618,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,10568,U,,Autocuration,,,,,,1,0,,BAO_0000019,13986,,22224
A,,,CHEMBL627619,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,10568,U,,Autocuration,,,,,,1,0,,BAO_0000019,13987,,22224
A,,,CHEMBL627620,,Pseudo-first-order rate constant of the compound,,15359,U,,Autocuration,,,,,,1,0,,BAO_0000019,13988,,22224
A,,,CHEMBL627621,,Pseudo-first-order rate constant with 1-min time point,,15359,U,,Autocuration,,,,,,1,0,,BAO_0000019,13989,,22224
A,,,CHEMBL627622,,Pseudo-first-order rate constant without 1-min time point,,15359,U,,Autocuration,,,,,,1,0,,BAO_0000019,13990,,22224
A,,,CHEMBL627623,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13991,,22224
A,,,CHEMBL627624,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13992,,22224
A,,,CHEMBL627625,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,10431,U,,Autocuration,,,,,,1,0,,BAO_0000019,13993,,22224
A,,,CHEMBL628523,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,15704,U,,Autocuration,,,,,,1,0,,BAO_0000019,13994,,22224
A,,,CHEMBL628524,,The alkaline hydrolysis second order rate constant(K OH) of the compound,,15287,U,,Autocuration,,,,,,1,0,,BAO_0000019,13995,,22224
A,,,CHEMBL628525,,The efflux rate constant of the compound,,7516,U,,Autocuration,,,,,,1,0,,BAO_0000019,13996,,22224
A,,,CHEMBL625732,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,U,,Autocuration,,,,,,1,0,,BAO_0000019,13997,,22224
A,,,CHEMBL625733,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,U,,Autocuration,,,,,,1,0,,BAO_0000019,13998,,22224
F,,,CHEMBL625734,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,12973,U,,Autocuration,,,,,,1,0,,BAO_0000019,13999,,22224
A,,,CHEMBL625913,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,12973,U,,Autocuration,,,,,,1,0,,BAO_0000019,14000,,22224
A,,,CHEMBL625914,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,8696,U,,Autocuration,,,,,,1,0,,BAO_0000019,14001,,22224
A,,,CHEMBL625915,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,15052,U,,Autocuration,,,,,,1,0,,BAO_0000019,14002,,22224
A,,,CHEMBL625916,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,15052,U,,Autocuration,,,,,,1,0,,BAO_0000019,14003,,22224
A,,,CHEMBL625917,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,10503,U,,Autocuration,,,,,,1,0,,BAO_0000019,14004,,22224
A,,,CHEMBL625918,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14005,,22224
A,,,CHEMBL625919,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14006,,22224
A,,,CHEMBL625920,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14007,,22224
A,,,CHEMBL874453,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14008,,22224
A,,,CHEMBL625921,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14009,,22224
A,,,CHEMBL625922,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,10503,U,,Autocuration,,,,,,1,0,,BAO_0000019,14010,,22224
A,,,CHEMBL625923,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14011,,22224
A,,,CHEMBL625924,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14012,,22224
A,,,CHEMBL625925,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14013,,22224
A,,,CHEMBL625926,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14014,,22224
A,10116.0,,CHEMBL627704,Rattus norvegicus,Biodistribution in rat lung at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14015,In vivo,50597
A,10116.0,,CHEMBL627705,Rattus norvegicus,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14016,In vivo,50597
A,10116.0,,CHEMBL627706,Rattus norvegicus,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14017,In vivo,50597
A,10116.0,,CHEMBL627707,Rattus norvegicus,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14018,In vivo,50597
A,10116.0,,CHEMBL627708,Rattus norvegicus,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14019,In vivo,50597
A,10116.0,,CHEMBL628361,Rattus norvegicus,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14020,In vivo,50597
A,10116.0,,CHEMBL628362,Rattus norvegicus,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,,13100,N,,Intermediate,,,,,,1,1,,BAO_0000218,14021,In vivo,50597
A,10116.0,,CHEMBL628363,Rattus norvegicus,Biodistribution in rat striatum at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14022,In vivo,50597
A,10116.0,,CHEMBL628364,Rattus norvegicus,Biodistribution in rat striatum at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14023,In vivo,50597
A,10116.0,,CHEMBL628365,Rattus norvegicus,Biodistribution in rat striatum at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14024,In vivo,50597
A,10116.0,,CHEMBL874454,Rattus norvegicus,Biodistribution in rat striatum at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14025,In vivo,50597
A,10116.0,,CHEMBL628531,Rattus norvegicus,Biodistribution in rat striatum at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14026,In vivo,50597
A,10116.0,,CHEMBL628532,Rattus norvegicus,Biodistribution in rat striatum at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14027,In vivo,50597
A,10116.0,,CHEMBL628533,Rattus norvegicus,Biodistribution in rat striatum at 3 hr after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14028,In vivo,50597
A,10116.0,,CHEMBL628534,Rattus norvegicus,Biodistribution in rat striatum at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Striatum,2435.0,,1,1,,BAO_0000218,14029,In vivo,50597
A,10116.0,,CHEMBL628535,Rattus norvegicus,Biodistribution in rat thyroid at 120 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14030,In vivo,50597
A,10116.0,,CHEMBL628536,Rattus norvegicus,Biodistribution in rat thyroid at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14031,In vivo,50597
A,10116.0,,CHEMBL628537,Rattus norvegicus,Biodistribution in rat thyroid at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14032,In vivo,50597
A,10116.0,,CHEMBL628538,Rattus norvegicus,Biodistribution in rat thyroid at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14033,In vivo,50597
A,10116.0,,CHEMBL628539,Rattus norvegicus,Biodistribution in rat thyroid at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14034,In vivo,50597
A,10116.0,,CHEMBL630297,Rattus norvegicus,Biodistribution in rat thyroid at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14035,In vivo,50597
A,10116.0,,CHEMBL630298,Rattus norvegicus,Biodistribution in rat thyroid at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14036,In vivo,50597
A,10116.0,,CHEMBL630299,Rattus norvegicus,Biodistribution in rest of brain of rat 120 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14037,In vivo,50597
A,10116.0,,CHEMBL628094,Rattus norvegicus,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14038,In vivo,50597
A,10116.0,,CHEMBL628095,Rattus norvegicus,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14039,In vivo,50597
A,10116.0,,CHEMBL874648,Rattus norvegicus,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14040,In vivo,50597
A,10116.0,,CHEMBL628096,Rattus norvegicus,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14041,In vivo,50597
A,10116.0,,CHEMBL628097,Rattus norvegicus,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14042,In vivo,50597
A,10116.0,,CHEMBL628098,Rattus norvegicus,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,,13100,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14043,In vivo,50597
A,,,CHEMBL628099,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14044,,22224
A,,,CHEMBL628100,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14045,,22224
A,,,CHEMBL628101,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14046,,22224
A,,,CHEMBL628102,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14047,,22224
A,,,CHEMBL628103,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14048,,22224
A,,,CHEMBL628104,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14049,,22224
A,,,CHEMBL628105,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14050,,22224
A,,,CHEMBL628106,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,13331,U,,Autocuration,,,,,,1,0,,BAO_0000019,14051,,22224
A,10116.0,,CHEMBL628107,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14052,,50597
F,,,CHEMBL628108,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,10086,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,14053,,22224
A,10116.0,,CHEMBL628109,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14054,,50597
F,,,CHEMBL625299,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,10086,U,,Autocuration,,,Urine,1088.0,,1,0,,BAO_0000218,14055,,22224
A,10116.0,,CHEMBL625300,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14056,,50597
A,10116.0,,CHEMBL625301,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14057,,50597
A,10116.0,,CHEMBL625302,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14058,,50597
A,10116.0,,CHEMBL874649,Rattus norvegicus,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,,10086,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14059,,50597
A,10116.0,,CHEMBL625303,Rattus norvegicus,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,,13248,N,,Intermediate,,,,,,1,1,,BAO_0000218,14060,,50597
A,10116.0,,CHEMBL625463,Rattus norvegicus,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,,13248,N,,Intermediate,,,,,,1,1,,BAO_0000218,14061,,50597
A,9606.0,,CHEMBL625464,Homo sapiens,In vitro metabolism in human liver microsomes,,14527,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14062,,50587
A,9606.0,,CHEMBL625465,Homo sapiens,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,,3008,N,,Intermediate,,,,,,1,1,,BAO_0000218,14063,,50587
A,9615.0,,CHEMBL625466,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14064,,50588
A,9615.0,,CHEMBL625467,Canis lupus familiaris,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14065,,50588
A,10116.0,,CHEMBL625468,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14066,,50597
A,10116.0,,CHEMBL625469,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14067,,50597
A,10116.0,,CHEMBL625470,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14068,,50597
A,10116.0,,CHEMBL632418,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14069,,50597
A,10116.0,,CHEMBL627250,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14070,,50597
A,10116.0,,CHEMBL627251,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14071,,50597
A,10116.0,,CHEMBL627252,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14072,,50597
A,10116.0,,CHEMBL627253,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14073,,50597
A,10116.0,,CHEMBL627254,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14074,,50597
A,10116.0,,CHEMBL875471,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14075,,50597
A,10116.0,,CHEMBL627255,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14076,,50597
A,10116.0,,CHEMBL627256,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14077,,50597
A,10116.0,,CHEMBL627257,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14078,,50597
A,10116.0,,CHEMBL627258,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14079,,50597
A,10116.0,,CHEMBL627259,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14080,,50597
A,10116.0,,CHEMBL627260,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14081,,50597
A,10116.0,,CHEMBL623256,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14082,,50597
A,10116.0,,CHEMBL874413,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14083,,50597
A,10116.0,,CHEMBL623257,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14084,,50597
A,10116.0,,CHEMBL623258,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14085,,50597
A,10116.0,,CHEMBL623259,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14086,,50597
A,10116.0,,CHEMBL623260,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14087,,50597
A,10116.0,,CHEMBL623261,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14088,,50597
A,10116.0,,CHEMBL623262,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14089,,50597
A,10116.0,,CHEMBL623263,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14090,,50597
A,10116.0,,CHEMBL623264,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14091,,50597
A,10116.0,,CHEMBL623265,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14092,,50597
A,10116.0,,CHEMBL623266,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14093,,50597
A,10116.0,,CHEMBL623267,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14094,,50597
A,10116.0,,CHEMBL623268,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14095,,50597
A,10116.0,,CHEMBL623269,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14096,,50597
A,10116.0,,CHEMBL623270,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14097,,50597
A,10116.0,,CHEMBL623271,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14098,,50597
A,10116.0,,CHEMBL623272,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14099,,50597
A,10116.0,,CHEMBL623273,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14100,,50597
A,10116.0,,CHEMBL623274,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14101,,50597
A,10116.0,,CHEMBL874414,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14102,,50597
A,10116.0,,CHEMBL623275,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14103,,50597
A,10116.0,,CHEMBL629150,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14104,,50597
A,10116.0,,CHEMBL623276,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14105,,50597
A,10116.0,,CHEMBL623277,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14106,,50597
A,10116.0,,CHEMBL623112,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14107,,50597
A,10116.0,,CHEMBL623113,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14108,,50597
A,10116.0,,CHEMBL623800,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14109,,50597
A,10116.0,,CHEMBL623801,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14110,,50597
A,10116.0,,CHEMBL623802,Rattus norvegicus,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14111,In vivo,50597
A,10116.0,,CHEMBL623803,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,14112,In vivo,50597
A,10116.0,,CHEMBL623970,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,14113,In vivo,50597
A,10116.0,,CHEMBL623971,Rattus norvegicus,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Uterus,995.0,,1,1,,BAO_0000218,14114,In vivo,50597
A,10116.0,,CHEMBL623972,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14115,In vivo,50597
A,10116.0,,CHEMBL623973,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14116,In vivo,50597
A,10116.0,,CHEMBL623974,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14117,In vivo,50597
A,10116.0,,CHEMBL623975,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14118,In vivo,50597
A,10116.0,,CHEMBL623976,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14119,In vivo,50597
A,10116.0,,CHEMBL623977,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14120,In vivo,50597
A,10116.0,,CHEMBL623978,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14121,In vivo,50597
A,10116.0,,CHEMBL623979,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14122,In vivo,50597
A,10116.0,,CHEMBL623980,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14123,In vivo,50597
A,10116.0,,CHEMBL623981,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14124,In vivo,50597
A,10116.0,,CHEMBL626278,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14125,In vivo,50597
A,10116.0,,CHEMBL626279,Rattus norvegicus,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14126,In vivo,50597
A,10090.0,,CHEMBL626280,Mus musculus,Biodistribution in mice bladder plus excreted urine was determined,,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14127,In vivo,50594
A,10090.0,,CHEMBL626281,Mus musculus,"Percentage biodistribution in mouse blood, 10 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14128,,50594
A,10090.0,,CHEMBL626282,Mus musculus,"Percentage biodistribution in mouse blood, 30 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14129,,50594
A,10090.0,,CHEMBL626283,Mus musculus,"Percentage biodistribution in mouse blood, 5 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14130,,50594
A,10090.0,,CHEMBL626284,Mus musculus,"Percentage biodistribution in mouse blood, 60 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14131,,50594
A,10090.0,,CHEMBL626285,Mus musculus,"Percentage biodistribution in mouse brain, 10 minutes post injection",,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14132,,50594
A,10090.0,,CHEMBL626286,Mus musculus,"Percentage biodistribution in mouse brain, 30 minutes post injection",,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14133,,50594
A,10090.0,,CHEMBL626287,Mus musculus,"Percentage biodistribution in mouse brain, 5 minutes post injection",,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14134,,50594
A,10090.0,,CHEMBL626288,Mus musculus,"Percentage biodistribution in mouse brain, 60 minutes post injection",,14045,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14135,,50594
A,10090.0,,CHEMBL626289,Mus musculus,"Percentage biodistribution in mouse heart, 10 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14136,,50594
A,10090.0,,CHEMBL626290,Mus musculus,"Percentage biodistribution in mouse heart, 30 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14137,,50594
A,10090.0,,CHEMBL626291,Mus musculus,"Percentage biodistribution in mouse heart, 5 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14138,,50594
A,10090.0,,CHEMBL839888,Mus musculus,"Percentage biodistribution in mouse heart, 60 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14139,,50594
A,10090.0,,CHEMBL626292,Mus musculus,"Percentage biodistribution in mouse intestine, 10 minutes post injection",,14045,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,14140,,50594
A,10090.0,,CHEMBL626293,Mus musculus,"Percentage biodistribution in mouse intestine, 30 minutes post injection",,14045,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,14141,,50594
A,10090.0,,CHEMBL626294,Mus musculus,"Percentage biodistribution in mouse intestine, 5 minutes post injection",,14045,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,14142,,50594
A,10090.0,,CHEMBL626295,Mus musculus,"Percentage biodistribution in mouse intestine, 60 minutes post injection",,14045,N,,Intermediate,,,Intestine,160.0,,1,1,,BAO_0000218,14143,,50594
A,10090.0,,CHEMBL627659,Mus musculus,"Percentage biodistribution in mouse liver, 10 minutes post injection",,14045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14144,,50594
A,10090.0,,CHEMBL627660,Mus musculus,"Percentage biodistribution in mouse liver, 30 minutes of post injection",,14045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14145,,50594
A,10090.0,,CHEMBL627661,Mus musculus,"Percentage biodistribution in mouse liver, 5 minutes post injection",,14045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14146,,50594
A,10090.0,,CHEMBL627662,Mus musculus,Biodistribution in mice liver at 60 minutes of post injection,,14045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14147,In vivo,50594
A,10090.0,,CHEMBL627663,Mus musculus,Biodistribution in mice lungs at 10 min of post injection,,14045,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14148,In vivo,50594
A,10090.0,,CHEMBL627664,Mus musculus,"Percentage biodistribution in mouse lung, 30 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14149,,50594
A,10090.0,,CHEMBL627665,Mus musculus,"Percentage biodistribution in mousee lung, 5 minutes post injection",,14045,N,,Intermediate,,,,,,1,1,,BAO_0000218,14150,,50594
A,10090.0,,CHEMBL627666,Mus musculus,Biodistribution in mice lungs at 60 min of post injection,,14045,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14151,In vivo,50594
A,10090.0,,CHEMBL627667,Mus musculus,Percentage biodistribution in mouse spleen,,14045,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14152,,50594
A,10090.0,,CHEMBL627668,Mus musculus,Percentage biodistribution in mouse stomach,,14045,N,,Intermediate,,,Stomach,945.0,,1,1,,BAO_0000218,14153,,50594
A,10090.0,,CHEMBL627669,Mus musculus,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,,11745,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14154,,50594
A,,,CHEMBL627670,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,13257,U,,Autocuration,,,Urinary bladder,1255.0,,1,0,,BAO_0000218,14155,In vivo,22224
A,,,CHEMBL627671,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,13257,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,14156,In vivo,22224
A,,,CHEMBL627672,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,13257,U,,Autocuration,,,Bone element,1474.0,,1,0,,BAO_0000218,14157,In vivo,22224
A,,,CHEMBL627673,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14158,In vivo,22224
A,,,CHEMBL627674,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,13257,U,,Autocuration,,,Kidney,2113.0,,1,0,,BAO_0000218,14159,In vivo,22224
A,,,CHEMBL627675,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,13257,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000218,14160,In vivo,22224
A,,,CHEMBL627676,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,13257,U,,Autocuration,,,Lung,2048.0,,1,0,,BAO_0000218,14161,In vivo,22224
A,,,CHEMBL627677,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14162,In vivo,22224
A,,,CHEMBL627678,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14163,,22224
A,10116.0,,CHEMBL627679,Rattus norvegicus,Affinity for protein binding expressed as association constant in fresh rat serum,,7095,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,14164,,50597
A,,,CHEMBL627680,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,12185,U,,Autocuration,,,,,,1,0,,BAO_0000019,14165,,22224
A,,,CHEMBL627681,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,12185,U,,Autocuration,,,,,,1,0,,BAO_0000019,14166,,22224
A,,,CHEMBL627682,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,12185,U,,Autocuration,,,,,,1,0,,BAO_0000019,14167,,22224
A,,,CHEMBL627683,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,12185,U,,Autocuration,,,,,,1,0,,BAO_0000019,14168,,22224
A,,,CHEMBL627684,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,12686,U,,Autocuration,,,,,,1,0,,BAO_0000019,14169,,22224
A,,,CHEMBL874441,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,12686,U,,Autocuration,,,,,,1,0,,BAO_0000019,14170,,22224
A,,,CHEMBL627685,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,12686,U,,Autocuration,,,,,,1,0,,BAO_0000019,14171,,22224
A,,,CHEMBL627686,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,12686,U,,Autocuration,,,,,,1,0,,BAO_0000019,14172,,22224
A,,,CHEMBL627687,,Apparent rate constant Koff for inactivation of dTMP synthase.,,8057,U,,Autocuration,,,,,,1,0,,BAO_0000019,14173,,22224
A,,,CHEMBL627688,,The irreversible inhibitor activity by second order rate equation.,,15778,U,,Autocuration,,,,,,1,0,,BAO_0000019,14174,,22224
A,10116.0,,CHEMBL628038,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,,12375,N,,Intermediate,,,,,,1,1,,BAO_0000218,14175,,50597
A,10116.0,,CHEMBL628039,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,,12375,N,,Intermediate,,,,,,1,1,,BAO_0000218,14176,,50597
A,10116.0,,CHEMBL628040,Rattus norvegicus,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,,12375,N,,Intermediate,,,,,,1,1,,BAO_0000218,14177,,50597
A,,,CHEMBL628041,,Dissociation rate calculated from the first-order equation using t1/2 value,,13588,U,,Autocuration,,,,,,1,0,,BAO_0000019,14178,,22224
A,,,CHEMBL630226,,The compound was tested for Binding constant against DNA,,15039,U,,Autocuration,,,,,,1,0,,BAO_0000019,14179,,22224
A,,,CHEMBL628042,,First order rate constant for cyclization of the compound,,9500,U,,Autocuration,,,,,,1,0,,BAO_0000019,14180,,22224
A,,,CHEMBL625232,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,10014,U,,Autocuration,,,,,,1,0,,BAO_0000019,14181,,22224
A,,,CHEMBL625233,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,10014,U,,Autocuration,,,,,,1,0,,BAO_0000019,14182,,22224
A,,,CHEMBL625979,,Hydrolysis rate constant was determined,,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14183,,22224
A,,,CHEMBL625980,,Observed first order rate constant,,10026,U,,Autocuration,,,,,,1,0,,BAO_0000019,14184,,22224
A,,,CHEMBL625981,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,U,,Autocuration,,,,,,1,0,,BAO_0000019,14185,,22224
A,,,CHEMBL625982,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,U,,Autocuration,,,,,,1,0,,BAO_0000019,14186,,22224
A,,,CHEMBL625983,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14187,,22224
A,,,CHEMBL625984,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14188,,22224
A,,,CHEMBL625985,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14189,,22224
A,,,CHEMBL625986,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14190,,22224
A,,,CHEMBL625987,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14191,,22224
A,,,CHEMBL625988,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14192,,22224
A,,,CHEMBL625989,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14193,,22224
A,,,CHEMBL625990,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14194,,22224
A,,,CHEMBL625991,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14195,,22224
A,,,CHEMBL625992,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14196,,22224
A,,,CHEMBL625993,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14197,,22224
A,,,CHEMBL631973,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14198,,22224
A,,,CHEMBL632143,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14199,,22224
A,,,CHEMBL632144,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14200,,22224
A,,,CHEMBL632145,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14201,,22224
A,,,CHEMBL632146,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14202,,22224
A,,,CHEMBL632147,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14203,,22224
A,,,CHEMBL632148,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14204,,22224
A,,,CHEMBL632149,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14205,,22224
A,,,CHEMBL632150,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14206,,22224
A,,,CHEMBL632151,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14207,,22224
A,9606.0,,CHEMBL632152,Homo sapiens,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,,3008,N,,Intermediate,,,,,,1,1,,BAO_0000218,14208,,50587
A,9606.0,,CHEMBL632153,Homo sapiens,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,4509,N,,Intermediate,,,,,,1,1,,BAO_0000218,14209,,50587
A,9606.0,,CHEMBL632154,Homo sapiens,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,,4509,N,,Intermediate,,,,,,1,1,,BAO_0000218,14210,,50587
A,10298.0,,CHEMBL632155,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14211,,50602
A,10298.0,,CHEMBL632156,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14212,,50602
A,10298.0,,CHEMBL632157,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14213,,50602
A,10298.0,,CHEMBL632158,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14214,,50602
A,10298.0,,CHEMBL632159,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14215,,50602
A,10298.0,,CHEMBL626305,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14216,,50602
A,10298.0,,CHEMBL626306,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14217,,50602
A,10298.0,,CHEMBL626307,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14218,,50602
A,10298.0,,CHEMBL626308,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14219,,50602
A,10298.0,,CHEMBL626479,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14220,,50602
A,10298.0,,CHEMBL626480,Human herpesvirus 1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,,8613,N,,Intermediate,,,,,,1,1,,BAO_0000218,14221,,50602
P,,,CHEMBL626481,,Calculated partition coefficient (clogP) (MlogP),,6021,U,,Autocuration,,,,,,1,0,,BAO_0000100,14222,,22229
A,,,CHEMBL626482,,Equipotent potent ratio relative to carbachol (nicotinic activity),,9348,U,,Autocuration,,,,,,1,0,,BAO_0000019,14223,,22224
A,9615.0,,CHEMBL626483,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",,15592,N,,Intermediate,,,,,,1,1,,BAO_0000218,14224,,50588
A,9615.0,,CHEMBL626484,Canis lupus familiaris,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",,15592,N,,Intermediate,,,,,,1,1,,BAO_0000218,14225,,50588
P,,,CHEMBL626485,,Solubility at pH 7.4 in micro g/mL;NA denotes available,,15592,U,,Autocuration,,,,,,1,0,,BAO_0000100,14226,,22229
P,,,CHEMBL626486,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,15592,U,,Autocuration,,,,,,1,0,,BAO_0000100,14227,,22229
P,,,CHEMBL626487,,Solubility at pH 7.4 in ug/mL;NA denotes not available,,15592,U,,Autocuration,,,,,,1,0,,BAO_0000100,14228,,22229
A,9615.0,,CHEMBL626488,Canis lupus familiaris,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,,15592,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,14229,In vivo,50588
A,10116.0,,CHEMBL626489,Rattus norvegicus,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,,7095,N,,Intermediate,,,Serum,1977.0,,1,1,,BAO_0000218,14230,,50597
A,,,CHEMBL626490,,Area under the MAP curve measured over 5 min; ND means Not determined,,16618,U,,Autocuration,,,,,,1,0,,BAO_0000019,14231,,22224
P,,,CHEMBL626491,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,16835,U,,Autocuration,,,,,,1,0,,BAO_0000100,14232,,22224
P,,,CHEMBL626492,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,15284,U,,Autocuration,,,,,,1,0,,BAO_0000100,14233,,22229
A,,,CHEMBL626493,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,15750,U,,Autocuration,,,,,,1,0,,BAO_0000019,14234,,22224
A,10116.0,,CHEMBL626494,Rattus norvegicus,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,,16618,N,,Intermediate,,,,,,1,1,,BAO_0000218,14235,In vivo,50597
A,,,CHEMBL626495,,Half life after oral tested,,16618,U,,Autocuration,,,,,,1,0,,BAO_0000218,14236,In vivo,22224
A,10116.0,,CHEMBL626496,Rattus norvegicus,Half life was determined in plasma of rat; NT indicates not tested,,15812,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,14237,,50597
A,10116.0,,CHEMBL626497,Rattus norvegicus,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,,16618,N,,Intermediate,,,,,,1,1,,BAO_0000218,14238,In vivo,50597
A,,,CHEMBL626498,,Oral bioavailability after oral tested,,16618,U,,Autocuration,,,,,,1,0,,BAO_0000218,14239,In vivo,22224
A,10116.0,,CHEMBL626499,Rattus norvegicus,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),,13098,N,,Intermediate,,,,,,1,1,,BAO_0000218,14240,,50597
A,10116.0,,CHEMBL626500,Rattus norvegicus,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),,13098,N,,Intermediate,,,,,,1,1,,BAO_0000218,14241,,50597
A,10116.0,,CHEMBL626501,Rattus norvegicus,half life was determined in plasma of rat; NT indicates not tested,,15812,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,14242,,50597
A,10116.0,,CHEMBL626502,Rattus norvegicus,half life was determined in plasma of rat; NT means not tested,,15812,N,,Intermediate,,,Plasma,1969.0,,1,1,,BAO_0000218,14243,,50597
A,10116.0,,CHEMBL626503,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14244,,50597
A,10116.0,,CHEMBL626504,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); inactive,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14245,,50597
A,10116.0,,CHEMBL626505,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14246,,50597
A,10116.0,,CHEMBL626506,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14247,,50597
A,10116.0,,CHEMBL626507,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14248,,50597
A,10116.0,,CHEMBL626508,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14249,,50597
A,10116.0,,CHEMBL626509,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14250,,50597
A,10116.0,,CHEMBL875480,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14251,,50597
A,10116.0,,CHEMBL626510,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14252,,50597
A,10116.0,,CHEMBL626511,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14253,,50597
A,10116.0,,CHEMBL626512,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14254,,50597
A,10116.0,,CHEMBL628208,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14255,,50597
A,10116.0,,CHEMBL628209,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14256,,50597
A,10116.0,,CHEMBL628210,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14257,,50597
A,10116.0,,CHEMBL628211,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14258,,50597
A,10116.0,,CHEMBL628212,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14259,,50597
A,10116.0,,CHEMBL628213,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14260,,50597
A,10116.0,,CHEMBL628214,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14261,,50597
A,10116.0,,CHEMBL628215,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14262,,50597
A,10116.0,,CHEMBL628216,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14263,,50597
A,10116.0,,CHEMBL626595,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14264,,50597
A,10116.0,,CHEMBL626596,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14265,,50597
A,10116.0,,CHEMBL626597,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14266,,50597
A,10116.0,,CHEMBL626598,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14267,,50597
A,10116.0,,CHEMBL622242,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14268,,50597
A,10116.0,,CHEMBL622243,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14269,,50597
A,10116.0,,CHEMBL622244,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14270,,50597
A,10116.0,,CHEMBL622245,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14271,,50597
A,10116.0,,CHEMBL622246,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14272,,50597
A,10116.0,,CHEMBL622247,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14273,,50597
A,10116.0,,CHEMBL622248,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14274,,50597
A,10116.0,,CHEMBL877483,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14275,,50597
A,10116.0,,CHEMBL622249,Rattus norvegicus,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14276,,50597
A,9615.0,,CHEMBL622250,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14277,,50588
A,9615.0,,CHEMBL622251,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14278,,50588
A,9615.0,,CHEMBL622252,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14279,,50588
A,9615.0,,CHEMBL622253,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14280,,50588
A,9615.0,,CHEMBL622254,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14281,,50588
A,9615.0,,CHEMBL622255,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14282,,50588
A,9615.0,,CHEMBL622256,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14283,,50588
A,9615.0,,CHEMBL622257,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14284,,50588
A,9615.0,,CHEMBL622258,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14285,,50588
A,9615.0,,CHEMBL622259,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14286,,50588
A,9615.0,,CHEMBL622927,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14287,,50588
A,9615.0,,CHEMBL622928,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14288,,50588
A,9615.0,,CHEMBL622929,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14289,,50588
A,9615.0,,CHEMBL623182,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14290,,50588
A,9615.0,,CHEMBL623183,Canis lupus familiaris,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14291,,50588
A,10116.0,,CHEMBL623184,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14292,,50597
A,10116.0,,CHEMBL623185,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14293,,50597
A,10116.0,,CHEMBL877484,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14294,,50597
A,10116.0,,CHEMBL627274,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14295,,50597
A,10116.0,,CHEMBL623186,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14296,,50597
A,10116.0,,CHEMBL623187,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14297,,50597
A,10116.0,,CHEMBL623188,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14298,,50597
A,10116.0,,CHEMBL628055,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14299,,50597
A,10116.0,,CHEMBL628056,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14300,,50597
A,10116.0,,CHEMBL628200,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14301,,50597
A,10116.0,,CHEMBL628201,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14302,,50597
A,10116.0,,CHEMBL628202,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14303,,50597
A,10116.0,,CHEMBL628203,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14304,,50597
A,10116.0,,CHEMBL628204,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14305,,50597
A,10116.0,,CHEMBL628205,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14306,,50597
A,10116.0,,CHEMBL628206,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14307,,50597
A,,,CHEMBL628207,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14308,In vivo,22224
A,,,CHEMBL627220,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14309,In vivo,22224
A,,,CHEMBL627221,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14310,In vivo,22224
A,,,CHEMBL627222,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14311,In vivo,22224
A,,,CHEMBL627223,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14312,In vivo,22224
A,,,CHEMBL632062,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14313,In vivo,22224
A,,,CHEMBL632063,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,13257,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000218,14314,In vivo,22224
A,,,CHEMBL632064,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,13257,U,,Autocuration,,,Urinary bladder,1255.0,,1,0,,BAO_0000218,14315,In vivo,22224
A,,,CHEMBL632065,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,13257,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,14316,In vivo,22224
A,,,CHEMBL632066,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,13257,U,,Autocuration,,,Bone element,1474.0,,1,0,,BAO_0000218,14317,In vivo,22224
A,,,CHEMBL632067,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14318,In vivo,22224
A,,,CHEMBL629188,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,13257,U,,Autocuration,,,Kidney,2113.0,,1,0,,BAO_0000218,14319,In vivo,22224
A,,,CHEMBL629189,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,13257,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000218,14320,In vivo,22224
A,,,CHEMBL629190,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,13257,U,,Autocuration,,,Lung,2048.0,,1,0,,BAO_0000218,14321,In vivo,22224
A,,,CHEMBL629191,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14322,In vivo,22224
A,,,CHEMBL629192,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14323,In vivo,22224
A,,,CHEMBL629193,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14324,In vivo,22224
A,,,CHEMBL629194,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14325,In vivo,22224
A,,,CHEMBL629195,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14326,In vivo,22224
A,,,CHEMBL629373,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14327,In vivo,22224
A,,,CHEMBL629374,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,13257,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000218,14328,In vivo,22224
A,,,CHEMBL629375,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14329,In vivo,22224
A,,,CHEMBL629376,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,13257,U,,Autocuration,,,Urinary bladder,1255.0,,1,0,,BAO_0000218,14330,In vivo,22224
A,,,CHEMBL629377,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,13257,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,14331,In vivo,22224
A,,,CHEMBL629378,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,13257,U,,Autocuration,,,Bone element,1474.0,,1,0,,BAO_0000218,14332,In vivo,22224
A,,,CHEMBL629379,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14333,In vivo,22224
A,,,CHEMBL629151,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,13257,U,,Autocuration,,,Kidney,2113.0,,1,0,,BAO_0000218,14334,In vivo,22224
A,,,CHEMBL629152,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,13257,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000218,14335,In vivo,22224
A,,,CHEMBL629153,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,13257,U,,Autocuration,,,Lung,2048.0,,1,0,,BAO_0000218,14336,In vivo,22224
A,,,CHEMBL629154,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14337,In vivo,22224
A,,,CHEMBL629155,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14338,In vivo,22224
A,,,CHEMBL629156,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14339,In vivo,22224
A,,,CHEMBL629157,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14340,In vivo,22224
A,,,CHEMBL629158,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14341,In vivo,22224
A,,,CHEMBL629159,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14342,In vivo,22224
A,,,CHEMBL629160,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14343,In vivo,22224
A,,,CHEMBL629161,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,13257,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000218,14344,In vivo,22224
A,,,CHEMBL629162,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,13257,U,,Autocuration,,,Urinary bladder,1255.0,,1,0,,BAO_0000218,14345,In vivo,22224
A,,,CHEMBL629163,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,13257,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,14346,In vivo,22224
A,,,CHEMBL629164,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,13257,U,,Autocuration,,,Bone element,1474.0,,1,0,,BAO_0000218,14347,In vivo,22224
A,,,CHEMBL629165,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14348,In vivo,22224
A,,,CHEMBL629166,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,13257,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000218,14349,In vivo,22224
A,,,CHEMBL629167,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,13257,U,,Autocuration,,,Lung,2048.0,,1,0,,BAO_0000218,14350,In vivo,22224
A,,,CHEMBL629168,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14351,In vivo,22224
A,,,CHEMBL629169,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14352,,22224
A,,,CHEMBL629170,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14353,,22224
A,,,CHEMBL631153,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14354,,22224
A,,,CHEMBL875121,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14355,,22224
A,,,CHEMBL631154,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14356,,22224
A,,,CHEMBL631155,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,2193,U,,Autocuration,,,,,,1,0,,BAO_0000019,14357,,22224
A,,,CHEMBL631156,,Hydrolysis rate constant was determined,,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14358,,22224
A,,,CHEMBL631157,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14359,,22224
A,,,CHEMBL631158,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14360,,22224
A,,,CHEMBL631159,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14361,,22224
A,,,CHEMBL631160,,Observed second order rate constant,,10026,U,,Autocuration,,,,,,1,0,,BAO_0000019,14362,,22224
A,,,CHEMBL631161,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,10281,U,,Autocuration,,,,,,1,0,,BAO_0000019,14363,,22224
A,,,CHEMBL631162,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,10014,U,,Autocuration,,,,,,1,0,,BAO_0000019,14364,,22224
A,,,CHEMBL630313,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,10014,U,,Autocuration,,,,,,1,0,,BAO_0000019,14365,,22224
A,,,CHEMBL630314,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14366,,22224
A,,,CHEMBL630315,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14367,,22224
A,,,CHEMBL630316,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14368,,22224
A,,,CHEMBL630986,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14369,,22224
A,,,CHEMBL630987,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14370,,22224
A,,,CHEMBL630988,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14371,,22224
A,,,CHEMBL630989,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14372,,22224
A,,,CHEMBL630990,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14373,,22224
A,,,CHEMBL630991,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14374,,22224
A,,,CHEMBL630992,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14375,,22224
A,,,CHEMBL630993,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14376,,22224
A,,,CHEMBL630994,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,13028,U,,Autocuration,,,,,,1,0,,BAO_0000019,14377,,22224
A,10116.0,,CHEMBL630995,Rattus norvegicus,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,,10014,N,,Intermediate,,,,,,1,1,,BAO_0000218,14378,,50597
A,,,CHEMBL629252,,Association constant for compound at 31 degree C was determined,,9962,U,,Autocuration,,,,,,1,0,,BAO_0000019,14379,,22224
A,,,CHEMBL629253,,Calculated antagonist equilibrium dissociation constant of the compound,,12029,U,,Autocuration,,,,,,1,0,,BAO_0000019,14380,,22224
A,,,CHEMBL629944,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,12029,U,,Autocuration,,,,,,1,0,,BAO_0000019,14381,,22224
A,10141.0,,CHEMBL629945,Cavia porcellus,Dissociation constants vs LTE4 on guinea pig trachea,,10583,N,,Intermediate,,,Trachea,3126.0,,1,1,,BAO_0000218,14382,,50512
A,,,CHEMBL629946,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14383,,22224
A,,,CHEMBL629947,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14384,,22224
A,,,CHEMBL629948,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14385,,22224
A,,,CHEMBL856024,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14386,,22224
A,,,CHEMBL629949,,Affinity constant KD value was derived from TMP,,7493,U,,Autocuration,,,,,,1,0,,BAO_0000019,14387,,22224
A,,,CHEMBL629950,,Apparent dissociation (binding) rate constant was evaluated,,8371,U,,Autocuration,,,,,,1,0,,BAO_0000019,14388,,22224
P,,,CHEMBL630127,,Dissociation constant (KD) of the compound,,13114,U,,Autocuration,,,,,,1,0,,BAO_0000100,14389,,22224
P,,,CHEMBL630128,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,15515,U,,Autocuration,,,,,,1,0,,BAO_0000100,14390,,22224
P,,,CHEMBL630129,,Dissociation constant from ESR titration experiments,,522,U,,Autocuration,,,,,,1,0,,BAO_0000100,14391,,22224
,,,CHEMBL630130,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,13888,U,,Autocuration,,,,,,1,0,,BAO_0000019,14392,,22224
P,,,CHEMBL875234,,Dissociation constant was evaluated.,,2616,U,,Autocuration,,,,,,1,0,,BAO_0000100,14393,,22224
P,,,CHEMBL630131,,Dissociation constant was reported,,3798,U,,Autocuration,,,,,,1,0,,BAO_0000100,14394,,22224
A,10116.0,,CHEMBL630132,Rattus norvegicus,Dissociation constant was determined in rat pituitary cells.,,8731,N,,Intermediate,,,,,,1,1,,BAO_0000218,14395,,50597
A,,,CHEMBL630133,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,11892,U,,Autocuration,,,,,,1,0,,BAO_0000019,14396,,22224
A,,,CHEMBL630134,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,11892,U,,Autocuration,,,,,,1,0,,BAO_0000019,14397,,22224
A,,,CHEMBL630135,,Equilibrium dissociation constant of the compound,,2582,U,,Autocuration,,,,,,1,0,,BAO_0000019,14398,,22224
A,,,CHEMBL630136,,Equilibrium dissociation constant was determined,,11892,U,,Autocuration,,,,,,1,0,,BAO_0000019,14399,,22224
A,,,CHEMBL630137,,Kinetic constant KD was evaluated,,13396,U,,Autocuration,,,,,,1,0,,BAO_0000019,14400,,22224
A,,,CHEMBL630138,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,603,U,,Autocuration,,,,,,1,0,,BAO_0000019,14401,,22224
A,,,CHEMBL630139,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,15673,U,,Autocuration,,,,,,1,0,,BAO_0000019,14402,,22224
A,,,CHEMBL630140,,Rate constant for hydrolysis in aqueous acetone.,,10368,U,,Autocuration,,,,,,1,0,,BAO_0000019,14403,,22224
A,,,CHEMBL875235,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,14228,U,,Autocuration,,,,,,1,0,,BAO_0000019,14404,,22224
A,10116.0,,CHEMBL876439,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14405,,50597
A,10116.0,,CHEMBL630605,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14406,,50597
A,10116.0,,CHEMBL630606,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14407,,50597
A,10116.0,,CHEMBL630607,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14408,,50597
A,10116.0,,CHEMBL630608,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14409,,50597
A,10116.0,,CHEMBL630609,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14410,,50597
A,10116.0,,CHEMBL630610,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14411,,50597
A,10116.0,,CHEMBL630611,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14412,,50597
A,10116.0,,CHEMBL629552,Rattus norvegicus,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14413,,50597
A,10116.0,,CHEMBL629733,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14414,,50597
A,10116.0,,CHEMBL629734,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14415,,50597
A,10116.0,,CHEMBL629735,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14416,,50597
A,10116.0,,CHEMBL629736,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14417,,50597
A,10116.0,,CHEMBL629737,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14418,,50597
A,10116.0,,CHEMBL629738,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14419,,50597
A,10116.0,,CHEMBL629739,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14420,,50597
A,10116.0,,CHEMBL629740,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14421,,50597
A,10116.0,,CHEMBL629741,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14422,,50597
A,10116.0,,CHEMBL629742,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14423,,50597
A,10116.0,,CHEMBL629743,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14424,,50597
A,10116.0,,CHEMBL629744,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14425,,50597
A,10116.0,,CHEMBL629745,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14426,,50597
A,10116.0,,CHEMBL629746,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14427,,50597
A,10116.0,,CHEMBL629747,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14428,,50597
A,10116.0,,CHEMBL629748,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14429,,50597
A,10116.0,,CHEMBL629749,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14430,,50597
A,10116.0,,CHEMBL629750,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14431,,50597
A,10116.0,,CHEMBL629751,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14432,,50597
A,10116.0,,CHEMBL629752,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14433,,50597
A,10116.0,,CHEMBL629753,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14434,,50597
A,10116.0,,CHEMBL629754,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14435,,50597
A,10116.0,,CHEMBL629755,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14436,,50597
A,10116.0,,CHEMBL629756,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14437,,50597
A,10116.0,,CHEMBL629757,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14438,,50597
A,10116.0,,CHEMBL629758,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14439,,50597
A,10116.0,,CHEMBL629759,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14440,,50597
A,10116.0,,CHEMBL629760,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14441,,50597
A,10116.0,,CHEMBL876443,Rattus norvegicus,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,,11510,N,,Intermediate,,,,,,1,1,,BAO_0000218,14442,,50597
A,9615.0,,CHEMBL629761,Canis lupus familiaris,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14443,,50588
A,9615.0,,CHEMBL629762,Canis lupus familiaris,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14444,,50588
A,10090.0,,CHEMBL629763,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14445,,50594
A,10090.0,,CHEMBL629764,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14446,,50594
A,10090.0,,CHEMBL629765,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14447,,50594
A,10090.0,,CHEMBL629766,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14448,,50594
A,10090.0,,CHEMBL629767,Mus musculus,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14449,,50594
A,9615.0,,CHEMBL629768,Canis lupus familiaris,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14450,,50588
A,10090.0,,CHEMBL629769,Mus musculus,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14451,,50594
A,9615.0,,CHEMBL629770,Canis lupus familiaris,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14452,,50588
A,9615.0,,CHEMBL629771,Canis lupus familiaris,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14453,,50588
A,10090.0,,CHEMBL629772,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14454,,50594
A,10090.0,,CHEMBL629773,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14455,,50594
A,10090.0,,CHEMBL625455,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14456,,50594
A,10090.0,,CHEMBL625456,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14457,,50594
A,10090.0,,CHEMBL625457,Mus musculus,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,,8310,N,,Intermediate,,,,,,1,1,,BAO_0000218,14458,,50594
A,10116.0,,CHEMBL625458,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14459,,50597
A,10116.0,,CHEMBL625459,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14460,,50597
A,10116.0,,CHEMBL875483,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14461,,50597
A,10116.0,,CHEMBL634779,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14462,,50597
A,10116.0,,CHEMBL625460,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14463,,50597
A,10116.0,,CHEMBL626117,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14464,,50597
A,10116.0,,CHEMBL626118,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14465,,50597
A,10116.0,,CHEMBL628342,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14466,,50597
A,10116.0,,CHEMBL628343,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14467,,50597
A,10116.0,,CHEMBL628344,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14468,,50597
A,10116.0,,CHEMBL628345,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14469,,50597
A,10116.0,,CHEMBL628346,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14470,,50597
A,10116.0,,CHEMBL628347,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14471,,50597
A,10116.0,,CHEMBL628348,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14472,,50597
A,10116.0,,CHEMBL628349,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14473,,50597
A,10116.0,,CHEMBL875611,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14474,,50597
A,10116.0,,CHEMBL628350,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14475,,50597
A,10116.0,,CHEMBL628351,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14476,,50597
A,10116.0,,CHEMBL628352,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14477,,50597
A,10116.0,,CHEMBL628353,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14478,,50597
A,10116.0,,CHEMBL628354,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14479,,50597
A,10116.0,,CHEMBL626667,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14480,,50597
A,10116.0,,CHEMBL626668,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14481,,50597
A,10116.0,,CHEMBL626669,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14482,,50597
A,10116.0,,CHEMBL626670,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14483,,50597
A,10116.0,,CHEMBL626671,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14484,,50597
A,10116.0,,CHEMBL626672,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14485,,50597
A,10116.0,,CHEMBL626673,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14486,,50597
A,10116.0,,CHEMBL626674,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14487,,50597
A,10116.0,,CHEMBL626675,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14488,,50597
A,10116.0,,CHEMBL626676,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14489,,50597
A,10116.0,,CHEMBL626677,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14490,,50597
A,10116.0,,CHEMBL626678,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14491,,50597
A,10116.0,,CHEMBL626679,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14492,,50597
A,10116.0,,CHEMBL875612,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14493,,50597
A,10116.0,,CHEMBL626680,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14494,,50597
A,10116.0,,CHEMBL626681,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14495,,50597
A,10116.0,,CHEMBL626682,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14496,,50597
A,10116.0,,CHEMBL626683,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14497,,50597
A,10116.0,,CHEMBL626684,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14498,,50597
A,10116.0,,CHEMBL626685,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14499,,50597
A,10116.0,,CHEMBL626686,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14500,,50597
A,10116.0,,CHEMBL626687,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14501,,50597
A,10116.0,,CHEMBL624978,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14502,,50597
A,10116.0,,CHEMBL624979,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14503,,50597
A,10116.0,,CHEMBL624980,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14504,,50597
A,10116.0,,CHEMBL624981,Rattus norvegicus,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14505,,50597
A,9615.0,,CHEMBL624982,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14506,,50588
A,,,CHEMBL627564,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14507,In vivo,22224
A,,,CHEMBL627565,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14508,In vivo,22224
A,,,CHEMBL627566,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14509,In vivo,22224
A,,,CHEMBL627567,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14510,In vivo,22224
A,,,CHEMBL627568,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,13257,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000218,14511,In vivo,22224
A,,,CHEMBL627569,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,13257,U,,Autocuration,,,Kidney,2113.0,,1,0,,BAO_0000218,14512,In vivo,22224
A,,,CHEMBL627570,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,13257,U,,Autocuration,,,Urinary bladder,1255.0,,1,0,,BAO_0000218,14513,In vivo,22224
A,,,CHEMBL627571,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,13257,U,,Autocuration,,,Blood,178.0,,1,0,,BAO_0000218,14514,In vivo,22224
A,,,CHEMBL627572,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,13257,U,,Autocuration,,,Bone element,1474.0,,1,0,,BAO_0000218,14515,In vivo,22224
A,,,CHEMBL627573,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14516,In vivo,22224
A,,,CHEMBL627574,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,13257,U,,Autocuration,,,Kidney,2113.0,,1,0,,BAO_0000218,14517,In vivo,22224
A,,,CHEMBL627575,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,13257,U,,Autocuration,,,Liver,2107.0,,1,0,,BAO_0000218,14518,In vivo,22224
A,,,CHEMBL627576,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,13257,U,,Autocuration,,,Lung,2048.0,,1,0,,BAO_0000218,14519,In vivo,22224
A,,,CHEMBL627577,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14520,In vivo,22224
A,,,CHEMBL627578,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14521,In vivo,22224
A,,,CHEMBL627579,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14522,In vivo,22224
A,,,CHEMBL627580,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14523,In vivo,22224
A,,,CHEMBL627581,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14524,In vivo,22224
A,,,CHEMBL627582,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,13257,U,,Autocuration,,,,,,1,0,,BAO_0000218,14525,In vivo,22224
A,,,CHEMBL627583,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14526,In vivo,22224
A,,,CHEMBL627584,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,13257,U,,Autocuration,,,Spleen,2106.0,,1,0,,BAO_0000218,14527,In vivo,22224
A,,,CHEMBL627585,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,13257,U,,Autocuration,,,Prostate gland,2367.0,,1,0,,BAO_0000218,14528,In vivo,22224
A,,,CHEMBL627586,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,13257,U,,Autocuration,,,Muscle tissue,2385.0,,1,0,,BAO_0000218,14529,In vivo,22224
A,10116.0,,CHEMBL627587,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14530,In vivo,50597
A,10116.0,,CHEMBL627588,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14531,In vivo,50597
A,10116.0,,CHEMBL628250,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14532,In vivo,50597
A,10116.0,,CHEMBL628251,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14533,In vivo,50597
A,10116.0,,CHEMBL628252,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14534,In vivo,50597
A,10116.0,,CHEMBL628253,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14535,In vivo,50597
A,10116.0,,CHEMBL628254,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14536,In vivo,50597
A,10116.0,,CHEMBL877493,Rattus norvegicus,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14537,In vivo,50597
A,10116.0,,CHEMBL628255,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14538,In vivo,50597
A,10116.0,,CHEMBL628256,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14539,In vivo,50597
A,10116.0,,CHEMBL628257,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14540,In vivo,50597
A,10116.0,,CHEMBL628258,Rattus norvegicus,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14541,In vivo,50597
A,10116.0,,CHEMBL628259,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14542,In vivo,50597
A,10116.0,,CHEMBL628429,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14543,In vivo,50597
A,10116.0,,CHEMBL626862,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14544,In vivo,50597
A,10116.0,,CHEMBL626863,Rattus norvegicus,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14545,In vivo,50597
A,10116.0,,CHEMBL625886,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,,15413,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,14546,In vivo,50597
A,10116.0,,CHEMBL625887,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,,15413,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,14547,In vivo,50597
A,10116.0,,CHEMBL625888,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cortex,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14548,In vivo,50597
A,10116.0,,CHEMBL625889,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14549,In vivo,50597
A,10116.0,,CHEMBL625890,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14550,In vivo,50597
A,10116.0,,CHEMBL625891,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14551,In vivo,50597
A,10116.0,,CHEMBL625892,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14552,In vivo,50597
A,10116.0,,CHEMBL625893,Rattus norvegicus,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14553,In vivo,50597
A,10116.0,,CHEMBL625894,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,,15413,N,,Intermediate,,,Cerebellum,2037.0,,1,1,,BAO_0000218,14554,In vivo,50597
A,10116.0,,CHEMBL625895,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat cortex,,15413,N,,Intermediate,,,,,,1,1,,BAO_0000218,14555,In vivo,50597
A,,,CHEMBL625896,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,U,,Autocuration,,,,,,1,0,,BAO_0000019,14556,,22224
A,,,CHEMBL625897,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14557,,22224
A,,,CHEMBL625898,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14558,,22224
A,,,CHEMBL625899,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,568,U,,Autocuration,,,,,,1,0,,BAO_0000019,14559,,22224
A,,,CHEMBL626124,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,U,,Autocuration,,,,,,1,0,,BAO_0000019,14560,,22224
A,562.0,,CHEMBL628500,Escherichia coli,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,,7624,N,,Intermediate,,,,,,1,1,,BAO_0000218,14561,,50212
A,10116.0,,CHEMBL857856,Rattus norvegicus,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",,7624,N,,Intermediate,,,,,,1,1,,BAO_0000218,14562,,50597
A,10116.0,,CHEMBL628501,Rattus norvegicus,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",,7624,N,,Intermediate,,,,,,1,1,,BAO_0000218,14563,,50597
A,,,CHEMBL628502,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,4643,U,,Autocuration,,,,,,1,0,,BAO_0000019,14564,,22224
A,,,CHEMBL628503,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,11532,U,,Autocuration,,,,,,1,0,,BAO_0000019,14565,,22224
A,,,CHEMBL628504,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,11018,U,,Autocuration,,,,,,1,0,,BAO_0000019,14566,,22224
A,,,CHEMBL628505,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14567,,22224
A,,,CHEMBL874452,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14568,,22224
A,,,CHEMBL628506,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14569,,22224
A,,,CHEMBL628507,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14570,,22224
A,,,CHEMBL628508,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14571,,22224
A,,,CHEMBL628509,,Michaelis constant (KM) was evaluated,,8949,U,,Autocuration,,,,,,1,0,,BAO_0000019,14572,,22224
A,,,CHEMBL628510,,Reaction rate parameter value for phosphate with transfer with respect to ATP,,12404,U,,Autocuration,,,,,,1,0,,BAO_0000019,14573,,22224
B,,,CHEMBL628511,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,7625,U,,Autocuration,,,,,,1,0,,BAO_0000019,14574,,22224
B,,,CHEMBL628512,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,7625,U,,Autocuration,,,,,,1,0,,BAO_0000019,14575,,22224
B,,,CHEMBL628513,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,7625,U,,Autocuration,,,,,,1,0,,BAO_0000019,14576,,22224
B,,,CHEMBL628514,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,7625,U,,Autocuration,,,,,,1,0,,BAO_0000019,14577,,22224
A,,,CHEMBL628515,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,12908,U,,Autocuration,,,,,,1,0,,BAO_0000019,14578,,22224
A,,,CHEMBL628516,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,10368,U,,Autocuration,,,,,,1,0,,BAO_0000019,14579,,22224
A,,,CHEMBL628517,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,13108,U,,Autocuration,,,,,,1,0,,BAO_0000019,14580,,22224
A,,,CHEMBL628518,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,13108,U,,Autocuration,,,,,,1,0,,BAO_0000019,14581,,22224
A,,,CHEMBL628519,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,15217,U,,Autocuration,,,,,,1,0,,BAO_0000019,14582,,22224
A,,,CHEMBL628520,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,15217,U,,Autocuration,,,,,,1,0,,BAO_0000019,14583,,22224
A,,,CHEMBL628521,,Binding constant was determined,,10933,U,,Autocuration,,,,,,1,0,,BAO_0000019,14584,,22224
A,,,CHEMBL630443,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14585,,22224
A,,,CHEMBL630444,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14586,,22224
A,,,CHEMBL857732,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14587,,22224
P,,,CHEMBL630445,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,14915,U,,Autocuration,,,,,,1,0,,BAO_0000100,14588,,22224
A,,,CHEMBL630446,,Catalytic rate constant of the compound,,8847,U,,Autocuration,,,,,,1,0,,BAO_0000019,14589,,22224
B,,,CHEMBL630447,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,15357,U,,Autocuration,,,,,,1,0,,BAO_0000019,14590,,22224
A,,,CHEMBL630448,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,2869,U,,Autocuration,,,,,,1,0,,BAO_0000019,14591,,22224
A,,,CHEMBL630449,,Catalytic rate constant against phospholipase A2 was determined,,3484,U,,Autocuration,,,,,,1,0,,BAO_0000019,14592,,22224
A,,,CHEMBL630450,,"Compound was evaluated for catalytic constant, Kcat",,1373,U,,Autocuration,,,,,,1,0,,BAO_0000019,14593,,22224
A,,,CHEMBL630451,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,8142,U,,Autocuration,,,,,,1,0,,BAO_0000019,14594,,22224
A,,,CHEMBL630452,,Kcat calculated from 0.693/T1/2,,14131,U,,Autocuration,,,,,,1,0,,BAO_0000019,14595,,22224
A,,,CHEMBL630453,,Kcat was determined,,17269,U,,Autocuration,,,,,,1,0,,BAO_0000019,14596,,22224
A,,,CHEMBL630454,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,3485,U,,Autocuration,,,,,,1,0,,BAO_0000019,14597,,22224
A,,,CHEMBL630455,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,3485,U,,Autocuration,,,,,,1,0,,BAO_0000019,14598,,22224
A,,,CHEMBL631487,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,3485,U,,Autocuration,,,,,,1,0,,BAO_0000019,14599,,22224
A,,,CHEMBL631488,,Kcat value was determined,,5962,U,,Autocuration,,,,,,1,0,,BAO_0000019,14600,,22224
A,,,CHEMBL876440,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,3133,U,,Autocuration,,,,,,1,0,,BAO_0000019,14601,,22224
A,,,CHEMBL631489,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,3133,U,,Autocuration,,,,,,1,0,,BAO_0000019,14602,,22224
A,,,CHEMBL857742,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14603,,22224
A,,,CHEMBL631490,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14604,,22224
A,,,CHEMBL631491,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14605,,22224
A,,,CHEMBL631492,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14606,,22224
A,,,CHEMBL631493,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14607,,22224
A,,,CHEMBL631494,,Kinetic parameter for rate of conversion to PABA was determined,,4892,U,,Autocuration,,,,,,1,0,,BAO_0000019,14608,,22224
A,,,CHEMBL631495,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,3133,U,,Autocuration,,,,,,1,0,,BAO_0000019,14609,,22224
A,10116.0,,CHEMBL631496,Rattus norvegicus,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,11488,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14610,,50597
A,10116.0,,CHEMBL631497,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",,11488,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14611,,50597
A,10116.0,,CHEMBL631498,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",,11488,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14612,,50597
A,10116.0,,CHEMBL629776,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",,11488,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14613,,50597
A,10116.0,,CHEMBL629777,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",,11488,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14614,,50597
A,10116.0,,CHEMBL629778,Rattus norvegicus,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",,11488,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14615,,50597
A,10116.0,,CHEMBL630456,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14616,,50597
A,10116.0,,CHEMBL630457,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14617,,50597
A,10116.0,,CHEMBL630458,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14618,,50597
A,10116.0,,CHEMBL630459,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14619,,50597
A,10116.0,,CHEMBL630460,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14620,,50597
A,10116.0,,CHEMBL876550,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14621,,50597
A,10116.0,,CHEMBL630461,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14622,,50597
A,10116.0,,CHEMBL630462,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14623,,50597
A,10116.0,,CHEMBL630463,Rattus norvegicus,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14624,,50597
A,10116.0,,CHEMBL630464,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14625,,50597
A,10116.0,,CHEMBL630465,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14626,,50597
A,10116.0,,CHEMBL630466,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14627,,50597
A,10116.0,,CHEMBL630467,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14628,,50597
A,10116.0,,CHEMBL630633,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14629,,50597
A,10116.0,,CHEMBL630634,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14630,,50597
A,10116.0,,CHEMBL630635,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14631,,50597
A,10116.0,,CHEMBL630636,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14632,,50597
A,10116.0,,CHEMBL630637,Rattus norvegicus,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,,11488,N,,Intermediate,,,,,,1,1,,BAO_0000218,14633,,50597
A,9986.0,,CHEMBL630638,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14634,,50592
A,9986.0,,CHEMBL630639,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14635,,50592
A,9986.0,,CHEMBL630640,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14636,,50592
A,9986.0,,CHEMBL876551,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14637,,50592
A,9986.0,,CHEMBL630641,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14638,,50592
A,9986.0,,CHEMBL630642,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14639,,50592
A,9986.0,,CHEMBL630643,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14640,,50592
A,9986.0,,CHEMBL630644,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14641,,50592
A,9986.0,,CHEMBL630645,Oryctolagus cuniculus,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14642,,50592
A,9986.0,,CHEMBL625599,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14643,,50592
A,9986.0,,CHEMBL625600,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14644,,50592
A,9986.0,,CHEMBL625601,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14645,,50592
A,9986.0,,CHEMBL625602,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",,7132,N,,Intermediate,,,Feces,1988.0,,1,1,,BAO_0000218,14646,,50592
A,9986.0,,CHEMBL627470,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14647,,50592
A,9986.0,,CHEMBL627471,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14648,,50592
A,9986.0,,CHEMBL627472,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14649,,50592
A,9986.0,,CHEMBL627473,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14650,,50592
A,9986.0,,CHEMBL627474,Oryctolagus cuniculus,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",,7132,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14651,,50592
A,10116.0,,CHEMBL627475,Rattus norvegicus,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14652,In vivo,50597
A,10116.0,,CHEMBL627476,Rattus norvegicus,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14653,In vivo,50597
A,9615.0,,CHEMBL627477,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14654,,50588
A,9615.0,,CHEMBL627478,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14655,,50588
A,9615.0,,CHEMBL627479,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14656,,50588
A,9615.0,,CHEMBL627480,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14657,,50588
A,9615.0,,CHEMBL627481,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14658,,50588
A,9615.0,,CHEMBL627482,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14659,,50588
A,9615.0,,CHEMBL627483,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14660,,50588
A,9615.0,,CHEMBL875636,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14661,,50588
A,9615.0,,CHEMBL625764,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14662,,50588
A,9615.0,,CHEMBL625765,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14663,,50588
A,9615.0,,CHEMBL625766,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14664,,50588
A,9615.0,,CHEMBL625767,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14665,,50588
A,9615.0,,CHEMBL625768,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14666,,50588
A,9615.0,,CHEMBL625769,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14667,,50588
A,9615.0,,CHEMBL625770,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14668,,50588
A,9615.0,,CHEMBL625771,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14669,,50588
A,9615.0,,CHEMBL625772,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14670,,50588
A,9615.0,,CHEMBL625773,Canis lupus familiaris,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14671,,50588
A,10116.0,,CHEMBL625774,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14672,,50597
A,10116.0,,CHEMBL625775,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14673,,50597
A,10116.0,,CHEMBL625776,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14674,,50597
A,10116.0,,CHEMBL625777,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14675,,50597
A,10116.0,,CHEMBL625778,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14676,,50597
A,10116.0,,CHEMBL625779,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14677,,50597
A,10116.0,,CHEMBL625780,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14678,,50597
A,10116.0,,CHEMBL625781,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14679,,50597
A,10116.0,,CHEMBL875637,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14680,,50597
A,10116.0,,CHEMBL626473,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14681,,50597
A,10116.0,,CHEMBL626474,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14682,,50597
A,10116.0,,CHEMBL626475,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14683,,50597
A,10116.0,,CHEMBL626476,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14684,,50597
A,10116.0,,CHEMBL634397,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14685,,50597
A,10116.0,,CHEMBL626477,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14686,,50597
A,10116.0,,CHEMBL631069,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14687,,50597
A,10116.0,,CHEMBL631070,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14688,,50597
A,10116.0,,CHEMBL631071,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14689,,50597
A,10116.0,,CHEMBL631072,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14690,,50597
A,10116.0,,CHEMBL631073,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14691,,50597
A,10116.0,,CHEMBL631074,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14692,,50597
A,10116.0,,CHEMBL631075,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14693,,50597
A,10116.0,,CHEMBL631725,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14694,,50597
A,10116.0,,CHEMBL631726,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14695,,50597
A,10116.0,,CHEMBL631727,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14696,,50597
A,10116.0,,CHEMBL631728,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14697,,50597
A,10116.0,,CHEMBL631729,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14698,,50597
A,10116.0,,CHEMBL631730,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14699,,50597
A,10116.0,,CHEMBL631731,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14700,,50597
A,10116.0,,CHEMBL631910,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14701,,50597
A,10116.0,,CHEMBL631911,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,,15413,N,,Intermediate,,,Hippocampus,10000000.0,,1,1,,BAO_0000218,14702,In vivo,50597
A,10116.0,,CHEMBL631912,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14703,In vivo,50597
A,10116.0,,CHEMBL631913,Rattus norvegicus,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,,15413,N,,Intermediate,,,Hypothalamus,1898.0,,1,1,,BAO_0000218,14704,In vivo,50597
A,10116.0,,CHEMBL631914,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14705,In vivo,50597
A,10116.0,,CHEMBL631915,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14706,In vivo,50597
A,10116.0,,CHEMBL875778,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14707,In vivo,50597
A,10116.0,,CHEMBL631916,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14708,In vivo,50597
A,10116.0,,CHEMBL631917,Rattus norvegicus,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14709,In vivo,50597
A,10116.0,,CHEMBL631918,Rattus norvegicus,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14710,In vivo,50597
A,10116.0,,CHEMBL631919,Rattus norvegicus,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14711,In vivo,50597
A,10116.0,,CHEMBL631920,Rattus norvegicus,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14712,In vivo,50597
A,10116.0,,CHEMBL631921,Rattus norvegicus,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14713,In vivo,50597
A,10116.0,,CHEMBL631922,Rattus norvegicus,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14714,In vivo,50597
A,10116.0,,CHEMBL631923,Rattus norvegicus,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14715,In vivo,50597
A,10116.0,,CHEMBL631924,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14716,In vivo,50597
A,10116.0,,CHEMBL630234,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14717,In vivo,50597
A,10116.0,,CHEMBL630235,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14718,In vivo,50597
A,10116.0,,CHEMBL630236,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14719,In vivo,50597
A,10116.0,,CHEMBL630237,Rattus norvegicus,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14720,In vivo,50597
A,10116.0,,CHEMBL630238,Rattus norvegicus,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14721,In vivo,50597
A,10116.0,,CHEMBL630239,Rattus norvegicus,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14722,In vivo,50597
A,10116.0,,CHEMBL630303,Rattus norvegicus,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14723,In vivo,50597
A,10116.0,,CHEMBL630304,Rattus norvegicus,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14724,In vivo,50597
A,10116.0,,CHEMBL630305,Rattus norvegicus,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,,,,1,1,,BAO_0000218,14725,In vivo,50597
A,10116.0,,CHEMBL630306,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14726,In vivo,50597
A,10116.0,,CHEMBL630307,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14727,In vivo,50597
A,10116.0,,CHEMBL630308,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14728,In vivo,50597
A,10116.0,,CHEMBL630309,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14729,In vivo,50597
A,10116.0,,CHEMBL629309,Rattus norvegicus,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14730,In vivo,50597
A,10116.0,,CHEMBL629993,Rattus norvegicus,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14731,In vivo,50597
A,10116.0,,CHEMBL629994,Rattus norvegicus,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14732,In vivo,50597
A,10116.0,,CHEMBL629995,Rattus norvegicus,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14733,In vivo,50597
A,10116.0,,CHEMBL631993,Rattus norvegicus,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14734,In vivo,50597
A,10116.0,,CHEMBL631994,Rattus norvegicus,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14735,In vivo,50597
A,10116.0,,CHEMBL631995,Rattus norvegicus,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14736,In vivo,50597
A,10116.0,,CHEMBL631996,Rattus norvegicus,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14737,In vivo,50597
A,10116.0,,CHEMBL631997,Rattus norvegicus,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14738,In vivo,50597
A,10116.0,,CHEMBL631998,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14739,In vivo,50597
A,10116.0,,CHEMBL631999,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14740,In vivo,50597
A,10116.0,,CHEMBL632000,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14741,In vivo,50597
A,10116.0,,CHEMBL632001,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14742,In vivo,50597
A,10116.0,,CHEMBL874424,Rattus norvegicus,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14743,In vivo,50597
A,10116.0,,CHEMBL632002,Rattus norvegicus,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14744,In vivo,50597
A,10116.0,,CHEMBL632003,Rattus norvegicus,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14745,In vivo,50597
A,,,CHEMBL632004,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,3133,U,,Autocuration,,,,,,1,0,,BAO_0000019,14746,,22224
A,,,CHEMBL632005,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14747,,22224
A,,,CHEMBL632006,,Compound was tested for amidase rate in the presence of N62C screen enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14748,,22224
A,,,CHEMBL632007,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14749,,22224
A,,,CHEMBL632008,,Compound was tested for amidase rate in the presence of S166C screen enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14750,,22224
A,,,CHEMBL632009,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14751,,22224
A,,,CHEMBL632010,,Compound was tested for esterase rate in the presence of N62C screen enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14752,,22224
A,,,CHEMBL857750,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14753,,22224
A,,,CHEMBL632011,,Compound was tested for esterase rate in the presence of S166C screen enzyme,,2742,U,,Autocuration,,,,,,1,0,,BAO_0000019,14754,,22224
A,,,CHEMBL632012,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14755,,22224
A,,,CHEMBL632013,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14756,,22224
A,,,CHEMBL632014,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14757,,22224
A,,,CHEMBL629622,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14758,,22224
A,,,CHEMBL629623,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14759,,22224
A,,,CHEMBL629624,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14760,,22224
A,,,CHEMBL629625,,Ratio of Kcat to that of Km was determined,,17269,U,,Autocuration,,,,,,1,0,,BAO_0000019,14761,,22224
A,,,CHEMBL629626,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14762,,22224
A,,,CHEMBL629627,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,2276,U,,Autocuration,,,,,,1,0,,BAO_0000019,14763,,22224
A,,,CHEMBL629628,,"Compound was evaluated for constant, Kd",,15917,U,,Autocuration,,,,,,1,0,,BAO_0000019,14764,,22224
A,,,CHEMBL629629,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,10933,U,,Autocuration,,,,,,1,0,,BAO_0000019,14765,,22224
A,,,CHEMBL629630,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,10933,U,,Autocuration,,,,,,1,0,,BAO_0000019,14766,,22224
A,,,CHEMBL856030,,Dissociation Constant of compound determined,,14293,U,,Autocuration,,,,,,1,0,,BAO_0000019,14767,,22224
B,,,CHEMBL629631,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,6698,U,,Autocuration,,,,,,1,0,,BAO_0000019,14768,,22224
B,,,CHEMBL629632,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,6698,U,,Autocuration,,,,,,1,0,,BAO_0000019,14769,,22224
P,,,CHEMBL629633,,Dissociation constant of compound with Fructose was determined,,4318,U,,Autocuration,,,,,,1,0,,BAO_0000100,14770,,22224
P,,,CHEMBL629634,,Dissociation constant of compound with Fructose was determined; Not determined,,4318,U,,Autocuration,,,,,,1,0,,BAO_0000100,14771,,22224
P,,,CHEMBL629635,,Dissociation constant of compound with Lactulose was determined,,4318,U,,Autocuration,,,,,,1,0,,BAO_0000100,14772,,22224
P,,,CHEMBL629636,,Dissociation constant of compound with Lactulose was determined; Not determined,,4318,U,,Autocuration,,,,,,1,0,,BAO_0000100,14773,,22224
P,,,CHEMBL629637,,Dissociation constant of the Compound,,14959,U,,Autocuration,,,,,,1,0,,BAO_0000100,14774,,22224
P,,,CHEMBL629638,,Dissociation constant by non-linear regression analysis,,5913,U,,Autocuration,,,,,,1,0,,BAO_0000100,14775,,22224
P,,,CHEMBL629639,,Dissociation constant was determined,,14218,U,,Autocuration,,,,,,1,0,,BAO_0000100,14776,,22224
P,,,CHEMBL629640,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,10689,U,,Autocuration,,,,,,1,0,,BAO_0000100,14777,,22224
P,,,CHEMBL629641,,Dissociation constant was determined,,13925,U,,Autocuration,,,,,,1,0,,BAO_0000100,14778,,22224
P,,,CHEMBL631344,,Dissociation constant was determined,,16359,U,,Autocuration,,,,,,1,0,,BAO_0000100,14779,,22224
A,10116.0,,CHEMBL631345,Rattus norvegicus,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,,10944,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14780,,50597
A,,,CHEMBL631346,,The dissociation constant determined by fluorescence displacement assay,,11080,U,,Autocuration,,,,,,1,0,,BAO_0000019,14781,,22224
A,,,CHEMBL631524,,kd value surface plasmon resonance (SPR) method,,17805,U,,Autocuration,,,,,,1,0,,BAO_0000019,14782,,22224
A,10116.0,,CHEMBL631525,Rattus norvegicus,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,,10944,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14783,,50597
F,,,CHEMBL631526,,First dissociation constant of the binding of compound to V30M TTR,,16645,U,,Autocuration,,,,,,1,0,,BAO_0000019,14784,,22224
F,,,CHEMBL631527,,Second dissociation constant of the binding of compound to V30M TTR,,16645,U,,Autocuration,,,,,,1,0,,BAO_0000019,14785,,22224
A,,,CHEMBL631528,,"Compound was evaluated for equilibrium constant, Ke",,7793,U,,Autocuration,,,,,,1,0,,BAO_0000019,14786,,22224
A,,,CHEMBL631529,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,12199,U,,Autocuration,,,Hypothalamus,1898.0,,1,0,,BAO_0000019,14787,,22224
A,,,CHEMBL631530,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,12199,U,,Autocuration,,,Hypothalamus,1898.0,,1,0,,BAO_0000019,14788,,22224
A,,,CHEMBL631531,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14789,,22224
A,,,CHEMBL631532,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14790,,22224
A,,,CHEMBL631533,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,9680,U,,Autocuration,,,,,,1,0,,BAO_0000019,14791,,22224
A,10090.0,,CHEMBL876552,Mus musculus,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14792,,50594
A,10090.0,,CHEMBL631534,Mus musculus,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14793,,50594
A,10090.0,,CHEMBL631535,Mus musculus,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14794,,50594
A,10090.0,,CHEMBL631536,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14795,,50594
A,10090.0,,CHEMBL631537,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14796,,50594
A,10090.0,,CHEMBL631538,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14797,,50594
A,10090.0,,CHEMBL631539,Mus musculus,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14798,,50594
A,10090.0,,CHEMBL631540,Mus musculus,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,,13758,N,,Intermediate,,,,,,1,1,,BAO_0000218,14799,,50594
A,10116.0,,CHEMBL625637,Rattus norvegicus,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,14800,,50597
A,10116.0,,CHEMBL625638,Rattus norvegicus,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,,14393,N,,Intermediate,,,,,,1,1,,BAO_0000218,14801,,50597
A,10116.0,,CHEMBL625639,Rattus norvegicus,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",,15078,N,,Intermediate,,,,,,1,1,,BAO_0000218,14802,,50597
A,10116.0,,CHEMBL625640,Rattus norvegicus,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14803,In vivo,50597
A,10116.0,,CHEMBL625641,Rattus norvegicus,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14804,In vivo,50597
A,10116.0,,CHEMBL625642,Rattus norvegicus,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14805,In vivo,50597
A,10116.0,,CHEMBL625643,Rattus norvegicus,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14806,In vivo,50597
A,10116.0,,CHEMBL625644,Rattus norvegicus,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14807,In vivo,50597
A,10116.0,,CHEMBL625645,Rattus norvegicus,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14808,In vivo,50597
A,10116.0,,CHEMBL625646,Rattus norvegicus,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14809,In vivo,50597
A,10116.0,,CHEMBL625647,Rattus norvegicus,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14810,In vivo,50597
A,10116.0,,CHEMBL625648,Rattus norvegicus,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14811,In vivo,50597
A,10116.0,,CHEMBL625649,Rattus norvegicus,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14812,In vivo,50597
A,10116.0,,CHEMBL625650,Rattus norvegicus,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14813,In vivo,50597
A,10116.0,,CHEMBL625651,Rattus norvegicus,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14814,In vivo,50597
A,10116.0,,CHEMBL625652,Rattus norvegicus,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,14815,In vivo,50597
A,10116.0,,CHEMBL625653,Rattus norvegicus,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Zone of skin,14.0,,1,1,,BAO_0000218,14816,In vivo,50597
A,10116.0,,CHEMBL625654,Rattus norvegicus,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14817,In vivo,50597
A,10116.0,,CHEMBL625655,Rattus norvegicus,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,,13925,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14818,In vivo,50597
A,10116.0,,CHEMBL625656,Rattus norvegicus,Biodistribution of Compound in rat blood after 15 minutes of administration,,9712,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14819,In vivo,50597
A,10116.0,,CHEMBL625657,Rattus norvegicus,Biodistribution of Compound in rat blood after 2 minutes of administration,,9712,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14820,In vivo,50597
A,10116.0,,CHEMBL625658,Rattus norvegicus,Biodistribution of Compound in rat brain after 15 minutes of administration,,9712,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14821,In vivo,50597
A,10116.0,,CHEMBL625659,Rattus norvegicus,Biodistribution of Compound in rat brain after 2 minutes of administration,,9712,N,,Intermediate,,,Brain,955.0,,1,1,,BAO_0000218,14822,In vivo,50597
A,10116.0,,CHEMBL625660,Rattus norvegicus,Biodistribution of Compound in rat heart after 15 minutes of administration,,9712,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14823,In vivo,50597
A,10116.0,,CHEMBL625661,Rattus norvegicus,Biodistribution of Compound in rat heart after 2 minutes of administration,,9712,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14824,In vivo,50597
A,10116.0,,CHEMBL625662,Rattus norvegicus,Biodistribution of Compound in rat liver after 15 minutes of administration,,9712,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14825,In vivo,50597
A,10116.0,,CHEMBL625663,Rattus norvegicus,Biodistribution of Compound in rat liver after 2 minutes of administration,,9712,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14826,In vivo,50597
A,10116.0,,CHEMBL875621,Rattus norvegicus,Biodistribution of Compound in rat lung after 15 minutes of administration,,9712,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14827,In vivo,50597
A,10116.0,,CHEMBL628382,Rattus norvegicus,Biodistribution of Compound in rat lung after 2 minutes of administration,,9712,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14828,In vivo,50597
A,10116.0,,CHEMBL628383,Rattus norvegicus,Biodistribution of Compound in rat muscle after 15 minutes of administration,,9712,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14829,In vivo,50597
A,10116.0,,CHEMBL628384,Rattus norvegicus,Biodistribution of Compound in rat muscle after 2 minutes of administration,,9712,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14830,In vivo,50597
A,10116.0,,CHEMBL628385,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,,13925,N,,Intermediate,,,,,,1,1,,BAO_0000218,14831,,50597
A,10116.0,,CHEMBL875753,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,,13925,N,,Intermediate,,,,,,1,1,,BAO_0000218,14832,,50597
A,10116.0,,CHEMBL628386,Rattus norvegicus,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,,13925,N,,Intermediate,,,,,,1,1,,BAO_0000218,14833,,50597
A,10116.0,,CHEMBL628387,Rattus norvegicus,Organ distribution in rat blood 2 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14834,,50597
A,10116.0,,CHEMBL628388,Rattus norvegicus,Organ distribution in rat blood 2 hr after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14835,,50597
A,10116.0,,CHEMBL628389,Rattus norvegicus,Organ distribution in rat blood 30 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14836,,50597
A,10116.0,,CHEMBL632756,Rattus norvegicus,Organ distribution in rat blood 30 min after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14837,,50597
A,10116.0,,CHEMBL628390,Rattus norvegicus,Organ distribution in rat brain 2 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14838,,50597
A,10116.0,,CHEMBL631811,Rattus norvegicus,Organ distribution in rat brain 2 hr after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14839,,50597
A,10116.0,,CHEMBL631812,Rattus norvegicus,Organ distribution in rat brain 30 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14840,,50597
A,10116.0,,CHEMBL631813,Rattus norvegicus,Organ distribution in rat heart 2 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14841,,50597
A,10116.0,,CHEMBL631814,Rattus norvegicus,Organ distribution in rat heart 2 hr after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14842,,50597
A,10116.0,,CHEMBL631815,Rattus norvegicus,Organ distribution in rat heart 30 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14843,,50597
A,10116.0,,CHEMBL631816,Rattus norvegicus,Organ distribution in rat kidney 2 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14844,,50597
A,10116.0,,CHEMBL875758,Rattus norvegicus,Organ distribution in rat kidney 2 hr after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14845,,50597
A,10116.0,,CHEMBL631817,Rattus norvegicus,Organ distribution in rat kidney 30 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14846,,50597
A,10116.0,,CHEMBL631818,Rattus norvegicus,Organ distribution in rat liver 2 minutes after intravenous injection,,6941,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14847,,50597
A,10116.0,,CHEMBL631819,Rattus norvegicus,Organ distribution in rat liver 2 hr after intravenous injection,,6941,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14848,,50597
A,10116.0,,CHEMBL631820,Rattus norvegicus,Organ distribution in rat liver 30 minutes after intravenous injection,,6941,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14849,,50597
A,10116.0,,CHEMBL631821,Rattus norvegicus,Organ distribution in rat lung 2 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14850,,50597
A,10116.0,,CHEMBL631822,Rattus norvegicus,Organ distribution in rat lung 2 hr after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14851,,50597
A,10116.0,,CHEMBL631823,Rattus norvegicus,Organ distribution in rat lung 30 minutes after intravenous injection,,6941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14852,,50597
A,10116.0,,CHEMBL631824,Rattus norvegicus,Organ distribution in rat muscle 2 minutes after intravenous injection,,6941,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14853,,50597
A,10116.0,,CHEMBL631825,Rattus norvegicus,Organ distribution in rat muscle 2 hr after intravenous injection,,6941,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14854,,50597
A,10116.0,,CHEMBL631826,Rattus norvegicus,Organ distribution in rat muscle 30 minutes after intravenous injection,,6941,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14855,,50597
A,10090.0,,CHEMBL631827,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,14856,In vivo,50594
A,10090.0,,CHEMBL631828,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,14857,In vivo,50594
A,10090.0,,CHEMBL631829,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,14858,In vivo,50594
A,10116.0,,CHEMBL875759,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14859,,50597
A,10116.0,,CHEMBL631830,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14860,,50597
A,10116.0,,CHEMBL631831,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14861,,50597
A,10116.0,,CHEMBL631832,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14862,,50597
A,10116.0,,CHEMBL631833,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14863,,50597
A,10116.0,,CHEMBL631834,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14864,,50597
A,10116.0,,CHEMBL631835,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14865,,50597
A,10116.0,,CHEMBL631836,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14866,,50597
A,10116.0,,CHEMBL631837,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14867,,50597
A,10116.0,,CHEMBL631838,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14868,,50597
A,10116.0,,CHEMBL631839,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14869,,50597
A,10116.0,,CHEMBL631840,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14870,,50597
A,10116.0,,CHEMBL631841,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14871,,50597
A,10116.0,,CHEMBL631842,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14872,,50597
A,10116.0,,CHEMBL631843,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14873,,50597
A,10116.0,,CHEMBL631844,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14874,,50597
A,10116.0,,CHEMBL631845,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14875,,50597
A,10116.0,,CHEMBL631846,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14876,,50597
A,10116.0,,CHEMBL875760,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14877,,50597
A,10116.0,,CHEMBL632199,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14878,,50597
A,10116.0,,CHEMBL631847,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14879,,50597
A,10116.0,,CHEMBL631848,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14880,,50597
A,10116.0,,CHEMBL628707,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14881,,50597
A,10116.0,,CHEMBL628708,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14882,,50597
A,10116.0,,CHEMBL628709,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14883,,50597
A,10116.0,,CHEMBL628710,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14884,,50597
A,10116.0,,CHEMBL628711,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14885,,50597
A,10116.0,,CHEMBL628712,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14886,,50597
A,10116.0,,CHEMBL628713,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14887,,50597
A,10116.0,,CHEMBL628714,Rattus norvegicus,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,,12582,N,,Intermediate,,,Urine,1088.0,,1,1,,BAO_0000218,14888,,50597
A,10116.0,,CHEMBL628715,Rattus norvegicus,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",,7415,N,,Intermediate,,,,,,1,1,,BAO_0000218,14889,,50597
A,,,CHEMBL629179,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,7313,U,,Autocuration,,,,,,1,0,,BAO_0000019,14890,,22224
A,,,CHEMBL629180,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,7313,U,,Autocuration,,,,,,1,0,,BAO_0000019,14891,,22224
A,,,CHEMBL875108,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,7313,U,,Autocuration,,,,,,1,0,,BAO_0000019,14892,,22224
A,,,CHEMBL629181,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14893,,22224
A,,,CHEMBL629182,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14894,,22224
A,,,CHEMBL629183,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14895,,22224
A,,,CHEMBL629184,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14896,,22224
A,,,CHEMBL629185,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14897,,22224
A,,,CHEMBL629186,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14898,,22224
A,,,CHEMBL629187,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14899,,22224
A,,,CHEMBL629887,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14900,,22224
A,,,CHEMBL629888,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14901,,22224
A,,,CHEMBL629889,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14902,,22224
A,,,CHEMBL629890,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14903,,22224
A,,,CHEMBL629891,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14904,,22224
A,,,CHEMBL629892,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14905,,22224
A,,,CHEMBL629893,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,7570,U,,Autocuration,,,Adrenal cortex,1235.0,,1,0,,BAO_0000019,14906,,22224
A,,,CHEMBL629894,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14907,,22224
A,,,CHEMBL629895,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,7570,U,,Autocuration,,,,,,1,0,,BAO_0000019,14908,,22224
A,9615.0,,CHEMBL875109,Canis lupus familiaris,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",,14122,U,,Autocuration,,,,,,1,0,,BAO_0000218,14909,In vivo,22224
A,9541.0,,CHEMBL629896,Macaca fascicularis,Absolute bioavailability in male cynomolgus monkeys,,16449,U,,Autocuration,,,,,,1,0,,BAO_0000218,14910,In vivo,22224
A,10116.0,,CHEMBL629897,Rattus norvegicus,Absolute bioavailability in maleSprague-Dawley rats,,16449,U,,Autocuration,,,,,,1,0,,BAO_0000218,14911,In vivo,22224
A,10116.0,,CHEMBL629898,Rattus norvegicus,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14912,In vivo,50597
A,10116.0,,CHEMBL630057,Rattus norvegicus,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14913,In vivo,50597
A,10116.0,,CHEMBL630058,Rattus norvegicus,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14914,In vivo,50597
A,10116.0,,CHEMBL630059,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14915,In vivo,50597
A,10116.0,,CHEMBL630060,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14916,In vivo,50597
A,10116.0,,CHEMBL630061,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14917,In vivo,50597
A,10116.0,,CHEMBL630062,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14918,In vivo,50597
A,10116.0,,CHEMBL630063,Rattus norvegicus,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14919,In vivo,50597
A,10116.0,,CHEMBL630064,Rattus norvegicus,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14920,In vivo,50597
A,10116.0,,CHEMBL630065,Rattus norvegicus,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14921,In vivo,50597
A,10116.0,,CHEMBL630066,Rattus norvegicus,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14922,In vivo,50597
A,10116.0,,CHEMBL630067,Rattus norvegicus,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14923,In vivo,50597
A,10116.0,,CHEMBL630068,Rattus norvegicus,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Lung,2048.0,,1,1,,BAO_0000218,14924,In vivo,50597
A,10116.0,,CHEMBL631113,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14925,In vivo,50597
A,10116.0,,CHEMBL631114,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14926,In vivo,50597
A,10116.0,,CHEMBL631115,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14927,In vivo,50597
A,10116.0,,CHEMBL631116,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14928,In vivo,50597
A,10116.0,,CHEMBL630528,Rattus norvegicus,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14929,In vivo,50597
A,10116.0,,CHEMBL630529,Rattus norvegicus,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14930,In vivo,50597
A,10116.0,,CHEMBL630530,Rattus norvegicus,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14931,In vivo,50597
A,10116.0,,CHEMBL630531,Rattus norvegicus,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14932,In vivo,50597
A,10116.0,,CHEMBL630532,Rattus norvegicus,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14933,In vivo,50597
A,10116.0,,CHEMBL630533,Rattus norvegicus,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Muscle tissue,2385.0,,1,1,,BAO_0000218,14934,In vivo,50597
A,10090.0,,CHEMBL630534,Mus musculus,Biodistribution in normal mice blood after 120 hr,,15045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14935,In vivo,50594
A,10090.0,,CHEMBL630535,Mus musculus,Biodistribution in normal mice blood after 24 hr,,15045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14936,In vivo,50594
A,10090.0,,CHEMBL630536,Mus musculus,Biodistribution in normal mice blood after 4 hr,,15045,N,,Intermediate,,,Blood,178.0,,1,1,,BAO_0000218,14937,In vivo,50594
A,10090.0,,CHEMBL630537,Mus musculus,Biodistribution in normal mice bone after 120 hr,,15045,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,14938,In vivo,50594
A,10090.0,,CHEMBL630538,Mus musculus,Biodistribution in normal mice bone after 24 hr,,15045,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,14939,In vivo,50594
A,10090.0,,CHEMBL630539,Mus musculus,Biodistribution in normal mice bone after 4 hr,,15045,N,,Intermediate,,,Bone,10000001.0,,1,1,,BAO_0000218,14940,In vivo,50594
A,10090.0,,CHEMBL630540,Mus musculus,Biodistribution in normal mice heart after 120 hr,,15045,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14941,In vivo,50594
A,10090.0,,CHEMBL630541,Mus musculus,Biodistribution in normal mice heart after 24 hr,,15045,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14942,In vivo,50594
A,10090.0,,CHEMBL630542,Mus musculus,Biodistribution in normal mice heart after 4 hr,,15045,N,,Intermediate,,,Heart,948.0,,1,1,,BAO_0000218,14943,In vivo,50594
A,10090.0,,CHEMBL630543,Mus musculus,Biodistribution in normal mice kidney after 120 hr,,15045,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14944,In vivo,50594
A,10090.0,,CHEMBL630544,Mus musculus,Biodistribution in normal mice kidney after 24 hr,,15045,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14945,In vivo,50594
A,10090.0,,CHEMBL630545,Mus musculus,Biodistribution in normal mice kidney after 4 hr,,15045,N,,Intermediate,,,Kidney,2113.0,,1,1,,BAO_0000218,14946,In vivo,50594
A,10090.0,,CHEMBL630546,Mus musculus,Biodistribution in normal mice liver after 120 hr,,15045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14947,In vivo,50594
A,10090.0,,CHEMBL630547,Mus musculus,Biodistribution in normal mice liver after 24 hr,,15045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14948,In vivo,50594
A,10090.0,,CHEMBL630548,Mus musculus,Biodistribution in normal mice liver after 4 hr,,15045,N,,Intermediate,,,Liver,2107.0,,1,1,,BAO_0000218,14949,In vivo,50594
A,10090.0,,CHEMBL630549,Mus musculus,Biodistribution in normal mice spleen after 120 hr,,15045,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14950,In vivo,50594
A,10090.0,,CHEMBL630550,Mus musculus,Biodistribution in normal mice spleen after 24 hr,,15045,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14951,In vivo,50594
A,10090.0,,CHEMBL876426,Mus musculus,Biodistribution in normal mice spleen after 4 hr,,15045,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14952,In vivo,50594
A,10116.0,,CHEMBL630551,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14953,In vivo,50597
A,10116.0,,CHEMBL630552,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14954,In vivo,50597
A,10116.0,,CHEMBL630553,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14955,In vivo,50597
A,10116.0,,CHEMBL630554,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14956,In vivo,50597
A,10116.0,,CHEMBL630555,Rattus norvegicus,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14957,In vivo,50597
A,10116.0,,CHEMBL630556,Rattus norvegicus,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14958,In vivo,50597
A,10116.0,,CHEMBL630557,Rattus norvegicus,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14959,In vivo,50597
A,10116.0,,CHEMBL630558,Rattus norvegicus,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14960,In vivo,50597
A,10116.0,,CHEMBL630559,Rattus norvegicus,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14961,In vivo,50597
A,10116.0,,CHEMBL630560,Rattus norvegicus,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Spleen,2106.0,,1,1,,BAO_0000218,14962,In vivo,50597
A,10116.0,,CHEMBL876427,Rattus norvegicus,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,,12017,N,,Intermediate,,,Thyroid gland,2046.0,,1,1,,BAO_0000218,14963,In vivo,50597
A,10116.0,,CHEMBL630561,Rattus norvegicus,The Kel values in female wistar rats.,,14941,N,,Intermediate,,,,,,1,1,,BAO_0000218,14964,,50597
A,,,CHEMBL630562,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,4646,U,,Autocuration,,,,,,1,0,,BAO_0000019,14965,,22224
A,,,CHEMBL630563,,Hydrolysis rate constant of the compound,,8847,U,,Autocuration,,,,,,1,0,,BAO_0000019,14966,,22224
P,,,CHEMBL629673,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,11778,U,,Autocuration,,,,,,1,0,,BAO_0000100,14967,,22229
A,,,CHEMBL629674,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14968,,22224
A,,,CHEMBL629675,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14969,,22224
A,,,CHEMBL629676,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14970,,22224
A,,,CHEMBL629677,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,2363,U,,Autocuration,,,,,,1,0,,BAO_0000019,14971,,22224
A,,,CHEMBL629678,,Apparent inactivation rate constant was evaluated,,8371,U,,Autocuration,,,,,,1,0,,BAO_0000019,14972,,22224
A,,,CHEMBL629679,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,14883,U,,Autocuration,,,,,,1,0,,BAO_0000019,14973,,22224
A,,,CHEMBL629680,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,14883,U,,Autocuration,,,,,,1,0,,BAO_0000019,14974,,22224
A,,,CHEMBL629681,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,4643,U,,Autocuration,,,,,,1,0,,BAO_0000019,14975,,22224
A,,,CHEMBL629682,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,3519,U,,Autocuration,,,,,,1,0,,BAO_0000019,14976,,22224
A,,,CHEMBL629683,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,10600,U,,Autocuration,,,,,,1,0,,BAO_0000019,14977,,22224
F,,,CHEMBL629684,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,8501,U,,Autocuration,,,,,,1,0,,BAO_0000019,14978,,22224
P,,,CHEMBL629685,,Dissociation constant was determined,,8505,U,,Autocuration,,,,,,1,0,,BAO_0000100,14979,,22224
P,,,CHEMBL629686,,Dissociation constant was determined,,9778,U,,Autocuration,,,,,,1,0,,BAO_0000100,14980,,22224
P,,,CHEMBL872932,,Dissociation constant at pH 7.4,,9778,U,,Autocuration,,,,,,1,0,,BAO_0000100,14981,,22224
P,,,CHEMBL629687,,Dissociation constant in presence of 1 mM dithiothreitol,,9778,U,,Autocuration,,,,,,1,0,,BAO_0000100,14982,,22224
A,,,CHEMBL872931,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,13007,U,,Autocuration,,,,,,1,0,,BAO_0000019,14983,,22224
A,,,CHEMBL628151,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,13007,U,,Autocuration,,,,,,1,0,,BAO_0000019,14984,,22224
A,,,CHEMBL628152,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,13007,U,,Autocuration,,,,,,1,0,,BAO_0000019,14985,,22224
A,,,CHEMBL628153,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,13007,U,,Autocuration,,,,,,1,0,,BAO_0000019,14986,,22224
A,,,CHEMBL628154,,Kinetic constant for aromatization of androstenedione,,11482,U,,Autocuration,,,,,,1,0,,BAO_0000019,14987,,22224
A,,,CHEMBL628155,,Kinetic constant for aromatization of testosterone,,11482,U,,Autocuration,,,,,,1,0,,BAO_0000019,14988,,22224
A,,,CHEMBL628156,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,2303,U,,Autocuration,,,,,,1,0,,BAO_0000019,14989,,22224
A,,,CHEMBL628157,,Local inhibition constant was determined,,11964,U,,Autocuration,,,,,,1,0,,BAO_0000019,14990,,22224
A,4932.0,,CHEMBL857533,Saccharomyces cerevisiae,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,,3140,N,,Intermediate,,,,,,1,1,,BAO_0000218,14991,,50347
P,,,CHEMBL628158,,Dissociation constant value of the compound,,10650,U,,Autocuration,,,,,,1,0,,BAO_0000100,14992,,22224
A,,,CHEMBL628159,,In vitro permeability through cornea without epithelium,,4667,U,,Autocuration,,,Cornea,964.0,,1,0,,BAO_0000019,14993,,22224
A,,,CHEMBL875616,,In vitro permeability through intact cornea,,4667,U,,Autocuration,,,Cornea,964.0,,1,0,,BAO_0000019,14994,,22224
A,9986.0,,CHEMBL628160,Oryctolagus cuniculus,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,,9199,N,,Intermediate,,,Cornea,964.0,,1,1,,BAO_0000218,14995,,50592
A,,,CHEMBL628161,,Rate of enzyme inactivation for the compound was determined,,11966,U,,Autocuration,,,,,,1,0,,BAO_0000019,14996,,22224
A,,,CHEMBL628162,,In vitro permeability through cornea without epithelium,,4667,U,,Autocuration,,,Cornea,964.0,,1,0,,BAO_0000019,14997,,22224
A,,,CHEMBL628163,,In vitro permeability through intact cornea,,4667,U,,Autocuration,,,Cornea,964.0,,1,0,,BAO_0000019,14998,,22224
A,,,CHEMBL628164,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,14999,,22224
A,,,CHEMBL628165,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15000,,22224
A,,,CHEMBL628166,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15001,,22224
A,,,CHEMBL628167,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15002,,22224
A,,,CHEMBL628168,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15003,,22224
A,,,CHEMBL628169,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15004,,22224
A,,,CHEMBL628170,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15005,,22224
A,,,CHEMBL628171,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15006,,22224
A,,,CHEMBL627434,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15007,,22224
A,,,CHEMBL627435,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15008,,22224
A,,,CHEMBL628110,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15009,,22224
A,,,CHEMBL628111,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15010,,22224
A,,,CHEMBL628112,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15011,,22224
A,,,CHEMBL628260,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15012,,22224
A,,,CHEMBL628261,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,8354,U,,Autocuration,,,,,,1,0,,BAO_0000019,15013,,22224
A,10090.0,,CHEMBL628262,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15014,In vivo,50594
A,9606.0,,CHEMBL628263,Homo sapiens,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15015,In vivo,50587
A,10090.0,,CHEMBL628264,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15016,In vivo,50594
A,10090.0,,CHEMBL628265,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15017,In vivo,50594
A,10090.0,,CHEMBL628266,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15018,In vivo,50594
A,10090.0,,CHEMBL628267,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15019,In vivo,50594
A,10090.0,,CHEMBL628268,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15020,In vivo,50594
A,10090.0,,CHEMBL628269,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15021,In vivo,50594
A,10090.0,,CHEMBL628270,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15022,In vivo,50594
A,10090.0,,CHEMBL628271,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15023,In vivo,50594
A,10090.0,,CHEMBL628272,Mus musculus,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),,14439,N,,Intermediate,,,,,,1,1,,BAO_0000218,15024,In vivo,50594
